
<html lang="en"     class="pb-page"  data-request-id="b1a64852-d3fc-4043-8d86-842c8b41cd2c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-8;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b02000;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents" /></meta><meta name="dc.Creator" content="Ana C.  Carrasco" /></meta><meta name="dc.Creator" content="Vanessa  Rodríguez-Fanjul" /></meta><meta name="dc.Creator" content="Abraha  Habtemariam" /></meta><meta name="dc.Creator" content="Ana M.  Pizarro" /></meta><meta name="dc.Description" content="Six complexes of formula [Ir(η5:κ1-C5Me4CH2py)(C,N)]PF6, where C5Me4CH2py is 2-((2,3,4,5-tetramethylcyclopentadienyl)methyl)pyridine, and C,N is 2-phenylpyridine (1), 7,8-benzoquinoline (2), 1-phen..." /></meta><meta name="Description" content="Six complexes of formula [Ir(η5:κ1-C5Me4CH2py)(C,N)]PF6, where C5Me4CH2py is 2-((2,3,4,5-tetramethylcyclopentadienyl)methyl)pyridine, and C,N is 2-phenylpyridine (1), 7,8-benzoquinoline (2), 1-phen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 24, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02000" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02000" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02000" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02000" /></link>
        
    
    

<title>Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02000" /></meta><meta property="og:title" content="Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0008.jpeg" /></meta><meta property="og:description" content="Six complexes of formula [Ir(η5:κ1-C5Me4CH2py)(C,N)]PF6, where C5Me4CH2py is 2-((2,3,4,5-tetramethylcyclopentadienyl)methyl)pyridine, and C,N is 2-phenylpyridine (1), 7,8-benzoquinoline (2), 1-phenylisoquinoline (3), 2-(p-tolyl)pyridine (4), 4-chloro-2-phenylquinoline (5), or 2-(2,4-difluorophenyl)pyridine (6), have been synthesized. The cyclopentadienyl ligand bears a tethered pyridine that binds to the metal center, resulting in an Ir(η5:κ1-C5Me4CH2pyN) tether-ring structure, as confirmed by the X-ray crystal structures of 1, 2, 4, 5, and 6. Nontether versions of 1 and 2 were synthesized to aid unambiguous correlation between structure and activity. While nontether complexes are highly potent toward MCF7 cancer cells (similar to cisplatin), complexes bearing the tether-ring structure, 1–6, are exceptionally more potent (1–2 orders of magnitude). Additionally, 1–6 disrupt mitochondrial membrane potential (ΔΨm) and induce oxidative stress. Internalization studies strongly correlate intracellular accumulation and anticancer activity in tether and nontether complexes. We present a new class of organo-iridium drug candidates bearing a structural feature that results in a leap in anticancer potency." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02000"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02000">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02000&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02000&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02000&amp;href=/doi/10.1021/acs.jmedchem.9b02000" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4005-4021</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01879" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02039" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ana C. Carrasco</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana C. Carrasco</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IMDEA Nanociencia, Faraday 9, 28049 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana+C.++Carrasco">Ana C. Carrasco</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vanessa Rodríguez-Fanjul</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vanessa Rodríguez-Fanjul</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IMDEA Nanociencia, Faraday 9, 28049 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vanessa++Rodr%C3%ADguez-Fanjul">Vanessa Rodríguez-Fanjul</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3386-5874" title="Orcid link">http://orcid.org/0000-0002-3386-5874</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Abraha Habtemariam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abraha Habtemariam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IMDEA Nanociencia, Faraday 9, 28049 Madrid, Spain</div><div class="loa-info-affiliations-info">Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abraha++Habtemariam">Abraha Habtemariam</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ana M. Pizarro</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana M. Pizarro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">IMDEA Nanociencia, Faraday 9, 28049 Madrid, Spain</div><div class="loa-info-affiliations-info">Unidad Asociada de Nanobiotecnología CNB-CSIC-IMDEA, 28049 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#5938373877293023382b2b361930343d3c3877362b3e"><span class="__cf_email__" data-cfemail="d4b5bab5faa4bdaeb5a6a6bb94bdb9b0b1b5fabba6b3">[email protected]</span></a>. Phone: 0034912998847.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana+M.++Pizarro">Ana M. Pizarro</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3037-9835" title="Orcid link">http://orcid.org/0000-0003-3037-9835</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02000&amp;href=/doi/10.1021%2Facs.jmedchem.9b02000" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4005–4021</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 24, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 December 2019</li><li><span class="item_label"><b>Published</b> online</span>24 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02000" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02000</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4005%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAna%2BC.%2BCarrasco%252C%2BVanessa%2BRodr%25C3%25ADguez-Fanjul%252C%2BAbraha%2BHabtemariam%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D8%26contentID%3Dacs.jmedchem.9b02000%26title%3DStructurally%2BStrained%2BHalf-Sandwich%2BIridium%2528III%2529%2BComplexes%2BAs%2BHighly%2BPotent%2BAnticancer%2BAgents%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4021%26publicationDate%3DApril%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02000"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1179</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02000" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;C. Carrasco&quot;},{&quot;first_name&quot;:&quot;Vanessa&quot;,&quot;last_name&quot;:&quot;Rodríguez-Fanjul&quot;},{&quot;first_name&quot;:&quot;Abraha&quot;,&quot;last_name&quot;:&quot;Habtemariam&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;M. Pizarro&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;4005-4021&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02000&quot;},&quot;abstract&quot;:&quot;Six complexes of formula [Ir(η5:κ1-C5Me4CH2py)(C,N)]PF6, where C5Me4CH2py is 2-((2,3,4,5-tetramethylcyclopentadienyl)methyl)pyridine, and C,N is 2-phenylpyridine (1), 7,8-benzoquinoline (2), 1-phenylisoquinoline (3), 2-(p-tolyl)pyridine (4), 4-chloro-2-phenylquinoline (5), or 2-(2,4-difluorophenyl)pyridine (6), have been synthesized. The cyclopentadienyl ligand bears a tethered pyridine that binds to the metal center, resulting in an Ir(η5:κ1-C5Me4CH2pyN) tether-ring structure, as confirmed by the X-ray crystal structures of 1, 2, 4, 5, and 6. Nontether versions of 1 and 2 were synthesized to aid unambiguous correlation between structure and activity. While nontether complexes are highly potent toward MCF7 cancer cells (similar to cisplatin), complexes bearing the tether-ring structure, 1–6, are exceptionally more potent (1–2 orders of magnitude). Additionally, 1–6 disrupt mitochondrial membrane potential (ΔΨm) and induce oxidative stress. Internalization studies strongly correlate intracellular accumulation &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02000&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02000" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02000&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02000" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02000&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02000" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02000&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02000&amp;href=/doi/10.1021/acs.jmedchem.9b02000" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02000" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02000" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02000%26sid%3Dliteratum%253Aachs%26pmid%3D32207946%26genre%3Darticle%26aulast%3DCarrasco%26date%3D2020%26atitle%3DStructurally%2BStrained%2BHalf-Sandwich%2BIridium%2528III%2529%2BComplexes%2BAs%2BHighly%2BPotent%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D8%26spage%3D4005%26epage%3D4021%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (7)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292316" title="Transition metals">Transition metals</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/jmcmar.2020.63.issue-8/20200423/jmcmar.2020.63.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Six complexes of formula [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(C,N)]PF<sub>6</sub>, where C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py is 2-((2,3,4,5-tetramethylcyclopentadienyl)methyl)pyridine, and C,N is 2-phenylpyridine (<b>1</b>), 7,8-benzoquinoline (<b>2</b>), 1-phenylisoquinoline (<b>3</b>), 2-(<i>p</i>-tolyl)pyridine (<b>4</b>), 4-chloro-2-phenylquinoline (<b>5</b>), or 2-(2,4-difluorophenyl)pyridine (<b>6</b>), have been synthesized. The cyclopentadienyl ligand bears a tethered pyridine that binds to the metal center, resulting in an Ir(η<sup>5</sup>:κ<sup>1</sup>-<i>C</i><sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py<i>N</i>) tether-ring structure, as confirmed by the X-ray crystal structures of <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b>. Nontether versions of <b>1</b> and <b>2</b> were synthesized to aid unambiguous correlation between structure and activity. While nontether complexes are highly potent toward MCF7 cancer cells (similar to cisplatin), complexes bearing the tether-ring structure, <b>1</b>–<b>6</b>, are exceptionally more potent (1–2 orders of magnitude). Additionally, <b>1</b>–<b>6</b> disrupt mitochondrial membrane potential (ΔΨ<sub><i>m</i></sub>) and induce oxidative stress. Internalization studies strongly correlate intracellular accumulation and anticancer activity in tether and nontether complexes. We present a new class of organo-iridium drug candidates bearing a structural feature that results in a leap in anticancer potency.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64188" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64188" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Interest in bioinorganic chemistry inspired by the clinical success of cisplatin has contributed to the fast development of new organometallic compounds with biological applications.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the past decade, a number of studies of both cyclometalated and half-sandwich cyclopentadienyl iridium(III) compounds have reported that such organo-iridium complexes exhibit promising anticancer activity.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Our understanding of the mechanism of action of iridium-based metallodrug candidates is in constant development, and studies on drug accumulation and localization are mandatory in this endeavor.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Iridium metallodrugs have been reported to target different organelles, from the endoplasmic reticulum<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> to the lysosomes.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The mitochondria is also a likely target because its polarized membrane attracts and retains lipophilic cations, the latter defined by criteria that organo-iridium compounds often fulfill.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Importantly, cancer cells have an unusually high mitochondrial membrane potential,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> which contributes to the interest of mitochondria as intracellular targets in cancer research.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Mitochondria and mitochondrial metabolism plasticity are essential in tumor initiation, in sustaining the growth and survival of cancer cells, as well as in the cancer cell response to treatment.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> They are the major intracellular source of reactive oxygen species (ROS), which in turn are involved in signaling cell growth and differentiation at low and moderate doses, while a severe increase of ROS can induce irreversible oxidative damage of cellular components and trigger cell death.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Excess ROS is closely related to mitochondrial membrane potential dissipation, and both are associated with the induction of regulated cell death (RCD) in cancer cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Mitochondria-driven cell death has emerged as a very appealing goal: causing mitochondria dysfunction and ROS overproduction has proved incompatible with tumor progression.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Iridium(III) cyclopentadienyl complexes are known to target the intracellular redox balance, particularly sensitive in cancer cells,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> by generating an excessive level of ROS and thus driving the cancer cell to death.<a onclick="showRef(event, 'cit2b ref13'); return false;" href="javascript:void(0);" class="ref cit2b ref13">(2b,13)</a></div><div class="NLM_p">Following a rational design aimed at increasing the anticancer activity of Ir(III) complexes of general formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R)(XY)Cl]<sup>0/+</sup>, Sadler and co-workers have investigated the correlation between anticancer potency and structure.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Modification of the electronic properties of the iridium center by varying the different ligands around it can help fine-tune both the chemical and biological activities of Ir-Cp compounds. The introduction of phenyl rings on the cyclopentadienyl ligand (R = phenyl or biphenyl),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the use of anionic C,N-chelating ligands (XY = phenylpyridine),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and replacement of the chlorido ligand by a pyridine<a onclick="showRef(event, 'cit13a ref17'); return false;" href="javascript:void(0);" class="ref cit13a ref17">(13a,17)</a> have resulted in complexes with submicromolar anticancer activity in a number of cancer cells lines. Liu has explored an array of complexes bearing a variety of XY ligands, including imine-<i>N</i>-heterocyclic carbenes,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> phenoxide <i>N</i>-heterocyclic carbenes,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and phosphine-imine,<a onclick="showRef(event, 'cit5b'); return false;" href="javascript:void(0);" class="ref cit5b">(5b)</a> achieving cytotoxic potency as good as that of cisplatin (in the micromolar range). Additional exploration of the modification of the η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R moiety have been investigated by McGowan, who has derivatized the cyclopentadienyl ligand with different-length terminal alcohols<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and amines.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">We and others have previously used derivatized arenes bearing a functional tethering group in Ru(II)–arene complexes capable of κ-binding to the metal center, thereby creating a switch (labile bond in the time frame of the desired reaction) for selective activation, whether for biological or other applications such as catalysis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Iridium complexes bearing Cp functionalized with tethering ligands (e.g., containing coordinating nitrogen, phosphorus or oxygen), capable of chelation, have also been explored for catalytic transformations such as reductive amination,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> dehalogenation,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> stereoselective C–H activation,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and transfer hydrogenation reactions.<a onclick="showRef(event, 'ref23 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref25">(23,25)</a></div><div class="NLM_p">Here we report a series of pyridine-tethered iridium(III)-cyclopentadienyl complexes of formula [Ir(η:<sup>5</sup>κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(C,N)]PF<sub>6</sub>, bearing: (i) a derivative of a C,N-binding 2-phenylpyridine or 7,8-benzoquinoline bidentate ligand, and (ii) a tether ring formed by the binding of ligand η<sup>5</sup>-<i>C</i><sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>pyridine-κ<i>N</i> to the Ir(III) metal center, resulting in a doubly chelated organo-iridium structure. In comparison to previously reported Ir(III)-Cp anticancer candidates, the central iridium atom in these complexes lacks a monodentate ligand, known as the “leaving group”, in its first coordination sphere. However, the chelate formed by η<sup>5</sup>-<i>C</i><sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>pyridine-κ<i>N</i> could behave as hemilabile, providing our system with the capability of activation. We have investigated the reversible opening and closure dynamics of the hemilabile chelate ring against nucleophiles such as DMSO and water. The tether ring is open in pure DMSO, affording the κ-bound DMSO adduct. However, the chelate readily closes upon dissolution in aqueous solution, reversing to the initial closed-tether structure.</div><div class="NLM_p last">In vitro assays in cancer cells revealed an extraordinary potent activity of our tethered pyridine complexes, with IC<sub>50</sub> values in the nanomolar range. To better understand the role of the extra tether ring on the new compounds’ biological activity, we have synthesized and investigated also nontether analogues, i.e., similar complexes regarding the first coordination sphere of the complex yet lacking the additional tether ring. Guided by results recently reported by our group for complex <b>1</b>, which displays unambiguous and exclusive localization in the mitochondria of MCF7 cells,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> we studied the loss of mitochondrial transmembrane potential (ΔΨ<i><sub>m</sub></i>) and generation of ROS, processes that can be linked to mitochondrial targeting and to cell death by disrupting the intracellular redox homeostasis. Finally, we have investigated iridium accumulation in cancer cells, finding that exceptionally high compound internalization might explain the great potency of this class of organo-iridium anticancer candidates.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis and Characterization</h3><div class="NLM_p">Thirteen iridium(III) cyclopentadienyl complexes with typical half-sandwich structure were synthesized and are shown in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. The synthesis of complex <b>1</b> has been recently reported by us.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Iridium(III) Cyclopentadienyl Complexes Synthesized in This Work<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Complexes <b>1</b>–<b>6</b>, <b>1b</b>, <b>1d</b>, and <b>2b</b> are monocations and were isolated as hexafluorofosphate salts. Complexes <b>1a</b>, <b>1c</b>, <b>2a</b>, and <b>2c</b>, are neutral. Z is the monodentate labile ligand in nontethered complexes of formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R)(C,N)(Z)]<sup>0/+</sup>.</p></p></figure><div class="NLM_p">Complexes <b>1</b>–<b>6</b>, of general formula [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(C,N)]PF<sub>6</sub> (C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py = 2-((2,3,4,5-tetramethylcyclopentadienyl)methyl)pyridine), where C,N is 2-phenylpyridine, Phpy (<b>1</b>), 7,8-benzoquinoline, Bzq (<b>2</b>), 1-phenylisoquinoline, Phq (<b>3</b>), 2-(<i>p</i>-tolyl)pyridine, MePhpy (<b>4</b>), 4-chloro-2-phenylquinoline, ClPhq (<b>5</b>), and 2-(2,4-difluorophenyl)pyridine, dFPhpy (<b>6</b>), were synthesized by aquation of the dichlorido monomer [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)Cl<sub>2</sub>] by chloride sequestration with silver nitrate, adapting a reported procedure.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Subsequent addition of the corresponding ancillary bidentate C,N ligand in dichloromethane led to formation of complexes <b>1</b>–<b>6</b> as cationic species [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(C,N)]<sup>+</sup>, which were isolated as the hexafluorophosphate salts in good yields (45–60%). All complexes were obtained as the closed-tether species, whereby the pyridine moiety of the η<sup>5</sup>-bound cyclopentadienyl ligand in C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py is coordinatively attached to the iridium center in a κ<i>N</i> manner, forming an additional chelate hereinafter referred to as “tether ring” or “tether”. While the η<sup>5</sup>-Cp ligand is firmly bound to the iridium in a η<sup>5</sup> fashion, affording a half-sandwich structure, the κ<i>N</i>-bound pyridine could be susceptible to dissociation from the metal center by nucleophilic attack on the iridium. Pyridine-bearing complexes and the subsequent pyridine–metal dissociation in this class of metallodrugs have been reported as a successful feature to afford controlled activation (generating a vacancy in the metal’s first coordination sphere) of the metal center in Ru(II)–arene<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and Ir(III)–C<sub>5</sub>Me<sub>4</sub>R complexes.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> In our design, the otherwise leaving pyridine group is attached to the rest of the metal-based structure, tethered to the complex and forming an extra chelate. Provided that the pyridine dissociates from the metal, such a process would be reversible, perhaps allowing for control over the extent of the compound’s reactivity in the biological environment. X-ray crystal structure analysis (complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b>) aided to unequivocally assign the closed-tether ring structures.</div><div class="NLM_p">A nontether series analogous to <b>1</b> and a nontether series analogous to <b>2</b> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) were synthesized in order to probe the biological effect of having the extra chelate Ir(η<sup>5</sup>:κ<sup>1</sup>-<i>C</i><sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py<i>N</i>) in our structure. These analogues were designed to represent complexes <b>1</b>–<b>6</b> if the Ir–N(tether) bond would be reactive in water or biological media, that is, to confirm the stability of the tether ring structure in the cell-based assays. Complexes bearing 2-phenylpyridine with formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(Phpy)Z]<sup>0/+</sup> (Z = Cl, <b>1a</b>; Z = py, <b>1b</b>), [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)(Phpy)Z]<sup>0/+</sup> (C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph = ((2,3,4,5-tetramethylcyclopentadienyl)methyl)benzene, Z = Cl, <b>1c</b>; Z = py, <b>1d</b>), and 7,8-benzoquinoline with formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(Bzq)Z]<sup>0/+</sup> (Z = Cl, <b>2a</b>; Z = py, <b>2b</b>), and [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)(Bzq)Cl] (<b>2c</b>), were synthesized in good yields (59–99%) according to literature methods.<a onclick="showRef(event, 'cit16b ref28'); return false;" href="javascript:void(0);" class="ref cit16b ref28">(16b,28)</a> Complexes <b>1a</b>, <b>1c</b>, <b>2a</b>, and <b>2c</b> were isolated as neutral, while cationic complexes <b>1b</b>, <b>1d</b>, and <b>2b</b> were isolated as the hexafluorophosphate salts. Complexes <b>1a</b> and <b>2a</b> have been previously reported by Ling et al.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Complexes <b>1b</b>, <b>1c</b>, <b>1d</b>, <b>2b</b>, and <b>2c</b> have not been reported before.</div><div class="NLM_p">All 13 complexes in this work were fully characterized by elemental analysis, <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy (Supporting Information (SI), <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figures S1–S13</a>), mass spectrometry, and complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b> also by single crystal X-ray diffraction, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> of this manuscript. Synthesis and characterization of the substituted Cp ligands, and the corresponding Cp dimers or monomers are not included in this manuscript as they are already reported.<a onclick="showRef(event, 'ref23 ref30'); return false;" href="javascript:void(0);" class="ref ref23 ref30">(23,30)</a></div><div class="NLM_p last">Complexes <b>1</b>–<b>6</b>, <b>1a</b>–<b>1d</b>, and <b>2a</b>–<b>2c</b> exhibited good solubility in polar aprotic solvents such as dimethyl sulfoxide (DMSO) and <i>N</i>,<i>N</i>-dimethylformamide (DMF), and chlorinated solvents such as chloroform (CHCl<sub>3</sub>) and dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>). Complexes <b>1</b>–<b>6</b> were poorly soluble in aqueous solutions, thus impairing kinetic studies in water by means of <sup>1</sup>H NMR spectroscopy. Nontoxic amounts of DMSO or DMF were used in the biological experiments to assist dissolution. The complexes were fully soluble at the maximum concentration used during the biological assays (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S14</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S1</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> X-ray Crystal Structures</h3><div class="NLM_p">Crystals suitable for X-ray analysis were obtained from chloroform solutions at 298 K for [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phpy)]PF<sub>6</sub> (<b>1</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Bzq)]PF<sub>6</sub> (<b>2</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(MePhpy)]PF<sub>6</sub> (<b>4</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(ClPhq)]PF<sub>6</sub> (<b>5</b>), and [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(dFPhpy)]PF<sub>6</sub> (<b>6</b>). X-ray diffraction data corresponding to closed-tether complexes were collected for all complexes and are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of complexes: [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phpy)]PF<sub>6</sub> (<b>1</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Bzq)]PF<sub>6</sub> (<b>2</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(MePhpy)]PF<sub>6</sub> (<b>4</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(ClPhq)]PF<sub>6</sub> (<b>5</b>), and [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(dFPhpy)]PF<sub>6</sub> (<b>6</b>). Thermal ellipsoids show 50% probability. Hydrogen atoms and counterions (PF<sub>6</sub>) have been omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Selected bond lengths and angles are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and detailed crystallographic data in <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information. The complexes adopt the expected “piano-stool” geometry for half-sandwich iridium η<sup>5</sup>-bound to the substituted cyclopentadienyl ligand occupying three of the six pseudo-octahedral positions. The other three positions in the first coordination sphere are occupied by a bidentate chelating ligand and a pyridine group (pendant from the η<sup>5</sup>-bound cyclopentadienyl), forming a five-membered tether ring in the structure. Structures of closed-tether complexes <b>1</b> and <b>2</b> crystallized with four molecules, <b>5</b> with eight molecules, and <b>4</b> and <b>6</b> with two molecules in the unit cell and interstitial chloroform. Complex <b>1</b> adopts the two possible orientations for the bidentate asymmetric ligand Phpy, showing the N2 and C16 atoms bound to the iridium atom in a statistical proportion of 62% and 38%, respectively. Therefore, the crystal contains the two isomers arbitrarily placed in that distribution. The crystal structures of the five complexes show similar bond lengths and angles. In particular, the Ir–N1 distances for the five crystal structures are not significantly different from one another (<3σ) ranging from 2.086(6) to 2.099(6) Å. The Ir–centroid distances vary in the range 1.800–1.830 Å.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected Bond Lengths (Å) and Angles (deg) for Complexes [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phpy)]PF<sub>6</sub> (<b>1</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Bzq)]PF<sub>6</sub> (<b>2</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py(MePhpy)]PF<sub>6</sub> (<b>4</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(ClPhq)]PF<sub>6</sub> (<b>5</b>), and [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(dFPhpy)]PF<sub>6</sub> (<b>6</b>)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0006.gif" alt="" id="GRAPHIC-d7e1359-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">complex</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>6</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C1</td><td class="colsep0 rowsep0" align="center">2.111(7)</td><td class="colsep0 rowsep0" align="center">2.144(5)</td><td class="colsep0 rowsep0" align="center">2.127(7)</td><td class="colsep0 rowsep0" align="center">2.147(7)</td><td class="colsep0 rowsep0" align="center">2.116(5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C2</td><td class="colsep0 rowsep0" align="center">2.195(7)</td><td class="colsep0 rowsep0" align="center">2.170(6)</td><td class="colsep0 rowsep0" align="center">2.151(8)</td><td class="colsep0 rowsep0" align="center">2.268(7)</td><td class="colsep0 rowsep0" align="center">2.226(5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C3</td><td class="colsep0 rowsep0" align="center">2.210(7)</td><td class="colsep0 rowsep0" align="center">2.196(5)</td><td class="colsep0 rowsep0" align="center">2.201(7)</td><td class="colsep0 rowsep0" align="center">2.238(7)</td><td class="colsep0 rowsep0" align="center">2.236(5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C4</td><td class="colsep0 rowsep0" align="center">2.169(8)</td><td class="colsep0 rowsep0" align="center">2.232(5)</td><td class="colsep0 rowsep0" align="center">2.207(7)</td><td class="colsep0 rowsep0" align="center">2.236(7)</td><td class="colsep0 rowsep0" align="center">2.193(6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C5</td><td class="colsep0 rowsep0" align="center">2.202(8)</td><td class="colsep0 rowsep0" align="center">2.205(6)</td><td class="colsep0 rowsep0" align="center">2.224(7)</td><td class="colsep0 rowsep0" align="center">2.130(8)</td><td class="colsep0 rowsep0" align="center">2.170(7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–centroid</td><td class="colsep0 rowsep0" align="center">1.805</td><td class="colsep0 rowsep0" align="center">1.807</td><td class="colsep0 rowsep0" align="center">1.800</td><td class="colsep0 rowsep0" align="center">1.830</td><td class="colsep0 rowsep0" align="center">1.813</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–N1</td><td class="colsep0 rowsep0" align="center">2.097(6)</td><td class="colsep0 rowsep0" align="center">2.098(4)</td><td class="colsep0 rowsep0" align="center">2.099(6)</td><td class="colsep0 rowsep0" align="center">2.086(6)</td><td class="colsep0 rowsep0" align="center">2.097(5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–N2</td><td class="colsep0 rowsep0" align="center">2.064(7)(A)/2.075(7)(B)</td><td class="colsep0 rowsep0" align="center">2.087(5)</td><td class="colsep0 rowsep0" align="center">2.110(7)</td><td class="colsep0 rowsep0" align="center">2.145(6)</td><td class="colsep0 rowsep0" align="center">2.081(5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C16</td><td class="colsep0 rowsep0" align="center">2.075(7)(A)/2.064(7)(B)</td><td class="colsep0 rowsep0" align="center">2.077(6)</td><td class="colsep0 rowsep0" align="center">2.053(8)</td><td class="colsep0 rowsep0" align="center">2.049(7)</td><td class="colsep0 rowsep0" align="center">2.051(6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ir–C1–C6</td><td class="colsep0 rowsep0" align="center">110.6(5)</td><td class="colsep0 rowsep0" align="center">111.2(4)</td><td class="colsep0 rowsep0" align="center">112.1(5)</td><td class="colsep0 rowsep0" align="center">110.6(5)</td><td class="colsep0 rowsep0" align="center">111.1(4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C16–Ir–N2</td><td class="colsep0 rowsep0" align="center">77.7(3)</td><td class="colsep0 rowsep0" align="center">78.8(2)</td><td class="colsep0 rowsep0" align="center">78.3(3)</td><td class="colsep0 rowsep0" align="center">77.6(3)</td><td class="colsep0 rowsep0" align="center">78.3(2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C16–Ir–N1</td><td class="colsep0 rowsep0" align="center">93.4(2)(A)/92.1(2)(B)</td><td class="colsep0 rowsep0" align="center">93.6(19)</td><td class="colsep0 rowsep0" align="center">90.4(3)</td><td class="colsep0 rowsep0" align="center">92.9(3)</td><td class="colsep0 rowsep0" align="center">92.4(2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">N2–Ir–N1</td><td class="colsep0 rowsep0" align="center">92.1(2)(A)/93.4(2)(B)</td><td class="colsep0 rowsep0" align="center">90.1(18)</td><td class="colsep0 rowsep0" align="center">96.1(2)</td><td class="colsep0 rowsep0" align="center">91.8(2)</td><td class="colsep0 rowsep0" align="center">90.7(18)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">offset C6<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">0.348 (+)</td><td class="colsep0 rowsep0" align="center">0.311 (+)</td><td class="colsep0 rowsep0" align="center">0.298 (+)</td><td class="colsep0 rowsep0" align="center">0.308 (+)</td><td class="colsep0 rowsep0" align="center">0.317 (+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C1–centroid–Ir</td><td class="colsep0 rowsep0" align="center">86.69</td><td class="colsep0 rowsep0" align="center">86.50</td><td class="colsep0 rowsep0" align="center">87.60</td><td class="colsep0 rowsep0" align="center">87.12</td><td class="colsep0 rowsep0" align="center">86.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">5.08</td><td class="colsep0 rowsep0" align="center">3.33</td><td class="colsep0 rowsep0" align="center">0.96</td><td class="colsep0 rowsep0" align="center">1.78</td><td class="colsep0 rowsep0" align="center">3.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">θ[Cp,py]<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">75.21</td><td class="colsep0 rowsep0" align="center">77.39</td><td class="colsep0 rowsep0" align="center">80.84</td><td class="colsep0 rowsep0" align="center">74.26</td><td class="colsep0 rowsep0" align="center">77.63</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">Schematic drawing including atom numbering of the core structure is presented for clarity.</p></div><div class="footnote" id="t1fn1"><sup><sup>b</sup></sup><p class="last">Offset of C6 with respect to the plane formed by Ir-bound cyclopentadienyl (carbons C1–C5); (+) toward iridium.</p></div><div class="footnote" id="t1fn2"><sup><sup>c</sup></sup><p class="last">Torsion angle of the planes containing C1, Ir, N1, and C7.</p></div><div class="footnote" id="t1fn3"><sup><sup>d</sup></sup><p class="last">Angle between the plane of the cyclopentadienyl ring and the plane of the tethered pyridine.</p></div></div></div><div class="NLM_p">The five-member ring formed by the heteroditopic ligand η<sup>5</sup>-<i>C</i><sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>pyridine-κ<i>N</i> might present some structural tension as previously observed by us for Ru(II) complexes bearing the ligand η<sup>6</sup>-2-aminobiphenyl-κ<i>N</i><a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a> or η<sup>6</sup>-phenylacetate-κ<i>O</i>.<a onclick="showRef(event, 'cit22b'); return false;" href="javascript:void(0);" class="ref cit22b">(22b)</a> Strain release might have a crucial impact on the reactivity of the Ir–N1 bond when the complex is exposed to nucleophiles inside the cell. A useful parameter to assess the tether ring strain is the offset of C6 with regard to the plane that contains the η<sup>5</sup>-bound cyclopentadienyl (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The C6 offset ranges from 0.298 to 0.348 Å toward the iridium atom in complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b>, while the rest of the four methyl groups on the cyclopentadienyl structure (C12–C15) show an offset away from the iridium center (0.019–0.282 Å; SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S3</a>). Likewise, comparison of the X-ray structure of complex <b>1</b> with the nontether structure <b>1a</b> published by Li et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> shows a pronounced offset of the five methyl groups on the Cp away from the iridium with respect to the plane that contains the η<sup>5</sup>-cyclopentadienyl (0.015–0.163 Å; SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S3</a>). An additional parameter that can help to understand the strain introduced in the structure by the tether ring is the angle between the iridium atom, the cyclopentadienyl centroid, and C1 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Expected to be approximately 90°, any deviation from that value represents a tilt on the cyclopentadienyl ligand with regard to the plane perpendicular to the Ir–centroid distance. We found that in the five crystal structures analyzed here such angle ranges from 86.50° to 87.60°, showing how the closure of the tether ring tilts the Cp by C1 toward the tethering nitrogen. Such tension in tether ring-bearing Ru(II)–arene complexes has been previously reported, and it has been successfully related to the dynamics of the activation of the metal–nitrogen bond.<a onclick="showRef(event, 'cit22a cit22b'); return false;" href="javascript:void(0);" class="ref cit22a cit22b">(22a,b)</a> We also observed a pronounce difference in an important parameter when comparing <b>1</b> to <b>1a</b> and to the analogous structure [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>C<sub>6</sub>H<sub>4</sub>C<sub>6</sub>H<sub>5</sub>)(Phpy)py]<sup>+</sup>.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> The Ir–centroid distance was shorter in our tether-bearing structure, <b>1</b>: 1.805 Å, when compared to both <b>1a</b> (CCDC 683546), 1.826 Å and [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>C<sub>6</sub>H<sub>4</sub>C<sub>6</sub>H<sub>5</sub>)(Phpy)py]<sup>+</sup> (CCDC 956067), 1.838 Å, supporting the fact that the tether ring appears to result in an unusually short distance between the iridium(III) and the cyclopentadienyl ring, indicating a stronger (more stable) Ir−η<sup>5</sup>-Cp bond.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the parameters that relate to the tether ring constraint by X-ray structure analysis in closed-tether complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b> (left), versus their nontether Ir(III) half-sandwich analogues (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Reactivity toward Dimethyl Sulfoxide</h3><div class="NLM_p">Strong affinity of iridium(III) complexes to bind dimethyl sulfoxide is well-known, and such an interaction appears to show a clear preference for the small molecule to coordinate the iridium center in a κ<i>S</i> fashion.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> We chose DMSO as the model nucleophile to activate the Ir–N(py) bond in the tether ring in complexes <b>1</b>–<b>6</b>, reaction that can be easily followed by <sup>1</sup>H NMR and UV–vis. Importantly, DMSO is a common solvent used in cell studies to aid dissolution when the drug to be tested for biological activity is poorly soluble in water, as is the case of the complexes in this work.</div><div class="NLM_p">Reactivity of the Ir–N(py) tether ring bond in complexes <b>1</b>–<b>6</b> toward dimethyl sulfoxide was studied by <sup>1</sup>H NMR spectroscopy in pure [D<sub>6</sub>]DMSO at 298 K. Analysis of the <sup>1</sup>H NMR spectra proved to be reliable evidence for the open- versus closed-tether ring status in Ir(III) cyclopentadienyl complexes in solution. <sup>1</sup>H NMR spectra of freshly prepared 6–7 mM solutions for each complex were recorded in situ after sample preparation (<i>t</i><sub>0</sub> ≤ 5 min). The DMSO coordination to the iridium center was complete for all the complexes in less than 14 h and remained unchanged up to 24 h. No additional side products were observed during this time. The time dependence of the <sup>1</sup>H NMR spectra is illustrated for complex <b>1</b> in SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S15</a>. Initially, the <sup>1</sup>H NMR spectra displayed one major set of peaks at high field attributable to the closed-tether species: four singlets at 1.4–2.5 ppm assignable to the four methyl groups in the Cp ligand, and a minor set of peaks assignable to the open-tether species, four singlets in the narrower range 1.6–1.8 ppm. The second set of peaks increased over time, while the first set disappeared, indicating total conversion from <b>1</b> to <b>1</b><b>-dmso</b> of formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phpy)(DMSO)]<sup>+</sup>.</div><div class="NLM_p">UV–visible spectroscopy was then used to determine the kinetic parameters. UV–vis data of 0.1 mM solutions were recorded over time (<i>t</i><sub>0</sub> ≤ 1 min) until no further changes were observed. The time dependence of the UV–vis absorption spectra of the dimethyl sulfoxide solution of complexes <b>1</b>–<b>6</b> are shown in SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S16</a>. In every case, the substitution reaction followed pseudo first-order kinetics (insets in SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S16</a>), corresponding to the rate constants <i>k</i><sub>DMSO</sub> listed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, ranging from 34.29 for the slowest <b>5</b> to 216.98 × 10<sup>–6</sup> s<sup>–1</sup> for the fastest <b>2</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Rate Constants and Half-Times from DMSO Coordination (DMSO-Driven Tether-Opening Process) of Tether Complexes <b>1</b>–<b>6</b> and Nontethered Complexes <b>1a</b>, <b>1b</b>, <b>1c</b>, <b>2a</b>, and <b>2b</b> at 298 K as Determined by UV–Visible Spectroscopy</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">complex</th><th class="colsep0 rowsep0" align="center">Cp</th><th class="colsep0 rowsep0" align="center">X,Y ligand</th><th class="colsep0 rowsep0" align="center">Z ligand</th><th class="colsep0 rowsep0" align="center" char="±"><i>k</i> x 10<sup>–6</sup> [s<sup>–1</sup>]</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> [min]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py</td><td class="colsep0 rowsep0" align="left">Phpy</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">70.28 ± 4.31</td><td class="colsep0 rowsep0" align="char" char="±">165.00 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py</td><td class="colsep0 rowsep0" align="left">Bzq</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">216.98 ± 3.32</td><td class="colsep0 rowsep0" align="char" char="±">53.24 ± 0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py</td><td class="colsep0 rowsep0" align="left">Phq</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">63.18 ± 2.95</td><td class="colsep0 rowsep0" align="char" char="±">183.21 ± 8.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py</td><td class="colsep0 rowsep0" align="left">MePhpy</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">110.57 ± 8.24</td><td class="colsep0 rowsep0" align="char" char="±">158.67 ± 17.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py</td><td class="colsep0 rowsep0" align="left">ClPhq</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">34.29 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">336.87 ± 1.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py</td><td class="colsep0 rowsep0" align="left">dFPhpy</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">43.72 ± 3.85</td><td class="colsep0 rowsep0" align="char" char="±">264.26 ± 22.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>5</sub></td><td class="colsep0 rowsep0" align="left">Phpy</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">10.27 ± 1.84</td><td class="colsep0 rowsep0" align="char" char="±">1124.85 ± 208.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>5</sub></td><td class="colsep0 rowsep0" align="left">Phpy</td><td class="colsep0 rowsep0" align="left">py</td><td class="colsep0 rowsep0" align="char" char="±">3.06 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">3771.76 ± 135.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">Phpy</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">7.09 ± 0.52</td><td class="colsep0 rowsep0" align="char" char="±">1630.55 ± 119.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>5</sub></td><td class="colsep0 rowsep0" align="left">Bzq</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">8.21 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">1405.76 ± 27.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="left">C<sub>5</sub>Me<sub>5</sub></td><td class="colsep0 rowsep0" align="left">Bzq</td><td class="colsep0 rowsep0" align="left">py</td><td class="colsep0 rowsep0" align="char" char="±">2.93 ± 0.76</td><td class="colsep0 rowsep0" align="char" char="±">3936.97 ± 1087.92</td></tr></tbody></table></div></div><div class="NLM_p">To understand the effect of the tether ring structural constrain on the Ir–N(py) reactivity of this class of compound, interaction with DMSO was investigated for nontethered analogues of <b>1</b>: complexes <b>1a</b>, <b>1b</b>, and <b>1c</b> (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S17</a>). All complexes convert to the Ir–DMSO adduct [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R)(Phpy)(DMSO)]<sup>+</sup> (R = Me for <b>1a</b> and <b>1b</b>, and CH<sub>2</sub>Ph for <b>1c</b>) over time. The different species were characterized by <sup>1</sup>H NMR, while UV–vis spectra allowed for determination of the kinetic constants (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The results show that nontethered analogues of <b>1</b> are less reactive toward DMSO coordination than tethered complexes <b>1</b>–<b>6</b>. Reaction of complex <b>1a</b> is 7× slower (10.27 ± 1.84 × 10<sup>–6</sup> s<sup>–1</sup>), <b>1b</b> is 23× slower (3.06 ± 0.11 × 10<sup>–6</sup> s<sup>–1</sup>), and <b>1c</b> is 10× slower (7.09 ± 0.52 × 10<sup>–6</sup> s<sup>–1</sup>) than <b>1</b> (70.28 ± 4.31 × 10<sup>–6</sup> s<sup>–1</sup>). In the case of analogues of complex <b>2</b> (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S17</a>), for which <i>k</i><sub>DMSO</sub> is determined as 216.98 ± 3.32 × 10<sup>–6</sup> s<sup>–1</sup>, a similar yet more pronounced tendency is observed: <b>2a</b> is 26× slower (8.21 ± 0.16 × 10<sup>–6</sup> s<sup>–1</sup>), while <b>2b</b> is 74× slower (2.93 ± 0.76 × 10<sup>–6</sup> s<sup>–1</sup>).</div><div class="NLM_p">Faster hydrolysis rate for metal–Cl in comparison to metal–pyridine-κ<i>N</i> has been previously reported for iridium(III) and also for other metal complexes such as Ru(II)<a onclick="showRef(event, 'cit13a ref27 ref32'); return false;" href="javascript:void(0);" class="ref cit13a ref27 ref32">(13a,27,32)</a> and Rh(III),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> indicating that chlorido is a better leaving group in aqueous solution than the pyridine ligand. This explains the trend observed for the rate constants in the substitution reactions of nontethered complexes <b>1a</b>–<b>1c</b>, <i>k</i><sub>DMSO</sub>(<b>1a</b>) ∼ <i>k</i><sub>DMSO</sub>(<b>1c</b>) > <i>k</i><sub>DMSO</sub>(<b>1b</b>), and <b>2a</b> and <b>2b</b>, <i>k</i><sub>DMSO</sub>(<b>2a</b>) > <i>k</i><sub>DMSO</sub>(<b>2b</b>). Accordingly, we would have expected <i>k</i><sub>DMSO</sub>(<b>1</b>) and <i>k</i><sub>DMSO</sub>(<b>2</b>) to have the slowest rate in their respective series because the leaving group is a pyridine-κ<i>N</i> forming a chelate. Surprisingly, the opposite is observed, and the substitution reactions by DMSO in complexes <b>1</b>–<b>6</b> is significantly faster (up to 74-fold) than in complexes <b>1a</b>–<b>1c</b>, and <b>2a</b> and <b>2b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S18</a>). We attribute this rapid reaction with the strong nucleophile DMSO to the structural constraint in the five-membered tether ring, as discussed above regarding their X-ray structures (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). It is curious to note that complex <b>2</b>, the most biologically potent of the series (vide infra), shows the fastest <i>k</i><sub>DMSO</sub> (216.98 × 10<sup>–6</sup> s<sup>–1</sup>) of complexes <b>1</b>–<b>6</b>.</div><div class="NLM_p last">Dimethyl sulfoxide is a common solvent to aid dissolution during biological assays of metal complexes. We thus investigated the reactivity of our complexes when, upon dissolution in DMSO and formation of the Ir–DMSO adduct, they were diluted into water at ca. pH 7. Strikingly, once the Ir-DMSO adduct is redissolved in water, the tether ring forms again, likely via the aqua-adduct intermediate, and the complex largely precipitates as a yellow powder due to the low solubility in water of the closed-tether compound (complex <b>1</b>, as an example in SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S19</a>). Despite the fast reactivity of the metal center in pure DMSO, the stability of the η<sup>5</sup>:κ<sup>1</sup>-tether ring-bearing organometallic moiety appears to play therefore a crucial role in aqueous solution, perhaps preserving the cationic doubly chelated structure and protecting the iridium(III) center from nucleophilic attack in aqueous (biological) media.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cytotoxicity/Antiproliferative Activity of Ir(III) Compounds against Cancer Cells</h3><div class="NLM_p">The activity of the Ir(III) complexes on cell viability was evaluated against MCF7 human breast cancer cells. Our assay to determine the IC<sub>50</sub> values includes both cytotoxicity (cell death) and antiproliferative effects (inhibition of growth). Our results reveal that all Ir(III) compounds resulted in a decrease of the global population of MCF7 cells compared to control at the concentrations used (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) at least as efficiently as cisplatin, complexes <b>1</b>–<b>6</b> being significantly more active: highly potent, well below the micromolar range. The IC<sub>50</sub> values for <b>2</b>, <b>3</b>, and <b>4</b> were 0.06 ± 0.02, 0.05 ± 0.01, and 0.05 ± 0.01 μM, respectively, followed by <b>1</b>, <b>5</b>, and <b>6</b>, with IC<sub>50</sub> values of 0.11 ± 0.03, 0.22 ± 0.00, and 0.19 ± 0.02 μM, respectively. The nontethered analogues <b>1a</b>–<b>d</b> and <b>2a</b>–<b>c</b> were also evaluated. Their potency, with IC<sub>50</sub> values ranging from 14.90 ± 3.39 μM (<b>2a</b>) to 1.85 ± 1.13 μM (<b>1d</b>), was similar to that of cisplatin (9.7 ± 1.9 μM). All were, however, less active than the tether ring-bearing complexes.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cytotoxicity/antiproliferative activity of Ir(III) compounds in MCF7 breast cancer cells. Cells were treated with different concentrations of each iridium complex for 24 h and allowed to recover for 72 h. CDDP was used as positive control (IC<sub>50</sub> = 9.7 ± 1.9 μM). Experiments were performed in triplicate, and data are displayed as an average of at least two independent experiments. All values were compared to the untreated controls and to one another for statistical significance calculations: <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Effects of Ir(III) Complexes on the Growth of MCF7 and MRC-5 Cells in Vitro<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (μM) ± SD</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">MCF7</th><th class="colsep0 rowsep0" align="center" char="±">MRC-5</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (MRC-5)/IC<sub>50</sub> (MCF7)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">1.16 ± 0.30</td><td class="colsep0 rowsep0" align="char" char=".">10.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="char" char="±">12.37 ± 1.85</td><td class="colsep0 rowsep0" align="char" char="±">20.77 ± 4.62</td><td class="colsep0 rowsep0" align="char" char=".">1.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char="±">9.30 ± 1.09</td><td class="colsep0 rowsep0" align="char" char="±">15.20 ± 0.59</td><td class="colsep0 rowsep0" align="char" char=".">1.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="char" char="±">3.34 ± 0.70</td><td class="colsep0 rowsep0" align="char" char="±">16.63 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">4.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="char" char="±">1.85 ± 1.13</td><td class="colsep0 rowsep0" align="char" char="±">16.18 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">8.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.33 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">22.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char="±">14.90 ± 3.39</td><td class="colsep0 rowsep0" align="char" char="±">35.74 ± 5.99</td><td class="colsep0 rowsep0" align="char" char=".">2.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.05 ± 0.35</td><td class="colsep0 rowsep0" align="char" char="±">19.82 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">3.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="char" char="±">4.42 ± 1.19</td><td class="colsep0 rowsep0" align="char" char="±">5.54 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.90 ± 0.43</td><td class="colsep0 rowsep0" align="char" char=".">38.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">0.05 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">4.59 ± 1.71</td><td class="colsep0 rowsep0" align="char" char=".">91.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="±">0.22 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">1.52 ± 0.17</td><td class="colsep0 rowsep0" align="char" char=".">6.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="±">0.19 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">5.50 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">28.95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The drug treatment period was 24 h (+72 h cell recovery).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> is defined as the concentration of drug required to inhibit cell population growth by 50% compared to control, as a result of varying degrees of drug cytotoxicity and antiproliferative activity. CDDP was used as positive control (IC<sub>50</sub> = 9.7 ± 1.9 μM for MCF7 and 15.2 ± 5.7 μM for MRC-5 cells). Experiments were performed in triplicate, and data are displayed as an average of at least two independent experiments. All values were compared to the untreated controls and to one another for statistical significance calculations: <i>p</i> < 0.001.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Ratio IC<sub>50</sub> (MRC-5)/IC<sub>50</sub> (MCF7) represent the IC<sub>50</sub> values in MRC-5 cells divided by IC<sub>50</sub> values in MCF7 cells for each Ir(III) compound.</p></div></div></div><div class="NLM_p">We were not expecting the IC<sub>50</sub> data to show such an increased potency by introducing a tether ring in the Ir(III) structure. Our previous results regarding Ru(II)–arene complexes presenting the same type of tethered structure had shown a similar behavior in water,<a onclick="showRef(event, 'cit22a cit22b'); return false;" href="javascript:void(0);" class="ref cit22a cit22b">(22a,b)</a> where the complexes were extraordinarily stable at neutral pH and accordingly had presented no effect in cell viability. Complexes <b>1</b>–<b>6</b> appear as robust in water at neutral pH, yet conversely to ruthenium(II) tethers, our data suggest that introduction of the tethering η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py-κ<i>N</i> ligand confers high anticancer potency to the Ir(III) half-sandwich complexes.</div><div class="NLM_p">In the past decade, a number of studies have reported Ir(III)-cyclopentadienyl complexes with typical half-sandwich structure as potent as clinically used drug cisplatin in a range of cancer cells. Sadler reported the optimization of the C<sub>5</sub>Me<sub>4</sub>R-derivative, finding that an extended hydrophobic face on the derivative-Cp ligand increases cytotoxicity in comparison to C<sub>5</sub>Me<sub>5</sub>-Ir(III) (ca. 10- to 100-fold),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> while substituting <i>N</i>,<i>N</i>-ancillary ligands for their isoelectronic C,N-analogous would also afford a significant increase in the cytotoxic potency.<a onclick="showRef(event, 'ref16 ref34'); return false;" href="javascript:void(0);" class="ref ref16 ref34">(16,34)</a> Further exploration of the effect on the XY bidentate ligand in the general structure [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(XY)Cl] has been a subject of much research,<a onclick="showRef(event, 'cit5a cit13e ref19 ref35'); return false;" href="javascript:void(0);" class="ref cit5a cit13e ref19 ref35">(5a,13e,19,35)</a> reporting complexes as active as cisplatin in a number of cancer cell lines. The next leap in cytotoxicity with regard to SAR came from varying the monodentate ligand, also known as the “leaving group”. The chemical reactivity of the bond between this ligand and the metal center can have a dramatic influence on the cytotoxicity of the compound. In particular, the substitution of the Cl monodentate ligand by a pyridine-κ<i>N</i> group, affording the complex [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>C<sub>6</sub>H<sub>4</sub>C<sub>6</sub>H<sub>5</sub>)(Phpy)(py)]PF<sub>6</sub> resulted in an enhanced cytotoxic potency, with an IC<sub>50</sub> value of 0.12 μM toward A2780 cells,<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> producing the most potent C<sub>5</sub>Me<sub>5</sub>-derivative Ir(III) complex reported to date.</div><div class="NLM_p">Our IC<sub>50</sub> results of nontether complexes appear to be consistent with the reported SAR regarding monodentate ligand (Z) optimization in complexes of formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R)(XY)(Z)]<sup><i>n</i>+</sup>. For example, comparison of anticancer potency of <b>1b</b> vs <b>1a</b>, <b>1d</b> vs <b>1c</b>, and <b>2b</b> vs <b>2a</b> appears to show that pyridine-bearing complexes are more active than the chlorido counterparts. This has been previously related to excess reactivity of the latter, that is, bearing rapidly hydrolyzing Ir–Z bonds results in lower potency, perhaps due to a short activation time less compatible with reaching the biological target site.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a></div><div class="NLM_p">The latter concept regarding the link between anticancer potency and lack of hydrolysis of the Ir(III)–N(py) bond in aqueous solution appears to apply to our new family of tether ring-bearing complexes <b>1</b>–<b>6</b>. Strikingly active, all six complexes show high potency toward MCF7 human cancer cells, considerably higher than CDDP (0.05–0.22 vs 9.7 μM), and also significantly higher than the nontether analogues (1.85–14.90 μM), even those bearing a κ<i>N</i>-bound pyridine as monodentate ligand. Importantly, such different anticancer potency between tether and nontether analogues represents an indirect proof that the tether ring remains stable in the biological media. We argue that the double chelate results in a closed tether Ir(III) structure which allows for effective transport to the target in the nucleophile-rich intracellular environment.</div><div class="NLM_p">Additional IC<sub>50</sub> determinations using <i>N</i>,<i>N</i>-dimethylformamide (DMF) as a vehicle to aid dissolution of complexes <b>1</b>–<b>6</b> were also carried out. DMF behaves in many ways like DMSO; it is a very polar solvent that dissolves most organic and inorganics salts, but it is not significantly nucleophilic for our studies and does not coordinate to our closed tether complexes <b>1</b>–<b>6</b> (see SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S20</a> showing the stability of ca. 7 mM complex <b>1</b> as an example in [D<sub>7</sub>]DMF by <sup>1</sup>H NMR). Cell viability screening results in MCF7 are in agreement with the IC<sub>50</sub> values obtained with DMSO as a vehicle for our cell viability tests, supporting the observation that a possible DMSO-mediated tether ring opening would have no effect in the cell viability tests in aqueous solution, further supporting the stability of complexes <b>1</b>–<b>6</b> in aqueous biological media. Determination of IC<sub>50</sub> values in ovarian cancer cell line A2780 using both DMSO and DMF as vehicles also corroborated this observation. Data of these experiments are included in the Supporting Information (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S4</a>).</div><div class="NLM_p">To explore the ubiquitous potency of our new family of iridium-tether complexes, we also tested complexes <b>1</b>–<b>6</b> toward additional human cancer cells from tissues of different origin: colon tumor cell line HCT116, breast cancer cell line MDA-MB-231, and pancreatic cancer cell lines MIA PaCa-2 and PANC-1 (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S5</a>). All tether complexes present high potency, with IC<sub>50</sub> values in the submicromolar range, about 2 orders of magnitude lower than those of cisplatin.</div><div class="NLM_p last">Finally, we also assayed healthy-cell toxicity of Ir(III) complexes on MRC-5, a nontumorigenic human lung fibroblast cell type, to investigate cancer cell selectivity, by the MTS assay (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S21</a>). Despite presenting high toxicity in noncancerous cells, all Ir(III) compounds showed higher IC<sub>50</sub> values in MRC-5 cells compared to MCF7 cells. Remarkably, while nontether complexes <b>1a</b>–<b>1d</b>, and <b>2a</b>–<b>2c</b> show a IC<sub>50</sub> (MRC-5)/IC<sub>50</sub> (MCF7) toxicity ratio in the range 1.25–8.75, the same ratio for <b>1</b>–<b>6</b> spans 2 orders of magnitude (up to 91.80 for <b>4</b>), showing that the tether complexes appear to exhibit some selectivity toward cancer cells.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Induction of Intracellular Reactive Oxygen Species (ROS) by Ir(III) Compounds in MCF7 Cells</h3><div class="NLM_p">It is increasingly recognized that generation of excessive levels of ROS by different anticancer drugs can lead to oxidative stress and activation of cell death processes in a variety of organisms.<a onclick="showRef(event, 'ref12 ref36'); return false;" href="javascript:void(0);" class="ref ref12 ref36">(12,36)</a> Motivated by the fact that the anticancer activity of Ir(III)-cyclopentadienyl complexes can be linked to the increase of ROS production by targeting the redox balance in tumor cells,<a onclick="showRef(event, 'cit2b cit13a cit13b cit13c ref37'); return false;" href="javascript:void(0);" class="ref cit2b cit13a cit13b cit13c ref37">(2b,13a−c,37)</a> we investigated intracellular ROS level alteration in MCF7 cells. We used the cell-permeable nonfluorescent probe DCFH-DA, which internalizes, hydrolyses, and converts into highly fluorescent DCF upon oxidation by various reactive oxygen species. Our assay indicates generalized oxidative stress rather than an accurate measure of specific reactive oxygen or nitrogen species. As it can be seen in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, none of the nontethered iridium complexes <b>1a</b>–<b>1d</b> induced a significant level of total ROS, while compound <b>1</b> triggered ROS production at the higher concentration used (1 μM). Results obtained for nontethered complexes <b>2a</b>–<b>2c</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) are similar to those of complexes <b>1a</b>–<b>1d</b>, yet compound <b>2</b>, which is significantly more active than <b>1</b>, induced high sustained levels of total ROS at all concentrations tested. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C shows that compounds <b>3</b>–<b>6</b> all produced similar ROS accumulation than that observed for <b>2</b>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. ROS induction by Ir(III) complexes in MCF7 cells. Cells were incubated for 90 min with Ir(III) compounds <b>1</b>, <b>1a</b>, <b>1b</b>, <b>1c</b>, <b>1d</b> (A), <b>2</b>, <b>2a</b>, <b>2b</b>, <b>2c</b> (B), and <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, and <b>6</b> (C). Concentrations are expressed in micromolar units (μM). ROS levels were measured by fluorescence spectroscopy after DCFH-DA treatment. The results are expressed as the fold increase of cell fluorescence compared to control. Data are representative of three independent experiments. All values were compared to the untreated controls and to one another for statistical significance calculations; <i>p</i> < 0.001 for ***.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our results correlate well with the anticancer potency of the Ir(III) complexes studied in this work as all tethered compounds <b>1</b>–<b>6</b> showed greater cytotoxicity and induction of total ROS levels, whereas the nontethered iridium complexes presented low anticancer activity and did not induce ROS generation at the highest concentration tested. Following these results, we next investigated whether one of the major antioxidant systems in cells, such as the thioredoxin reductase system, would be implicated in iridium(III)-driven cell death.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Inhibition of TrxR Activity by Ir(III) Complexes in Vitro and in MCF7 Cells</h3><div class="NLM_p">The Trx system comprises the small redox protein thioredoxin (Trx), selenocysteine-containing thioredoxin reductase (TrxR) and NADPH. It is a key antioxidant system in mammalian cells and plays important roles in maintaining the redox intracellular balance controlling ROS production.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Recent studies have indicated that TrxR can be strongly inhibited by metal-based anticancer candidates, particularly of gold and iridium, in experiments carried out in a test tube, i.e., outside the cell.<a onclick="showRef(event, 'ref20 ref39'); return false;" href="javascript:void(0);" class="ref ref20 ref39">(20,39)</a> Importantly, TrxR is a ROS-scavenging enzyme, highly expressed in cancer cells, protecting them from death.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">We evaluated the inhibitory effect of the Ir(III) complexes on the enzymatic activity of TrxR (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S6</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S22</a>). Among all the tethered compounds, <b>1</b>, <b>2</b>, and <b>3</b> were effective inhibitors of TrxR activity, exhibiting EC<sub>50</sub> values of 0.31, 2.5, and 6.1 μM, respectively. Under the same experimental conditions, compound <b>5</b> was less effective, with EC<sub>50</sub> value equal to 38.8 μM, while compounds <b>4</b> and <b>6</b> were devoid of activity against the enzyme at concentrations up to 50 μM. Nontethered complexes bearing a chlorido ligand cause no alterations in TrxR activity, and strong inhibition by <b>1b</b> and moderate inhibitory effect for <b>2b</b> was observed (EC<sub>50</sub> values of 0.032 and 4.2 μM, respectively), intriguingly, the two complexes bearing a pyridine-κ<i>N</i> as a monodentate leaving group.</div><div class="NLM_p last">We have previously observed divergence between the TrxR inhibition results in the test tube and in cell lysates for a family of cytotoxic Au(III)–bisthiosemicarbazone complexes.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> We then determined the TrxR activity in cell lysates of MCF7 cells after treatment with the iridium(III) compounds in order to relate such interaction to anticancer activity (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S6</a>). Complex <b>2</b> showed the most effective TrxR inhibition, which accounted for a modest 28%. The data suggested that while most of the complexes reported here appear to inhibit the selenoenzyme in buffer solution in the low micromolar and submicromolar range, they appear not to be strong inhibitors of the enzyme upon cell internalization.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Induction of Mitochondrial Dysfunction by Ir(III) Compounds in MCF7 Cells</h3><div class="NLM_p">Mitochondria are the main producers of ROS in the cell, and mitochondrial damage may markedly increase intracellular ROS levels.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Loss of the mitochondrial membrane potential (ΔΨ<i><sub>m</sub></i>) is an important indicator of mitochondrial dysfunction, a universal event that occurs in RCD in cancer cells.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> A number of studies have related iridium(III) complexes-driven cell death to ΔΨ<i><sub>m</sub></i> disruption.<a onclick="showRef(event, 'cit13e ref44'); return false;" href="javascript:void(0);" class="ref cit13e ref44">(13e,44)</a> We studied the impact of the Ir(III)compounds on mitochondrial membrane integrity in MCF7 cells using flow cytometry analysis. MCF7 cells were exposed to 0.25 μM of the iridium complexes and the changes in ΔΨ<sub><i>m</i></sub> were detected by JC-10 staining. We included cells treated with carbonyl cyanide <i>m</i>-chlorophenyl hydrazone (CCCP) as positive control, and untreated cells as negative control. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> (see also SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S7</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S23</a>), after exposition of MCF7 cells to equimolar quantities of Ir(III) complexes, the fluorescence emission of JC-10 changed at different levels. Our results show that all nontethered complexes <b>1a</b>–<b>1d</b> and <b>2a</b>–<b>2c</b> presented no changes in the ΔΨ<sub><i>m</i></sub> compared to untreated control cells. In contrast, all tether compounds <b>1</b>–<b>6</b> induce depolarization of the mitochondrial membrane that follow the trend of the positive control CCCP, albeit complexes <b>5</b> and <b>6</b> did not show a significant effect. Compounds <b>1</b> and <b>4</b> induced similar changes on the mitochondria membrane polarization to the positive control CCCP (ratios F4/F2 of 0.20 ± 0.01 and 0.17 ± 0.01, respectively, versus 0.18 ± 0.02 for the control), whereas <b>2</b> and <b>3</b> showed the strongest effect in the ΔΨ<sub><i>m</i></sub> in the series (F4/F2 ratios of 0.32 ± 0.01 and 0.33 ± 0.02, respectively).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of Ir(III) complexes on loss of mitochondrial membrane potential (ΔΨ<sub><i>m</i></sub>) in MCF7 cells. Ratio of fluorescence in F4/F2 of a flow cytometry dot plot for MCF7 cells treated with iridium complexes for 24 h compared to negative (untreated) and positive (100 μM carbonyl cyanide 3-chlorophenylhydrazone (CCCP)) control cells. Data are representative of three independent experiments and values are expressed in mean ± SD. All values were compared to the untreated controls and to one another for statistical significance calculations; <i>p</i> < 0.001 for ***.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our results show that complexes <b>1</b>–<b>6</b> have an impact in ΔΨ<i><sub>m</sub></i> in contrast to the nontethered compounds <b>1a</b>–<b>1d</b> and <b>2a</b>–<b>2c</b> at the concentration tested (0.25 μM), implying that this effect is most significant for the observed differences in anticancer potency exhibited by tether versus the nontether series. We have recently reported the localization of complex <b>1</b> in cryopreserved MCF7 cells with nanometric resolution by using a combination of 3D synchrotron-based techniques; cryo soft X-ray tomography (cryo-SXT) and cryo hard X-ray fluorescence (cryo-XRF). We have shown unambiguously the exclusive localization of complex <b>1</b> in the mitochondria of cryopreserved MCF7 cells,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> without mechanical manipulation, staining, or labeling of the samples. We argue here that complexes <b>1</b>–<b>6</b>, bearing hydrophobic ligands, behave as lipophilic cations, and as such, they are attracted by the negative membrane potential of the mitochondrial inner membrane,<a onclick="showRef(event, 'cit6d'); return false;" href="javascript:void(0);" class="ref cit6d">(6d)</a> which is even more negative in some tumors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It is reasonable to assume that once the complexes cross the cellular outer membrane against their concentration gradient, they will preferentially and efficiently accumulate in the inward side of the inner mitochondrial membrane.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Accumulation of Ir(III) Complexes in MCF7 Cells</h3><div class="NLM_p">Considering our previous work reporting unequivocal results for exclusive mitochondria targeting of complex <b>1</b>,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and tentatively assuming a similar behavior for complexes <b>1</b>–<b>6</b>, we tested whether the high potency of the tethered-Ir(III) complexes correlates with overall intracellular accumulation of the compounds. For that, total cellular internalization of iridium (net uptake between influx and efflux) into MCF7 cells were determined by inductively coupled plasma mass spectrometry (ICP-MS). First, we used two different concentrations for 24 h cell exposure: 0.005 μM, which is 1/10 IC<sub>50</sub> of the most active compounds (<b>3</b> and <b>4</b>), and 0.25 μM, which is 5× IC<sub>50</sub> of <b>3</b> and <b>4</b> and approximately the IC<sub>50</sub> of the least actively tether-Ir(III) compound <b>5</b>. All iridium(III) complexes <b>1</b>–<b>6</b> were accumulated inside the cell (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) without significant differences among them for the two conditions assayed and extraordinarily efficient even at very low drug exposure.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cellular Accumulation of Ir(III) Complexes (as ng Ir/10<sup>6</sup> Cells) in MCF7 Breast Cancer Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">internalization (ng Ir/10<sup>6</sup> cells)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">0.005 μM<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">0.25 μM<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">1 μM<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.33 ± 0.12</td><td class="colsep0 rowsep0" align="center">29.7 ± 3.7</td><td class="colsep0 rowsep0" align="center">100.2 ± 16.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">14.5 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">12.4 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">9.3 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1d</b></td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">17.0 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">0.55 ± 0.07</td><td class="colsep0 rowsep0" align="center">55.6 ± 8.0</td><td class="colsep0 rowsep0" align="center">201.7 ± 22.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">0.37 ± 0.05</td><td class="colsep0 rowsep0" align="center">71.7 ± 10.3</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">0.44 ± 0.06</td><td class="colsep0 rowsep0" align="center">40.1 ± 3.5</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">0.42 ± 0.05</td><td class="colsep0 rowsep0" align="center">54.2 ± 6.2</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">0.65 ± 0.04</td><td class="colsep0 rowsep0" align="center">64.3 ± 4.6</td><td class="colsep0 rowsep0" align="center">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Drug-treatment period was 24 h of exposure to 0.005 or 0.25 μM of Ir(III) tether complexes <b>1</b>–<b>6</b>.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Cells were treated with 1 μM of Ir(III) compounds <b>1</b>, <b>1a</b>–<b>1d</b>, and <b>2</b> for 8 h. Cellular number was determined by counting on a hemocytometer prior to digestion. Iridium content was normalized to 10<sup>6</sup> cells per sample. Each value represents the mean ± CI. All values were compared to the untreated controls; <i>p</i> < 0.001. nd, not determined.</p></div></div></div><div class="NLM_p last">Most importantly, we investigated the effect of the tether ring on iridium internalization in order to relate this feature to their potent cytotoxicity. We tested tether and nontether analogues: <b>1</b>, <b>1a</b>, <b>1b</b>, <b>1c</b>, and <b>1d</b>, and <b>2</b>. In the cell viability assays, the IC<sub>50</sub> values obtained for these complexes varied from nanomolar to micromolar concentrations; therefore, to be able to use a high equimolar concentration without compromising cell viability, cells were treated with 1 μM of <b>1</b>, <b>1a</b>, <b>1b</b>, <b>1c</b>, <b>1d</b>, and <b>2</b> for 8 h. <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> shows that compounds <b>1a</b>, <b>1b</b>, <b>1c</b>, and <b>1d</b> displayed similar low levels of iridium accumulation (14.5 ± 3.0, 12.4 ± 2.5, 9.3 ± 1.8, and 17.0 ± 1.2 ng Ir/10<sup>6</sup> cells for <b>1a</b>, <b>1b</b>, <b>1c</b>, and <b>1d</b>, respectively), whereas the cellular uptake of <b>1</b> was increased up to 10-fold when compared to them (100.2 ± 16.0 ng Ir/10<sup>6</sup> cells). Strikingly, complex <b>2</b> showed extraordinary Ir accumulation, the highest of all complexes tested (201.7 ± 22.4 ng Ir/10<sup>6</sup> cells). These results show that the degree of uptake of all Ir(III) complexes correlates significantly with the IC<sub>50</sub> data. Compounds <b>1a</b>, <b>1b</b>, <b>1c</b>, and <b>1d</b> were the least potent and displayed the lowest cellular accumulation, whereas <b>2</b> presents the highest potency against MCF7 cells and the highest uptake efficiency.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It has been previously reported that the derivatized C<sub>5</sub>Me<sub>4</sub>R ring and the different chelating XY ligands play an important role in the anticancer activity of a number of Ir(III)–Cp complexes.<a onclick="showRef(event, 'ref15 ref45'); return false;" href="javascript:void(0);" class="ref ref15 ref45">(15,45)</a> Importantly, the presence of a strongly bound pyridine ligand significantly improves the anticancer potency of this class of drug candidates.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> Here we report the synthesis and characterization of a series of iridium(III) cyclopentadienyl complexes <b>1</b>–<b>6</b> with typical half-sandwich structure. In comparison to the already reported Ir(III)–Cp metallodrugs, complexes <b>1</b>–<b>6</b> of general formula [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(C,N)]PF<sub>6</sub>, include a very particular feature in their structure, an additional chelate ring formed by coordinative binding of a pyridine-κ<i>N</i>, which is tethered to the η<sup>5</sup>-bound cyclopentadienyl ring (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). We report the first five crystal structures of Ir(III) complexes bearing the heteroditopic ligand η<sup>5</sup>-<i>C</i><sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>pyridine-κ<i>N</i> and substituted C,N bidentate chelating ligands, highlighting the structural robustness of our doubly chelated Ir-tether complexes. The tether ring feature appears to confer extraordinary anticancer potency toward MCF7 cancer cells to this new class of metallodrugs, up to 2 orders of magnitude more active than clinically used anticancer drug cisplatin. Complexes <b>1</b>–<b>6</b> are equally potent in additional cancer cells, such as A2780, HCT116, MDA-MB-231, MIA PaCa-2, and PANC-1. For comparison purposes, we have synthesized a number of nontethered analogues, complexes <b>1a</b>–<b>1d</b> and <b>2a</b>–<b>2c</b> of general formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R)(Phpy/Bzq)Z]<sup>0/+</sup> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>), which helped to rationalize the observed high activity of the tether-bearing complexes. Such a comparison was also decisive as an indirect proof of tether ring stability in biological media. We have shown that the tether complexes are readily reactive toward DMSO, yet they are extraordinarily stable in water. We have tried to relate the unexpected leap in potency to total ROS production and mitochondria depolarization. In addition, these complexes clearly distinguish themselves from their nontether counterparts in their internalization and target-reaching capabilities. They appear to internalize readily even at very low drug concentrations and target efficiently and exclusively the cell mitochondria in MCF7 cells without deviating from their intracellular goal.</div><div class="NLM_p last">We argue that the tether ring in complexes <b>1</b>–<b>6</b>, and the extra stabilization that it provides the complexes with, shelters the metal center toward nucleophilic attack, protecting the Ir(III) closed-tether structure, a lipophilic cation that, attracted by the negative potential of the mitochondrial inner membrane, targets the cancer cell mitochondria in a highly efficient manner. The tether ring structural feature in this new class of Ir-tether anticancer agents results in an extraordinary leap in anticancer potency, probably related to a highly efficient internalization followed by a clear targeting of the cell mitochondria, its depolarization and the subsequent oxidative stress.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Materials</h3><div class="NLM_p last">IrCl<sub>3</sub>·3H<sub>2</sub>O was acquired from Johnson Matthey. 2-(2,4-Difluorophenyl)pyridine, 2-(<i>p</i>-tolyl)pyridine, 4-chloro-2-phenylquinoline, 2.5 M <i>n</i>-buthylithium (<i>n</i>-BuLi), silver nitrate (AgNO<sub>3</sub>), sodium acetate (NaOAc), formic acid (FA), ammonium hexafluorophosphate (NH<sub>4</sub>PF<sub>6</sub>), and 1.0 M benzylmagnesium bromide were purchased from Sigma-Aldrich. 2-Picoline, 2,3,4,5-tetramethylcyclopentenone, and 1,2,3,4-pentamethylcyclopentadiene were acquired from Alfa Aesar. 1-Phenylisoquinoline was purchased from FluoroChem. 2-Phenylpyridine, 7,8-benzoquinoline, diisopropylamine (DIPA), dry tetrahydrofuran (THF), dichloromethane (DCM), dimethylformamide (DMF), and dichloroethane (DCE) were acquired from Acros Organics, dimethyl sulfoxide (DMSO) from VWR International, ethanol and Celite from Sharlau, dry methanol from Alfa Aesar, and diethyl ether from Fisher Scientific. For NMR spectroscopy, the solvents used were CDCl<sub>3</sub> and [D<sub>6</sub>]DMSO from VWR International, and [D<sub>7</sub>]DMF from abcr GmbH.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Experimental Details</h3><div class="NLM_p">Reactions were carried out in oven-dried glassware under inert atmosphere (argon or nitrogen) using standard vacuum line techniques. Room or ambient temperature refers to 20–25 °C. Reactions involving heating were performed using blocks and a contact thermocouple. Under reduced pressure refers to the use of a Büchi Rotavapor R-200/210 with a Büchi V-491 heating bath and a Büchii V-800/850 vacuum controller. The rotary evaporator condenser is fitted to Huber Minichiller 280 recirculating cooler filled with ethylene glycol and set to −5 °C.</div><div class="NLM_p">All tested compounds, including cisplatin (Sigma-Aldrich, ≥99.9%), possess a purity of at least ≥95%, as determined by combustion analysis.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phpy)]PF<sub>6</sub> (<b>1</b>)</h4><div class="NLM_p last">A solution of [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)Cl<sub>2</sub>](40.0 mg, 0.084 mmol, 1.0 equiv) and AgNO<sub>3</sub> (28.5 mg, 0.168 mmol, 2.0 equiv) in deionized water (13.4 mL) was stirred at ambient temperature overnight. The resulting precipitate (AgCl) was removed by filtration over Celite, washed through with deionized water, and the filtrate was concentrated in vacuo until dryness. The desired aqua complex was used in the next step without further purification. It was dissolved in anhydrous dichloromethane (28.2 mL), and 2-phenylpyridine (27.1 μL, 0.019 mmol, 2.3 equiv) and NaOAc (31.2 mg, 0.380 mmol, 4.5 equiv) were added to the solution. The reaction mixture was heated under reflux in an Ar atmosphere for 24 h. The resulting solution was filtered over Celite, washed through with dichloromethane, and concentrated in vacuo until dryness. The solid was washed with diethyl ether, redissolved in methanol, and an excess of NH<sub>4</sub>PF<sub>6</sub> (68.5 mg, 0.42 mmol, 5.0 equiv) was added. The solution was left to stand in the freezer (−20 °C) overnight, and the resulting product was collected by filtration, washed with diethyl ether, and dried under vacuum. The title compound was obtained as brown-orange powder (42.4 mg, 71%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.87 (d, <i>J</i> = 5.3 Hz, 1H), 8.02 (d, <i>J</i> = 8.1 Hz, 1H), 7.91–7.85 (m, 2H), 7.79 (dd, <i>J</i> = 5.7, 3.1 Hz, 1H), 7.65 (td, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.38–7.31 (m, 2H), 7.24 (dd, <i>J</i> = 5.7, 3.2 Hz, 2H), 6.80 (t, <i>J</i> = 6.1 Hz, 1H), 6.56 (dd, <i>J</i> = 5.8, 1.2 Hz, 1H), 4.25 (d, <i>J</i> = 18.9 Hz, 1H), 3.98 (d, <i>J</i> = 19.0 Hz, 1H), 2.39 (s, 3H), 1.97 (s, 3H), 1.60 (s, 3H), 1.46 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 179.71 (C), 166.78 (C), 162.99 (C), 152.03 (CH), 149.08 (CH), 143.85 (C), 139.09 (CH), 138.48 (CH), 134.82 (CH), 131.59 (CH), 125.36 (CH), 125.16 (CH), 124.90 (CH), 124.22 (CH), 124.18 (CH), 120.06 (CH), 103.11 (C), 91.91 (C), 91.81 (C), 91.44 (C), 71.52 (C), 32.47 (CH<sub>2</sub>), 9.25 (CH<sub>3</sub>), 9.23 (CH<sub>3</sub>), 8.39 (CH<sub>3</sub>), 8.08 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>26</sub>H<sub>26</sub>F<sub>6</sub>N<sub>2</sub>PIr (703.68): C, 44.38; H, 3.72; N, 3.98. Found C, 44.45; H, 3.82; N, 3.99. MS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>Ir [M]<sup>+</sup> 559.2; found 559.3. Suitable crystals for X-ray diffraction were obtained by crystallization from chloroform/methanol at 298 K.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(Phpy)Cl] (<b>1a</b>)</h4><div class="NLM_p last">A solution of [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)Cl<sub>2</sub>]<sub>2</sub> (60.0 mg, 0.076 mmol, 1.0 equiv), 2-phenylpyridine (21.6 μL, 0.152 mmol, 2.0 equiv), and NaOAc (24.9 mg, 0.304 mmol, 4.0 equiv) in dichloromethane (3.3 × 10<sup>–3</sup> M) was heated under reflux in a N<sub>2</sub> atmosphere for 24 h. The solution was filtered over Celite, washed through with dichloromethane, and concentrated in vacuo until dryness. The solid was washed with diethyl ether and dried under vacuum. The title compound was obtained as a bright-orange solid (85.5 mg, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.70 (dd, <i>J</i> = 5.7, 0.6 Hz, 1H), 7.82 (d, <i>J</i> = 7.7 Hz, 2H), 7.70–7.63 (m, 2H), 7.21 (td, <i>J</i> = 7.4, 1.3 Hz, 1H), 7.10–7.01 (m, 2H), 1.68 (s, 15H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 167.56 (C), 163.51 (C), 151.49 (CH), 144.22 (C), 137.08 (CH), 135.97 (CH), 131.17 (CH), 123.99 (CH), 122.38 (CH), 122.21 (CH), 119.02 (CH), 88.67 (5 × Q), 9.06 (5 × CH<sub>3</sub>). Elemental Analysis calculated for C<sub>21</sub>H<sub>23</sub>ClNIr (517.10): C 48.78, H 4.48, N 2.71; found C 48.80, H 4.55, N 2.67. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>23</sub>NIr [M]<sup>+</sup> 482.2; found 482.3.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(Phpy)(py)]PF<sub>6</sub> (<b>1b</b>)</h4><div class="NLM_p last">A solution of <b>1a</b> (40.0 mg, 0.05 mmol, 1.0 equiv) and AgNO<sub>3</sub> (8.5 mg, 0.05 mmol, 1.0 equiv) in dry methanol (0.01 M) was left to stir overnight at ambient temperature. The precipitate (AgCl) was removed by filtration through a syringe filter, and excess pyridine (40 μL, 0.5 mmol, 10.0 equiv) was added to the filtrate. The reaction mixture was stirred overnight at ambient temperature. The volume was slowly reduced to less than half on a rotatory evaporator before NH<sub>4</sub>PF<sub>6</sub> (40.8 mg, 0.25 mmol, 5.0 equiv) was added. The solution was left to stand in the freezer (−20 °C) overnight, and the corresponding product was collected by filtration and washed with diethyl ether and dried under vacuum. The title compound was obtained as an orange solid (30.3 mg, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 9.11 (d, <i>J</i> = 5.7 Hz, 1H), 8.48–8.44 (m, 2H), 7.88 (dd, <i>J</i> = 7.5, 0.8 Hz, 1H), 7.83–7.74 (m, 2H), 7.65–7.57 (m, 3H), 7.37 (td, <i>J</i> = 7.4, 1.3 Hz, 1H), 7.31–7.26 (m, 2H), 7.18 (td, <i>J</i> = 7.6, 1.1 Hz, 1H), 1.60 (s, 15H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 160.98 (C), 153.47 (2 × CH), 152.44 (C), 145.59 (C), 139.13 (CH), 138.57 (CH), 134.88 (CH), 132.06 (CH), 127.19 (CH), 125.77 (CH), 125.59 (CH), 124.46 (CH), 124.04 (CH), 119.24 (CH), 90.56 (5 × C), 8.65 (5 × CH<sub>3</sub>). Elemental Analysis calculated for C<sub>26</sub>H<sub>28</sub>F<sub>6</sub>N<sub>2</sub>PIr (705.70): C 44.25, H 4.00, N 3.97; found C 43.99, H 4.00, N 4.03. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>23</sub>NIr [M]<sup>+</sup> 482.2; found 482.2.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)(Phpy)(Cl)] (<b>1c</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1a</b>, complex <b>1c</b> was prepared using the [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)Cl<sub>2</sub>]<sub>2</sub> dimer (35.0 mg, 0.04 mmol, 1.0 equiv), 2-phenylpyridine (11.4 μL, 0.08 mmol, 2.0 equiv) as the bidentate chelating ligand, and NaOAc (13.12 mg, 0.16 mmol, 4.0 equiv) as a weak base. The title compound was obtained as a bright-orange solid (37.2 mg, 79%). <sup>1</sup>H NMR (400 Mz, CDCl<sub>3</sub>): δ = 8.74 (dd, <i>J</i> = 5.7, 0.7 Hz, 1H), 7.86 (t, <i>J</i> = 8.5 Hz, 2H), 7.72–7.66 (m, 2H), 7.32–7.26 (m, 2H), 7.25–7.18 (m, 2H), 7.16–7.03 (m, 4H), 3.46 (q, <i>J</i> = 16.0 Hz, 2H), 1.71 (dd, <i>J</i> = 21.2, 1.2 Hz, 12H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 167.50 (C), 162.91 (C), 151.59 (CH), 144.23 (C), 138.82 (C), 137.23 (CH), 136.03 (CH), 131.25 (CH), 128.70 (CH), 128.25 (CH), 126.49(CH), 124.09 (CH), 122.51 (CH), 122.36 (CH), 119.11 (CH), 90.78 (C), 90.17 (C), 89.93 (C), 88.98 (C), 87.16 (C), 30.31(CH<sub>2</sub>), 9.51 (CH<sub>3</sub>), 9.42 (CH<sub>3</sub>), 9.12 (CH<sub>3</sub>), 9.11 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>27</sub>H<sub>27</sub>ClNIr (593.19): C 54.67, H 4.59, N, 2.36; found C 55.08, H 4.50, N 2.59. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>27</sub>NIr [M]<sup>+</sup> 558.2; found 558.3.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)(Phpy)(py)]PF<sub>6</sub> (<b>1d</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1b</b>, complex <b>1d</b> was prepared from a solution of <b>1c</b> (20.0 mg, 0.030 mmol, 1.0 equiv), AgNO<sub>3</sub> (5.1 mg, 0.030 mmol, 1.0 equiv), pyridine (24.3 μL, 0.300 mmol, 10.0 equiv), and NH<sub>4</sub>PF<sub>6</sub> (24.5 mg, 0.150 mmol, 5.0 equiv). The title compound was obtained as a bright-yellow solid (23 mg, 98%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 9.17 (d, <i>J</i> = 5.7 Hz, 1H), 8.52 (d, <i>J</i> = 5.1 Hz, 2H), 7.94 (d, <i>J</i> = 7.1 Hz, 1H), 7.81 (dt, <i>J</i> = 14.7, 7.0 Hz, 2H), 7.69–7.58 (m, 3H), 7.40 (t, <i>J</i> = 6.8 Hz, 1H), 7.34–7.27 (m, 3H), 7.21 (t, <i>J</i> = 7.4 Hz, 2H), 7.09 (d, <i>J</i> = 7.3 Hz, 2H), 3.43–3.31 (m, 2H), 1.65 (d, <i>J</i> = 4.2 Hz, 6H), 1.61 (d, <i>J</i> = 5.5 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 166.84 (C), 160.38 (C), 153.47 (2 × CH), 152.53 (CH), 145.57 (C), 139.26 (CH), 138.72 (CH), 137.33 (C), 134.96 (CH), 132.19 (CH), 128.91 (2 × CH), 128.14 (2 × CH), 127.26 (2 × CH), 126.92 (CH), 125.61 (CH), 124.57 (CH), 124.20 (CH), 119.38 (CH), 93.17 (CH), 91.76 (CH), 91.32 (CH), 90.84 (CH), 89.18 (CH), 29.49 (CH<sub>2</sub>), 9.13 (CH<sub>3</sub>), 9.06 (CH<sub>3</sub>), 8.67 (CH<sub>3</sub>), 8.61 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>32</sub>H<sub>32</sub> F<sub>6</sub>N<sub>2</sub>PIr (781.80): C 49.16, H 4.13, N 3.58; found C 49.07, H 4.14, N 3.56. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>32</sub>H<sub>32</sub>N<sub>2</sub>Ir [M]<sup>+</sup> 637.2; found 637.1.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)Ir(Bzq)]PF<sub>6</sub> (<b>2</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1</b>, complex <b>2</b> was prepared using 7,8-benzoquinoline, Bzq (34.1 mg, 0.019 mmol, 2.3 equiv), as bidentate chelating ligand. The title compound was obtained as brown-yellow powder (35.9 mg, 58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 9.15 (d, <i>J</i> = 5.3 Hz, 1H), 8.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.99 (dd, <i>J</i> = 16.2, 7.9 Hz, 2H), 7.77–7.71 (m, 3H), 7.65 (t, <i>J</i> = 7.5 Hz, 1H), 7.59 (td, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 6.57 (t, <i>J</i> = 6.7 Hz, 1H), 6.10 (d, <i>J</i> = 4.6 Hz, 1H), 4.33 (d, <i>J</i> = 19.0 Hz, 1H), 4.04 (d, <i>J</i> = 19.0 Hz, 1H), 2.54 (s, 3H), 2.08 (s, 3H), 1.62 (s, 3H), 1.44 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 179.60 (C), 160.47 (C), 156.67 (C), 150.78 (CH), 149.08 (CH), 141.05 (C), 138.45 (CH), 137.70 (CH), 134.86 (C), 132.14 (CH), 130.86 (CH), 130.34 (CH), 127.89 (C), 125.33 (CH), 124.82 (CH), 124.16 (CH), 123.18 (CH), 122.23 (CH), 103.01 (C), 91.68 (2 × C), 91.51 (C), 71.24 (C), 32.56 (CH<sub>2</sub>), 9.42 (CH<sub>3</sub>), 9.30 (CH<sub>3</sub>), 8.56 (CH<sub>3</sub>), 8.29 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>28</sub>H<sub>26</sub>F<sub>6</sub>N<sub>2</sub>PIr (727.70): C, 46.21; H, 3.60; N, 3.85. Found: C, 46.28; H, 3.50; N, 3.83. MS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>28</sub>H<sub>26</sub>N<sub>2</sub>Ir [M]<sup>+</sup> 583.2; found 583.3. Suitable crystals for X-ray diffraction were obtained by crystallization from chloroform at 298 K.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(Bzq)Cl] (<b>2a</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1a</b>, complex <b>2a</b> was prepared using dimer [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)Cl<sub>2</sub>]<sub>2</sub>(60.0 mg, 0.076 mmol, 1.0 equiv), 7,8-benzoquinoline (27.2 mg, 0.152 mmol, 2.0 equiv) as bidentate chelating ligand, and NaOAc (24.9 mg, 0.304 mmol, 4.0 equiv). The title compound was obtained as an intense orange solid (85 mg, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.96 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 8.14 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 8.06 (dd, <i>J</i> = 7.1, 0.9 Hz, 1H), 7.82 (d, <i>J</i> = 8.8 Hz, 1H), 7.65–7.59 (m, 1H), 7.58–7.51 (m, 2H), 7.47 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 1.75 (s, 15H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 161.00 (C), 157.56 (C), 149.14 (CH), 142.09 (C), 135.87 (CH), 134.18 (C), 132.66 (CH), 130.81 (CH), 130.20 (CH), 127.20 (C), 123.19 (CH), 121.61 (CH), 120.26 (CH), 88.50 (5 × C), 9.24 (5 × CH<sub>3</sub>). Elemental Analysis calculated for C<sub>23</sub>H<sub>23</sub>ClNIr (541.11): C 51.05, H 4.25, N 2.59; found C 50.75, H 4.30, N 2.59. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>23</sub>NIr [M]<sup>+</sup> 506.2; found 506.2.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(Bzq)(py)]PF<sub>6</sub> (<b>2b</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1b</b>, complex <b>2b</b> was prepared from a solution of <b>2a</b> (30.0 mg, 0.055 mmol, 1.0 equiv), AgNO<sub>3</sub> (9.4 mg, 0.055 mmol, 1.0 equiv), and pyridine (44.5 μL, 0.550 mmol, 10.0 equiv). The title compound was obtained as an orange solid (28.6 mg, 78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 9.43 (dd, <i>J</i> = 5.4, 1.1 Hz, 1H), 8.50 (dd, <i>J</i> = 6.5, 1.4 Hz, 2H), 8.28 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 8.15–8.10 (m, 1H), 7.95 (dd, <i>J</i> = 8.1, 5.4 Hz, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.77–7.72 (m, 1H), 7.68 (d, <i>J</i> = 7.4 Hz, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.54 (tt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.20 (dd, <i>J</i> = 7.5, 6.6 Hz, 2H), 1.65 (s, 15H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 159.62 (C), 157.16 (C), 153.80 (2 × CH), 151.46 (CH), 142.80 (C), 138.98 (CH), 138.10 (CH), 134.42 (C), 132.15 (CH), 131.46 (CH), 130.17 (CH), 127.58 (C), 127.44 (2 × CH), 124.75 (CH), 124.58 (CH), 122.48 (CH), 90.70 (5 × C), 9.13 (5 × CH<sub>3</sub>). Elemental Analysis calculated for C<sub>28</sub>H<sub>28</sub>F<sub>6</sub>N<sub>2</sub>PIr (729.72): C 46.09, H 3.87, N 3.84; found C 46.41, H 3.72, N 3.96. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>23</sub>NIr [M]<sup>+</sup> 506.2; found 506.2.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)(Bzq)(Cl)] (<b>2c</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1a</b>, complex <b>2c</b> was prepared using dimer [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>Ph)Cl<sub>2</sub>]<sub>2</sub> (35.0 mg, 0.040 mmol, 1.0 equiv), 7,8-benzoquinoline (14.3 mg, 0.08 mmol, 2.0 equiv) as bidentate chelating ligand, and NaOAc (13.2 mg, 0.160 mmol, 4.0 equiv). The title compound was obtained as an intense orange solid (29 mg, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.99 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 8.14 (ddd, <i>J</i> = 8.0, 7.5, 1.1 Hz, 2H), 7.84 (d, <i>J</i> = 8.8 Hz, 1H), 7.67–7.61 (m, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.49 (dd, <i>J</i> = 7.9, 5.3 Hz, 1H), 7.31–7.26 (m, 2H), 7.24–7.18 (m, 1H), 7.17–7.13 (m, 2H), 3.52 (q, <i>J</i> = 16.0 Hz, 2H), 1.81 (d, <i>J</i> = 2.1 Hz, 6H), 1.75 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 160.40 (C), 157.52 (C), 149.26 (CH), 142.08 (C), 138.83 (C), 136.01 (CH), 134.25 (C), 132.75 (CH), 130.86 (CH), 130.24 (CH), 128.71 (2xCH), 128.27 (2 × CH), 127.27 (C), 126.53 (CH), 123.25 (CH), 121.70 (CH), 120.43 (CH), 90.59 (C), 89.97 (C), 89.89 (C), 88.88 (C), 86.94 (C), 30.50 (CH<sub>2</sub>), 9.69 (CH<sub>3</sub>), 9.60 (CH<sub>3</sub>), 9.29 (CH<sub>3</sub>), 9.25 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>29</sub>H<sub>27</sub>ClNIr (617.21): C 56.43, H 4.41, N 2.27; found C 56.71, H 4.43, N 2.37. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>29</sub>H<sub>27</sub>NIr [M]<sup>+</sup> 582.2; found 582.3.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phq)]PF<sub>6</sub> (<b>3</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1</b>, complex <b>3</b> was prepared using 1-phenylisoquinoline, Phq (38.9 mg, 0.190 mmol, 2.3 equiv), as bidentate chelating ligand. The title compound was obtained as a brown-orange powder (42.9 mg, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 9.02–8.95 (m, 1H), 8.71 (d, <i>J</i> = 6.4 Hz, 1H), 8.46 (d, <i>J</i> = 7.4 Hz, 1H), 8.02–7.97 (m, 1H), 7.91 (dd, <i>J</i> = 7.4, 1.3 Hz, 1H), 7.86–7.80 (m, 2H), 7.68–7.60 (m, 2H), 7.41 (d, <i>J</i> = 7.4 Hz, 1H), 7.35–7.27 (m, 1H), 6.73 (t, <i>J</i> = 6.0 Hz, 1H), 6.45 (dd, <i>J</i> = 5.8, 1.1 Hz, 1H), 4.31 (d, <i>J</i> = 19.0 Hz, 1H), 4.05 (d, <i>J</i> = 19.1 Hz, 1H), 2.41 (s, 3H), 2.01 (s, 3H), 1.62 (s, 3H), 1.41 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 179.82 (C), 167.71 (C), 166.41 (C), 149.39 (CH), 145.21 (C), 143.70 (CH), 138.45 (CH), 137.52 (C), 135.06 (CH), 132.10 (CH), 131.53 (CH), 130.91 (CH), 129.08 (CH), 127.98(CH), 126.86 (C), 126.37 (CH), 125.53 (CH), 124.87 (CH), 123.94 (CH), 122.51 (CH), 103.35 (C), 92.35 (C), 92.07 (C), 91.64 (C), 72.56 (C), 32.56 (CH<sub>2</sub>), 9.49 (CH<sub>3</sub>), 9.34 (CH<sub>3</sub>), 8.48 (CH<sub>3</sub>), 8.18 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>30</sub>H<sub>28</sub>F<sub>6</sub>N<sub>2</sub>PIr (753.75): C, 47.81; H, 3.74; N, 3.72. Found: C, 47.88; H, 3.74; N, 3.64. MS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>30</sub>H<sub>28</sub>N<sub>2</sub>Ir [M]<sup>+</sup> 609.2; found 609.3.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(MePhpy)]PF<sub>6</sub> (<b>4</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1</b>, complex <b>4</b> was prepared using 2-(<i>p</i>-tolyl)pyridine, MePhpy (32.0 μL, 0.190 mmol, 2.3 equiv), as bidentate chelating ligand. The title compound was obtained as an orange solid (32.2 mg, 54%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.81 (d, <i>J</i> = 5.5 Hz, 1H), 7.96 (d, <i>J</i> = 8.1 Hz, 1H), 7.87–7.82 (m, 1H), 7.75 (d, <i>J</i> = 7.9 Hz, 1H), 7.65 (td, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.58 (s, 1H), 7.36 (d, <i>J</i> = 7.9 Hz, 1H), 7.29–7.26 (m, 1H), 7.06 (dd, <i>J</i> = 7.9, 1.0 Hz, 1H), 6.80 (t, <i>J</i> = 6.2 Hz, 1H), 6.57 (dd, <i>J</i> = 5.8, 1.3 Hz, 1H), 4.23 (d, <i>J</i> = 19.0 Hz, 1H), 3.99 (d, <i>J</i> = 19.0 Hz, 1H), 2.42 (s, <i>J</i> = 3.8 Hz, 3H), 2.38 (s, 3H), 1.97 (s, 3H), 1.59 (s, 3H), 1.46 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 179.77 (C), 166.91 (C), 163.21 (C), 151.82 (CH), 149.16 (CH), 141.78 (C), 141.20 (C), 138.93 (CH), 138.45 (CH), 135.47 (CH), 125.37 (CH), 125.23 (CH), 124.95 (CH), 124.89 (CH), 123.62 (CH), 119.69 (CH), 102.97 (C), 91.71 (C), 91.65 (C), 91.38 (C), 71.48 (C), 32.47 (CH<sub>2</sub>), 21.90 (CH<sub>3</sub>), 9.25 (2 × CH<sub>3</sub>), 8.41 (CH<sub>3</sub>), 8.08 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>27</sub>H<sub>28</sub>F<sub>6</sub>N<sub>2</sub>PIr (717.71): C, 45.18; H, 3.93; N, 3.90. Found: C, 45.18; H, 3.94; N, 3.91. MS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>28</sub>N<sub>2</sub>Ir [M]<sup>+</sup> 573.2; found 573.3. Suitable crystals for X-ray diffraction were obtained by crystallization from chloroform at 298 K.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(ClPhq)]PF<sub>6</sub> (<b>5</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1</b>, complex <b>5</b> was prepared using 4-chloro-2-phenylquinoline, ClPhq (45.5 mg, 0.190 mmol, 2.3 equiv), as bidentate chelating ligand. The title compound was obtained as orange crystals (28.9 mg, 44%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.31 (d, <i>J</i> = 8.3 Hz, 1H), 8.27 (dd, <i>J</i> = 8.3, 1.1 Hz, 1H), 8.16 (s, 1H), 7.96–7.90 (m, 2H), 7.87–7.83 (m, 1H), 7.77–7.72 (m, 1H), 7.72–7.67 (m, 1H), 7.58 (d, <i>J</i> = 7.9 Hz, 1H), 7.35–7.27 (m, 2H), 6.78–6.72 (m, 2H), 4.55 (d, <i>J</i> = 19.2 Hz, 1H), 4.11 (d, <i>J</i> = 19.2 Hz, 1H), 2.39 (s, 3H), 2.01 (s, 3H), 1.27 (s, 3H), 1.07 (s, 3H). <sup>13</sup>C NMR (101 MHz CDCl<sub>3</sub>): δ = 179.46 (C), 168.69 (C), 165.22 (C), 150.88 (CH), 147.76 (C), 146.52 (C), 144.51 (Q), 138.44 (CH), 135.01 (CH), 133.85 (CH), 132.65 (CH), 128.79 (CH), 128.68 (CH), 126.83 (CH), 126.26 (CH), 125.65 (CH), 125.51 (C), 125.19 (CH), 124.36 (CH), 117.33 (CH), 99.46 (C), 97.57 (C), 93.22 (C), 86.54 (C), 76.47 (C), 32.94 (CH<sub>2</sub>), 10.34 (CH<sub>3</sub>), 9.37 (CH<sub>3</sub>), 9.30 (CH<sub>3</sub>), 8.49 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>30</sub>H<sub>27</sub>ClF<sub>6</sub>N<sub>2</sub>PIr (788.19): C 45.72, H 3.45, N 3.55; found C 45.40, H 3.45, N 3.68. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>30</sub>H<sub>27</sub>ClN<sub>2</sub>Ir [M]<sup>+</sup> 643.2; found 643.3. Suitable crystals for X-ray diffraction were obtained by crystallization from chloroform at 298 K.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(dFPhpy)]PF<sub>6</sub> (<b>6</b>)</h4><div class="NLM_p last">Following the procedure to synthesize complex <b>1</b>, complex <b>6</b> was prepared using 2-(2,4-difluorophenyl)pyridine, dFPhpy (29.0 μL, 0.190 mmol, 2.3 equiv), as bidentate chelating ligand. The title compound was obtained as orange crystals (35.8 mg, 57%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.93 (d, <i>J</i> = 5.2 Hz, 1H), 8.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.90 (t, <i>J</i> = 7.8 Hz, 1H), 7.70 (td, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.41–7.34 (m, 2H), 7.28 (dd, <i>J</i> = 8.3, 2.6 Hz, 1H), 6.87 (t, <i>J</i> = 6.7 Hz, 1H), 6.71 (ddd, <i>J</i> = 12.2, 8.9, 2.3 Hz, 1H), 6.59 (dd, <i>J</i> = 5.8, 1.2 Hz, 1H), 4.28 (d, <i>J</i> = 19.0 Hz, 1H), 3.98 (d, <i>J</i> = 19.0 Hz, 1H), 2.37 (s, 3H), 1.95 (s, 3H), 1.58 (s, 3H), 1.46 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ = 179.69 (C), 166.65 (d, C, <i>J</i><sub>CF</sub> = 4.6 Hz), 164.29 (dd, C, <sup>1</sup><i>J</i><sub>CF</sub> = 258.6 Hz), 163.37 (d, C, <i>J</i><sub>CF</sub> = 6.9 Hz), 162.4 (dd, C, <sup>1</sup><i>J</i><sub>CF</sub> = 263.4 Hz) 152.41 (CH), 149.06 (CH), 139.67 (CH), 138.84 (CH), 128.07 (C), 125.67 (CH), 125.19 (CH), 124.39 (CH), 123.74 (d, CH, <i>J</i><sub>CF</sub> = 19.7 Hz), 116.91 (d, CH, <i>J</i><sub>CF</sub> = 17.8 Hz), 103.91 (C), 100.28 (t, CH, <i>J</i><sub>CF</sub> = 26.6 Hz), 92.59 (C), 92.38 (C), 91.77 (C), 72.21 (C), 32.43 (CH<sub>2</sub>), 9.20 (CH<sub>3</sub>), 9.14 (CH<sub>3</sub>), 8.17 (CH<sub>3</sub>), 7.98 (CH<sub>3</sub>). Elemental Analysis calculated for C<sub>26</sub>H<sub>24</sub>F<sub>8</sub>N<sub>2</sub>PIr (739.67): C 42.22, H 3.27, N 3.79; found C 41.95, H 3.33, N 3.95. MS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>24</sub>F<sub>2</sub>N<sub>2</sub>Ir [M]<sup>+</sup> 595.2; found 595.3. Suitable crystals for X-ray diffraction were obtained by crystallization from chloroform/methanol at 298 K.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methods and Instrumentation</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Single Crystal X-ray Diffraction</h4><div class="NLM_p">Suitable crystals for <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b> were coated with mineral oil mounted on Mitegen MicroMounts. The samples were measured at 150 K in a Bruker D8 KAPPA APEX II diffractometer with CCD area detector, equipped with graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The substantial redundancy in data allowed empirical absorption corrections (SADABS) to be applied using multiple measurements of symmetry-equivalent reflections. Raw intensity data frames were integrated with the SAINT program, which also applied corrections for Lorentz and polarization effects. The Bruker SHELXTL software package was used for space group determination, structure solution, and refinement. The space group determination was based on a check of the Laue symmetry, and systematic absences were confirmed using the structure solution. The structures were solved by direct methods (SHELXL-2014/7), completed with different Fourier syntheses, and refined with full-matrix least-squares using SHELXS minimizing ω(<i>F</i><sub>o</sub><sup>2</sup> – <i>F</i><sub>c</sub><sup>2</sup>)<sup>2</sup>. Weighted <i>R</i> factors (<i>R</i><sub>w</sub>) and goodness of fit (<i>S</i>) are based on <i>F</i><sup>2</sup>; conventional <i>R</i> factors (<i>R</i>) are based on <i>F</i>. All non-hydrogen atoms were refined with anisotropic displacement parameters. Hydrogen atom positions were geometrically calculated and allowed to ride on their parent carbon or nitrogen atoms with fixed isotropic U. All scattering factors and anomalous dispersion factors are contained in the SHELXTL 6.10 program library. Statistical analysis for significant differences were performed using the three-sigma limits (>3σ).</div><div class="NLM_p last">The crystal structures of compounds <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b> have been deposited at the Cambridge Crystallographic Data Centre with deposition numbers 1962283, 1968141, 1968143, 1968145, and 1968213, respectively.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Nuclear Magnetic Resonance (NMR) Spectroscopy</h4><div class="NLM_p last"><sup>1</sup>H NMR spectra were recorded in 5 mm NMR tubes using a Bruker DPX 400 MHz spectrometer at room temperature. <sup>1</sup>H NMR chemical shifts were internally referenced to CDCl<sub>3</sub> (7.26 ppm), [<i>d</i><sub>6</sub>]DMSO (2.50 ppm) and [<i>d</i><sub>7</sub>]DMF (8.03 ppm). Chemical shifts, δ, are quoted in part per million (ppm) downfield of trimethylsilane. Coupling constants, <i>J</i>, are reported to the nearest 0.1 Hz. The splitting patterns for the spectra assignment are abbreviated to singlet (s), doublet (d), triplet (t), quartet (q), and multiplet (m). Data processing was carried out using MestreNova, version 6.0 (Mestrelab Research, SL).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Elemental Analysis</h4><div class="NLM_p last">Elemental analysis was carried out using a Leco analytical elemental analyzer, CHNS-932.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Mass Spectrometry (MS)</h4><div class="NLM_p last">Low resolution mass spectra were acquired using an Expression-L compact mass spectrometer with <i>m</i>/<i>z</i> 2000 mass range equipped with an electrospray ionization (ESI) ion source and a single quadrupole analyzer. 0.1% FA methanol was used as the solvent to prepare the iridium diluted samples ([Ir] ca. 0.1 μM) and as eluent. MS analyses were carried out through direct infusion of the sample using a syringe pump.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> UV–vis Absorption Spectroscopy</h4><div class="NLM_p last">UV–vis absorption data were collected using an Agilent Cary 5000 UV–vis–NIR or an Agilent Cary 60 both equipped with temperature controller, using 1 cm path length quartz cuvettes (800 μL). Spectra were recorded at different temperatures in aqueous solutions from 200 to 600 nm. Data were processed using OriginPro version 9.0 (OriginLab, Northampton, MA).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Dimethyl Sulfoxide Coordination</h4><div class="NLM_p last">Dimethyl sulfoxide solutions of the Ir(III) complexes (ca. 6–8 mM at 298 K) were prepared by dissolving <b>1</b>–<b>6</b> in [D<sub>6</sub>]DMSO. <sup>1</sup>H NMR spectra were recorded in situ after sample preparation (data collection at ca. 5 min after dissolution) and at different times up to 24 h. Speciation of each closed-tether complex, i.e., conversion into the dimethyl sulfoxide open-tether species, was quantified by integration of a H<sub>py</sub> signal (an aromatic proton of the tethered pyridine) in the <sup>1</sup>H NMR spectra. In another set of experiments, for the kinetic study by UV–vis spectroscopy, dimethyl sulfoxide solutions of the Ir(III) complexes (ca. 0.1 mM at 298 K) were prepared by dissolving <b>1</b>–<b>6</b> in DMSO. UV–vis absorption spectra were recorded at 298 K at different time intervals, from 200 to 600 nm. To determine the reaction rate <i>k</i> and the half-life <i>t</i><sub>1/2</sub>, we first plotted the difference Absorption spectra (Abs<sub>t</sub> – Abs<sub>0</sub>) to select the optimum wavelength at which the formation of the Ir–DMSO adduct was observed. Then we plotted the Ln of this absorbance (LnAbs) versus time, and <i>k</i><sub>DMSO</sub> was obtained from the subsequent lineal fitting. Statistical analysis for significant differences were performed using the three-sigma limits (>3σ).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Cell Culture</h4><div class="NLM_p">MCF7 and MDA-MB-231 human breast cancer cell lines were obtained from American Type Culture Collection (ATCC). A2780 human ovarian cancer cell line, HCT116 human colorectal cancer cell line, PANC-1 human pancreatic carcinoma, and MRC-5 fibroblast-like lung normal cells were obtained from the European Collection of Cell Culture (ECACC), Public Health England (PHE). MIA PaCa-2 human pancreatic cancer cell line was kindly provided by Dr. A. Somoza (IMDEA Nanociencia, Spain). MCF7 and MIA PaCa-2 were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) Low Glucose (LabClinics), MDA-MB-231, and PANC-1 in DMEM High Glucose (LabClinics), A2780 in Roswell Park Memorial Institute (RPMI) 1640 medium (VWR), HCT116 in McCoy’s 5A medium (LabClinics), and MRC-5 in Minimum Essential Medium with Earle’s Balanced Salt Solutions (MEM (EBSS); GE Healthcare). All media were supplemented with 10% fetal bovine serum (Gibco, Life Technologies), 1% of 2 mM GlutaMAX-I (Gibco, Life Technologies) and 1% penicillin/streptomycin (VWR). Media for MRC-5 was also supplemented with 1% Non-Essential Amino Acids (NEAA, Merck Millipore).</div><div class="NLM_p last">All cell lines were grown as adherent monolayers at 37 °C in a 5% CO<sub>2</sub> humidified atmosphere. Cells were cultured for at least 7–10 days upon thawing, subcultured at approximately 70–80% confluency, and experiments were conducted on exponentially growing cells.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Exposure to Ir(III) Compounds</h4><div class="NLM_p last">Stock solutions of the Ir(III) complexes (16 mM) were first prepared by dissolving each compound in 100% sterile DMSO (or DMF) to assist dissolution and stored at −20 °C. The compounds were then diluted in medium to get the desired concentration for treating the cells. All compounds were soluble at the maximum concentration tested in the biological assays (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S14</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Table S1</a>). ICP-OES was used to corroborate solubility in culture media for complex <b>1</b> as a representative example of complexes <b>1</b>–<b>6</b> (data not shown). Additionally, stability in aqueous solution and in saline (0.9% NaCl) at 37 °C was corroborated by means of UV–vis (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S24</a>). Prior to all treatments, cells were allowed to adhere for 24 or 48 h and then exposed to the test compounds. All experiments were performed in parallel with DMSO (or DMF) as vehicle control. Cisplatin, a metal-based cytotoxic agent used to treat various types of cancers in the clinic, was used as a positive control in all assays.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Determination of IC<sub>50</sub> Values</h4><div class="NLM_p last">For the evaluation of cellular cytotoxicity/antiproliferative activity, 5000 MCF7, A2780, MIA PaCa-2, MDA-MB-231, PANC-1 cells, 1000 HCT116 cells, and 3000 MRC-5 cells were seeded in 96-well plates (VWR) and grown for 48 h in complete medium. Solutions of the Ir(III) compounds were prepared and added to the wells to obtain a final concentration ranging from 0 to 50 (or 100 μM for the less cytotoxic complexes), and the cells were incubated for 24 h at 37 °C. Following 24 h of drug exposure, cells were washed with PBS (Fisher Scientific), supplied with fresh medium, and allowed to grow for 72 h. The protein content (proportional to living cells in culture) was measured using the sulforhodamine B (SRB) assay<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> for MCF7, A2780, MIA PaCa-2, MDA-MB-231, PANC-1, and HCT116 cells, and the MTS assay for MRC-5 cells, using a UV–visible spectrophotometer (Sinergy H4 microplate reader) at 510 and 490 nm, respectively. The percentage of surviving cells was calculated from the ratio of absorbance of treated to nontreated cells (control cells). The IC<sub>50</sub> value was determined as the concentration of drug required to inhibit cell population growth by 50% compared to control, as a result of a combination of drug cytotoxicity and antiproliferative activity, and is presented as a mean ± CI of two to three independent experiments of four replicates each.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Cellular Accumulation in MCF7 Cells</h4><div class="NLM_p last">MCF7 cells were seeded at a density of 2.0 × 10<sup>6</sup> cells/100 mm Petri dish in 9 mL of culture medium (three dishes were prepared per compound tested, and three untreated control dishes). After 24 h of incubation at 37 °C, cells were exposed to the Ir(III) complexes. Solutions of the Ir(III) compounds were prepared by diluting a freshly prepared stock solution (in DMSO) of the corresponding complex in media to a final concentration of 0.005, 0.25, or 1 μM. After 8 or 24 h of drug exposure at 37 °C in a 5% CO<sub>2</sub> incubator, the drug-containing medium was removed, and the cells were washed with PBS, trypsinized, and counted using a hemocytometer. Cells were centrifuged, the media eliminated, and cell pellets were stored at −20 °C until digestion for ICP-MS analysis for <sup>191</sup>Ir content. These experiments were all carried out in triplicate.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> ICP-MS Analysis</h4><div class="NLM_p">ICP-MS analyses were carried out on a PerkinElmer NexION 300 ICP-MS instrument. The water used for ICP-MS analysis was purified using a Millipore Milli-Q element system. The iridium standard (SCP Science, 1000 ppm) was diluted with ultrapure water to 10 ppm. The standards for calibration were freshly prepared by diluting this stock solution with 2% HNO<sub>3</sub> + 0.5% HCl (v/v) in ultrapure water. The concentrations used for the calibration of the instrument were 500, 50, 5, 0.5, and 0.05 ppb. Samples were diluted 1:10 with 2% HNO<sub>3</sub> + 0.5% HCl (v/v) in ultrapure water. All calibrants and samples contained 30 ppb Re and 30 ppb Rh as internal standards.</div><div class="NLM_p last">Cell pellets were digested as described below. To each cell pellet, 0.3 mL of ultrapure 70% HNO<sub>3</sub> (0.3 mL; Sigma-Aldrich) were added, and the samples were transferred into Wheaton V-Vials with a PTFE-faced rubber-lined cap (Sigma-Aldrich). The vials were heated in an oven at 80 °C for 16 h to fully digest the samples and allowed to cool. Each sample was then transferred to a 15 mL tube. Then 0.3 mL of ultrapure 37% HCl (Sigma-Aldrich) was added to each tube for metal stabilization. Doubly deionized water was then added for a maximum final concentration of 5% HNO<sub>3</sub> (suitable for ICP-MS analysis) prior to quantification of <sup>191</sup>Ir.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> TrxR Activity Assay by DTNB Assay (in Vitro)</h4><div class="NLM_p last">An established microplate reader based assay was performed with minor modifications to determine the inhibition of TrxR. Commercially available Thioredoxin Reductase Assay Kit (Sigma-Aldrich) was used for this purpose. In this assay, the isolated rat liver TrxR enzyme catalyzes the reduction of 5,5′-dithiobis(2-nitrobenzoic)acid (DTNB) with NADPH to 5-thio-2-nitrobenzoic acid (TNB), which produces a strong yellow color, measured at 412 nm.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The compounds were freshly dissolved at various concentrations in media from the DMSO stock solutions. Aliquots (3 μL) of the enzyme solution were added to each well, which contained 47 μL of potassium phosphate buffer pH 7.0 and the Ir(III) compounds in graded concentrations, or vehicle (DMSO) without compounds (control probe), in a 96-well plate. The resulting solutions were incubated for 90 min (shaking every 30 min) at 37 °C. A master mixture in potassium phosphate buffer pH 7.0 and 50 mM EDTA containing DTNB and NADPH was then added (final concentration: 2 mM and 240 μM, respectively). After mixing, the formation of TNB was monitored with a microplate reader (Sinergy H4 microplate reader) at 412 nm in 31 s intervals for 10 min. The increase in TNB concentration over time followed a linear trend, and the enzymatic activity was calculated as the slopes (increase in absorbance per second) thereof. For each tested compound, the noninterference with the assay components was confirmed by a negative control experiment using an enzyme-free solution. The EC<sub>50</sub> values were calculated as the concentration of compound decreasing the enzymatic activity of the untreated control by 50% and are given as the means and error of two or three repeated experiments in triplicate or quadruplicate.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> TrxR Activity Assay in Cell Lysates</h4><div class="NLM_p last">MCF7 cells were seeded at a density of 3.0 × 10<sup>6</sup> cells/T75 flask in 16 mL of culture medium (three flasks were prepared per compound tested, and three untreated control flasks) and incubated for 24 h at 37 °C. After that time, cells were treated with various concentrations of the Ir(III) complexes for 24 h at 37 °C, and then they were harvested and washed twice with phosphate-buffered saline (PBS). Total cellular proteins were extracted with a mixture of RIPA buffer (Thermo Scientific) and Protease Inhibitor Cocktail (MedChem Express) for 5 min on ice and subsequent scraping. The total protein content was quantified using the Pierce BCA Protein Assay Kit (Thermo Scientific). TrxR activity in cell lysates was measured by the DTNB assay. Briefly, the cell extract containing 100 μg of total proteins was incubated in a final reaction volume of 50 μL containing potassium phosphate buffer pH 7.0 for 90 min (shaking every 30 min) at 37 °C. The reaction was started by addition of NADPH and DNTB, and then the TrxR activity was detected by measurement of TNB quantity at 412 nm as described above.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Intracellular ROS Determination by the DCFH-DA Assay</h4><div class="NLM_p last">2′,7′-Dichlorofluorescin diacetate (DCFH-DA) is a cell-permeable nonfluorescent probe. DCFH-DA is de-esterified inside the cell to DCFH, which turns to highly fluorescent 2′,7′-dichlorofluorescein, DCF, upon oxidation. DCFH is useful for the detection of reactive oxygen species (ROS) and for the determination of the degree of overall oxidative stress. ROS directly determined by the DCFH-DA assay include peroxyl, alkoxyl, NO<sub>2</sub><sup>•</sup>, carbonate (CO<sub>3</sub><sup>•–</sup>), and OH<sup>•</sup> radicals and peroxynitrite anion. Additionally, it can detect cellular peroxides efficiently if they are decomposed to radicals. In our protocol 50000 MCF7 cells per well were seeded in a 24-well plate and allowed to adhere for 24 h at 37 °C. Then 200 μL per well of serial dilutions of different Ir(III) complexes in medium were added to obtain the required final test concentrations of Ir(III) compounds (0–1 μM). Immediately after 90 min of exposure to Ir(III) complexes at 37 °C, the fluorescein-labeled probe DCFH-DA (20 μM) was added to each well, and incubation continued for 30 min at 37 °C in the dark. After being taken up by cells, the nonfluorescent DCFH-DA is hydrolyzed to DCFH and trapped within the cell. The nonfluorescent DCFH is then oxidized to fluorescent dichlorofluorescin (DCF) by action of cellular ROS. The DCF fluorescence intensity generated is directly proportional to total ROS levels, and it is indicative of an increase in the oxidative stress caused by iridium exposure.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The fluorescence was then measured on a spectrofluorometer at λ<sub>ex</sub> = 485 nm and λ<sub>em</sub> = 535 nm. The fluorescence induction factor (fold) for each concentration of Ir(III) compounds was calculated by dividing the reading of each well by the average reading of the negative control (0 μM Ir(III)).</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Mitochondrial Transmembrane Potential Determination Using Flow Cytometry</h4><div class="NLM_p last">The change in mitochondrial membrane potential (ΔΨ<sub><i>m</i></sub>) due to exposure of MCF7 cells to the Ir(III) compounds was assessed by the lipophilic cationic dye 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetramethyl benzimidazol carbocyanine iodide (JC-10, abcam) and fluorescence activated cell sorting (FACS). JC-10 dye emits green fluorescence (520 nm) in its monomeric form and, as a lipophilic cation, can selectively enter into mitochondrial matrix, forming aggregates and switching color from green to red (emission at 570 nm). When apoptosis occurs, the ΔΨ<i><sub>m</sub></i> is reduced and JC-10 disaggregates, which is indicated by green fluorescence (and a reduction of the red emission). Briefly, MCF7 cells were seeded at a density of 2.0 × 10<sup>6</sup> cells/100 mm Petri dish in 9 mL of culture medium (three dishes were prepared per compound tested, and three untreated control dishes) and incubated for 24 h at 37 °C. After 24 h of incubation, cells were treated with 0.25 μM of the Ir(III) complexes for 24 h at 37 °C. For positive control, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was used to depolarize the mitochondrial membrane potential. Cells were exposed at 100 μM of CCCP for 45 min. After incubation, the drug-containing medium was removed and the cells were washed with PBS, trypsinized, and centrifuged. The JC-10 staining solution was prepared by diluting the JC-10 stock solution into the assay buffer. The cell pellets were then resuspended in the JC-10 dye-loading solution and incubated at room temperature for 30 min, protected from light. After incubation, the proportion of green and red fluorescence intensity was immediately detected by a CYTOMICS FC 500 analyzer (5 colors, 1 laser, 488 nm, Beckman Coulter) using the FL1 channel for the green fluorescent monomeric signal and the FL2 channel for the orange-red fluorescent aggregated signal. Fluorescence was excited at 490 nm, and the emission was measured at 520 nm (monomeric form) and 570 (aggregate form). Flow cytometry dot plots establish four different cellular populations: F1, high red and low green fluorescence, F2 high red and green fluorescence, F3 low red and green fluorescence, and F4 low red and high green fluorescence (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">Figure S23</a>). The ratio between the cellular populations in F4 and F2 indicates mitochondrial depolarization by an increase in the fluorescence intensity green/red ratio. The 520 nm/570 nm emission ratio was determined from three different replicates, and the F4/F2 ratio of Ir(III)-treated or CCCP-treated cells was compared with the control cells. All the experiments were performed in triplicate.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Statistical Analysis</h4><div class="NLM_p last">All statistical analyses were performed using R Statistical Software (version 3.3.2 (2016–10–31); R Foundation for Statistical Computing, Vienna, Austria) by one-way analysis of variance (ANOVA) (*<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001) unless otherwise stated.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02000" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02000?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02000</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra of all complexes synthesized in this work; chemical reactivity of the iridium complexes in DMSO, water, and DMF; stability in aqueous solution and saline; aqueous solubility of complexes <b>1</b>–<b>6</b>; X-ray crystallographic data of complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b>; IC<sub>50</sub> values in several cell lines, inhibition of TrxR, and effect of mitochondrial membrane potential of the iridium complexes in MCF7 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_002.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_003.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>4</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_004.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>5</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_005.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>6</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_006.cif" class="ext-link">CIF</a>)</p></li><li><p class="inline">Molecular formula strings and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_007.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf">jm9b02000_si_001.pdf (3.17 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_002.cif">jm9b02000_si_002.cif (1.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_003.cif">jm9b02000_si_003.cif (938.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_004.cif">jm9b02000_si_004.cif (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_005.cif">jm9b02000_si_005.cif (2.9 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_006.cif">jm9b02000_si_006.cif (794.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_007.csv">jm9b02000_si_007.csv (1.94 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02000" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana M. Pizarro</span> - <span class="hlFld-Affiliation affiliation">IMDEA
Nanociencia, Faraday 9, 28049 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Unidad
Asociada de Nanobiotecnología CNB-CSIC-IMDEA, 28049 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3037-9835" title="Orcid link">http://orcid.org/0000-0003-3037-9835</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#85e4ebe4abf5ecffe4f7f7eac5ece8e1e0e4abeaf7e2"><span class="__cf_email__" data-cfemail="fa9b949bd48a93809b888895ba93979e9f9bd495889d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana C. Carrasco</span> - <span class="hlFld-Affiliation affiliation">IMDEA
Nanociencia, Faraday 9, 28049 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanessa Rodríguez-Fanjul</span> - <span class="hlFld-Affiliation affiliation">IMDEA
Nanociencia, Faraday 9, 28049 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3386-5874" title="Orcid link">http://orcid.org/0000-0002-3386-5874</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abraha Habtemariam</span> - <span class="hlFld-Affiliation affiliation">IMDEA
Nanociencia, Faraday 9, 28049 Madrid, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. J. Perles and Dr. M. Ramı́rez for the collection of X-ray data. Dr. Z. Pardo and Dr. A. Arnáiz (IMDEA Nanociencia) are gratefully acknowledged for assistance with NMR experiments and cell culture techniques, respectively. We acknowledge funding from the EC (FP7-PEOPLE-2013-CIG, no. 631396), and from the Spanish MINECO (RYC-2012-11231, CTQ2014-60100-R, SEV-2016-0686, and CTQ2017-84932-P). A.H. was supported by the Comunidad Autónoma de Madrid (Professorship of Excellence 2016-T3/IND-2054).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Phpy</td><td class="NLM_def"><p class="first last">2-phenylpyridine</p></td></tr><tr><td class="NLM_term">Bzq</td><td class="NLM_def"><p class="first last">7,8-benzoquinoline</p></td></tr><tr><td class="NLM_term">Phq</td><td class="NLM_def"><p class="first last">1-phenylisoquinoline</p></td></tr><tr><td class="NLM_term">MePhpy</td><td class="NLM_def"><p class="first last">2-(<i>p</i>-tolyl)pyridine</p></td></tr><tr><td class="NLM_term">ClPhpy</td><td class="NLM_def"><p class="first last">4-chloro-2-phenylquinoline</p></td></tr><tr><td class="NLM_term">dFPhpy</td><td class="NLM_def"><p class="first last">2-(2,4-difluorophenyl)pyridine</p></td></tr><tr><td class="NLM_term">RCD</td><td class="NLM_def"><p class="first last">regulated cell death</p></td></tr><tr><td class="NLM_term">CDDP</td><td class="NLM_def"><p class="first last"><i>cis</i>-diamminedichloridoplatinum(II), cisplatin</p></td></tr><tr><td class="NLM_term">DCFH-DA</td><td class="NLM_def"><p class="first last">2′,7′-dichlorofluorescein diacetate</p></td></tr><tr><td class="NLM_term">Trx</td><td class="NLM_def"><p class="first last">thioredoxin</p></td></tr><tr><td class="NLM_term">TrxR</td><td class="NLM_def"><p class="first last">thioredoxin reductase</p></td></tr><tr><td class="NLM_term">CCCP</td><td class="NLM_def"><p class="first last">carbonyl cyanide <i>m</i>-chlorophenyl hydrazine</p></td></tr><tr><td class="NLM_term"><i>n</i>-BuLi</td><td class="NLM_def"><p class="first last"><i>n</i>-buthylithium</p></td></tr><tr><td class="NLM_term">NaOAc</td><td class="NLM_def"><p class="first last">sodium acetate</p></td></tr><tr><td class="NLM_term">FA</td><td class="NLM_def"><p class="first last">formic acid</p></td></tr><tr><td class="NLM_term">DIPA</td><td class="NLM_def"><p class="first last">diisopropylamine</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle’s Medium</p></td></tr><tr><td class="NLM_term">MEM</td><td class="NLM_def"><p class="first last">minimum essential medium</p></td></tr><tr><td class="NLM_term">EBSS</td><td class="NLM_def"><p class="first last">Earle’s Balance Salt Solution</p></td></tr><tr><td class="NLM_term">NEAA</td><td class="NLM_def"><p class="first last">nonessential amino acids</p></td></tr><tr><td class="NLM_term">DTNB</td><td class="NLM_def"><p class="first last">5,5′-dithiobis(2-nitrobenzoic)acid</p></td></tr><tr><td class="NLM_term">TNB</td><td class="NLM_def"><p class="first last">5-thio-2-nitrobenzoic acid</p></td></tr><tr><td class="NLM_term">JC-10</td><td class="NLM_def"><p class="first last">5,5′,6,6′-tetrachloro-1,1′,3,3′-tetramethyl benzimidazole carbocyanide iodide</p></td></tr><tr><td class="NLM_term">FACS</td><td class="NLM_def"><p class="first last">fluorescence activated cell sorting</p></td></tr><tr><td class="NLM_term">cryo-SXT</td><td class="NLM_def"><p class="first last">cryo soft X-ray tomography</p></td></tr><tr><td class="NLM_term">cryo-XRF</td><td class="NLM_def"><p class="first last">cryo hard X-ray fluorescence</p></td></tr><tr><td class="NLM_term">ICP-MS</td><td class="NLM_def"><p class="first last">inductively coupled plasma mass spectrometry</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67865" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67865" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzler-Nolte, N.</span></span> <span> </span><span class="NLM_article-title">Organometallic anticancer compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1021/jm100020w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100020w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVeksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3-25&issue=1&author=G.+Gasserauthor=I.+Ottauthor=N.+Metzler-Nolte&title=Organometallic+anticancer+compounds&doi=10.1021%2Fjm100020w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic anticancer compounds</span></div><div class="casAuthors">Gasser, Gilles; Ott, Ingo; Metzler-Nolte, Nils</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The quest for alternative drugs to the well-known cisplatin and its derivs., which are still used in more than 50% of the treatment regimes for patients suffering from cancer, is highly needed.  In this context, organometallic compds., which are defined as metal complexes contg. at least one direct, covalent metal-carbon bond, have recently been found to be promising anticancer drug candidates.  Organometallics have a great structural variety (ranging from linear to octahedral and even beyond), have far more diverse stereochem. than org. compds. (for an octahedral complex with six different ligands, 30 stereoisomers exist!), and by rational ligand design, provide control over key kinetic properties (such as hydrolysis rate of ligands).  Furthermore, they are kinetically stable, usually uncharged, and relatively lipophilic and their metal atom is in a low oxidn. state.  Because of these fundamental differences compared to "classical coordination metal complexes", organometallics offer ample opportunities in the design of novel classes of medicinal compds., potentially with new metal-specific modes of action.  Interestingly, all the typical classes of organometallics such as metallocenes, half-sandwich, carbene-, CO-, or -ligands, which have been widely used for catalysis or biosensing purposes, have now also found application in medicinal chem..  In this Perspective, we report on the recent advances in the discovery of organometallics with proven antiproliferative activity.  We are emphasizing those compds. where efforts have been made to identify their mol. target and mode of action by biochem. or cell biol. studies.  This Perspective covers more classes of compds. and in more detail than a recent tutorial review by Hartinger and Dyson.  Furthermore, whereas recent reviews and book contributions attest to the rapid development of bioorganometallic chem. in general, this Perspective focuses on their potential application as anticancer chemotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51OmjvSXWo7Vg90H21EOLACvtfcHk0lguKySZbvPMyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVeksb3N&md5=2a95cf3540aed5e66aa655bb38ef4ff8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm100020w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100020w%26sid%3Dliteratum%253Aachs%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DOtt%26aufirst%3DI.%26aulast%3DMetzler-Nolte%26aufirst%3DN.%26atitle%3DOrganometallic%2520anticancer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D3%26epage%3D25%26doi%3D10.1021%2Fjm100020w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Caporale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massi, M.</span></span> <span> </span><span class="NLM_article-title">Cyclometallated iridium(III) complexes for life science</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2018.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ccr.2018.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslGjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2018&pages=71-91&author=C.+Caporaleauthor=M.+Massi&title=Cyclometallated+iridium%28III%29+complexes+for+life+science&doi=10.1016%2Fj.ccr.2018.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated iridium(III) complexes for life science</span></div><div class="casAuthors">Caporale, Chiara; Massi, Massimiliano</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-91</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photoluminescent cyclometalated iridium(III) complexes are now a well established class of organometallic compds. with advantageous potential applications in biol. and life science.  While these complexes, along with other luminescent transition metals and lanthanoid complexes, were initially proposed as alternative markers to org. fluorophores in the staining of cells, it is now evident that their specific biol. behavior makes this class of compds. useful in broader areas of life science such as imaging, sensing and therapy.  The crit. factors for the effective design of cyclometalated iridium(III) complexes with specific biol. properties are still rather difficult to rationalize, and often mainly rely of aspects such as the intrinsic charge of the complex, its lipophilicity and its aq. soly.  This review overviews the area of cyclometalated iridium(III) complexes in biol., with an emphasis on comparing the various conditions that these compds. have been assessed for their biol. potential, such as the specific tested cells lines, concn. of internalization, incubation time, and mechanism of cellular entrance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK_6EFQtoARLVg90H21EOLACvtfcHk0lioAI3bCL4PBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslGjsrk%253D&md5=bcdc5fc7074ced9f63ec4752a50418af</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2018.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2018.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DCaporale%26aufirst%3DC.%26aulast%3DMassi%26aufirst%3DM.%26atitle%3DCyclometallated%2520iridium%2528III%2529%2520complexes%2520for%2520life%2520science%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2018%26volume%3D363%26spage%3D71%26epage%3D91%26doi%3D10.1016%2Fj.ccr.2018.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qamar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hands-Portman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organometallic iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/cb400070a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400070a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1335-1343&issue=6&author=J.+M.+Hearnauthor=I.+Romero-Canelonauthor=B.+Qamarauthor=Z.+Liuauthor=I.+Hands-Portmanauthor=P.+J.+Sadler&title=Organometallic+iridium%28III%29+anticancer+complexes+with+new+mechanisms+of+action%3A+NCI-60+screening%2C+mitochondrial+targeting%2C+and+apoptosis&doi=10.1021%2Fcb400070a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis</span></div><div class="casAuthors">Hearn, Jessica M.; Romero-Canelon, Isolda; Qamar, Bushra; Liu, Zhe; Hands-Portman, Ian; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1335-1343</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Platinum complexes related to cisplatin, cis-[PtCl2(NH3)2], are successful anticancer drugs; however, other transition metal complexes offer potential for combating cisplatin resistance, decreasing side effects, and widening the spectrum of activity.  Organometallic half-sandwich iridium (IrIII) complexes [Ir(Cpx)(XY)Cl]+/0 (Cpx = biphenyltetramethylcyclopentadienyl and XY = phenanthroline , bipyridine , or phenylpyridine ) all hydrolyze rapidly, forming monofunctional G adducts on DNA with addnl. intercalation of the Ph substituents on the Cpx ring.  In comparison, highly potent [Ir(η5-Cpxph)(NMe2-azpy)Cl]PF6 (complex 4, Cpx = phenyltetramethylcyclopentadienyl and XY = N,N-dimethylphenylazopyridine) does not hydrolyze.  All show higher potency toward A2780 human ovarian cancer cells compared to cisplatin, with [Ir(η5-Cp xbiph)(phen)Cl]PF6 (complex 1), [Ir(η5-Cpxbiph)(ppy)Cl] (complex 3), and complex 4 also demonstrating higher potency in the National Cancer Institute (NCI) NCI-60 cell-line screen.  Use of the NCI COMPARE algorithm (which predicts mechanisms of action (MoAs) for emerging anticancer compds. by correlating NCI-60 patterns of sensitivity) shows that the MoA of these IrIII complexes has no correlation to cisplatin (or oxaliplatin), with complex 3 and complex 4 emerging as particularly novel compds.  Those findings by COMPARE were exptl. probed by TEM of A2780 cells exposed to complex 1, showing mitochondrial swelling and activation of apoptosis after 24 h.  Significant changes in mitochondrial membrane polarization were detected by flow cytometry, and the potency of the complexes was enhanced ∼5× by co-administration with a low concn. (5 μM) of the γ-glutamyl cysteine synthetase inhibitor L-buthionine sulfoximine (L-BSO).  These studies reveal potential polypharmacol. of organometallic IrIII complexes, with MoA and cell selectivity governed by structural changes in the chelating ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdNXSST9mEbbVg90H21EOLACvtfcHk0lioAI3bCL4PBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt70%253D&md5=a5b824f70514e503cb25b07dfcefab74</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fcb400070a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400070a%26sid%3Dliteratum%253Aachs%26aulast%3DHearn%26aufirst%3DJ.%2BM.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DQamar%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHands-Portman%26aufirst%3DI.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganometallic%2520iridium%2528III%2529%2520anticancer%2520complexes%2520with%2520new%2520mechanisms%2520of%2520action%253A%2520NCI-60%2520screening%252C%2520mitochondrial%2520targeting%252C%2520and%2520apoptosis%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D1335%26epage%3D1343%26doi%3D10.1021%2Fcb400070a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hally, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svitelova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresoli-Obach, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchan, V.</span></span> <span> </span><span class="NLM_article-title">Towards novel photodynamic anticancer agents generating superoxide anion radicals: a cyclometalated Ir(III) complex conjugated to a far-red emitting coumarin</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6311</span>– <span class="NLM_lpage">6315</span>, <span class="refDoi"> DOI: 10.1002/anie.201901268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fanie.201901268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvVCjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=6311-6315&issue=19&author=V.+Novohradskyauthor=A.+Roviraauthor=C.+Hallyauthor=A.+Galindoauthor=G.+Viguerasauthor=A.+Gandiosoauthor=M.+Svitelovaauthor=R.+Bresoli-Obachauthor=H.+Kostrhunovaauthor=L.+Markovaauthor=J.+Kasparkovaauthor=S.+Nonellauthor=J.+Ruizauthor=V.+Brabecauthor=V.+Marchan&title=Towards+novel+photodynamic+anticancer+agents+generating+superoxide+anion+radicals%3A+a+cyclometalated+Ir%28III%29+complex+conjugated+to+a+far-red+emitting+coumarin&doi=10.1002%2Fanie.201901268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated IrIII Complex Conjugated to a Far-Red Emitting Coumarin</span></div><div class="casAuthors">Novohradsky, Vojtech; Rovira, Anna; Hally, Cormac; Galindo, Alex; Vigueras, Gloria; Gandioso, Albert; Svitelova, Marie; Bresoli-Obach, Roger; Kostrhunova, Hana; Markova, Lenka; Kasparkova, Jana; Nonell, Santi; Ruiz, Jose; Brabec, Viktor; Marchan, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6311-6315</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Although cyclometalated IrIII complexes have emerged as promising photosensitizers for photodynamic therapy, some key drawbacks still hamper clin. translation, such as operability in the phototherapeutic window and reactive oxygen species (ROS) prodn. efficiency and selectivity.  In this work, a cyclometalated IrIII complex conjugated to a far-red-emitting coumarin, IrIII-COUPY, is reported with highly favorable properties for cancer phototherapy.  IrIII-COUPY was efficiently taken up by HeLa cells and showed no dark cytotoxicity and impressive photocytotoxicity indexes after irradn. with green and blue light, even under hypoxia.  Importantly, a clear correlation between cell death and intracellular generation of superoxide anion radicals after visible light irradn. was demonstrated.  This strategy opens the door to novel fluorescent photodynamic therapy agents with promising applications in theragnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9slQpnjEet7Vg90H21EOLACvtfcHk0ljVTpwVWPHXKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvVCjs7c%253D&md5=83a14a65fc4640b504a3ee147449e887</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201901268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201901268%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DRovira%26aufirst%3DA.%26aulast%3DHally%26aufirst%3DC.%26aulast%3DGalindo%26aufirst%3DA.%26aulast%3DVigueras%26aufirst%3DG.%26aulast%3DGandioso%26aufirst%3DA.%26aulast%3DSvitelova%26aufirst%3DM.%26aulast%3DBresoli-Obach%26aufirst%3DR.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DMarkova%26aufirst%3DL.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DNonell%26aufirst%3DS.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DMarchan%26aufirst%3DV.%26atitle%3DTowards%2520novel%2520photodynamic%2520anticancer%2520agents%2520generating%2520superoxide%2520anion%2520radicals%253A%2520a%2520cyclometalated%2520Ir%2528III%2529%2520complex%2520conjugated%2520to%2520a%2520far-red%2520emitting%2520coumarin%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26issue%3D19%26spage%3D6311%26epage%3D6315%26doi%3D10.1002%2Fanie.201901268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2018.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ccr.2018.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&pages=34-76&author=A.+Zamoraauthor=G.+Viguerasauthor=V.+Rodr%C3%ADguezauthor=M.+D.+Santanaauthor=J.+Ruiz&title=Cyclometalated+iridium%28III%29+luminescent+complexes+in+therapy+and+phototherapy&doi=10.1016%2Fj.ccr.2018.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy</span></div><div class="casAuthors">Zamora, Ana; Vigueras, Gloria; Rodriguez, Venancio; Santana, M. Dolores; Ruiz, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-76</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Octahedral Ir(III) complexes bearing cyclometalated ligands exhibit a great stability in biol. media and are excellent therapeutical and phototherapeutical candidates for some major human ailments.  Interesting examples of the use of luminescent iridium compds. in the area of cancer diagnosis and treatment have been recently reported, including modulators in protein-protein interactions, membrane-disruptors or mitochondria-targeted agents.  Likewise, the scope of their conjugation to targeting vehicles as well as to smart nanoplatforms has been studied as a mean for an adequate delivery to cancer cells.  Furthermore, several Ir(III) compds. have recently been found to be promising photodynamic therapy (PDT) agents both for cancer and Alzheimer's disease.  Addnl., their use as photoactive species in photoactivated chemotherapy (PACT) has also been explored in spite of their high photostability.  Finally, new developments of Ir(III)-based drugs in infectious and inflammatory diseases, and neurol. disorders, will be also discussed, including a direct inhibitor of Staphylococcus aureus, contg. one amino group in the N̂N ligand, a TACE inhibitor (an enzyme involved in the formation of the biol. active form of TNF-α) and a photosensitizer inducing oxidn. of amyloidogenic peptides and controlling their aggregation pathways under mild conditions.  The mechanism of action of Ir(III) agents together with the relationship between their structures and biomedicinal activities will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLTlzv1pXTKbVg90H21EOLACvtfcHk0ljVTpwVWPHXKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWntbo%253D&md5=92e1198e87793fb1249ed293679f9247</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2018.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2018.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DA.%26aulast%3DVigueras%26aufirst%3DG.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DV.%26aulast%3DSantana%26aufirst%3DM.%2BD.%26aulast%3DRuiz%26aufirst%3DJ.%26atitle%3DCyclometalated%2520iridium%2528III%2529%2520luminescent%2520complexes%2520in%2520therapy%2520and%2520phototherapy%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2018%26volume%3D360%26spage%3D34%26epage%3D76%26doi%3D10.1016%2Fj.ccr.2018.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Organometallic iridium arene compounds: the effects of C-donor ligands on anticancer activity</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1246/cl.190179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1246%2Fcl.190179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVygsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=916-924&issue=8&author=R.+M.+Lordauthor=P.+C.+McGowan&title=Organometallic+iridium+arene+compounds%3A+the+effects+of+C-donor+ligands+on+anticancer+activity&doi=10.1246%2Fcl.190179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Iridium Arene Compounds: The Effects of C-Donor Ligands on Anticancer Activity</span></div><div class="casAuthors">Lord, Rianne M.; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">916-924</span>CODEN:
                <span class="NLM_cas:coden">CMLTAG</span>;
        ISSN:<span class="NLM_cas:issn">0366-7022</span>.
    
            (<span class="NLM_cas:orgname">Chemical Society of Japan</span>)
        </div><div class="casAbstract">A review.  In the past decade, libraries of iridium organometallic arene compds. have expanded rapidly, with the majority of their applications aimed towards effective catalysts and potential anti-cancer drug candidates.  Researchers have begun to adapt the traditional "piano-stool" structures to include different bidentate ligands, ancillary ligands and extend the aromaticity and functionality of the arene substituent, all in the hope to optimize their activities and allow the detn. of structure activity relationships.  Many of the complexes incorporate N- and O-donor ligands, but more recently, these structures have been expanded to include C-donor ligands such as cyclometalated bidentate ligands and N-heterocyclic carbenes.  This mini-review highlights the recent and ongoing research in C-donor iridium arene complexes, and discusses their importance as potential anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo03nxcgwhbKLVg90H21EOLACvtfcHk0ljVTpwVWPHXKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVygsLrL&md5=3fcbc5f2f7b98fc99416fa10b086027c</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1246%2Fcl.190179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.190179%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DOrganometallic%2520iridium%2520arene%2520compounds%253A%2520the%2520effects%2520of%2520C-donor%2520ligands%2520on%2520anticancer%2520activity%26jtitle%3DChem.%2520Lett.%26date%3D2019%26volume%3D48%26issue%3D8%26spage%3D916%26epage%3D924%26doi%3D10.1246%2Fcl.190179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Exploring the cellular accumulation of metal complexes</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1170</span>, <span class="refDoi"> DOI: 10.1039/B922209J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FB922209J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=20104335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFehsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1159-1170&issue=5&author=C.+A.+Puckettauthor=R.+J.+Ernstauthor=J.+K.+Barton&title=Exploring+the+cellular+accumulation+of+metal+complexes&doi=10.1039%2FB922209J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the cellular accumulation of metal complexes</span></div><div class="casAuthors">Puckett, Cindy A.; Ernst, Russell J.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1159-1170</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Transition metal complexes offer great potential as diagnostic and therapeutic agents, and a growing no. of biol. applications have been explored.  To be effective, these complexes must reach their intended target inside the cell.  Here the authors review the cellular accumulation of metal complexes, including their uptake, localization, and efflux.  Metal complexes are taken up inside cells through various mechanisms, including passive diffusion and entry through org. and metal transporters.  Emphasis is placed on the methods used to examine cellular accumulation, to identify the mechanism(s) of uptake, and to monitor possible efflux.  Conjugation strategies that have been employed to improve the cellular uptake characteristics of metal complexes are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvQprb0Iwsx7Vg90H21EOLACvtfcHk0ljVTpwVWPHXKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFehsrc%253D&md5=3bf675e26d83b0b088347acb0453d357</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2FB922209J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB922209J%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DErnst%26aufirst%3DR.%2BJ.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DExploring%2520the%2520cellular%2520accumulation%2520of%2520metal%2520complexes%26jtitle%3DDalton%2520Trans.%26date%3D2010%26volume%3D39%26issue%3D5%26spage%3D1159%26epage%3D1170%26doi%3D10.1039%2FB922209J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pracharova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutillas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Exploring the effect of polypyridyl ligands on the anticancer activity of phosphorescent iridium(III) complexes: from proteosynthesis inhibitors to photodynamic therapy agents</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4619</span>, <span class="refDoi"> DOI: 10.1002/chem.201705362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fchem.201705362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29369444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlaqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=4607-4619&issue=18&author=J.+Pracharovaauthor=G.+Viguerasauthor=V.+Novohradskyauthor=N.+Cutillasauthor=C.+Janiakauthor=H.+Kostrhunovaauthor=J.+Kasparkovaauthor=J.+Ruizauthor=V.+Brabec&title=Exploring+the+effect+of+polypyridyl+ligands+on+the+anticancer+activity+of+phosphorescent+iridium%28III%29+complexes%3A+from+proteosynthesis+inhibitors+to+photodynamic+therapy+agents&doi=10.1002%2Fchem.201705362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the Effect of Polypyridyl Ligands on the Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents</span></div><div class="casAuthors">Pracharova, Jitka; Vigueras, Gloria; Novohradsky, Vojtech; Cutillas, Natalia; Janiak, Christoph; Kostrhunova, Hana; Kasparkova, Jana; Ruiz, Jose; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4607-4619</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of five kinetically inert bis-cyclometalated IrIII complexes of general formula [Ir(ĈN)2(N̂N)][PF6] [ĈN = 2-(para-trifluoromethylphenyl)benzimidazol-κN,-κC; N̂N = 1,10-phenanthroline (phen, 1), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq, 2), dipyrido[3,2-a:2',3'-c]phenazine (dppz, 3), benzo[i]dipyrido[3,2-a:2',3'-c]phenazine (dppn, 4), and dipyrido[3,2-a:2',3'-c]phenazine-10,11-imidazolone (dppz-izdo, 5)] were designed and synthesized to explore the effect of the degree of π conjugation of the polypyridyl ligand on their toxicity in cancer cells.  We show that less-lipophilic complexes 1 and 2 exhibit the highest toxicity [sub-micromolar inhibitory concn. (IC50) values] in A2780, HeLa, and MCF-7 cancer cells, and they are markedly more efficient than clin. used platinum drugs.  It is noteworthy that the investigated Ir agents display the capability to overcome acquired and inherent resistance to conventional cisplatin (in A2780cisR and MCF-7 cells, resp.).  We demonstrate that the Ir complexes, unlike clin. used platinum antitumor drugs, do not kill cells through DNA-damage response.  Rather, they kill cells by inhibiting protein translation by targeting preferentially the endoplasmic reticulum.  Our findings also reveal that the toxic effect of the Ir complexes can be significantly potentiated by irradn. with visible light (by more than two orders of magnitude).  The photopotentiation of the investigated Ir complexes can be attributed to a marked increase (≈10-30-fold) in intracellular reactive oxygen species.  Collectively, these data highlight the functional diversity of antitumor metal-based drugs and the usefulness of a mechanism-based rationale for selecting candidate agents that are effective against chemoresistant tumors for further preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tyZA_6aPyrVg90H21EOLACvtfcHk0lgiwnxBeoB7Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlaqsr0%253D&md5=20a1115cc9f05a8151cdc5b2360d72ba</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fchem.201705362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201705362%26sid%3Dliteratum%253Aachs%26aulast%3DPracharova%26aufirst%3DJ.%26aulast%3DVigueras%26aufirst%3DG.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DCutillas%26aufirst%3DN.%26aulast%3DJaniak%26aufirst%3DC.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DExploring%2520the%2520effect%2520of%2520polypyridyl%2520ligands%2520on%2520the%2520anticancer%2520activity%2520of%2520phosphorescent%2520iridium%2528III%2529%2520complexes%253A%2520from%2520proteosynthesis%2520inhibitors%2520to%2520photodynamic%2520therapy%2520agents%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2018%26volume%3D24%26issue%3D18%26spage%3D4607%26epage%3D4619%26doi%3D10.1002%2Fchem.201705362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">15772</span>– <span class="NLM_lpage">15782</span>, <span class="refDoi"> DOI: 10.1039/C8DT02963F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8DT02963F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=30357192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOjtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=15772-15782&issue=44&author=J.+Liauthor=Z.+Tianauthor=Z.+Xuauthor=S.+Zhangauthor=Y.+Fengauthor=L.+Zhangauthor=Z.+Liu&title=Highly+potent+half-sandwich+iridium+and+ruthenium+complexes+as+lysosome-targeted+imaging+and+anticancer+agents&doi=10.1039%2FC8DT02963F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents</span></div><div class="casAuthors">Li, JuanJuan; Tian, Zhenzhen; Xu, Zhishan; Zhang, Shumiao; Feng, Yaqian; Zhang, Lingdong; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">15772-15782</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this study, six half-sandwich luminescent iridium (Ir) and ruthenium (Ru) anticancer complexes bearing P̂ P-chelating ligands 1,2-bis(diphenylphosphino)benzene (dppbz) and 1,8-bis(diphenylphosphino)naphthalene (dppn) were synthesized and characterized via1H-NMR spectroscopy, 31P-NMR spectroscopy, mass spectrometry, elemental anal. and X-ray crystallog.  All the complexes displayed more potent anticancer activity than cisplatin towards A549 lung cancer cells and HeLa cervical cancer cells, esp. the most potent iridium complex Ir3, which was 73 times more potent than cisplatin against A549 cells.  Different from cisplatin, no nucleobase adducts of Ir3 were detected.  With the help of the self-luminescence of complex Ir3 and confocal microscopy, it was obsd. that Ir3 efficiently penetrated into the A549 cells via energy-dependent active transport, and specifically accumulated in lysosomes, affected the permeabilization of the lysosomal membranes and induced caspase-dependent cell death through lysosomal damage.  Both apoptosis and autophagy of the A549 cells were obsd.  The reactive oxygen species (ROS) elevation, redn. of the mitochondrial membrane potential and cell cycle arrest at the G0/G1 phase also contributed to the obsd. cytotoxicity of Ir3.  We demonstrate that these half-sandwich Ir and Ru anticancer complexes have different anticancer mechanism of action from that of cisplatin, which can be developed as potential multifunctional theranostic platforms that combine bioimaging and anticancer capabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-AeBQkxg7cLVg90H21EOLACvtfcHk0lgiwnxBeoB7Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjtb3N&md5=1b6b52b9a411ab835e3afa68a3333063</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1039%2FC8DT02963F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT02963F%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DHighly%2520potent%2520half-sandwich%2520iridium%2520and%2520ruthenium%2520complexes%2520as%2520lysosome-targeted%2520imaging%2520and%2520anticancer%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26issue%3D44%26spage%3D15772%26epage%3D15782%26doi%3D10.1039%2FC8DT02963F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Lysosome-targeted phosphine-imine half-sandwich iridium(III) anticancer complexes: synthesis, characterization, and biological activity</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1769</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.9b00080</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.9b00080" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=1761-1769&issue=8&author=Y.+Yangauthor=L.+Guoauthor=Z.+Tianauthor=X.+Geauthor=Y.+Gongauthor=H.+Zhengauthor=S.+Shiauthor=Z.+Liu&title=Lysosome-targeted+phosphine-imine+half-sandwich+iridium%28III%29+anticancer+complexes%3A+synthesis%2C+characterization%2C+and+biological+activity&doi=10.1021%2Facs.organomet.9b00080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosome-Targeted Phosphine-Imine Half-Sandwich Iridium(III) Anticancer Complexes: Synthesis, Characterization, and Biological Activity</span></div><div class="casAuthors">Yang, Yuliang; Guo, Lihua; Tian, Zhenzhen; Ge, Xingxing; Gong, Yuteng; Zheng, Hongmei; Shi, Shaopeng; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1761-1769</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis, characterization, and catalytic ability of converting coenzyme NADH to NAD+ and the anticancer activity of half-sandwich iridium(III) complexes with general formula of [(η5-Cpx)Ir(P̂N)Cl]PF6 (Cpx: Cp* or biphenyl Cpxbiph derivs.; P̂N: various phosphine-imine ligands) were investigated.  The crystal structure of the complex Ir4 showed a piano-stool geometry around the iridium(III) center.  This type of iridium(III) complexes had sufficient stability in aq. soln.  Most of the complexes showed good anticancer activities toward A549 cancer cells, which were higher than the clin. drug cisplatin.  In this series, complex Ir8 displayed the highest anticancer activity against A549 cells (IC50 = 4.7 μM), showing an approx. 4.5-fold more potent activity than cisplatin (IC50 = 21.30 μM).  The structure-activity relationship study showed that the cytotoxicity of these complexes may be primarily attributed to the coordination between iridium(III) and the coordinating atoms, and the nature of the imine N-substituents may not be a major factor affecting cytotoxicity.  Furthermore, this family of complexes causes cell death by cell stress, inducing apoptosis and necrosis, overprodn. of reactive oxygen species, and disruption of the mitochondrial membrane potential.  Most interestingly, the use of confocal microscopy provides insights into the microscopic mechanism that the typical complex Ir3 can penetrate into A549 cancer cells through a non-energy-dependent pathway and specifically distribute in lysosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqI_P9Qb_EbVg90H21EOLACvtfcHk0lgiwnxBeoB7Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvVGisL0%253D&md5=0013db9fe57e22a890980f9181d52f84</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.9b00080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.9b00080%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DLysosome-targeted%2520phosphine-imine%2520half-sandwich%2520iridium%2528III%2529%2520anticancer%2520complexes%253A%2520synthesis%252C%2520characterization%252C%2520and%2520biological%2520activity%26jtitle%3DOrganometallics%26date%3D2019%26volume%3D38%26issue%3D8%26spage%3D1761%26epage%3D1769%26doi%3D10.1021%2Facs.organomet.9b00080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Theranostic lysosomal targeting anticancer and antimetastatic agents: half-sandwich iridium(III) rhodamine complexes</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">15240</span>– <span class="NLM_lpage">15248</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b01863</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b01863" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A280%3ADC%252BB3MnhvVOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=15240-15248&issue=12&author=W.+Maauthor=X.+Geauthor=Z.+Xuauthor=S.+Zhangauthor=X.+Heauthor=J.+Liauthor=X.+Xiaauthor=X.+Chenauthor=Z.+Liu&title=Theranostic+lysosomal+targeting+anticancer+and+antimetastatic+agents%3A+half-sandwich+iridium%28III%29+rhodamine+complexes&doi=10.1021%2Facsomega.9b01863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes</span></div><div class="casAuthors">Ma Wenli; Ge Xingxing; Xu Zhishan; Zhang Shumiao; He Xiangdong; Li JuanJuan; Xia Xiaorong; Chen Xiaobing; Liu Zhe; Xu Zhishan</div><div class="citationInfo"><span class="NLM_cas:title">ACS omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">15240-15248</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Two rhodamine-modified half-sandwich Ir(III) complexes with the general formula [(Cp(x))Ir(CN) Cl] were synthesized and characterized, where Cp(x) is 1-biphenyl-2,3,4,5-tetramethylcyclopentadienyl (Cp(xbiph)).  Both complexes showed potent anticancer activity against A549, HeLa, and HepG2 cancer cells and normal cells, and altered ligands had an effect on proliferation resistance.  The complex enters cells through energy dependence, and because of the different ligands, not only could it affect the anticancer ability of the complex but also could affect the degree of complex lysosome targeting, lysosomal damage, and further prove the antiproliferative mechanism of the complex.  Excitingly, antimetastatic experiments demonstrated that complex 1 has the ability to block the migration of cancer cells.  Furthermore, although the complex did not show a stronger ability to interfere with the coenzyme NAD(+)/NADH pair by transfer hydrogenation, the intracellular reactive oxygen species (ROS) content has shown a marked increase.  NF-κB activity is increased by ROS regulation, and the role of ROS-NF-κB signaling pathway further induces apoptosis.  Moreover, cell flow experiments also demonstrated that complex 1 blocked the cell cycle in S phase, but the complex did not cause significant changes in the mitochondrial membrane potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTJXPyXuaAyJw7prLlxLOzfW6udTcc2eYqLccXRUFsTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnhvVOquw%253D%253D&md5=594f6cc1e2054e8b2da30fca1d2a984a</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b01863%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DTheranostic%2520lysosomal%2520targeting%2520anticancer%2520and%2520antimetastatic%2520agents%253A%2520half-sandwich%2520iridium%2528III%2529%2520rhodamine%2520complexes%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26issue%3D12%26spage%3D15240%26epage%3D15248%26doi%3D10.1021%2Facsomega.9b01863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeting cyclometalated iridium(III) complexes for tumor hypoxic imaging and therapy</span>. <i>Inorg. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1039/C9QI00081J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC9QI00081J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFSnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=1003-1010&issue=4&author=J.+Liauthor=H.+Chenauthor=L.+Zengauthor=T.+W.+Reesauthor=K.+Xiongauthor=Y.+Chenauthor=L.+Jiauthor=H.+Chao&title=Mitochondria-targeting+cyclometalated+iridium%28III%29+complexes+for+tumor+hypoxic+imaging+and+therapy&doi=10.1039%2FC9QI00081J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-targeting cyclometalated iridium(III) complexes for tumor hypoxic imaging and therapy</span></div><div class="casAuthors">Li, Jia; Chen, Hongmin; Zeng, Leli; Rees, Thomas W.; Xiong, Kai; Chen, Yu; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1003-1010</span>CODEN:
                <span class="NLM_cas:coden">ICFNAW</span>;
        ISSN:<span class="NLM_cas:issn">2052-1553</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Hypoxia is frequently found in the center of solid tumors.  It contributes to drug resistance and is a major obstacle in the development of effective cancer therapy.  Designing activatable theranostic agents for hypoxic cancer cells remains a big challenge.  We herein report five novel cyclometalated iridium(III) complexes with an attached anthraquinone moiety (Ir1-5) for hypoxic cancer cell therapy.  The complexes efficiently respond to hypoxia with a turn-on yellow phosphorescence and were successfully used to detect hypoxia within 3D multicellular tumor spheroids.  Moreover, the complexes are cytotoxic towards HeLa (human cervical carcinoma), HepG2 (Human hepatocellular carcinoma), A549 (human lung carcinoma), and A549R (cisplatin-resistant human lung carcinoma) cell lines, with Ir2 more than 50 times as active as cisplatin against the A549R cell line.  Investigation of the localization of Ir1-5 indicates that mitochondria are the main cellular targets.  Mitochondrial dysfunction and caspase-3 activation were found to be involved in the apoptotic cell death pathway induced by the complexes.  These results demonstrate that the complexes have great potential for tumor diagnosis and therapy in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLkTViELGGXLVg90H21EOLACvtfcHk0ljXDvKMaMovJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFSnsrg%253D&md5=29ddb97ff6b3959588cfca2104ce269d</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1039%2FC9QI00081J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9QI00081J%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DRees%26aufirst%3DT.%2BW.%26aulast%3DXiong%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DMitochondria-targeting%2520cyclometalated%2520iridium%2528III%2529%2520complexes%2520for%2520tumor%2520hypoxic%2520imaging%2520and%2520therapy%26jtitle%3DInorg.%2520Chem.%2520Front.%26date%3D2019%26volume%3D6%26issue%3D4%26spage%3D1003%26epage%3D1010%26doi%3D10.1039%2FC9QI00081J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Anticancer cyclometalated iridium(III) complexes with planar ligands: mitochondrial DNA damage and metabolism disturbance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3311</span>– <span class="NLM_lpage">3322</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3311-3322&issue=7&author=J.+J.+Caoauthor=Y.+Zhengauthor=X.+W.+Wuauthor=C.+P.+Tanauthor=M.+H.+Chenauthor=N.+Wuauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Anticancer+cyclometalated+iridium%28III%29+complexes+with+planar+ligands%3A+mitochondrial+DNA+damage+and+metabolism+disturbance&doi=10.1021%2Facs.jmedchem.8b01704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance</span></div><div class="casAuthors">Cao, Jian-Jun; Zheng, Yue; Wu, Xiao-Wen; Tan, Cai-Ping; Chen, Mu-He; Wu, Na; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3311-3322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Emerging studies have shown that mitochondrial DNA (mtDNA) is a potential target for cancer therapy.  Herein, six cyclometalated Ir(III) complexes Ir1-Ir6 contg. a series of extended planar diimine ligands have been designed and assessed for their efficacy as anticancer agents.  Ir1-Ir6 show much higher cytotoxicity than cisplatin and they can effectively localize to mitochondria.  Among them, complexes Ir3 and Ir4 with dipyrido[3,2-a:2',3'-c]phenazine (dppz) ligands can bind to DNA tightly in vitro, intercalate to mtDNA in situ, and induce mtDNA damage.  Ir3- and Ir4-impaired mitochondria exhibit decline of mitochondrial membrane potential, disability of ATP generation, disruption of mitochondrial energetic and metabolic status, which subsequently cause protective mitophagy, G0/G1 phase cell cycle arrest, and apoptosis.  In vivo antitumor evaluations also show that Ir4 can inhibit tumor xenograft growth effectively.  Overall, our work proves that targeting the mitochondrial genome may present an effective strategy to develop metal-based anticancer agents to overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR7bmxWFP0m7Vg90H21EOLACvtfcHk0ljXDvKMaMovJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFCrsbo%253D&md5=a2468f56f12e5b0d7b47fbfcc2b91d3e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01704%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%2BW.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DChen%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DAnticancer%2520cyclometalated%2520iridium%2528III%2529%2520complexes%2520with%2520planar%2520ligands%253A%2520mitochondrial%2520DNA%2520damage%2520and%2520metabolism%2520disturbance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D7%26spage%3D3311%26epage%3D3322%26doi%3D10.1021%2Facs.jmedchem.8b01704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span> <span> </span><span class="NLM_article-title">Imaging of a clickable anticancer iridium catalyst</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.jinorgbio.2017.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29306719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1Kqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2018&pages=179-185&author=X.+Wangauthor=M.+Zhuauthor=F.+Gaoauthor=W.+Weiauthor=Y.+Qianauthor=H.+K.+Liuauthor=J.+Zhao&title=Imaging+of+a+clickable+anticancer+iridium+catalyst&doi=10.1016%2Fj.jinorgbio.2017.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of a clickable anticancer iridium catalyst</span></div><div class="casAuthors">Wang, Xiuxiu; Zhu, Mingli; Gao, Fei; Wei, Wei; Qian, Yong; Liu, Hong-Ke; Zhao, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-185</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Iridium-based anticancer reagents are receiving increasing attention for their high cytotoxicity.  Herein, by activating C-H bonds in the well-known antioxidant α-phenyl-N-tert-butylnitrone (PBN), the authors synthesized and characterized a series of new iridium complexes.  Complex 1-AMP exhibited the best antiproliferation activity towards human ovarian cancer A2780 cells.  The azide group in complex 1-AMP underwent the Cu(I)-catalyzed azide - alkyne cycloaddn. (CuAAC) reaction and the resulting fluorescent imaging in cells suggested it mainly accumulated in mitochondria.  In comparison, to eliminate cytotoxicity of Cu(I) catalyst, the authors conducted a reaction between complex 1-AMP and a commercialized dye via strain-promoted alkyne-azide cycloaddn. (SPAAC) reaction in live cells, confirming its targeting mainly in the mitochondria.  Iridium-based anticancer complexes contg. a nitrone ligand and azide group may offer a useful tool to probe the mechanism of metallodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPshoq2YgcPLVg90H21EOLACvtfcHk0liWBLZ2P0wPiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1Kqtg%253D%253D&md5=80a57c2c0e15690a5531db2f17a5635a</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%2BK.%26aulast%3DZhao%26aufirst%3DJ.%26atitle%3DImaging%2520of%2520a%2520clickable%2520anticancer%2520iridium%2520catalyst%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D180%26spage%3D179%26epage%3D185%26doi%3D10.1016%2Fj.jinorgbio.2017.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zielonka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Vivar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">10043</span>– <span class="NLM_lpage">10120</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGrs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=10043-10120&issue=15&author=J.+Zielonkaauthor=J.+Josephauthor=A.+Sikoraauthor=M.+Hardyauthor=O.+Ouariauthor=J.+Vasquez-Vivarauthor=G.+Chengauthor=M.+Lopezauthor=B.+Kalyanaraman&title=Mitochondria-targeted+triphenylphosphonium-based+compounds%3A+syntheses%2C+mechanisms+of+action%2C+and+therapeutic+and+diagnostic+applications&doi=10.1021%2Facs.chemrev.7b00042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications</span></div><div class="casAuthors">Zielonka, Jacek; Joseph, Joy; Sikora, Adam; Hardy, Micael; Ouari, Olivier; Vasquez-Vivar, Jeannette; Cheng, Gang; Lopez, Marcos; Kalyanaraman, Balaraman</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10043-10120</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mitochondria are recognized as one of the most important targets for new drug design in cancer, cardiovascular, and neurol. diseases.  Currently, the most effective way to deliver drugs specifically to mitochondria is by covalent linking a lipophilic cation such as an alkyltriphenylphosphonium moiety to a pharmacophore of interest.  Other delocalized lipophilic cations, such as rhodamine, natural and synthetic mitochondria-targeting peptides, and nanoparticle vehicles, have also been used for mitochondrial delivery of small mols.  Depending on the approach used, and the potentials of cell and mitochondrial membranes, more than 1000-fold higher mitochondrial concn. can be achieved.  Mitochondrial targeting has been developed to study mitochondrial physiol. and dysfunction and the interaction between mitochondria and other subcellular organelles and for treatment of a variety of diseases such as neurodegeneration and cancer.  In this review, the authors discuss efforts to target small-mol. compds. to mitochondria for probing mitochondria function, as diagnostic tools and potential therapeutics.  The authors describe the physicochem. basis for mitochondrial accumulation of lipophilic cations, synthetic chem. strategies to target compds. to mitochondria, mitochondrial probes and sensors, and examples of mitochondrial targeting of bioactive compds.  Finally, the authors review published attempts to apply mitochondria-targeted agents for the treatment of cancer and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWcZcFkSXk57Vg90H21EOLACvtfcHk0liWBLZ2P0wPiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGrs7fJ&md5=53093198d06913e216b0614a8c7ff579</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00042%26sid%3Dliteratum%253Aachs%26aulast%3DZielonka%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DSikora%26aufirst%3DA.%26aulast%3DHardy%26aufirst%3DM.%26aulast%3DOuari%26aufirst%3DO.%26aulast%3DVasquez-Vivar%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DKalyanaraman%26aufirst%3DB.%26atitle%3DMitochondria-targeted%2520triphenylphosphonium-based%2520compounds%253A%2520syntheses%252C%2520mechanisms%2520of%2520action%252C%2520and%2520therapeutic%2520and%2520diagnostic%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26issue%3D15%26spage%3D10043%26epage%3D10120%26doi%3D10.1021%2Facs.chemrev.7b00042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heerdt, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augenlicht, L. H.</span></span> <span> </span><span class="NLM_article-title">Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1591</span>– <span class="NLM_lpage">1596</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1158%2F0008-5472.CAN-05-2717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=16452217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1591-1596&issue=3&author=B.+G.+Heerdtauthor=M.+A.+Houstonauthor=L.+H.+Augenlicht&title=Growth+properties+of+colonic+tumor+cells+are+a+function+of+the+intrinsic+mitochondrial+membrane+potential&doi=10.1158%2F0008-5472.CAN-05-2717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Growth Properties of Colonic Tumor Cells Are a Function of the Intrinsic Mitochondrial Membrane Potential</span></div><div class="casAuthors">Heerdt, Barbara G.; Houston, Michele A.; Augenlicht, Leonard H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1591-1596</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Development of malignant transformation in the colonic mucosa includes disruption in the equil. between proliferation and apoptosis, decreased expression and deletions of the mitochondrial genome, alterations in mitochondrial enzymic activity, and elevations in the mitochondrial membrane potential (Δψm).  Focusing on the role of the Δψm in tumor development and progression, we generated novel isogenic colonic carcinoma cell lines that exhibit highly significant, stable differences in their intrinsic Δψm.  Using these cell lines, we have recently shown that the intrinsic Δψm has a significant influence on steady state mitochondrial activity and the extent to which cells enter butyrate-mediated growth arrest and apoptotic cascades.  Here, we report that the Δψm is also profoundly linked to important tumorigenic properties of the cells.  Compared with cells with lower Δψm, cells with elevated intrinsic Δψm have an enhanced capacity to (a) respond to hypoxia by avoiding apoptosis and initiating angiogenesis, (b) escape anoikis and grow under anchorage-independent conditions, and (c) invade the basement membrane.  Combined with our previous work, these data implicate the intrinsic Δψm of colonic carcinoma cells in detg. the probability of tumor expansion and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRcqIWT8kVh7Vg90H21EOLACvtfcHk0liWBLZ2P0wPiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVentw%253D%253D&md5=2063013c39d7fea69216a7aeb7c2485b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2717%26sid%3Dliteratum%253Aachs%26aulast%3DHeerdt%26aufirst%3DB.%2BG.%26aulast%3DHouston%26aufirst%3DM.%2BA.%26aulast%3DAugenlicht%26aufirst%3DL.%2BH.%26atitle%3DGrowth%2520properties%2520of%2520colonic%2520tumor%2520cells%2520are%2520a%2520function%2520of%2520the%2520intrinsic%2520mitochondrial%2520membrane%2520potential%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D3%26spage%3D1591%26epage%3D1596%26doi%3D10.1158%2F0008-5472.CAN-05-2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Metabolic targets for cancer therapy</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1038/nrd4145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnrd4145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24113830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2nsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=829-846&issue=11&author=L.+Galluzziauthor=O.+Keppauthor=M.+G.+Vander+Heidenauthor=G.+Kroemer&title=Metabolic+targets+for+cancer+therapy&doi=10.1038%2Fnrd4145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic targets for cancer therapy</span></div><div class="casAuthors">Galluzzi, Lorenzo; Kepp, Oliver; Vander Heiden, Matthew G.; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-846</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Malignant cells exhibit metabolic changes, when compared to their normal counterparts, owing to both genetic and epigenetic alterations.  Although such a metabolic rewiring has recently been indicated as yet another general hallmark of cancer, accumulating evidence suggests that the metabolic alterations of each neoplasm represent a mol. signature that intimately accompanies and allows for different facets of malignant transformation.  During the past decade, targeting cancer metab. has emerged as a promising strategy for the development of selective antineoplastic agents.  Here, we discuss the intimate relationship between metab. and malignancy, focusing on strategies through which this central aspect of tumor biol. might be turned into cancer's Achilles heel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWJB7NELP1nLVg90H21EOLACvtfcHk0lhwQlby-DkrFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2nsr3M&md5=1c7d31d1d4494cfabe08604fbd44ffe0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd4145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4145%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMetabolic%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2013%26volume%3D12%26issue%3D11%26spage%3D829%26epage%3D846%26doi%3D10.1038%2Fnrd4145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porporato, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filigheddu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedro, J. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial metabolism and cancer</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fcr.2017.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29219147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCrt7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=265-280&issue=3&author=P.+E.+Porporatoauthor=N.+Filighedduauthor=J.+M.+B.+Pedroauthor=G.+Kroemerauthor=L.+Galluzzi&title=Mitochondrial+metabolism+and+cancer&doi=10.1038%2Fcr.2017.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial metabolism and cancer</span></div><div class="casAuthors">Porporato, Paolo Ettore; Filigheddu, Nicoletta; Pedro, Jose Manuel Bravo-San; Kroemer, Guido; Galluzzi, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-280</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Glycolysis has long been considered as the major metabolic process for energy prodn. and anabolic growth in cancer cells.  Although such a view has been instrumental for the development of powerful imaging tools that are still used in the clinics, it is now clear that mitochondria play a key role in oncogenesis.  Besides exerting central bioenergetic functions, mitochondria provide indeed building blocks for tumor anabolism, control redox and calcium homeostasis, participate in transcriptional regulation, and govern cell death.  Thus, mitochondria constitute promising targets for the development of novel anticancer agents.  However, tumors arise, progress, and respond to therapy in the context of an intimate crosstalk with the host immune system, and many immunol. functions rely on intact mitochondrial metab.  Here, we review the cancer cell-intrinsic and cell-extrinsic mechanisms through which mitochondria influence all steps of oncogenesis, with a focus on the therapeutic potential of targeting mitochondrial metab. for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsiHEGIV3l-rVg90H21EOLACvtfcHk0lhwQlby-DkrFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCrt7jP&md5=5ec7ae200ec5b2268ad6b33eb2a2ad91</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.155%26sid%3Dliteratum%253Aachs%26aulast%3DPorporato%26aufirst%3DP.%2BE.%26aulast%3DFiligheddu%26aufirst%3DN.%26aulast%3DPedro%26aufirst%3DJ.%2BM.%2BB.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26atitle%3DMitochondrial%2520metabolism%2520and%2520cancer%26jtitle%3DCell%2520Res.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D265%26epage%3D280%26doi%3D10.1038%2Fcr.2017.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Metabolic control of cell death</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span> (<span class="NLM_issue">6203</span>),  <span class="NLM_fpage">1250256</span>, <span class="refDoi"> DOI: 10.1126/science.1250256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1126%2Fscience.1250256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=25237106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A280%3ADC%252BC2M7isl2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=1250256&issue=6203&author=D.+R.+Greenauthor=L.+Galluzziauthor=G.+Kroemer&title=Metabolic+control+of+cell+death&doi=10.1126%2Fscience.1250256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Cell biology. Metabolic control of cell death</span></div><div class="casAuthors">Green Douglas R; Galluzzi Lorenzo; Kroemer Guido</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6203</span>),
    <span class="NLM_cas:pages">1250256</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beyond their contribution to basic metabolism, the major cellular organelles, in particular mitochondria, can determine whether cells respond to stress in an adaptive or suicidal manner.  Thus, mitochondria can continuously adapt their shape to changing bioenergetic demands as they are subjected to quality control by autophagy, or they can undergo a lethal permeabilization process that initiates apoptosis.  Along similar lines, multiple proteins involved in metabolic circuitries, including oxidative phosphorylation and transport of metabolites across membranes, may participate in the regulated or catastrophic dismantling of organelles.  Many factors that were initially characterized as cell death regulators are now known to physically or functionally interact with metabolic enzymes.  Thus, several metabolic cues regulate the propensity of cells to activate self-destructive programs, in part by acting on nutrient sensors.  This suggests the existence of "metabolic checkpoints" that dictate cell fate in response to metabolic fluctuations.  Here, we discuss recent insights into the intersection between metabolism and cell death regulation that have major implications for the comprehension and manipulation of unwarranted cell loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyuIOgwhutwFVwdslNBF-tfW6udTcc2eYCEpb0hNntZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7isl2lsA%253D%253D&md5=7b486b5c05c3780ac01f4d97025bf65e</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1250256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1250256%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMetabolic%2520control%2520of%2520cell%2520death%26jtitle%3DScience%26date%3D2014%26volume%3D345%26issue%3D6203%26spage%3D1250256%26doi%3D10.1126%2Fscience.1250256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of reactive oxygen species in signaling or stress responses</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nchembio.607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnchembio.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=21769097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=504-511&issue=8&author=B.+C.+Dickinsonauthor=C.+J.+Chang&title=Chemistry+and+biology+of+reactive+oxygen+species+in+signaling+or+stress+responses&doi=10.1038%2Fnchembio.607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of reactive oxygen species in signaling or stress responses</span></div><div class="casAuthors">Dickinson, Bryan C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">504-511</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) are a family of mols. that are continuously generated, transformed and consumed in all living organisms as a consequence of aerobic life.  The traditional view of these reactive O metabolites is one of oxidative stress and damage that leads to decline of tissue and organ systems in aging and disease.  However, emerging data show that ROS produced in certain situations can also contribute to physiol. and increased fitness.  Here, the authors provide a focused discussion on what factors lead ROS mols. to become signal and/or stress agents, highlighting how increasing knowledge of the underlying chem. of ROS can lead to advances in understanding their disparate contributions to biol.  An important facet of this emerging area at the chem.-biol. interface is the development of new tools to study these small mols. and their reactivity in complex biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8yowqTyr7O7Vg90H21EOLACvtfcHk0liwrLvz58P3lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D&md5=320823c1c7f9013a7c8f3d6c2f3f6952</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.607%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DChemistry%2520and%2520biology%2520of%2520reactive%2520oxygen%2520species%2520in%2520signaling%2520or%2520stress%2520responses%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26issue%3D8%26spage%3D504%26epage%3D511%26doi%3D10.1038%2Fnchembio.607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schieber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">ROS function in redox signaling and oxidative stress</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">R453</span>– <span class="NLM_lpage">R462</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2014.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.cub.2014.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24845678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=R453-R462&issue=10&author=M.+Schieberauthor=N.+S.+Chandel&title=ROS+function+in+redox+signaling+and+oxidative+stress&doi=10.1016%2Fj.cub.2014.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">ROS Function in Redox Signaling and Oxidative Stress</span></div><div class="casAuthors">Schieber, Michael; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">R453-R462</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxidative stress refers to elevated intracellular levels of reactive oxygen species (ROS) that cause damage to lipids, proteins and DNA.  Oxidative stress has been linked to a myriad of pathologies.  However, elevated ROS also act as signaling mols. in the maintenance of physiol. functions - a process termed redox biol.  In this review we discuss the two faces of ROS - redox biol. and oxidative stress - and their contribution to both physiol. and pathol. conditions.  Redox biol. involves a small increase in ROS levels that activates signaling pathways to initiate biol. processes, while oxidative stress denotes high levels of ROS that result in damage to DNA, protein or lipids.  Thus, the response to ROS displays hormesis, given that the opposite effect is obsd. at low levels compared with that seen at high levels.  Here, we argue that redox biol., rather than oxidative stress, underlies physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKHDL4BvUHLVg90H21EOLACvtfcHk0liwrLvz58P3lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D&md5=04979c81b50c4aefc5d19152d832febc</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2014.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2014.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DSchieber%26aufirst%3DM.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DROS%2520function%2520in%2520redox%2520signaling%2520and%2520oxidative%2520stress%26jtitle%3DCurr.%2520Biol.%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3DR453%26epage%3DR462%26doi%3D10.1016%2Fj.cub.2014.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogvadze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span> <span> </span><span class="NLM_article-title">Mitochondria, oxidative stress and cell death</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1007/s10495-007-0756-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1007%2Fs10495-007-0756-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=17453160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFamtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=913-922&issue=5&author=M.+Ottauthor=V.+Gogvadzeauthor=S.+Orreniusauthor=B.+Zhivotovsky&title=Mitochondria%2C+oxidative+stress+and+cell+death&doi=10.1007%2Fs10495-007-0756-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria, oxidative stress and cell death</span></div><div class="casAuthors">Ott, Martin; Gogvadze, Vladimir; Orrenius, Sten; Zhivotovsky, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In addn. to the well-established role of the mitochondria in energy metab., the regulation of cell death has recently emerged as a 2nd major function of these organelles.  This, in turn, seems to be intimately linked to their role as the major intracellular source of reactive O species (ROS), which are mainly generated at complex I and III of the respiratory chain.  Excessive ROS prodn. can lead to oxidn. of macromols. and has been implicated in mtDNA mutations, aging, and cell death.  Mitochondria-generated ROS play an important role in the release of cytochrome c and other pro-apoptotic proteins, which can trigger caspase activation and apoptosis.  Cytochrome c release occurs by a 2-step process that is initiated by the dissocn. of the hemoprotein from its binding to cardiolipin, which anchors it to the inner mitochondrial membrane.  The oxidn. of cardiolipin reduces cytochrome c binding and results in an increased level of "free" cytochrome c in the intermembrane space.  Conversely, mitochondrial antioxidant enzymes protect from apoptosis.  Hence, there is accumulating evidence supporting a direct link between mitochondria, oxidative stress, and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqDJmXD2adfbVg90H21EOLACvtfcHk0liwrLvz58P3lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFamtrw%253D&md5=8179de86db9a99c69c4b32c6164be463</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1007%2Fs10495-007-0756-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-007-0756-2%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DGogvadze%26aufirst%3DV.%26aulast%3DOrrenius%26aufirst%3DS.%26aulast%3DZhivotovsky%26aufirst%3DB.%26atitle%3DMitochondria%252C%2520oxidative%2520stress%2520and%2520cell%2520death%26jtitle%3DApoptosis%26date%3D2007%26volume%3D12%26issue%3D5%26spage%3D913%26epage%3D922%26doi%3D10.1007%2Fs10495-007-0756-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jezek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strich, R.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression</span>. <i>Antioxidants</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13</span>, <span class="refDoi"> DOI: 10.3390/antiox7010013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.3390%2Fantiox7010013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWhsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=13&author=J.+Jezekauthor=K.+F.+Cooperauthor=R.+Strich&title=Reactive+oxygen+species+and+mitochondrial+dynamics%3A+the+yin+and+yang+of+mitochondrial+dysfunction+and+cancer+progression&doi=10.3390%2Fantiox7010013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species and mitochondrial dynamics: The yin and yang of mitochondrial dysfunction and cancer progression</span></div><div class="casAuthors">Jezek, Jan; Cooper, Katrina F.; Strich, Randy</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13/1-13/24</span>CODEN:
                <span class="NLM_cas:coden">ANTIGE</span>;
        ISSN:<span class="NLM_cas:issn">2076-3921</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Mitochondria are organelles with a highly dynamic ultrastructure maintained by a delicate equil. between its fission and fusion rates.  Understanding the factors influencing this balance is important as perturbations to mitochondrial dynamics can result in pathol. states.  As a terminal site of nutrient oxidn. for the cell, mitochondrial powerhouses harness energy in the form of ATP in a process driven by the electron transport chain.  Contemporaneously, electrons translocated within the electron transport chain undergo spontaneous side reactions with oxygen, giving rise to superoxide and a variety of other downstream reactive oxygen species (ROS).  Mitochondrially-derived ROS can mediate redox signaling or, in excess, cause cell injury and even cell death.  Recent evidence suggests that mitochondrial ultrastructure is tightly coupled to ROS generation depending on the physiol. status of the cell.  Yet, the mechanism by which changes in mitochondrial shape modulate mitochondrial function and redox homeostasis is less clear.  Aberrant mitochondrial morphol. may lead to enhanced ROS formation, which, in turn, may deteriorate mitochondrial health and further exacerbate oxidative stress in a self-perpetuating vicious cycle.  Here, we review the latest findings on the intricate relationship between mitochondrial dynamics and ROS prodn., focusing mainly on its role in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9aXAJ8k2K7LVg90H21EOLACvtfcHk0lgUaax_8twpcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWhsbnL&md5=b1446a6dc2334495ea28d50cfd632cc9</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.3390%2Fantiox7010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fantiox7010013%26sid%3Dliteratum%253Aachs%26aulast%3DJezek%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DK.%2BF.%26aulast%3DStrich%26aufirst%3DR.%26atitle%3DReactive%2520oxygen%2520species%2520and%2520mitochondrial%2520dynamics%253A%2520the%2520yin%2520and%2520yang%2520of%2520mitochondrial%2520dysfunction%2520and%2520cancer%2520progression%26jtitle%3DAntioxidants%26date%3D2018%26volume%3D7%26spage%3D13%26doi%3D10.3390%2Fantiox7010013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&issue=7&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0lgUaax_8twpcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qamar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">The potent oxidant anticancer activity of organoiridium catalysts</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3941</span>– <span class="NLM_lpage">3946</span>, <span class="refDoi"> DOI: 10.1002/anie.201311161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fanie.201311161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkt1SqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3941-3946&issue=15&author=Z.+Liuauthor=I.+Romero-Canelonauthor=B.+Qamarauthor=J.+M.+Hearnauthor=A.+Habtemariamauthor=N.+P.+Barryauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=The+potent+oxidant+anticancer+activity+of+organoiridium+catalysts&doi=10.1002%2Fanie.201311161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The Potent Oxidant Anticancer Activity of Organoiridium Catalysts</span></div><div class="casAuthors">Liu, Zhe; Romero-Canelon, Isolda; Qamar, Bushra; Hearn, Jessica M.; Habtemariam, Abraha; Barry, Nicolas P. E.; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3941-3946</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Platinum complexes are the most widely used anticancer drugs; however, new generations of agents are needed.  The organoiridium(III) complex [(η5-Cpxbiph)Ir(phpy)(Cl)] (1-Cl), which contains π-bonded biphenyltetramethylcyclopentadienyl (Cpxbiph) and ĈN-chelated phenylpyridine (phpy) ligands, undergoes rapid hydrolysis of the chlorido ligand.  In contrast, the pyridine complex [(η5-Cpxbiph)Ir(phpy)(py)]+ (1-py) aquates slowly, and is more potent (in nanomolar amts.) than both 1-Cl and cisplatin towards a wide range of cancer cells.  The pyridine ligand protects 1-py from rapid reaction with intracellular glutathione.  The high potency of 1-py correlates with its ability to increase substantially the level of reactive oxygen species (ROS) in cancer cells.  The unprecedented ability of these iridium complexes to generate H2O2 by catalytic hydride transfer from the coenzyme NADH to oxygen is demonstrated.  Such organoiridium complexes are promising as a new generation of anticancer drugs for effective oxidant therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJEEYeD3qBGrVg90H21EOLACvtfcHk0lgUaax_8twpcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkt1SqtL4%253D&md5=302598b00ad64fcbb966b4d711511531</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201311161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201311161%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DQamar%26aufirst%3DB.%26aulast%3DHearn%26aufirst%3DJ.%2BM.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DN.%2BP.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520potent%2520oxidant%2520anticancer%2520activity%2520of%2520organoiridium%2520catalysts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D15%26spage%3D3941%26epage%3D3946%26doi%3D10.1002%2Fanie.201311161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Ruiz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1039/C7MT00242D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC7MT00242D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29131211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSit7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=93-107&issue=1&author=J.+M.+Hearnauthor=G.+M.+Hughesauthor=I.+Romero-Canelonauthor=A.+F.+Munroauthor=B.+Rubio-Ruizauthor=Z.+Liuauthor=N.+O.+Carragherauthor=P.+J.+Sadler&title=Pharmaco-genomic+investigations+of+organo-iridium+anticancer+complexes+reveal+novel+mechanism+of+action&doi=10.1039%2FC7MT00242D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action</span></div><div class="casAuthors">Hearn, Jessica M.; Hughes, George M.; Romero-Canelon, Isolda; Munro, Alison F.; Rubio-Ruiz, Belen; Liu, Zhe; Carragher, Neil O.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-107</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Resistance to platinum drugs (used in >50% of cancer chemotherapies) is a clin. problem.  Other precious metal complexes with distinct mechanisms of action might overcome this.  Half-sandwich organometallic complexes contg. arene or cyclopentadienyl (Cp) ligands show promise.  We screened two iridium(III) complexes [Ir(CpXbiph)(ppy)Cl] (ZL49, 1, ppy = phenylpyridine) and [Ir(CpXph)(azpyNMe2)Cl]PF6 (ZL109, 2, azpyNMe2 = N,N-dimethylphenylazopyridine) in 916 cancer cell lines from 28 tissue types.  On av., complex 2 was 78x more potent than 1, 36x more active than cisplatin (CDDP), and strongly active (nanomolar) in patient-derived ovarian cancer cell lines.  RNA sequencing of A2780 ovarian cells revealed upregulation of antioxidant responses (NRF2, AP-1) consistent with obsd. induction of reactive oxygen species (ROS).  Protein microarrays, high content imaging and cell cycle anal. showed S/G2 arrest, and late-stage DNA damage response without p53 requirement.  The triple-neg. breast cancer cell line OCUB-M was highly sensitive to 2 as were cell lines with KIT mutations.  Complex 2 exhibits a markedly different pattern of antiproliferative activity compared to the 253 drugs in the Sanger Cancer Genome database, but is most similar to osmium(II) arene complexes which share the same azopyridine ligand.  Redox modulation and DNA damage can provide a multi-targeting strategy, allowing compds. such as 2 to overcome cellular resistance to platinum anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBczIp0DsJF7Vg90H21EOLACvtfcHk0lgUaax_8twpcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSit7%252FJ&md5=d9c4d2fa7700f3f1c3b047ff07bcbf6d</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1039%2FC7MT00242D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MT00242D%26sid%3Dliteratum%253Aachs%26aulast%3DHearn%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DG.%2BM.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DMunro%26aufirst%3DA.%2BF.%26aulast%3DRubio-Ruiz%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPharmaco-genomic%2520investigations%2520of%2520organo-iridium%2520anticancer%2520complexes%2520reveal%2520novel%2520mechanism%2520of%2520action%26jtitle%3DMetallomics%26date%3D2018%26volume%3D10%26issue%3D1%26spage%3D93%26epage%3D107%26doi%3D10.1039%2FC7MT00242D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1491</span>– <span class="NLM_lpage">1501</span>, <span class="refDoi"> DOI: 10.1039/C4MT00112E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC4MT00112E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24828756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1491-1501&issue=8&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=A.+Kisovaauthor=H.+Kostrhunovaauthor=Z.+Liuauthor=P.+J.+Sadlerauthor=J.+Kasparkovaauthor=V.+Brabec&title=A+dual-targeting%2C+apoptosis-inducing+organometallic+half-sandwich+iridium+anticancer+complex&doi=10.1039%2FC4MT00112E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Kisova, Anna; Kostrhunova, Hana; Liu, Zhe; Sadler, Peter J.; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1491-1501</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cellular mechanism of action of an iridium(III) half-sandwich complex [(η5-C5Me4C6H4C6H5)Ir(phen)Cl]PF6 (phen = phenanthroline) (1) is reported.  Complex 1 was used to treat several cell lines, including cisplatin-sensitive, cisplatin-resistant (with intrinsic and acquired resistance) carcinoma cells with wild type p53 status as well as the cells with no intact p53 gene, and nontumorigenic cells.  Complex 1 preferentially kills cancer cells over nontumorigenic cells and exhibits no cross-resistance with cisplatin.  It appears to retain significant activity in human tumor cell lines that are refractory or poorly responsive to cisplatin, and in contrast to cisplatin it displays a high activity in human tumor cell lines that are characterized by both wild type and mutant p53 gene.  The mechanism of cell killing was established through detailed cell-based assays.  Complex 1 exhibits dual effects in killing cancer cells causing nuclear DNA damage and mitochondrial dysfunction involving ROS prodn. simultaneously.  Flow cytometric studies and impedance-based monitoring of cellular responses to 1 demonstrated that 1 acts more quickly than cisplatin to induce cell death and that 1 is a more effective apoptosis inducer than cisplatin in particular in early stages of treatment, when the apoptotic effects predominate over necrosis.  Overall, our findings confirm that 1 and its iridium derivs. represent promising candidates for further pre-clin. studies and new addns. to the growing family of nonplatinum metal-based anticancer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rhP03baUXLVg90H21EOLACvtfcHk0lgRmsWfprMHPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK&md5=5180cef5e67873d2336bb4cf2b24f95a</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1039%2FC4MT00112E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00112E%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DKisova%26aufirst%3DA.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DA%2520dual-targeting%252C%2520apoptosis-inducing%2520organometallic%2520half-sandwich%2520iridium%2520anticancer%2520complex%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D1491%26epage%3D1501%26doi%3D10.1039%2FC4MT00112E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Half-sandwich iridium(III) and ruthenium(II) complexes containing P^P-chelating ligands: a new class of potent anticancer agents with unusual redox features</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1705</span>– <span class="NLM_lpage">1716</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b01959</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b01959" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1705-1716&issue=4&author=J.+Liauthor=M.+Tianauthor=Z.+Tianauthor=S.+Zhangauthor=C.+Yanauthor=C.+Shaoauthor=Z.+Liu&title=Half-sandwich+iridium%28III%29+and+ruthenium%28II%29+complexes+containing+P%5EP-chelating+ligands%3A+a+new+class+of+potent+anticancer+agents+with+unusual+redox+features&doi=10.1021%2Facs.inorgchem.7b01959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P-P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features</span></div><div class="casAuthors">Li, JuanJuan; Tian, Meng; Tian, Zhenzhen; Zhang, Shumiao; Yan, Chao; Shao, Changfang; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1705-1716</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Half-sandwich Ir(III) pentamethylcyclopentadienyl and Ru(II) arene complexes contg. P-P-chelating ligands [(Cpx/arene)M(P-P)Cl]PF6, where M = Ir, Cpx is pentamethylcyclopentadienyl (Cp*), or 1-biphenyl-2,3,4,5-tetramethyl cyclopentadienyl (CpxbiPh); M = Ru, arene is 3-phenylpropan-1-ol (bz-PA), 4-phenylbutan-1-ol (bz-BA), or p-cymene (p-cym), and P-P is 2,20-bis(diphenylphosphino)-1,10-binaphthyl (BINAP), were synthesized and fully characterized, three of them by x-ray crystallog., and their potential as anticancer agents explored.  All five complexes showed potent anticancer activity toward HeLa and A549 cancer cells.  The introduction of a biphenyl substituent on the Cp* ring for the Ir complexes has no effect on the antiproliferative potency.  Ru complex [(η6-p-cym)Ru(P-P)Cl]PF6 (5) displayed the highest potency, ∼15 and 7.5 times more active than the clin. used cisplatin against A549 and HeLa cells, resp.  No binding to 9-MeA and 9-EtG nucleobases was obsd.  Although these types of complexes interact with ctDNA, DNA appears not to be the major target.  Compared to Ir complex [(η5-Cp*)Ir(P-P)Cl]PF6 (1), Ru complex (5) showed stronger ability to interfere with coenzyme NAD+/NADH couple through transfer hydrogenation reactions and to induce ROS in cells, which is consistent with their anticancer activities.  The redox properties of the complexes 1, 5, and ligand BINAP were evaluated by cyclic voltammetry.  Complexes 1 and 5 arrest cell cycles at the S phase, Sub-G1 phase and G1 phase, resp., and cause cell apoptosis toward A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19k_C9XVkq7Vg90H21EOLACvtfcHk0lgRmsWfprMHPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7c%253D&md5=728e52ac5ae4c1bed9c9a01b2bb36e07</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b01959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b01959%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DShao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DHalf-sandwich%2520iridium%2528III%2529%2520and%2520ruthenium%2528II%2529%2520complexes%2520containing%2520P%255EP-chelating%2520ligands%253A%2520a%2520new%2520class%2520of%2520potent%2520anticancer%2520agents%2520with%2520unusual%2520redox%2520features%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26issue%3D4%26spage%3D1705%26epage%3D1716%26doi%3D10.1021%2Facs.inorgchem.7b01959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Novel and versatile imine-N-heterocyclic carbene half-sandwich iridium(III) complexes as lysosome-targeted anticancer agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">11087</span>– <span class="NLM_lpage">11098</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b01656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b01656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGisLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=11087-11098&issue=17&author=Y.+Yangauthor=L.+Guoauthor=Z.+Tianauthor=Y.+Gongauthor=H.+Zhengauthor=S.+Zhangauthor=Z.+Xuauthor=X.+Geauthor=Z.+Liu&title=Novel+and+versatile+imine-N-heterocyclic+carbene+half-sandwich+iridium%28III%29+complexes+as+lysosome-targeted+anticancer+agents&doi=10.1021%2Facs.inorgchem.8b01656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents</span></div><div class="casAuthors">Yang, Yuliang; Guo, Lihua; Tian, Zhenzhen; Gong, Yuteng; Zheng, Hongmei; Zhang, Shumiao; Xu, Zhishan; Ge, Xingxing; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11087-11098</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We herein report the synthesis, characterization, luminescence properties, anticancer and antibacterial activities of a family of novel half-sandwich iridium(III) complexes of the general formula [(η5-Cpx)Ir(ĈN)Cl]PF6- [Cpx = pentamethylcyclopentadienyl (Cp*) or tetramethyl(biphenyl)-cyclopentadienyl (Cpxbiph)] bearing versatile imine-N-heterocyclic carbene ligands.  In this complex framework, substituents on four positions could be modulated, which distinguishes this class of complex and provides a large amt. of flexibilities and opportunities to tune the cytotoxicity of complexes.  The X-ray crystal structures of complexes 4 and 10 exhibit the expected "piano-stool" geometry.  With the exception of 1, 2 and 11, each complex shows potent cytotoxicity, with IC50 values ranging from 1.99 to 25.86 μM toward A549 human lung cancer cells.  First, the effect of four positions bearing different substituents in the complex framework on the anticancer activity, i.e. structure-activity relationship, was systematically studied.  Complex 8 (IC50 = 1.99 μM) displays the highest anticancer activities, whose cytotoxicity is more than 10-fold higher than that of the clin. platinum drug cisplatin against A549 cancer cells.  Second, their chem. reactivity including nucleobases binding, catalytic activity in converting coenzyme NADH to NAD+, reaction with glutathione (GSH), and bovine serum albumin (BSA) binding is investigated.  No reaction with nucleobase is obsd.  However, these iridium(III) complexes bind rapidly to GSH and can catalyze oxidn. of NADH to NAD+.  In addn., they show moderate binding affinity to BSA and the fluorescence quenching of BSA by the metal complexes is due to the static quenching.  Third, the mode of cell death was also explored through flow cytometry expts., including cell cycle, apoptosis induction, reactive oxygen species (ROS) and mitochondrial membrane potential.  It seems that cell cycle perturbation, apoptosis induction, increase of ROS level and loss of mitochondrial membrane potential together contribute to the anticancer potency of these complexes.  Last, the use of confocal microscopy provides insights into the microscopic mechanism that the typical and most active complex 8 enters A549 lung cancer cells mainly through energy-dependent pathway and is located in lysosome.  Furthermore, lysosome damage and nuclear morphol. were detected by confocal microscopy.  Nuclear condensation and apoptotic bodies may finally induce cells apoptosis.  Interestingly, complex 8 also shows antibacterial activity against Gram-pos. Staphyloccocus aureus (S. aureus).  This work may provide an alternative and effective strategy to smart design of potent organometallic half-sandwich iridium(III) anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryA_KrhDUdw7Vg90H21EOLACvtfcHk0lgRmsWfprMHPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGisLnI&md5=345e3e156257d405eab2daa17a85bb2c</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b01656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b01656%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DNovel%2520and%2520versatile%2520imine-N-heterocyclic%2520carbene%2520half-sandwich%2520iridium%2528III%2529%2520complexes%2520as%2520lysosome-targeted%2520anticancer%2520agents%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26issue%3D17%26spage%3D11087%26epage%3D11098%26doi%3D10.1021%2Facs.inorgchem.8b01656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organoiridium complexes: anticancer agents and catalysts</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1021/ar400266c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar400266c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFWisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=1174-1185&issue=4&author=Z.+Liuauthor=P.+J.+Sadler&title=Organoiridium+complexes%3A+anticancer+agents+and+catalysts&doi=10.1021%2Far400266c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Organoiridium Complexes: Anticancer Agents and Catalysts</span></div><div class="casAuthors">Liu, Zhe; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1174-1185</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this Account, we review recent developments in organoiridium complexes as both catalysts and anticancer agents.  Initial studies of anticancer activity with organoiridium complexes focused on square-planar IrI complexes because of their structural and electronic similarity to PtII anticancer complexes such as cisplatin.  Recently, researchers have studied half-sandwich IrIII anticancer complexes.  These complexes with the formula [(Cpx)Ir(L-L)Z]0/n+ (with Cp* or extended Cp* and L-L = chelated C-N or N-N ligands) have a much greater potency (nanomolar) toward a range of cancer cells (esp. leukemia, colon cancer, breast cancer, prostate cancer, and melanoma) than cisplatin.  Their mechanism of action may involve both an attack on DNA and a perturbation of the redox status of cells.  Some of these complexes can form IrIII-hydride complexes using coenzyme NAD(P)H as a source of hydride to catalyze the generation of H2 or the redn. of quinones to semiquinones.  Intriguingly, relatively unreactive organoiridium complexes contg. an imine as a monodentate ligand have prooxidant activity, which appears to involve catalytic hydride transfer to oxygen and the generation of hydrogen peroxide in cells.  In addn., researchers have designed inert IrIII complexes as potent kinase inhibitors.  Octahedral cyclometalated IrIII complexes not only serve as cell imaging agents, but can also inhibit tumor necrosis factor α, promote DNA oxidn., generate singlet oxygen when photoactivated, and exhibit good anticancer activity.  Although relatively unexplored, organoiridium chem. offers unique features that researchers can exploit to generate novel diagnostic agents and drugs with new mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1UaAsXCZPqbVg90H21EOLACvtfcHk0liuIMxKv9MHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFWisLs%253D&md5=149684628c06aa2b8e317acc778d6504</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Far400266c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far400266c%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganoiridium%2520complexes%253A%2520anticancer%2520agents%2520and%2520catalysts%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2014%26volume%3D47%26issue%3D4%26spage%3D1174%26epage%3D1185%26doi%3D10.1021%2Far400266c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruijnincx, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organometallic half-sandwich iridium anticancer complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3011</span>– <span class="NLM_lpage">3026</span>, <span class="refDoi"> DOI: 10.1021/jm2000932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2000932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2gsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3011-3026&issue=8&author=Z.+Liuauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=S.+A.+Fletcherauthor=A.+Kisovaauthor=O.+Vranaauthor=L.+Salassaauthor=P.+C.+Bruijnincxauthor=G.+J.+Clarksonauthor=V.+Brabecauthor=P.+J.+Sadler&title=Organometallic+half-sandwich+iridium+anticancer+complexes&doi=10.1021%2Fjm2000932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic half-sandwich iridium anticancer complexes</span></div><div class="casAuthors">Liu, Zhe; Habtemariam, Abraha; Pizarro, Ana M.; Fletcher, Sally A.; Kisova, Anna; Vrana, Oldrich; Salassa, Luca; Bruijnincx, Pieter C. A.; Clarkson, Guy J.; Brabec, Viktor; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3011-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The low-spin 5d6 IrIII organometallic half-sandwich complexes [(η5-Cpx)Ir(XY)Cl]0/+, Cpx = Cp*, tetramethyl(phenyl)cyclopentadienyl (Cpxph), or tetramethyl(biphenyl)cyclopentadienyl (Cpxbiph), XY = 1,10-phenanthroline (4-6), 2,2'-bipyridine (7-9), ethylenediamine (10 and 11), or picolinate (12-14), hydrolyze rapidly.  Complexes with N,N-chelating ligands readily form adducts with 9-ethylguanine but not 9-ethyladenine; picolinate complexes bind to both purines.  Cytotoxic potency toward A2780 human ovarian cancer cells increases with Ph substitution on Cp*: Cpxbiph > Cpxph > Cp*; Cpxbiph complexes 6 and 9 have submicromolar activity.  Guanine residues are preferential binding sites for 4-6 on plasmid DNA.  Hydrophobicity (log P), cell and nucleus accumulation of Ir correlate with cytotoxicity, 6>5>4; they distribute similarly within cells.  The ability to displace DNA intercalator ethidium bromide from DNA correlates with cytotoxicity and viscosity of Ir-DNA adducts.  The hydrophobicity and intercalative ability of Cpxph and Cpxbiph make a major contribution to the anticancer potency of their IrIII complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUJTiS3baZTrVg90H21EOLACvtfcHk0liuIMxKv9MHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2gsr4%253D&md5=38ab54bd3bac6e28fca46bbdbe01a91d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2000932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2000932%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DFletcher%26aufirst%3DS.%2BA.%26aulast%3DKisova%26aufirst%3DA.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DBruijnincx%26aufirst%3DP.%2BC.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganometallic%2520half-sandwich%2520iridium%2520anticancer%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D3011%26epage%3D3026%26doi%3D10.1021%2Fjm2000932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organometallic iridium(III) cyclopentadienyl anticancer complexes containing C,N-chelating ligands</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4702</span>– <span class="NLM_lpage">4710</span>, <span class="refDoi"> DOI: 10.1021/om2005468</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om2005468" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslGisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4702-4710&issue=17&author=Z.+Liuauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Organometallic+iridium%28III%29+cyclopentadienyl+anticancer+complexes+containing+C%2CN-chelating+ligands&doi=10.1021%2Fom2005468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands</span></div><div class="casAuthors">Liu, Zhe; Habtemariam, Abraha; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4702-4710</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organometallic Ir(III) cyclopentadienyl complexes [(η5-Cpx)Ir(C*N)Cl] {Cpx = Cp*, C*N = 2-(p-tolyl)pyridine (1), 2-phenylquinoline (2), 2-(2,4-difluorophenyl)pyridine (3), Cpx = tetramethyl(phenyl)cyclopentadienyl (Cpxph), C*N = 2-phenylpyridine (4), and Cpx = tetramethyl(biphenyl)cyclopentadienyl (Cpxbiph), C N = 2-phenylpyridine (5)} were synthesized and characterized.  The x-ray crystal structures of 2 and 5 were detd. and show typical piano-stool geometry.  All the complexes hydrolyzed rapidly in aq. soln. (<5 min) even at 278 K.  The pKa values of the aqua adducts 1A-5A are in the range 8.31-8.87 and follow the order 1A > 2A > 4A > 5A ≈ 3A.  Hydroxo-bridged dimers {[(η5-Cpx)Ir]2(μ-OD)3}+ (Cpx = Cp*, 6; Cpxph, 7; Cpxbiph, 8) are readily formed during pH titrns. at ca. pH 8.7.  Complexes 1 and 3-5 bind strongly to 9-ethylguanine (9-EtG), moderately strongly to 9-methyladenine (9-MeA), and hence preferentially to 9-EtG when in competition with 9-MeA.  The extent of guanine and adenine binding to complex 2 was significantly lower for both purines due to steric hindrance from the chelating ligand.  All complexes showed potent cytotoxicity, with IC50 values ranging from 6.5 to 0.7 μM toward A2780 human ovarian cancer cells.  Potency toward these cancer cells increased with addnl. Ph substitution on Cp*: Cpxbiph > Cpxph > Cp*.  Cpxbiph with complex 5 exhibited submicromolar activity (2× as active as cisplatin).  These data demonstrate how the aq. chem., nucleobase binding, and anticancer activity of C,N-bound Ir(III) cyclopentadienyl complexes can be controlled and fine-tuned by the modification of the chelating and cyclopentadienyl ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_bT6kaxdTcbVg90H21EOLACvtfcHk0liuIMxKv9MHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslGisLk%253D&md5=cd92942df6d6d29d1978ea7b1b447ccc</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fom2005468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom2005468%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganometallic%2520iridium%2528III%2529%2520cyclopentadienyl%2520anticancer%2520complexes%2520containing%2520C%252CN-chelating%2520ligands%26jtitle%3DOrganometallics%26date%3D2011%26volume%3D30%26issue%3D17%26spage%3D4702%26epage%3D4710%26doi%3D10.1021%2Fom2005468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5777</span>– <span class="NLM_lpage">5783</span>, <span class="refDoi"> DOI: 10.1021/ic200607j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic200607j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=5777-5783&issue=12&author=Z.+Liuauthor=L.+Salassaauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Contrasting+reactivity+and+cancer+cell+cytotoxicity+of+isoelectronic+organometallic+iridium%28III%29+complexes&doi=10.1021%2Fic200607j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span></div><div class="casAuthors">Liu, Zhe; Salassa, Luca; Habtemariam, Abraha; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5777-5783</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iridium(III) half-sandwich neutral cyclometalated 2-phenylpyridine (Hphpy) complex [Cp*Ir(phpy)Cl] (2, Cp* = η5-C5Me5) undergo substitution of the chloro ligand for nucleobases, exhibiting a promising cytotoxicity against human ovarian cancer cells.  Replacing the N,N-chelating ligand 2,2'-bipyridine (bpy) in the IrIII η5-pentamethylcyclopentadienyl complex [Cp*Ir(bpy)Cl]+ (1) with the C,N-chelating ligand Hphpy to give 2 switches on cytotoxicity toward A2780 human ovarian cancer cells (IC50 values of >100 μM for 1 and 10.8 μM for 2).  Ir-Cl hydrolysis is rapid for both complexes (hydrolysis equil. reached in <5 min at 278 K).  Complex 2 forms adducts with both 9-ethylguanine (9-EtG) and 9-methyladenine (9-MeA), but preferentially with 9-EtG when in competition (ca. 85% of total Ir after 24 h).  The x-ray crystal structure of [(η5-C5Me5)Ir(phpy)(9-EtG-N7)]NO3·1.5CH2Cl2 (3) confirms N7 binding to guanine.  Two-dimensional NMR spectra show that complex 2 binds to adenine mainly through N1, consistent with d. functional theory (DFT) calcns.  DFT calcns. indicate an interaction between the nitrogen of the NH2 group (9-MeA) and carbons from phpy in the adenine adduct of complex 2.  Calcns. show that the most stable geometry of the adduct [Cp*Ir(phpy)(9-EtG-κN7)]+ (3b) has the C6 of 9-EtG orientated toward the pyridine ring of phpy, and for [Cp*Ir(phpy)(9-MeA-κN1)]+ (4(N1)a), the NH2 group of 9-EtA is adjacent to the Ph ring side of phpy.  Complex 2 is more hydrophobic than complex 1, with log P values of 1.57 and -0.95, resp.  The strong nucleobase binding and high hydrophobicity of complex 2 probably contribute to its promising anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqMjGMrbypdbVg90H21EOLACvtfcHk0lgxJZz5QAcjVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D&md5=b60e6409afb934203732b78ce3169b6e</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fic200607j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic200607j%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DContrasting%2520reactivity%2520and%2520cancer%2520cell%2520cytotoxicity%2520of%2520isoelectronic%2520organometallic%2520iridium%2528III%2529%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D2011%26volume%3D50%26issue%3D12%26spage%3D5777%26epage%3D5783%26doi%3D10.1021%2Fic200607j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent half-sandwich iridium(III) anticancer complexes containing C^N-chelated and pyridine ligands</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5324</span>– <span class="NLM_lpage">5333</span>, <span class="refDoi"> DOI: 10.1021/om500644f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om500644f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2qtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=5324-5333&issue=19&author=Z.+Liuauthor=I.+Romero-Canelonauthor=A.+Habtemariamauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Potent+half-sandwich+iridium%28III%29+anticancer+complexes+containing+C%5EN-chelated+and+pyridine+ligands&doi=10.1021%2Fom500644f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C N-Chelated and Pyridine Ligands</span></div><div class="casAuthors">Liu, Zhe; Romero-Canelon, Isolda; Habtemariam, Abraha; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5324-5333</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis and characterization of eight half-sandwich cyclopentadienyl IrIII pyridine complexes of the type [(η5-Cpxph)Ir(phpy)Z]PF6, in which Cpxph = C5Me4C6H5 (tetramethyl(phenyl)cyclopentadienyl), phpy = 2-phenylpyridine as C N-chelating ligand, and Z = pyridine (py) or a pyridine deriv.  Three X-ray crystal structures have been detd.  The monodentate py ligands blocked hydrolysis; however, antiproliferative studies showed that all the Ir compds. are highly active toward A2780, A549, and MCF-7 human cancer cells.  In general the introduction of an electron-donating group (e.g., Me, NMe2) at specific positions on the pyridine ring resulted in increased antiproliferative activity, whereas electron-withdrawing groups (e.g., COMe, COOMe, CONEt2) decreased anticancer activity.  Complex 5 displayed the highest anticancer activity, exhibiting submicromolar potency toward a range of cancer cell lines in the National Cancer Institute NCI-60 screen, ca. 5 times more potent than the clin. platinum(II) drug cisplatin.  DNA binding appears not to be the major mechanism of action.  Although complexes [(η5-Cpxph)Ir(phpy)(py)]+ (1) and [(η5-Cpxph)Ir(phpy)(4-NMe2-py)]+ (5) did not cause cell apoptosis or cell cycle arrest after 24 h drug exposure in A2780 human ovarian cancer cells at IC50 concns., they increased the level of reactive oxygen species (ROS) dramatically and led to a loss of mitochondrial membrane potential (ΔΨm), which appears to contribute to the anticancer activity.  This class of organometallic Ir complexes has unusual features worthy of further exploration in the design of novel anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4VhzRgPrfYLVg90H21EOLACvtfcHk0lgxJZz5QAcjVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2qtrbN&md5=169fe702747f0c67d7c8c86f22ad8673</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fom500644f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom500644f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520half-sandwich%2520iridium%2528III%2529%2520anticancer%2520complexes%2520containing%2520C%255EN-chelated%2520and%2520pyridine%2520ligands%26jtitle%3DOrganometallics%26date%3D2014%26volume%3D33%26issue%3D19%26spage%3D5324%26epage%3D5333%26doi%3D10.1021%2Fom500644f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2018.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.jinorgbio.2018.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=30445339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2019&pages=1-7&author=Y.+Yangauthor=L.+Guoauthor=X.+Geauthor=S.+Shiauthor=Y.+Gongauthor=Z.+Xuauthor=X.+Zhengauthor=Z.+Liu&title=Structure-activity+relationships+for+highly+potent+half-sandwich+organoiridium%28III%29+anticancer+complexes+with+C%5EN-chelated+ligands&doi=10.1016%2Fj.jinorgbio.2018.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with ĈN-chelated ligands</span></div><div class="casAuthors">Yang, Yuliang; Guo, Lihua; Ge, Xingxing; Shi, Shaopeng; Gong, Yuteng; Xu, Zhishan; Zheng, Xiaofeng; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The authors herein report the synthesis, characterization, catalytic ability in converting coenzyme NADH to NAD+ and anticancer activity of half-sandwich iridium(III) complexes.  The mol. structure of the most cytotoxic complex (I), exhibiting the familiar "piano-stool" geometry, has been authenticated by x-ray crystallog.  The anticancer activities of these complexes can be governed via substituent effects of three tunable domains and the ligand substituted variants offer an effective chelate ligand set that distinguishes anticancer activity and catalytic ability.  Notably, complex I displays the greatest cytotoxic activities (IC50 = 0.85 μM), whose anticancer activity is more approx. 25-fold higher than that of cisplatin.  The initial cell death mechanistic insight displays that this group of iridium(III) complexes exerts anticancer effects via cell cycle arrest, apoptosis induction and loss of the mitochondrial membrane potential.  In addn., the confocal microscopy imaging shows that the complex I can damage lysosome.  Overall, preliminary structure-activity relationships study and understanding of the cell death mechanism perhaps provide a rational strategy for enhancing anticancer activity of this family of complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7f7tIODFG7Vg90H21EOLACvtfcHk0lgygxlMl2gX3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqt77P&md5=9de0bb1e253551e98e62473476bad8b1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2018.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2018.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DStructure-activity%2520relationships%2520for%2520highly%2520potent%2520half-sandwich%2520organoiridium%2528III%2529%2520anticancer%2520complexes%2520with%2520C%255EN-chelated%2520ligands%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2019%26volume%3D191%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.jinorgbio.2018.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Phenoxide chelated Ir(III) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">13781</span>– <span class="NLM_lpage">13787</span>, <span class="refDoi"> DOI: 10.1039/C8DT03159B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8DT03159B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=30238113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Gktb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=13781-13787&issue=39&author=Y.+Zhangauthor=S.+Zhangauthor=Z.+Tianauthor=J.+Liauthor=Z.+Xuauthor=S.+Liauthor=Z.+Liu&title=Phenoxide+chelated+Ir%28III%29+N-heterocyclic+carbene+complexes%3A+synthesis%2C+characterization%2C+and+evaluation+of+their+in+vitro+anticancer+activity&doi=10.1039%2FC8DT03159B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phenoxide chelated Ir(III) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity</span></div><div class="casAuthors">Zhang, Yujiao; Zhang, Shumiao; Tian, Zhenzhen; Li, Juanjuan; Xu, Zhishan; Li, Shanshan; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13781-13787</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Twelve novel half-sandwich Ir(III)-NHC complexes [(η5-Cpx)Ir(C-O)Cl] (C-O = bidentate imidazolylidenylphenoxide ligand) were synthesized and characterized.  These complexes showed higher cytotoxic activity toward A549 cells and HeLa cells than cisplatin.  An increase in the no. of contained Ph groups was related to better anticancer activity.  The reaction of complexes with nucleobases 9-MeA, nucleobases 9-EtG, plasmid DNA and CT-DNA showed no significant effects.  These complexes captured H from NADH and converted it to NAD+, which produced the reactive O species (ROS).  ROS decreased the mitochondrial membrane potential and lysosomal damage, finally inducing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr04mX8qAJFKbVg90H21EOLACvtfcHk0lgygxlMl2gX3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Gktb7M&md5=325a39b789721ecc3fcb36628ffd4c21</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2FC8DT03159B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT03159B%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DPhenoxide%2520chelated%2520Ir%2528III%2529%2520N-heterocyclic%2520carbene%2520complexes%253A%2520synthesis%252C%2520characterization%252C%2520and%2520evaluation%2520of%2520their%2520in%2520vitro%2520anticancer%2520activity%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26issue%3D39%26spage%3D13781%26epage%3D13787%26doi%3D10.1039%2FC8DT03159B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basri, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6812</span>– <span class="NLM_lpage">6815</span>, <span class="refDoi"> DOI: 10.1039/C6DT00186F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC6DT00186F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=26924272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Cru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=6812-6815&issue=16&author=S.+J.+Lucasauthor=R.+M.+Lordauthor=A.+M.+Basriauthor=S.+J.+Allisonauthor=R.+M.+Phillipsauthor=A.+J.+Blackerauthor=P.+C.+McGowan&title=Increasing+anti-cancer+activity+with+longer+tether+lengths+of+group+9+Cp*+complexes&doi=10.1039%2FC6DT00186F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes</span></div><div class="casAuthors">Lucas, Stephanie. J.; Lord, Rianne M.; Basri, Aida M.; Allison, Simon J.; Phillips, Roger M.; Blacker, A. John; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6812-6815</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Here in, authors report the cytotoxicity of both rhodium and iridium functionalized Cp* analogs of the [Cp*MCl2]2 dimers.  The functionalized dimers contain a hydroxy tethered arm of differing carbon length.  These show promising IC50 values when tested against HT-29, A2780 and cisplatin-resistant A2780cis human cancer cell lines, with the cytotoxicity improving proportionally with an increase in carbon tether length of the Cp* ring.  The most promising results are seen for the 14-carbon Cp* tethered rhodium (2d) and iridium (3b) complexes, which show up to a 24-fold increase in IC50 compared to the unfunctionalized [Cp*MCl2]2 dimer.  All complexes were potent inhibitors of purified thioredoxin reductase suggesting that disruption of cellular anti-oxidant function is one potential mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGQ-QoVtxExLVg90H21EOLACvtfcHk0lgygxlMl2gX3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Cru7o%253D&md5=34c1aecd2a9c0a25ea6b461caa5ccd09</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC6DT00186F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT00186F%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%2BJ.%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DBasri%26aufirst%3DA.%2BM.%26aulast%3DAllison%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DBlacker%26aufirst%3DA.%2BJ.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DIncreasing%2520anti-cancer%2520activity%2520with%2520longer%2520tether%2520lengths%2520of%2520group%25209%2520Cp%252A%2520complexes%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26issue%3D16%26spage%3D6812%26epage%3D6815%26doi%3D10.1039%2FC6DT00186F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, S. P.</span>; <span class="NLM_string-name">McGowan, P. C.</span>; <span class="NLM_string-name">Lanaro, R.</span>; <span class="NLM_string-name">Blacker, A. J.</span></span> <span> </span><span class="NLM_article-title">Metal complexes</span>. WO <span class="NLM_patent">2017103623</span>, June 22, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+P.+Marsden&author=P.+C.+McGowan&author=R.+Lanaro&author=A.+J.+Blacker&title=Metal+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DS.%2BP.%26atitle%3DMetal%2520complexes%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Peña, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Control of reversible activation dynamics of [Ru{η<sup>6</sup>:κ<sup>1</sup>-C<sub>6</sub>H<sub>5</sub>(C<sub>6</sub>H<sub>4</sub>)NH<sub>2</sub>}(XY)]<sup>n+</sup> and the effect of chelating-ligand variation</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">64</span>),  <span class="NLM_fpage">16231</span>– <span class="NLM_lpage">16241</span>, <span class="refDoi"> DOI: 10.1002/chem.201701681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fchem.201701681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=28734001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=16231-16241&issue=64&author=F.+Martinez-Pe%C3%B1aauthor=A.+M.+Pizarro&title=Control+of+reversible+activation+dynamics+of+%5BRu%7B%CE%B76%3A%CE%BA1-C6H5%28C6H4%29NH2%7D%28XY%29%5Dn%2B+and+the+effect+of+chelating-ligand+variation&doi=10.1002%2Fchem.201701681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Control of Reversible Activation Dynamics of [Ru{η6:κ1-C6H5(C6H4)NH2}(XY)]n+ and the Effect of Chelating-Ligand Variation</span></div><div class="casAuthors">Martinez-Pena, Francisco; Pizarro, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">64</span>),
    <span class="NLM_cas:pages">16231-16241</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The potential use of organoruthenium complexes as anticancer drugs is well known.  Herein, a family of activatable tethered ruthenium(II) arene complexes of general formula [Ru{η6:κ1-C6H5(C6H4)NH2}(XY)]n+ (closed tether ring) bearing different chelating XY ligands (XY=aliph. diamine, phenylenediamine, oxalato, bis(phosphino)ethane) is reported.  The activation of these complexes (closed- to open-tether conversion) occurs in methanol and DMSO at different rates and to different reaction extents at equil.  Most importantly, RuII-complex activation (cleavage of the Ru-Ntether bond) occurs in aq. soln. at high proton concn. (upon Ntether protonation).  The activation dynamics can be modulated by rational variation of the XY chelating ligand.  The electron-donating capability and steric hindrance of XY have a direct impact on the reactivity of the Ru-N bond, and XY=N,N'-dimethyl-, N,N'-diethyl-, and N,N,N',N'-tetramethylethylenediamine afford complexes that are more prone to activation.  Such activation in acidic media is fully reversible, and proton concn. also governs the deactivation rate, i.e., tether-ring closure slows down with decreasing pH.  Interaction of a closed-tether complex and its open-tether counterpart with 5'-guanosine monophosphate revealed selectivity of the active (open) complex towards interaction with nucleobases.  This work presents ruthenium tether complexes as exceptional pH-dependent switches with potential applications in cancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIXCi-JoklMrVg90H21EOLACvtfcHk0ljb3BjXgOYBIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsr3O&md5=ed28817ec8c3577eef9bdab196939268</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701681%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Pe%25C3%25B1a%26aufirst%3DF.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DControl%2520of%2520reversible%2520activation%2520dynamics%2520of%2520%255BRu%257B%25CE%25B76%253A%25CE%25BA1-C6H5%2528C6H4%2529NH2%257D%2528XY%2529%255Dn%252B%2520and%2520the%2520effect%2520of%2520chelating-ligand%2520variation%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26issue%3D64%26spage%3D16231%26epage%3D16241%26doi%3D10.1002%2Fchem.201701681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Peña, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante-Tadeo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Reversible pH-responsive behavior of ruthenium(II) arene complexes with tethered carboxylate</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5657</span>– <span class="NLM_lpage">5668</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b00625</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b00625" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFeksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=5657-5668&issue=9&author=F.+Martinez-Pe%C3%B1aauthor=S.+Infante-Tadeoauthor=A.+Habtemariamauthor=A.+M.+Pizarro&title=Reversible+pH-responsive+behavior+of+ruthenium%28II%29+arene+complexes+with+tethered+carboxylate&doi=10.1021%2Facs.inorgchem.8b00625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate</span></div><div class="casAuthors">Martinez-Pena, Francisco; Infante-Tadeo, Sonia; Habtemariam, Abraha; Pizarro, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5657-5668</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Five complexes [Ru(η6-C6H5CH2COOH)(XY)Cl]Cl/Na (XY = ethylenediamine (1), o-phenylenediamine (2), phenanthroline (3), and oxalato (4)) and [Ru(η6:κ1-C6H5CH2COO)(tmen)]Cl (tmen = N,N,N',N'-tetramethylethylenediamine, 5C) were synthesized and fully characterized.  Five new x-ray crystal structures ([Ru(η6-C6H5CH2COOH)(μ-Cl)Cl]2, 1, 3, 4, and 5C·PF6) were detd., which are the 1st examples of Ru(II) structures with phenylacetic acid as arene ligand.  Also, 5C·PF6 is the 1st example of a five-membered tether ring with a Ru(η6:κ1-arene:O) bond.  The tether ring in these complexes opens in acidic pH (<5) and closes reversibly in aq. soln.  The chlorido open-form undergoes aquation, and the aqua adduct can be obsd. (prior to ring closure) by NMR.  The speciation has an attractive complexity in the pH range 0-12, showing interconversion of the three species (chlorido, aqua, and closed tether), dependent on the proton concn. and the nature of the XY chelating ligand.  The closed tether version of 3, complex 3C, with σ-donor/π-acceptor phenanthroline as chelating ligand, opens up more readily (pH 4), while the tether ring in complex 5C hardly opens even at pH ≥1.  The authors detd. the pKa of the pendant carboxylic group and that of the aqua adduct (∼3 and ∼7, resp.), which can be finely tuned by the appropriate choice of XY.  Complexes 1 and 2, which predominate in their inactive (closed-tether) form in intracellular conditions, show some cytotoxic activity (IC50 130 and 117 μM, resp.) in A2780 ovarian cancer cells.  Complex 1 catalyzes the redn. through transfer hydrogenation of pyruvate to lactate and NAD+ to NADH in the presence of formate as H-source.  Co-incubation with Na formate decreases the IC50 value of 1 in A2780 cancer cells significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJkFUxNYPurVg90H21EOLACvtfcHk0ljb3BjXgOYBIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFeksro%253D&md5=e6e2301b58ef181364392616c7c18c6e</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b00625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b00625%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Pe%25C3%25B1a%26aufirst%3DF.%26aulast%3DInfante-Tadeo%26aufirst%3DS.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DReversible%2520pH-responsive%2520behavior%2520of%2520ruthenium%2528II%2529%2520arene%2520complexes%2520with%2520tethered%2520carboxylate%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26issue%3D9%26spage%3D5657%26epage%3D5668%26doi%3D10.1021%2Facs.inorgchem.8b00625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. S.</span></span> <span> </span><span class="NLM_article-title">pH-dependent modulation of reactivity in ruthenium(II) organometallics</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.7b00868</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.7b00868" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=294-297&issue=3&author=T.+J.+Priorauthor=H.+Savoieauthor=R.+W.+Boyleauthor=B.+S.+Murray&title=pH-dependent+modulation+of+reactivity+in+ruthenium%28II%29+organometallics&doi=10.1021%2Facs.organomet.7b00868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Dependent Modulation of Reactivity in Ruthenium(II) Organometallics</span></div><div class="casAuthors">Prior, Timothy J.; Savoie, Huguette; Boyle, Ross W.; Murray, Benjamin S.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-297</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The pH-dependent intramol. chelation of a tethered sulfonamide ligand in Ru(II) arene complexes is demonstrated, a process shown to modulate metal-centered reactivity toward the model ligand GMP within the physiol. relevant pH region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsgiFJTFtIH7Vg90H21EOLACvtfcHk0ljb3BjXgOYBIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKms7s%253D&md5=a79c66b44243539399f9d0f2dd76dfaf</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.7b00868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.7b00868%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DT.%2BJ.%26aulast%3DSavoie%26aufirst%3DH.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26aulast%3DMurray%26aufirst%3DB.%2BS.%26atitle%3DpH-dependent%2520modulation%2520of%2520reactivity%2520in%2520ruthenium%2528II%2529%2520organometallics%26jtitle%3DOrganometallics%26date%3D2018%26volume%3D37%26issue%3D3%26spage%3D294%26epage%3D297%26doi%3D10.1021%2Facs.organomet.7b00868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stodt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gencaslan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, W. S.</span></span> <span> </span><span class="NLM_article-title">Preparation, reactivity and peptide labelling properties of (η<sup>6</sup>-arene)ruthenium(II) complexes with pendant carboxylate groups</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2003</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1873</span>– <span class="NLM_lpage">1882</span>, <span class="refDoi"> DOI: 10.1002/ejic.200200599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fejic.200200599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=1873-1882&issue=10&author=R.+Stodtauthor=S.+Gencaslanauthor=I.+M.+M%C3%BCllerauthor=W.+S.+Sheldrick&title=Preparation%2C+reactivity+and+peptide+labelling+properties+of+%28%CE%B76-arene%29ruthenium%28II%29+complexes+with+pendant+carboxylate+groups&doi=10.1002%2Fejic.200200599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1002%2Fejic.200200599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200200599%26sid%3Dliteratum%253Aachs%26aulast%3DStodt%26aufirst%3DR.%26aulast%3DGencaslan%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DI.%2BM.%26aulast%3DSheldrick%26aufirst%3DW.%2BS.%26atitle%3DPreparation%252C%2520reactivity%2520and%2520peptide%2520labelling%2520properties%2520of%2520%2528%25CE%25B76-arene%2529ruthenium%2528II%2529%2520complexes%2520with%2520pendant%2520carboxylate%2520groups%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2003%26volume%3D2003%26issue%3D10%26spage%3D1873%26epage%3D1882%26doi%3D10.1002%2Fejic.200200599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Amarasekera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauchfuss, T. B.</span></span> <span> </span><span class="NLM_article-title">Interconversion of persulfido, sulfur hydride, and hydride ligands coordinated to CpRu(PPh<sub>3</sub>)<sub>2</sub><sup>+</sup></span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1021/ic00319a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00319a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaL1MXlsFCjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=3875-3883&issue=20&author=J.+Amarasekeraauthor=T.+B.+Rauchfuss&title=Interconversion+of+persulfido%2C+sulfur+hydride%2C+and+hydride+ligands+coordinated+to+CpRu%28PPh3%292%2B&doi=10.1021%2Fic00319a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">Interconversion of persulfido, sulfur hydride, and hydride ligands coordinated to CpRu(PPh3)2+</span></div><div class="casAuthors">Amarasekera, Jayantha; Rauchfuss, Thomas B.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3875-83</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">The electron-rich metallothiol CpRu(PPh3)2SH (I, Cp = η5-cyclopentadienyl) has been prepd. from the reactions of CpRu(PPh3)2Cl with NaSH and CpRu(PPh3)2H with elemental sulfur.  Carbonylation of I gives CpRu(PPh3)(CO)SH whereas the carbonylation of CpRu(PPh3)2Cl is thermodynamically unfavorable.  Protonation of I gives [CpRu(PPh3)2(SH2)]+.  Alkylation of I gives thiol complexes [CpRu(PPh3)2(RSH)]+ (R = Me); such complexes were also prepd. directly from CpRu(PPh3)2OTf (OTf = CF3SO3) and RSH.  The structure of the thiol complex [CpRu(PPh3)2(PrSH)]BF4·CH2Cl2 was detd. by x-ray methods.  [CpRu(PPh3)2(SH2)]+ reacts reversibly with H2 to give the dihydride [CpRu(PPh3)2H2]+.  Analogous results were found for [((2-SC4H3)CH2C5H4)Ru(PPh3)2]+; the S-bound thiophene ligand can be displaced by H2S, H2, H-, and SH-.  [CpRu(PPh3)2(H2S)]+ oxidizes in air to give [CpRu(PPh3)2]2(μ-S2]2+ (II).  Salts of II are formed in two-electron oxidns. of I with Ph3CBF4, Cp2Fe+, and I2 as well as electrochem.  A presumed intermediate in this oxidn. is [CpRu(PPh3)2]2(μ-S2)+.  This mixed-valence compd. disproportionates upon addn. of HOTf to give II and [CpRu(PPh3)2(SH2)]+.  The reaction of I with sulfur gave ruthenium polysulfides [CpRu(PPh3)]2Sx (x = 4, 6).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO_L-chZ0t7bVg90H21EOLACvtfcHk0lhI1aoZfzIHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlsFCjtb8%253D&md5=8149d2ea836929605afc6a84c0bb339b</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1021%2Fic00319a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00319a024%26sid%3Dliteratum%253Aachs%26aulast%3DAmarasekera%26aufirst%3DJ.%26aulast%3DRauchfuss%26aufirst%3DT.%2BB.%26atitle%3DInterconversion%2520of%2520persulfido%252C%2520sulfur%2520hydride%252C%2520and%2520hydride%2520ligands%2520coordinated%2520to%2520CpRu%2528PPh3%25292%252B%26jtitle%3DInorg.%2520Chem.%26date%3D1989%26volume%3D28%26issue%3D20%26spage%3D3875%26epage%3D3883%26doi%3D10.1021%2Fic00319a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span> <span> </span><span class="NLM_article-title">pH-dependent transfer hydrogenation, reductive amination, and dehalogenation of water-soluble carbonyl compounds and alkyl halides promoted by Cp*Ir complexes</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4903</span>– <span class="NLM_lpage">4910</span>, <span class="refDoi"> DOI: 10.1021/om010523v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om010523v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVyns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=4903-4910&issue=23&author=S.+Ogoauthor=N.+Makiharaauthor=Y.+Kanekoauthor=Y.+Watanabe&title=pH-dependent+transfer+hydrogenation%2C+reductive+amination%2C+and+dehalogenation+of+water-soluble+carbonyl+compounds+and+alkyl+halides+promoted+by+Cp*Ir+complexes&doi=10.1021%2Fom010523v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Dependent Transfer Hydrogenation, Reductive Amination, and Dehalogenation of Water-Soluble Carbonyl Compounds and Alkyl Halides Promoted by Cp*Ir Complexes</span></div><div class="casAuthors">Ogo, Seiji; Makihara, Nobuyuki; Kaneko, Yuichi; Watanabe, Yoshihito</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4903-4910</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper reports pH-dependent transfer hydrogenation, reductive amination, and dehalogenation of water-sol. substrates with the organometallic aqua complexes [Cp*IrIII(H2O)3]2+ (1, Cp* = η5-pentamethylcyclopentadienyl), [(Cp-py)IrIII(H2O)2]2+ (2, Cp-py = η5-(tetramethylcyclopentadienyl)methylpyridine), and [Cp*IrIII(bpy)(H2O)]2+ (3, bpy = 2,2'-bipyridine) as catalyst precursors and the formate ions HCOONa and HCOONH4 as H donors.  Because of the difference in the electron-donating ability of the Cp*, Cp-py, and bpy ligands, the Lewis acidity of the Ir ions of 1-3 are ordered in strength as follows: 1 > 2 > 3.  Complexes 1-3 are reversibly deprotonated to form the catalytically inactive hydroxo complexes [(Cp*IrIII)2(μ-OH)3]+ (5), [{(Cp-py)IrIII}2(μ-OH)2]2+ (6), and [Cp*IrIII(bpy)(OH)]+ (7) around pH 2.8, 4.5, and 6.6, resp.  The deprotonation behavior of 1-3 indicates that the more Lewis acidic Ir ions would lower the pKa values of the coordinated H2O ligands.  As a function of pH, the catalyst precursors 1 and 3 react with the formate ions to form the hydride complexes [(Cp*IrIII)2(μ-H)(μ-OH)(μ-HCOO)]+ (8) and [Cp*IrIII(bpy)(H)]+ (9), resp., which act as active catalysts in these catalytic redns.  A similar hydride complex would be formed from the reaction of 2 with the formate ions, though the authors have no definite structural information on the hydride complex.  The structures of 3(OTf)2·H2O (OTf = CF3SO3-), [(Cp-py)IrIIICl2] (4), 6(OTf)2, 7(OTf)·2H2O, and 8(PF6) were unequivocally detd. by x-ray anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnUp0HLLIHYrVg90H21EOLACvtfcHk0lhI1aoZfzIHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVyns70%253D&md5=84edfbaabe5cc5fa85baf4f439386654</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fom010523v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom010523v%26sid%3Dliteratum%253Aachs%26aulast%3DOgo%26aufirst%3DS.%26aulast%3DMakihara%26aufirst%3DN.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DY.%26atitle%3DpH-dependent%2520transfer%2520hydrogenation%252C%2520reductive%2520amination%252C%2520and%2520dehalogenation%2520of%2520water-soluble%2520carbonyl%2520compounds%2520and%2520alkyl%2520halides%2520promoted%2520by%2520Cp%252AIr%2520complexes%26jtitle%3DOrganometallics%26date%3D2001%26volume%3D20%26issue%3D23%26spage%3D4903%26epage%3D4910%26doi%3D10.1021%2Fom010523v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iggo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Half-sandwich iridium complexes—Synthesis and applications in catalysis</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>252</i></span> (<span class="NLM_issue">5–7</span>),  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">809</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2008.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ccr.2008.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislajs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2008&pages=782-809&issue=5%E2%80%937&author=J.+Liuauthor=X.+Wuauthor=J.+A.+Iggoauthor=J.+Xiao&title=Half-sandwich+iridium+complexes%E2%80%94Synthesis+and+applications+in+catalysis&doi=10.1016%2Fj.ccr.2008.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Half-sandwich iridium complexes-Synthesis and applications in catalysis</span></div><div class="casAuthors">Liu, Jianke; Wu, Xiaofeng; Iggo, Jon A.; Xiao, Jianliang</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">782-809</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A brief summary of the organometallic chem. of half-sandwich iridium complexes accomplished in the last a few years is given, with emphasis on chiral-at-metal complexes, the synthetic protocols employed and the stereochem. involved in relevant transformations.  The applications of these complexes in catalysis are highlighted by selected examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jMPMUw-MF7Vg90H21EOLACvtfcHk0lhI1aoZfzIHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislajs7o%253D&md5=03d22d55eba553258c7254081a651aa6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DIggo%26aufirst%3DJ.%2BA.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DHalf-sandwich%2520iridium%2520complexes%25E2%2580%2594Synthesis%2520and%2520applications%2520in%2520catalysis%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2008%26volume%3D252%26issue%3D5%25E2%2580%25937%26spage%3D782%26epage%3D809%26doi%3D10.1016%2Fj.ccr.2008.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikariya, T.</span></span> <span> </span><span class="NLM_article-title">Bifunctional triflylamide-tethered Cp′Rh and Cp′Ir complexes: A new entry for asymmetric hydrogenation catalysts</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2399</span>, <span class="refDoi"> DOI: 10.1021/om1001809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om1001809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=2397-2399&issue=11&author=M.+Itoauthor=Y.+Endoauthor=N.+Tejimaauthor=T.+Ikariya&title=Bifunctional+triflylamide-tethered+Cp%E2%80%B2Rh+and+Cp%E2%80%B2Ir+complexes%3A+A+new+entry+for+asymmetric+hydrogenation+catalysts&doi=10.1021%2Fom1001809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Triflylamide-Tethered Cp'Rh and Cp'Ir Complexes: A New Entry for Asymmetric Hydrogenation Catalysts</span></div><div class="casAuthors">Ito, Masato; Endo, Yoshinori; Tejima, Noriko; Ikariya, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2397-2399</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triflylamide-tethered complexes, [η5:η1-Me4C5(CH2)nNTf]MCl(MeCN) and [η5:η1-Me4C5(CH2)nNTf]M((R,R)-Msdpen) (M = Rh, Ir, n = 2-4, Tf = CF3SO2, Msdpen = MsNCH(C6H5)CH(C6H5)NH2, Ms = CH3SO2), were prepd. via ring closure of pendant NHTf groups of dimeric [η5-Me4C5(CH2)nNHTf]2M2Cl4 complexes and replacement of chloro and acetonitrile ligands with (R,R)-Msdpen-H.  The mol. structures of 9 complexes were detd. by x-ray crystallog. and their three-legged piano-stool structure characterized.  The tethered complexes [η5:η1-Me4C5(CH2)nNTf]M((R,R)-Msdpen) promote asym. hydrogenation of acetophenone, which indicates that the introduction of a suitable triflylamide tether unit changes their catalytic function from transfer hydrogenation to hydrogenation.  The catalytic activity of the C4 tethered complexes (94% to 96% yield and 93% ee) proved to be superior to those of C2 and C3 tethered ones, whose inferiority should be originated from the presence of a H bond between the protic amine and the sulfonyl O.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJBqwOv-PT7Vg90H21EOLACvtfcHk0lhI1aoZfzIHeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFehsb8%253D&md5=a23db403fc2d141b6378b2fb4a87af1a</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fom1001809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom1001809%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DTejima%26aufirst%3DN.%26aulast%3DIkariya%26aufirst%3DT.%26atitle%3DBifunctional%2520triflylamide-tethered%2520Cp%25E2%2580%25B2Rh%2520and%2520Cp%25E2%2580%25B2Ir%2520complexes%253A%2520A%2520new%2520entry%2520for%2520asymmetric%2520hydrogenation%2520catalysts%26jtitle%3DOrganometallics%26date%3D2010%26volume%3D29%26issue%3D11%26spage%3D2397%26epage%3D2399%26doi%3D10.1021%2Fom1001809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritzkow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enders, M.</span></span> <span> </span><span class="NLM_article-title">Rhodium(III) and iridium(III) complexes with quinolyl-functionalized Cp Ligands: synthesis and catalytic hydrogenation activity</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">4230</span>– <span class="NLM_lpage">4235</span>, <span class="refDoi"> DOI: 10.1002/ejic.200800217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fejic.200800217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=4230-4235&issue=27&author=G.+Kohlauthor=H.+Pritzkowauthor=M.+Enders&title=Rhodium%28III%29+and+iridium%28III%29+complexes+with+quinolyl-functionalized+Cp+Ligands%3A+synthesis+and+catalytic+hydrogenation+activity&doi=10.1002%2Fejic.200800217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1002%2Fejic.200800217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200800217%26sid%3Dliteratum%253Aachs%26aulast%3DKohl%26aufirst%3DG.%26aulast%3DPritzkow%26aufirst%3DH.%26aulast%3DEnders%26aufirst%3DM.%26atitle%3DRhodium%2528III%2529%2520and%2520iridium%2528III%2529%2520complexes%2520with%2520quinolyl-functionalized%2520Cp%2520Ligands%253A%2520synthesis%2520and%2520catalytic%2520hydrogenation%2520activity%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2008%26volume%3D2008%26issue%3D27%26spage%3D4230%26epage%3D4235%26doi%3D10.1002%2Fejic.200800217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Esteruelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Alvarez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oñate, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Sánchez, P.</span></span> <span> </span><span class="NLM_article-title">Iridium(I), iridium(III), and iridium(V) complexes containing the (2-methoxyethyl)cyclopentadienyl ligand</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5131</span>– <span class="NLM_lpage">5138</span>, <span class="refDoi"> DOI: 10.1021/om060511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om060511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVyrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5131-5138&issue=21&author=M.+A.+Esteruelasauthor=F.+J.+Fern%C3%A1ndez-Alvarezauthor=A.+M.+L%C3%B3pezauthor=E.+O%C3%B1ateauthor=P.+Ruiz-S%C3%A1nchez&title=Iridium%28I%29%2C+iridium%28III%29%2C+and+iridium%28V%29+complexes+containing+the+%282-methoxyethyl%29cyclopentadienyl+ligand&doi=10.1021%2Fom060511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Iridium(I), Iridium(III), and Iridium(V) Complexes Containing the (2-Methoxyethyl)cyclopentadienyl Ligand</span></div><div class="casAuthors">Esteruelas, Miguel A.; Fernandez-Alvarez, Francisco J.; Lopez, Ana M.; Onate, Enrique; Ruiz-Sanchez, Pilar</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5131-5138</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of [Ir(μ-Cl)(COE)2]2 (1) with LiCpO gives Ir(η5-CpO)(COE)2 (2; CpO = C5H4(CH2)2OMe; COE = cis-cyclooctene), which reacts with X2 to afford the Ir(III) derivs. [Ir(η5-CpO)X(μ-X)]2 [X = I (3), Cl (4)].  Complexes 3 and 4 react with PiPr3 to yield the corresponding species Ir(η5-CpO)(PiPr3)X2 [X = iodo (5), Cl (6)], which by addn. of LiHBEt3 give Ir(η5-CpO)(PiPr3)H2 (7).  The reactions of 5 and 6 with 2.0 equiv of AgBF4 in MeCN lead to [Ir(η5-CpO)(PiPr3)(NCMe)2][BF4]2 (8).  Treatment of 3 with 2.0 equiv of HSiEt3 per Ir affords the monohydride dimer [Ir(η5-CpO)I]2(μ-H)(μ-I) (9).  Complex 4 reacts with 4.0 equiv of HSiEt3 per Ir to give the Ir(V) silyl trihydride deriv. IrH3(η5-CpO)(SiEt3) (10), which in the presence of excess of HSiEt3 is transformed into IrH2(η5-CpO)(SiEt3)2 (11).  Treatment at -40° of 4 with 2.0 equiv of HSiEt3 per Ir leads to a mixt. of the hydride dichloro triethylsilyl complex IrH(η5-CpO)Cl2(SiEt3) (12), the dihydride chloro triethylsilyl compd. IrH2(η5-CpO)Cl(SiEt3) (14), and the monohydride dimer [Ir(η5-CpO)Cl]2(μ-H)(μ-Cl) (16).  Complex 16 was also prepd. by reaction of 4 with 1.0 equiv of HSiEt3 per Ir.  Complex 10 is easily deuterated in C6D6 at 80°.  The x-ray structures of 4, 8, and 9 are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlg5IKpmCrXLVg90H21EOLACvtfcHk0lioD_R-tV7N2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVyrs70%253D&md5=8b4142d1b404967d76279ce223f89be8</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fom060511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom060511f%26sid%3Dliteratum%253Aachs%26aulast%3DEsteruelas%26aufirst%3DM.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DF.%2BJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DA.%2BM.%26aulast%3DO%25C3%25B1ate%26aufirst%3DE.%26aulast%3DRuiz-S%25C3%25A1nchez%26aufirst%3DP.%26atitle%3DIridium%2528I%2529%252C%2520iridium%2528III%2529%252C%2520and%2520iridium%2528V%2529%2520complexes%2520containing%2520the%2520%25282-methoxyethyl%2529cyclopentadienyl%2520ligand%26jtitle%3DOrganometallics%26date%3D2006%26volume%3D25%26issue%3D21%26spage%3D5131%26epage%3D5138%26doi%3D10.1021%2Fom060511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conesa, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Fanjul, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrascosa, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloetens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Unambiguous intracellular localization and quantification of a potent iridium anticancer compound by correlative 3D cryo X-ray imaging</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">59</span>),  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1002/anie.201911510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fanie.201911510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyitb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=1270-1278&issue=59&author=J.+J.+Conesaauthor=A.+C.+Carrascoauthor=V.+Rodriguez-Fanjulauthor=Y.+Yangauthor=J.+L.+Carrascosaauthor=P.+Cloetensauthor=E.+Pereiroauthor=A.+M.+Pizarro&title=Unambiguous+intracellular+localization+and+quantification+of+a+potent+iridium+anticancer+compound+by+correlative+3D+cryo+X-ray+imaging&doi=10.1002%2Fanie.201911510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X-Ray Imaging</span></div><div class="casAuthors">Conesa, Jose Javier; Carrasco, Ana C.; Rodriguez-Fanjul, Vanessa; Yang, Yang; Carrascosa, Jose L.; Cloetens, Peter; Pereiro, Eva; Pizarro, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1270-1278</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The iridium half-sandwich complex [Ir(η5:κ1-C5Me4CH2py)(2-phenylpyridine)]PF6 is highly cytotoxic: 15-250× more potent than clin. used cisplatin in several cancer cell lines.  We have developed a correlative 3D cryo x-ray imaging approach to specifically localize and quantify iridium within the whole hydrated cell at nanometer resoln.  By means of cryo soft x-ray tomog. (cryo-SXT), which provides the cellular ultrastructure at 50 nm resoln., and cryo hard x-ray fluorescence tomog. (cryo-XRF), which provides the elemental sensitivity with a 70 nm step size, we have located the iridium anticancer agent exclusively in the mitochondria.  Our methodol. provides unique information on the intracellular fate of the metallodrug, without chem. fixation, labeling, or mech. manipulation of the cells.  This cryo-3D correlative imaging method can be applied to a no. of biochem. processes for specific elemental localization within the native cellular landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppmD9mj5i-CLVg90H21EOLACvtfcHk0lioD_R-tV7N2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyitb3J&md5=84ce048de8e589b0edf5148dbecde34c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.201911510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201911510%26sid%3Dliteratum%253Aachs%26aulast%3DConesa%26aufirst%3DJ.%2BJ.%26aulast%3DCarrasco%26aufirst%3DA.%2BC.%26aulast%3DRodriguez-Fanjul%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCarrascosa%26aufirst%3DJ.%2BL.%26aulast%3DCloetens%26aufirst%3DP.%26aulast%3DPereiro%26aufirst%3DE.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DUnambiguous%2520intracellular%2520localization%2520and%2520quantification%2520of%2520a%2520potent%2520iridium%2520anticancer%2520compound%2520by%2520correlative%25203D%2520cryo%2520X-ray%2520imaging%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26issue%3D59%26spage%3D1270%26epage%3D1278%26doi%3D10.1002%2Fanie.201911510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Betanzos-Lara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Photocontrolled nucleobase binding to an organometallic Ru(II) arene complex</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>, (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">6622</span>– <span class="NLM_lpage">6624</span>, <span class="refDoi"> DOI: 10.1039/b914153g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2Fb914153g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19865670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlalur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=6622-6624&issue=43&author=S.+Betanzos-Laraauthor=L.+Salassaauthor=A.+Habtemariamauthor=P.+J.+Sadler&title=Photocontrolled+nucleobase+binding+to+an+organometallic+Ru%28II%29+arene+complex&doi=10.1039%2Fb914153g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Photocontrolled nucleobase binding to an organometallic RuII arene complex</span></div><div class="casAuthors">Betanzos-Lara, Soledad; Salassa, Luca; Habtemariam, Abraha; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">6622-6624</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">[(P-cym)Ru(bpm)(py)][PF6]2 (p-cym = para-cymene, bpm = 2,2'-bipyrimidine and py = pyridine) is the 1st Ru(II) arene complex that can selectively photodissociate a monodentate ligand (py) when excited with visible light and form a reactive aqua deriv. ([(p-cym)Ru(bpm)(H2O)]2+) able to bind to a DNA base.  A complete set of DFT and TDDFT calcns. on [(p-cym)Ru(bpm)(py)]2+ was performed to characterize the singlet and triplet excited states of the complex and to obtain insights into the mechanism of ligand photodissocn.  To study the ability of [(p-cym)Ru(bpm)(py)]2+ to bind to DNA bases the authors performed an irradn. expt. of [(p-cym)Ru(bpm)(py)]2+ in the presence of 9-EtG (9-ethylguanine).  Irradn. of [(p-cym)Ru(bpm)(py)]2+ with white light at 310 K in D2O in the presence of 1 mol equiv. of 9-EtG results in the initial formation of the aqua complex followed by coordination of the nucleobase to the Ru center to form [(p-cym)Ru(bpm)(9-EtG)]2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlDJEskjoYv7Vg90H21EOLACvtfcHk0lgHV85NrnqYvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlalur%252FJ&md5=8b001e72fde1fc40c06814f7955aba09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fb914153g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb914153g%26sid%3Dliteratum%253Aachs%26aulast%3DBetanzos-Lara%26aufirst%3DS.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPhotocontrolled%2520nucleobase%2520binding%2520to%2520an%2520organometallic%2520Ru%2528II%2529%2520arene%2520complex%26jtitle%3DChem.%2520Commun.%26date%3D2009%26issue%3D43%26spage%3D6622%26epage%3D6624%26doi%3D10.1039%2Fb914153g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennessel, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span> <span> </span><span class="NLM_article-title">An efficient low-temperature route to polycyclic isoquinoline salt synthesis via C-H activation with [Cp*MCl<sub>2</sub>]<sub>2</sub> (M = Rh, Ir)</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">12414</span>– <span class="NLM_lpage">12419</span>, <span class="refDoi"> DOI: 10.1021/ja802415h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja802415h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtValu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=12414-12419&issue=37&author=L.+Liauthor=W.+W.+Brennesselauthor=W.+D.+Jones&title=An+efficient+low-temperature+route+to+polycyclic+isoquinoline+salt+synthesis+via+C-H+activation+with+%5BCp*MCl2%5D2+%28M+%3D+Rh%2C+Ir%29&doi=10.1021%2Fja802415h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Low-Temperature Route to Polycyclic Isoquinoline Salt Synthesis via C-H Activation with [Cp*MCl2]2 (M = Rh, Ir)</span></div><div class="casAuthors">Li, Ling; Brennessel, William W.; Jones, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12414-12419</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bi-, tri-, and tetracyclic isoquinoline salts were readily synthesized in excellent yields at room temp. from readily available starting materials after three reaction steps.  Arom. C-H activation was first promoted by sodium acetate with [Cp*MCl2]2 (M = Rh, Ir) at room temp. to form cyclometalated compds.  Dimethylacetylenedicarboxylate was then found to insert into the metal-carbon bonds of the cyclometalated compds.  Finally, the insertion compds. underwent oxidative coupling to form the desired isoquinoline salts and regenerate [Cp*MCl2]2.  All of the intermediate compds. following C-H activation, alkyne insertion, and oxidative coupling were fully characterized, including the detn. of X-ray structures in several cases, and the results shed light on the overall mechanism.  Moreover, it was possible to synthesize the isoquinoline salts from readily available starting materials using one-pot procedures; thus, this work provides a novel, efficient method for metal-mediated synthesis of heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHn36vG-iy7rVg90H21EOLACvtfcHk0lgHV85NrnqYvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtValu7%252FO&md5=21e6e55944575f2dee7a6e5727ac3a0d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja802415h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja802415h%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DBrennessel%26aufirst%3DW.%2BW.%26aulast%3DJones%26aufirst%3DW.%2BD.%26atitle%3DAn%2520efficient%2520low-temperature%2520route%2520to%2520polycyclic%2520isoquinoline%2520salt%2520synthesis%2520via%2520C-H%2520activation%2520with%2520%255BCp%252AMCl2%255D2%2520%2528M%2520%253D%2520Rh%252C%2520Ir%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26issue%3D37%26spage%3D12414%26epage%3D12419%26doi%3D10.1021%2Fja802415h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennessel, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span> <span> </span><span class="NLM_article-title">C-H activation of phenyl imines and 2-phenylpyridines with [Cp*MCl<sub>2</sub>]<sub>2</sub>(M = Ir, Rh): regioselectivity, kinetics, and mechanism</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3492</span>– <span class="NLM_lpage">3500</span>, <span class="refDoi"> DOI: 10.1021/om9000742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om9000742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3492-3500&issue=12&author=L.+Liauthor=W.+W.+Brennesselauthor=W.+D.+Jones&title=C-H+activation+of+phenyl+imines+and+2-phenylpyridines+with+%5BCp*MCl2%5D2%28M+%3D+Ir%2C+Rh%29%3A+regioselectivity%2C+kinetics%2C+and+mechanism&doi=10.1021%2Fom9000742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">C-H Activation of phenyl imines and 2-phenylpyridines with [Cp*MCl2]2 (M = Ir, Rh): regioselectivity, kinetics, and mechanism</span></div><div class="casAuthors">Li, Ling; Brennessel, William W.; Jones, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3492-3500</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium acetate promoted C-H activation in a series of para-substituted Ph imines has been examd. using [Cp*MCl2]2 (M = Ir, Rh).  The regioselectivity was investigated using a series of meta-substituted Ph imines (-OMe, -CH3, -F, -COOMe, -CF3, and -CN) and 2-phenylpyridines (-OMe, -Me, -CF3).  It was found that substrates with electron-donating substituents react significantly faster than substrates with electron-withdrawing substituents, which is consistent with an electrophilic C-H activation mechanism.  It was also found that the regioselectivity of the C-H activation was extremely sensitive to steric effects, with a meta Me group leading to only one regioisomer.  Solvent and temp. studies showed that the reaction rate can be increased both by increasing temp. and by using polar solvents such as methanol.  The regioselectivity was solvent dependent for the reaction with [Cp*IrCl2]2 but independent of solvent for the reaction with [Cp*RhCl2]2.  The regioselectivity was temp. independent for both metals.  With added acid, the arom. C-H activation was shown to be reversible.  Kinetic studies were performed, leading to the conclusion that [Cp*M(OAc)]+ is the key catalytic species responsible for the electrophilic C-H activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqnLGHN52E_LVg90H21EOLACvtfcHk0lgHV85NrnqYvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlKltro%253D&md5=9c8c6085e8de58df274267d7b958b901</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fom9000742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom9000742%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DBrennessel%26aufirst%3DW.%2BW.%26aulast%3DJones%26aufirst%3DW.%2BD.%26atitle%3DC-H%2520activation%2520of%2520phenyl%2520imines%2520and%25202-phenylpyridines%2520with%2520%255BCp%252AMCl2%255D2%2528M%2520%253D%2520Ir%252C%2520Rh%2529%253A%2520regioselectivity%252C%2520kinetics%252C%2520and%2520mechanism%26jtitle%3DOrganometallics%26date%3D2009%26volume%3D28%26issue%3D12%26spage%3D3492%26epage%3D3500%26doi%3D10.1021%2Fom9000742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGeagh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Peña, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merola, J. S.</span></span> <span> </span><span class="NLM_article-title">Extending the range of pentasubstituted cyclopentadienyl compounds: The synthesis of a series of tetramethyl(alkyl or aryl)cyclopentadienes (Cp<sup>*R</sup>), their iridium complexes and their catalytic activity for asymmetric transfer hydrogenation</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2014.06.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.poly.2014.06.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1CktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=120-135&author=D.+M.+Morrisauthor=M.+McGeaghauthor=D.+De+Pe%C3%B1aauthor=J.+S.+Merola&title=Extending+the+range+of+pentasubstituted+cyclopentadienyl+compounds%3A+The+synthesis+of+a+series+of+tetramethyl%28alkyl+or+aryl%29cyclopentadienes+%28Cp*R%29%2C+their+iridium+complexes+and+their+catalytic+activity+for+asymmetric+transfer+hydrogenation&doi=10.1016%2Fj.poly.2014.06.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Extending the range of pentasubstituted cyclopentadienyl compounds: The synthesis of a series of tetramethyl(alkyl or aryl)cyclopentadienes (Cp*R), their iridium complexes and their catalytic activity for asymmetric transfer hydrogenation</span></div><div class="casAuthors">Morris, David M.; McGeagh, Michael; De Pena, David; Merola, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-135</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tetramethyl(alkyl or aryl)cyclopentadienes were synthesized and the organometallic half-sandwich iridium complexes of the form [(η5-Cp*R)Ir(aa)Cl], Cp*R = tetramethyl(phenyl)cyclopentadienyl (Cp*Ph), tetramethyl(benzyl)cyclopentadienyl (Cp*Bn), tetramethyl(2-propyl)cyclopentadienyl (Cp*iPr), or tetramethyl(cyclohexyl)cyclopentadienyl (Cp*Cy) were prepd. and characterized.  The complexes adopt a piano stool configuration, forming diastereomers, with ratios similar to reported [(η5-Cp*)Ir(aa)Cl] complexes.  The complexes display an intermol. hydrogen bonding network in the solid state.  These complexes were tested for the asym. transfer hydrogenation of several ketones, showing that the R of the Cp*R drastically impacts both selectivity and rate of reaction.  Addnl., severe solvent effects are displayed when the reaction media is changed from aq. to org. solvent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouJ1mzgmiiMLVg90H21EOLACvtfcHk0ljmHROv4HS9PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1CktbbO&md5=43108cf82cdcf9af3c1ea0e8ed0416bc</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2014.06.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2014.06.053%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DD.%2BM.%26aulast%3DMcGeagh%26aufirst%3DM.%26aulast%3DDe%2BPe%25C3%25B1a%26aufirst%3DD.%26aulast%3DMerola%26aufirst%3DJ.%2BS.%26atitle%3DExtending%2520the%2520range%2520of%2520pentasubstituted%2520cyclopentadienyl%2520compounds%253A%2520The%2520synthesis%2520of%2520a%2520series%2520of%2520tetramethyl%2528alkyl%2520or%2520aryl%2529cyclopentadienes%2520%2528Cp%252AR%2529%252C%2520their%2520iridium%2520complexes%2520and%2520their%2520catalytic%2520activity%2520for%2520asymmetric%2520transfer%2520hydrogenation%26jtitle%3DPolyhedron%26date%3D2014%26volume%3D84%26spage%3D120%26epage%3D135%26doi%3D10.1016%2Fj.poly.2014.06.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">White, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitlis, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinekey, D. M.</span></span> <span> </span><span class="NLM_article-title">(η<sup>5</sup>-Pentamethylcyclopentadienyl)rhodium and -iridium compounds</span>. <i>Inorg. Synth.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1002/9780470132609.ch53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2F9780470132609.ch53" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=228-234&author=C.+Whiteauthor=A.+Yatesauthor=P.+M.+Maitlisauthor=D.+M.+Heinekey&title=%28%CE%B75-Pentamethylcyclopentadienyl%29rhodium+and+-iridium+compounds&doi=10.1002%2F9780470132609.ch53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1002%2F9780470132609.ch53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470132609.ch53%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DC.%26aulast%3DYates%26aufirst%3DA.%26aulast%3DMaitlis%26aufirst%3DP.%2BM.%26aulast%3DHeinekey%26aufirst%3DD.%2BM.%26atitle%3D%2528%25CE%25B75-Pentamethylcyclopentadienyl%2529rhodium%2520and%2520-iridium%2520compounds%26jtitle%3DInorg.%2520Synth.%26date%3D2007%26spage%3D228%26epage%3D234%26doi%3D10.1002%2F9780470132609.ch53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide complexes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4242</span>, <span class="refDoi"> DOI: 10.1021/cr0307291</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0307291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt12kt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=4203-4242&issue=9&author=E.+Alessio&title=Synthesis+and+reactivity+of+Ru-%2C+Os-%2C+Rh-%2C+and+Ir-halide-sulfoxide+complexes&doi=10.1021%2Fcr0307291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-Halide-Sulfoxide Complexes</span></div><div class="casAuthors">Alessio, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4203-4242</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review is presented on the synthesis and reactivity of ruthenium, osmium, rhodium, and iridium halide sulfoxide complexes.  Example complexes include [(DMSO)2H][trans-RuCl4(DMSO-S)] and mer,cis-[RuCl3(DPSO-O)2(DPSO)] (DPSO = di-Ph sulfoxide).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxy_YTdTN5cbVg90H21EOLACvtfcHk0ljmHROv4HS9PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt12kt7o%253D&md5=68570193fbd2199cb87a3c60ed5e7cb3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr0307291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0307291%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520Ru-%252C%2520Os-%252C%2520Rh-%252C%2520and%2520Ir-halide-sulfoxide%2520complexes%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26issue%3D9%26spage%3D4203%26epage%3D4242%26doi%3D10.1021%2Fcr0307291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Geer, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeth, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aird, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbiani, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano-Casal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswald, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">18269</span>– <span class="NLM_lpage">18274</span>, <span class="refDoi"> DOI: 10.1073/pnas.0505798102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1073%2Fpnas.0505798102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=16352726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1aq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=18269-18274&issue=51&author=F.+Wangauthor=A.+Habtemariamauthor=E.+P.+van+der+Geerauthor=R.+Fernandezauthor=M.+Melchartauthor=R.+J.+Deethauthor=R.+Airdauthor=S.+Guichardauthor=F.+P.+Fabbianiauthor=P.+Lozano-Casalauthor=I.+D.+Oswaldauthor=D.+I.+Jodrellauthor=S.+Parsonsauthor=P.+J.+Sadler&title=Controlling+ligand+substitution+reactions+of+organometallic+complexes%3A+tuning+cancer+cell+cytotoxicity&doi=10.1073%2Fpnas.0505798102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling ligand substitution reactions of organometallic complexes: Tuning cancer cell cytotoxicity</span></div><div class="casAuthors">Wang, Fuyi; Habtemariam, Abraha; van der Geer, Erwin P. L.; Fernandez, Rafael; Melchart, Michael; Deeth, Robert J.; Aird, Rhona; Guichard, Sylvie; Fabbiani, Francesca P. A.; Lozano-Casal, Patricia; Oswald, Iain D. H.; Jodrell, Duncan I.; Parsons, Simon; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">18269-18274</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Organometallic compds. offer broad scope for the design of therapeutic agents, but this avenue has yet to be widely explored.  A key concept in the design of anticancer complexes is optimization of chem. reactivity to allow facile attack on the target site (e.g., DNA) yet avoid attack on other sites assocd. with unwanted side effects.  How this result can be achieved for monofunctional "piano-stool" ruthenium(II) arene complexes of the type [(η6-arene)Ru(ethylenediamine)(X)]n+ was discussed.  A potentially important activation mechanism for reactions with biomols. is hydrolysis.  D. functional calcns. suggested that aquation (substitution of X by H2O) occurs by a concerted ligand interchange mechanism.  The kinetics and equil. for hydrolysis of 21 complexes, contg., as X, halides and pseudohalides, pyridine derivs., and a thiolate, together with benzene (bz) or a substituted bz as arene, using UV-visible spectroscopy, HPLC, and electrospray MS was studied.  The x-ray structures of six complexes are reported.  In general, complexes that hydrolyze either rapidly {e.g., X = halide [arene = hexamethylbenzene (hmb)]} or moderately slowly [e.g., X = azide, dichloropyridine (arene = hmb)] are active toward A2780 human ovarian cancer cells, whereas complexes that do not aquate (e.g., X = py) are inactive.  An intriguing exception is the X = thiophenolate complex, which undergoes little hydrolysis and appears to be activated by a different mechanism.  The ability to tune the chem. reactivity of this class of organometallic ruthenium arene compds. should be useful in optimizing their design as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2O8dQ7-JN3rVg90H21EOLACvtfcHk0ljmHROv4HS9PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1aq&md5=6fe88ad4395d83e757ba0a2c10b11599</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0505798102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0505798102%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BGeer%26aufirst%3DE.%2BP.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DMelchart%26aufirst%3DM.%26aulast%3DDeeth%26aufirst%3DR.%2BJ.%26aulast%3DAird%26aufirst%3DR.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DFabbiani%26aufirst%3DF.%2BP.%26aulast%3DLozano-Casal%26aufirst%3DP.%26aulast%3DOswald%26aufirst%3DI.%2BD.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DControlling%2520ligand%2520substitution%2520reactions%2520of%2520organometallic%2520complexes%253A%2520tuning%2520cancer%2520cell%2520cytotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D51%26spage%3D18269%26epage%3D18274%26doi%3D10.1073%2Fpnas.0505798102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridgewater, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldevila-Barreda, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imberti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Ligand-controlled reactivity and cytotoxicity of cyclometalated rhodium(III) complexes</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>2020</i></span>,  <span class="NLM_fpage">1052</span>, <span class="refDoi"> DOI: 10.1002/ejic.201901055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fejic.201901055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFyrtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2020&publication_year=2020&pages=1052&author=W.-Y.+Zhangauthor=H.+E.+Bridgewaterauthor=S.+Banerjeeauthor=J.+J.+Soldevila-Barredaauthor=G.+J.+Clarksonauthor=H.+Shiauthor=C.+Imbertiauthor=P.+J.+Sadler&title=Ligand-controlled+reactivity+and+cytotoxicity+of+cyclometalated+rhodium%28III%29+complexes&doi=10.1002%2Fejic.201901055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Controlled Reactivity and Cytotoxicity of Cyclometalated Rhodium(III) Complexes</span></div><div class="casAuthors">Zhang, Wen-Ying; Bridgewater, Hannah E.; Banerjee, Samya; Soldevila-Barreda, Joan J.; Clarkson, Guy J.; Shi, Huayun; Imberti, Cinzia; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">2020</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1052-1060</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report the synthesis, characterization and cytotoxicity of six cyclometalated rhodium(III) complexes [CpXRh(ĈN)Z]0/+, in which CpX = Cp*, Cpph, or Cpbiph, ĈN = benzo[h]quinoline, and Z = chloride or pyridine.  Three X-ray crystal structures showing the expected "piano-stool" configurations have been detd.  The chlorido complexes hydrolyzed faster in aq. soln., and reacted preferentially with 9-Et guanine or glutathione compared to their pyridine analogs.  The 1-biphenyl-2,3,4,5-tetramethylcyclopentadienyl complex [CpbiphRh(benzo-[h]quinoline)Cl] (3a) was the most efficient catalyst in coenzyme reduced NAD (NADH) oxidn. to NAD+ and induced an elevated level of reactive oxygen species (ROS) in A549 human lung cancer cells.  The pyridine complex [CpbiphRh(benzo[h]quinoline)py]+ (3b) was the most potent against A549 lung and A2780 ovarian cancer cell lines, being 5-fold more active than cisplatin towards A549 cells, and acted as a ROS scavenger.  This work highlights a ligand-controlled strategy to modulate the reactivity and cytotoxicity of cyclometalated rhodium anticancer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6VQ6ztgy5AbVg90H21EOLACvtfcHk0lg3aL9qeq8leA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFyrtLfJ&md5=8feb307309d12215fea24f37f6ee67d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fejic.201901055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201901055%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.-Y.%26aulast%3DBridgewater%26aufirst%3DH.%2BE.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSoldevila-Barreda%26aufirst%3DJ.%2BJ.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DImberti%26aufirst%3DC.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DLigand-controlled%2520reactivity%2520and%2520cytotoxicity%2520of%2520cyclometalated%2520rhodium%2528III%2529%2520complexes%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2020%26volume%3D2020%26spage%3D1052%26doi%3D10.1002%2Fejic.201901055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojtiskova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1039/C3MT00341H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC3MT00341H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24448555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsFGguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=682-690&issue=3&author=V.+Novohradskyauthor=Z.+Liuauthor=M.+Vojtiskovaauthor=P.+J.+Sadlerauthor=V.+Brabecauthor=J.+Kasparkova&title=Mechanism+of+cellular+accumulation+of+an+iridium%28III%29+pentamethylcyclopentadienyl+anticancer+complex+containing+a+C%2CN-chelating+ligand&doi=10.1039%2FC3MT00341H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of cellular accumulation of an iridium(iii) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand</span></div><div class="casAuthors">Novohradsky, Vojtech; Liu, Zhe; Vojtiskova, Marie; Sadler, Peter J.; Brabec, Viktor; Kasparkova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The effect of replacement of the N,N-chelating ligand 1,10-phenanthroline (phen) in the IrIII pentamethylcyclopentadienyl (Cp*) complex [(η5-Cp*)(Ir)(phen)Cl]+ (2) with the C,N-chelating ligand 7,8-benzoquinoline (bq) to give [(η5-Cp*)(Ir)(bq)Cl] (1) on the cytotoxicity of these Cp*IrIII complexes toward cancer cell lines was investigated.  Complex 2 is inactive, similar to other Cp*IrIII complexes contg. the N,N-chelating ligands.  In contrast, a single atom change (C- for N) in the chelating N,N ligand resulted in potency in human ovarian carcinoma cisplatin-sensitive A2780 cells, and, strikingly, 1 is active in the cisplatin-resistant human breast cancer MCF-7 and A2780/cisR cells.  Replacement of the N,N-chelating ligand with the C,N-chelating ligand gives rise to increased hydrophobicity, leading to higher cellular accumulation, higher DNA-bound iridium in cells and higher cytotoxicity.  The pathways involved in cellular accumulation of 1 have been further explored and compared with conventional cisplatin.  The results show that both energy-independent passive diffusion and energy-dependent transport play a role in accumulation of 1.  Further results were consistent with involvement of p-glycoprotein, multidrug resistance-assocd. protein 1 and glutathione metab. in the efflux of 1.  In contrast, the internalization of 1 mediated by the endocytotic uptake pathway(s) seems less likely.  Understanding the factors which contribute to the mechanism of cellular accumulation of this IrIII complex can now lead to the design of structurally similar metal complexes for antitumor chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmCkjVEglT3LVg90H21EOLACvtfcHk0lg3aL9qeq8leA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsFGguro%253D&md5=af8e7c06d3f791a4854f5fae66d164f4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC3MT00341H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MT00341H%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DVojtiskova%26aufirst%3DM.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DMechanism%2520of%2520cellular%2520accumulation%2520of%2520an%2520iridium%2528III%2529%2520pentamethylcyclopentadienyl%2520anticancer%2520complex%2520containing%2520a%2520C%252CN-chelating%2520ligand%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26issue%3D3%26spage%3D682%26epage%3D690%26doi%3D10.1039%2FC3MT00341H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of iridium and ruthenium complexes with (N, N), (N, O) and (O, O) coordinating bidentate ligands as potential anti-cancer agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">13800</span>– <span class="NLM_lpage">13802</span>, <span class="refDoi"> DOI: 10.1039/c2dt32104a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2Fc2dt32104a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=23015068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=13800-13802&issue=45&author=S.+J.+Lucasauthor=R.+M.+Lordauthor=R.+L.+Wilsonauthor=R.+M.+Phillipsauthor=V.+Sridharanauthor=P.+C.+McGowan&title=Synthesis+of+iridium+and+ruthenium+complexes+with+%28N%2C+N%29%2C+%28N%2C+O%29+and+%28O%2C+O%29+coordinating+bidentate+ligands+as+potential+anti-cancer+agents&doi=10.1039%2Fc2dt32104a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents</span></div><div class="casAuthors">Lucas, Stephanie J.; Lord, Rianne M.; Wilson, Rachel L.; Phillips, Roger M.; Sridharan, Visuvanathar; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">13800-13802</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Several Ru-arene and Ir-Cp* complexes have been prepd. incorporating (N,N), (N,O) and (O,O) coordinating bidentate ligands and have been active against both HT-29 and MCF-7 cell lines.  By incorporating a biol. active ligand into a metal complex the anti-cancer activity is increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorFglt1DDjDLVg90H21EOLACvtfcHk0lg3aL9qeq8leA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFygurvK&md5=6541d905c0bcac9fde8d042448e79af2</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1039%2Fc2dt32104a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2dt32104a%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%2BJ.%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DWilson%26aufirst%3DR.%2BL.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DSynthesis%2520of%2520iridium%2520and%2520ruthenium%2520complexes%2520with%2520%2528N%252C%2520N%2529%252C%2520%2528N%252C%2520O%2529%2520and%2520%2528O%252C%2520O%2529%2520coordinating%2520bidentate%2520ligands%2520as%2520potential%2520anti-cancer%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2012%26volume%3D41%26issue%3D45%26spage%3D13800%26epage%3D13802%26doi%3D10.1039%2Fc2dt32104a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paitandi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundal, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, D. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, structure, DNA/protein binding, and anticancer activity of some half-sandwich cyclometalated Rh(III) and Ir(III) complexes</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4491</span>– <span class="NLM_lpage">4506</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.5b00475</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.5b00475" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWns7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=4491-4506&issue=18&author=S.+Mukhopadhyayauthor=R.+K.+Guptaauthor=R.+P.+Paitandiauthor=N.+K.+Ranaauthor=G.+Sharmaauthor=B.+Kochauthor=L.+K.+Ranaauthor=M.+S.+Hundalauthor=D.+S.+Pandey&title=Synthesis%2C+structure%2C+DNA%2Fprotein+binding%2C+and+anticancer+activity+of+some+half-sandwich+cyclometalated+Rh%28III%29+and+Ir%28III%29+complexes&doi=10.1021%2Facs.organomet.5b00475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure, DNA/Protein Binding, and Anticancer Activity of Some Half-Sandwich Cyclometalated Rh(III) and Ir(III) Complexes</span></div><div class="casAuthors">Mukhopadhyay, Sujay; Gupta, Rakesh Kumar; Paitandi, Rajendra Prasad; Rana, Nishant Kumar; Sharma, Gunjan; Koch, Biplob; Rana, Love Karan; Hundal, Maninder Singh; Pandey, Daya Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4491-4506</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Schiff base ligands benzylidene(4-tert-butylphenyl)amine 4-Me ester (L1), (4-nitrobenzylidene)(4-tert-butylphenyl)amine (L2), and (4-cyanobenzylidene)(4-tert-butylphenyl)amine (L3) and the new series of cyclometalated mononuclear piano-stool complexes [(η5-C5Me5)RhCl(L1)] (1), [(η5-C5Me5)RhCl(L2)] (2), [(η5-C5Me5)RhCl(L3)] (3), [(η5-C5Me5)IrCl(L1)] (4), [(η5-C5Me5)IrCl(L2)] (5), and [(η5-C5Me5)IrCl(L3)] (6) have been synthesized.  The ligands L1-L3 and complexes 1-6 have been thoroughly characterized by satisfactory elemental analyses, spectral studies (ESI-MS, IR, 1H and 13C NMR, UV-vis), and structures of 1-3 authenticated by x-ray single-crystal analyses.  Efficient binding of 1-6 with calf thymus DNA (CT DNA) have been established by UV-vis and emission spectroscopic studies.  Protein binding (bovine serum albumin, BSA) has been investigated by UV-vis, fluorescence, synchronous, and 3D fluorescence spectroscopy.  Binding of the complexes with DNA through minor groove and hydrophobic interaction with proteins via sub domain IIA cavity has been substantiated by mol. docking studies.  The complexes exhibited significant cytotoxicity against the human lung cancer cell line (A549), and 1 and 2 showed better activity than cisplatin.  The cytotoxicity, morphol. changes, and apoptosis have been assessed by MTT assay, Hoechst 33342/PI staining, cell cycle anal. by fluorescence-activated cell sorting (FACS), and reactive oxygen species (ROS) generation by DCFH-DA dye.  The complexes 1-6 induce apoptosis in the order 2 > 1 > 4 > 3 > 5 > 6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDo45FSN-GgbVg90H21EOLACvtfcHk0livzwcxkJxApw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWns7zK&md5=44b44c05a869dd8fcf80b5e8c2397446</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.5b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.5b00475%26sid%3Dliteratum%253Aachs%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DPaitandi%26aufirst%3DR.%2BP.%26aulast%3DRana%26aufirst%3DN.%2BK.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DRana%26aufirst%3DL.%2BK.%26aulast%3DHundal%26aufirst%3DM.%2BS.%26aulast%3DPandey%26aufirst%3DD.%2BS.%26atitle%3DSynthesis%252C%2520structure%252C%2520DNA%252Fprotein%2520binding%252C%2520and%2520anticancer%2520activity%2520of%2520some%2520half-sandwich%2520cyclometalated%2520Rh%2528III%2529%2520and%2520Ir%2528III%2529%2520complexes%26jtitle%3DOrganometallics%26date%3D2015%26volume%3D34%26issue%3D18%26spage%3D4491%26epage%3D4506%26doi%3D10.1021%2Facs.organomet.5b00475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit35c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Štarha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trávníček, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crlíková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vančo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kašpárková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvořák, Z.</span></span> <span> </span><span class="NLM_article-title">Half-sandwich Ir(III) complex of <i>N</i>1-pyridyl-7-azaindole exceeds cytotoxicity of cisplatin at various human cancer cells and 3D multicellular tumor spheroids</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2749</span>– <span class="NLM_lpage">2759</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.8b00415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.8b00415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVyksrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2749-2759&issue=16&author=P.+%C5%A0tarhaauthor=Z.+Tr%C3%A1vn%C3%AD%C4%8Dekauthor=H.+Crl%C3%ADkov%C3%A1author=J.+Van%C4%8Doauthor=J.+Ka%C5%A1p%C3%A1rkov%C3%A1author=Z.+Dvo%C5%99%C3%A1k&title=Half-sandwich+Ir%28III%29+complex+of+N1-pyridyl-7-azaindole+exceeds+cytotoxicity+of+cisplatin+at+various+human+cancer+cells+and+3D+multicellular+tumor+spheroids&doi=10.1021%2Facs.organomet.8b00415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35cR"><div class="casContent"><span class="casTitleNuber">35c</span><div class="casTitle"><span class="NLM_cas:atitle">Half-Sandwich Ir(III) Complex of N1-Pyridyl-7-azaindole Exceeds Cytotoxicity of Cisplatin at Various Human Cancer Cells and 3D Multicellular Tumor Spheroids</span></div><div class="casAuthors">Starha, Pavel; Travnicek, Zdenek; Crlikova, Hana; Vanco, Jan; Kasparkova, Jana; Dvorak, Zdenek</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2749-2759</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The half-sandwich Ir(III) complexes [Ir(η5-Cpx)(phaza-)Cl] (1, 2), [Ir(η5-Cpx)(thaza-)Cl] (3, 4), and [Ir(η5-Cpx)(pyaza)Cl]PF6 (5, 6) contg. deprotonated 1-phenyl-7-azaindole (phaza-) and 1-(thiophen-2-yl)-7-azaindole (thaza-) and electroneutral 1-(pyridin-2-yl)-7-azaindole (pyaza), were prepd.; Cpx = pentamethylcyclopentadienyl (Cp*; for 1, 3, and 5) or 1,2,3,4-tetramethyl-5-phenylcyclopentadienyl (Cpph; for 2, 4, and 6).  The complexes were thoroughly characterized, including a single-crystal x-ray anal. of complexes 1, 5, and 6.  All of the complexes were screened for their in vitro cytotoxicity at the A2780 human ovarian carcinoma cell line and its A2780R cisplatin-resistant variant (2-dimensional culture cells).  The best-performing complex 6 was further studied against the human DU-145 prostatic carcinoma, A549 lung carcinoma, HCT116 colon carcinoma, HeLa cervix adenocarcinoma, and MCF7 breast adenocarcinoma cell lines (2-dimensional culture cells).  Complex 6 showed a cytotoxic profile different from that of cisplatin at the used cells, with the highest activity detected at the A2780, MCF7, and HCT116 cells (IC50 = 3.1, 6.9, and 10.4 μM, resp.).  Complex 6 exhibited relevant selectivity toward cancer cells (IC50 = 3.1-13.0 μM) over the MRC-5 human noncancerous lung fibroblast cells (IC50 > 50.0 μM).  Complex 6 was markedly more accumulated by the A2780 cells in comparison to cisplatin after 24 h exposure.  Flow cytometry studies showed that the cell cycle of the A2780 cells treated by complex 6 is modified differently (G0/G1 arrest) in comparison to cisplatin (G2/M arrest).  Addnl. to the monolayer (2D) cancer cell cultures, the cytotoxicity of complex 6 was for the 1st time among half-sandwich Ir(III) complexes also assessed at spheroid (3D) MCF7 cells, where its potency (IC50 = 22.9 μM for complex 6) remained significantly better than that for the ref. drug cisplatin (IC50 = 35.4 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmZ9Qa7xIqrVg90H21EOLACvtfcHk0livzwcxkJxApw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVyksrnJ&md5=033a05f9e4207e828bee77d440dc6fc8</span></div><a href="/servlet/linkout?suffix=cit35c&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.8b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.8b00415%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0tarha%26aufirst%3DP.%26aulast%3DTr%25C3%25A1vn%25C3%25AD%25C4%258Dek%26aufirst%3DZ.%26aulast%3DCrl%25C3%25ADkov%25C3%25A1%26aufirst%3DH.%26aulast%3DVan%25C4%258Do%26aufirst%3DJ.%26aulast%3DKa%25C5%25A1p%25C3%25A1rkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DDvo%25C5%2599%25C3%25A1k%26aufirst%3DZ.%26atitle%3DHalf-sandwich%2520Ir%2528III%2529%2520complex%2520of%2520N1-pyridyl-7-azaindole%2520exceeds%2520cytotoxicity%2520of%2520cisplatin%2520at%2520various%2520human%2520cancer%2520cells%2520and%25203D%2520multicellular%2520tumor%2520spheroids%26jtitle%3DOrganometallics%26date%3D2018%26volume%3D37%26issue%3D16%26spage%3D2749%26epage%3D2759%26doi%3D10.1021%2Facs.organomet.8b00415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit35d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Potent half-sandwich iridium(III) and ruthenium(II) anticancer complexes containing a P^O-chelated ligand</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2880</span>– <span class="NLM_lpage">2889</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.8b00402</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.8b00402" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCgtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2880-2889&issue=17&author=Q.+Duauthor=L.+Guoauthor=M.+Tianauthor=X.+Geauthor=Y.+Yangauthor=X.+Jianauthor=Z.+Xuauthor=Z.+Tianauthor=Z.+Liu&title=Potent+half-sandwich+iridium%28III%29+and+ruthenium%28II%29+anticancer+complexes+containing+a+P%5EO-chelated+ligand&doi=10.1021%2Facs.organomet.8b00402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35dR"><div class="casContent"><span class="casTitleNuber">35d</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Half-Sandwich Iridium(III) and Ruthenium(II) Anticancer Complexes Containing a P̂ O-Chelated Ligand</span></div><div class="casAuthors">Du, Qing; Guo, Lihua; Tian, Meng; Ge, Xingxing; Yang, Yuliang; Jian, Xiyan; Xu, Zhishan; Tian, Zhenzhen; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2880-2889</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Authors herein report the synthesis, characterization, and anticancer activity of a series of iridium(III) and ruthenium(II) half-sandwich complexes of the type [(Cpx/arene)M(P̂ O)Cl]PF6 (M = Ir, Cpx = pentamethylcyclopentadienyl (Cp*) or its Ph (Cpxph = C5Me4C6H5) or biphenyl (Cpxbiph = C5Me4C6H4C6H5) derivs.; M = Ru, arene = p-cymene (p-cym); P̂ O = phosphine phosphonic amide ligand (PPOA)).  The x-ray crystal structures of all complexes, in which the ligand can form six-membered rings with the metal center, have been detd.  All of the complexes show remarkable anticancer activities toward HeLa and A549 cancer cells, activities which are higher than that of the clin. anticancer drug cisplatin.  The incorporation of Ph substituents on the Cp* ring for iridium(III) complexes results in little variation in their anticancer activities.  These results can be attributed to the combinatorial action of the metal and PPOA ligand.  Hydrolysis and DNA cleavage are not the major mechanisms of action.  These complexes show potent catalytic activity in the transfer hydrogenation of NADH to NAD+.  Addnl., complexes [(η5-C5Me5)Ir(P̂ O)Cl]PF6 (1) and [(η6-p-cym)Ru(P̂ O)Cl]PF6 (4) arrest cell cycles at S and G2/M phase and S phase, resp.  Complexes 1 and 4 both can induce apoptosis of HeLa cancer cells.  Reactive oxygen species (ROS) and mitochondrial membrane potential tests were also performed to explore the mechanism of action.  When the concn. of the complexes is increased, the amt. of reactive oxygen species (ROS) increases dramatically and the mitochondrial membrane potential decreases significantly in HeLa cancer cells.  Overall, cell stress including cell cycle perturbation, apoptosis induction, increase in ROS level, and loss of mitochondrial membrane potential contributes to the anticancer potency of these complexes.  Interestingly, the use of confocal microscopy provides insights into the microscopic mechanism in which the typical and most active complex 1 can damage lysosomes.  This type of complex represents a potent platform for development of metal anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomw5aJyUsqBbVg90H21EOLACvtfcHk0livzwcxkJxApw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCgtrbP&md5=3eafda74018c1fcc5b220c69d187ddae</span></div><a href="/servlet/linkout?suffix=cit35d&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.8b00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.8b00402%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DJian%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DPotent%2520half-sandwich%2520iridium%2528III%2529%2520and%2520ruthenium%2528II%2529%2520anticancer%2520complexes%2520containing%2520a%2520P%255EO-chelated%2520ligand%26jtitle%3DOrganometallics%26date%3D2018%26volume%3D37%26issue%3D17%26spage%3D2880%26epage%3D2889%26doi%3D10.1021%2Facs.organomet.8b00402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit35e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Fluorescent half-sandwich phosphine-sulfonate iridium(III) and ruthenium(II) complexes as potential lysosome-targeted anticancer agents</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2018.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.dyepig.2018.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Chtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=821-830&author=Q.+Duauthor=Y.+Yangauthor=L.+Guoauthor=M.+Tianauthor=X.+Geauthor=Z.+Tianauthor=L.+Zhaoauthor=Z.+Xuauthor=J.+Liauthor=Z.+Liu&title=Fluorescent+half-sandwich+phosphine-sulfonate+iridium%28III%29+and+ruthenium%28II%29+complexes+as+potential+lysosome-targeted+anticancer+agents&doi=10.1016%2Fj.dyepig.2018.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35eR"><div class="casContent"><span class="casTitleNuber">35e</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent half-sandwich phosphine-sulfonate iridium(III) and ruthenium(II) complexes as potential lysosome-targeted anticancer agents</span></div><div class="casAuthors">Du, Qing; Yang, Yuliang; Guo, Lihua; Tian, Meng; Ge, Xingxing; Tian, Zhenzhen; Zhao, Liping; Xu, Zhishan; Li, Juanjuan; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">821-830</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis, characterization and biol. activity of neutral fluorescent Ir(III) and Ru(II) half-sandwich organometallic complexes contg. phosphine-sulfonate ligands are reported.  X-ray crystal structure of complexes 1-3, 10 and 11 exhibits the expected half-sandwich "three-legged piano-stool" pseudo-octahedral geometry.  Spectroscopic properties study displays that these complexes show rich fluorescence properties.  With the exception of 9, 10 and 11 toward A549 human lung cancer cells and 10 towards HeLa human cervical cancer cells, each complex shows promising cytotoxicity toward HeLa and A549 cells line with IC50 values in the range of 3.6-53.1 μM, and 6.5-34.5 μM, resp.  Hydrolysis, DNA cleavage and depolarization of the mitochondrial membrane potential (MMP) appear not to be the main mechanism of action.  However, these complexes are able to covert NADH to NAD+ via the transfer hydrogenation.  Mechanism studies by flow cytometry display that the complexes exert their anticancer efficacy by inducing apoptosis, perturbing the cell cycle and increasing the intracellular ROS level.  Furthermore, fluorescence property of these complexes provides a tool to investigate the microscopic mechanism by confocal microscopy.  Notably, the typical Ir(III) complex 3 can specially localize to lysosome and damage it.  In addn., complex 3 enters into HeLa cells mainly through energy-dependent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriesZrNPsiK7Vg90H21EOLACvtfcHk0ljDD15wU5qkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Chtr7L&md5=b5f3ca656352010a21340968c79b2f12</span></div><a href="/servlet/linkout?suffix=cit35e&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2018.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2018.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DFluorescent%2520half-sandwich%2520phosphine-sulfonate%2520iridium%2528III%2529%2520and%2520ruthenium%2528II%2529%2520complexes%2520as%2520potential%2520lysosome-targeted%2520anticancer%2520agents%26jtitle%3DDyes%2520Pigm.%26date%3D2019%26volume%3D162%26spage%3D821%26epage%3D830%26doi%3D10.1016%2Fj.dyepig.2018.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj-Yehia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi-Schaffer, F.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in apoptosis induction</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1023/A:1009616228304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1023%2FA%3A1009616228304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=11256882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=415-418&issue=5&author=H.+U.+Simonauthor=A.+Haj-Yehiaauthor=F.+Levi-Schaffer&title=Role+of+reactive+oxygen+species+%28ROS%29+in+apoptosis+induction&doi=10.1023%2FA%3A1009616228304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of reactive oxygen species (ROS) in apoptosis induction</span></div><div class="casAuthors">Simon, H.-U.; Haj-Yehia, A.; Levi-Schaffer, F.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-418</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 49 refs.  Reactive O species (ROS) and mitochondria play an important role in apoptosis induction under both physiol. and pathol. conditions.  Interestingly, mitochondria are both source and target of ROS.  Cytochrome c release from mitochondria, that triggers caspase activation, appears to be largely mediated by direct or indirect ROS action.  On the other hand, ROS have also anti-apoptotic effects.  This review focuses on the role of ROS in the regulation of apoptosis, esp. in inflammatory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPu13B3_9rGLVg90H21EOLACvtfcHk0ljDD15wU5qkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D&md5=752558ae104d1b8446ab51c6a63c8331</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1023%2FA%3A1009616228304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1009616228304%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DH.%2BU.%26aulast%3DHaj-Yehia%26aufirst%3DA.%26aulast%3DLevi-Schaffer%26aufirst%3DF.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520apoptosis%2520induction%26jtitle%3DApoptosis%26date%3D2000%26volume%3D5%26issue%3D5%26spage%3D415%26epage%3D418%26doi%3D10.1023%2FA%3A1009616228304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Circu, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aw, T. Y.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species, cellular redox systems, and apoptosis</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2009.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.freeradbiomed.2009.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=20045723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=749-762&issue=6&author=M.+L.+Circuauthor=T.+Y.+Aw&title=Reactive+oxygen+species%2C+cellular+redox+systems%2C+and+apoptosis&doi=10.1016%2Fj.freeradbiomed.2009.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species, cellular redox systems, and apoptosis</span></div><div class="casAuthors">Circu, Magdalena L.; Aw, Tak Yee</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">749-762</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are products of normal metab. and xenobiotic exposure, and depending on their concn., ROS can be beneficial or harmful to cells and tissues.  At physiol. low levels, ROS function as "redox messengers" in intracellular signaling and regulation, whereas excess ROS induce oxidative modification of cellular macromols., inhibit protein function, and promote cell death.  Addnl., various redox systems, such as the glutathione, thioredoxin, and pyridine nucleotide redox couples, participate in cell signaling and modulation of cell function, including apoptotic cell death.  Cell apoptosis is initiated by extracellular and intracellular signals via two main pathways, the death receptor- and the mitochondria-mediated pathways.  Various pathologies can result from oxidative stress-induced apoptotic signaling that is consequent to ROS increases and/or antioxidant decreases, disruption of intracellular redox homeostasis, and irreversible oxidative modifications of lipid, protein, or DNA.  In this review, we focus on several key aspects of ROS and redox mechanisms in apoptotic signaling and highlight the gaps in knowledge and potential avenues for further investigation.  A full understanding of the redox control of apoptotic initiation and execution could underpin the development of therapeutic interventions targeted at oxidative stress-assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDErrUmQqbTbVg90H21EOLACvtfcHk0ljDD15wU5qkaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKms78%253D&md5=8d9396ff7d0d303d853cd1edacb51a34</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2009.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2009.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DCircu%26aufirst%3DM.%2BL.%26aulast%3DAw%26aufirst%3DT.%2BY.%26atitle%3DReactive%2520oxygen%2520species%252C%2520cellular%2520redox%2520systems%252C%2520and%2520apoptosis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26issue%3D6%26spage%3D749%26epage%3D762%26doi%3D10.1016%2Fj.freeradbiomed.2009.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marullo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degtyareva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altavilla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doetsch, P. W.</span></span> <span> </span><span class="NLM_article-title">Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e81162</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0081162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1371%2Fjournal.pone.0081162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24260552" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=11&author=R.+Marulloauthor=E.+Wernerauthor=N.+Degtyarevaauthor=B.+Mooreauthor=G.+Altavillaauthor=S.+S.+Ramalingamauthor=P.+W.+Doetsch&title=Cisplatin+induces+a+mitochondrial-ROS+response+that+contributes+to+cytotoxicity+depending+on+mitochondrial+redox+status+and+bioenergetic+functions&doi=10.1371%2Fjournal.pone.0081162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0081162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0081162%26sid%3Dliteratum%253Aachs%26aulast%3DMarullo%26aufirst%3DR.%26aulast%3DWerner%26aufirst%3DE.%26aulast%3DDegtyareva%26aufirst%3DN.%26aulast%3DMoore%26aufirst%3DB.%26aulast%3DAltavilla%26aufirst%3DG.%26aulast%3DRamalingam%26aufirst%3DS.%2BS.%26aulast%3DDoetsch%26aufirst%3DP.%2BW.%26atitle%3DCisplatin%2520induces%2520a%2520mitochondrial-ROS%2520response%2520that%2520contributes%2520to%2520cytotoxicity%2520depending%2520on%2520mitochondrial%2520redox%2520status%2520and%2520bioenergetic%2520functions%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0081162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcomson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniforth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavros, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Targeted photoredox catalysis in cancer cells</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1038/s41557-019-0328-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fs41557-019-0328-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=31548671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVGgurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1041-1048&issue=11&author=H.+Huangauthor=S.+Banerjeeauthor=K.+Qiuauthor=P.+Zhangauthor=O.+Blacqueauthor=T.+Malcomsonauthor=M.+J.+Patersonauthor=G.+J.+Clarksonauthor=M.+Staniforthauthor=V.+G.+Stavrosauthor=G.+Gasserauthor=H.+Chaoauthor=P.+J.+Sadler&title=Targeted+photoredox+catalysis+in+cancer+cells&doi=10.1038%2Fs41557-019-0328-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted photoredox catalysis in cancer cells</span></div><div class="casAuthors">Huang, Huaiyi; Banerjee, Samya; Qiu, Kangqiang; Zhang, Pingyu; Blacque, Olivier; Malcomson, Thomas; Paterson, Martin J.; Clarkson, Guy J.; Staniforth, Michael; Stavros, Vasilios G.; Gasser, Gilles; Chao, Hui; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1041-1048</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Hypoxic tumors are a major problem for cancer photodynamic therapy.  Here, we show that photoredox catalysis can provide an oxygen-independent mechanism of action to combat this problem.  We have designed a highly oxidative Ir(III) photocatalyst, [Ir(ttpy)(pq)Cl]PF6 ([1]PF6, where 'ttpy' represents 4'-(p-tolyl)-2,2':6',2''-terpyridine and 'pq' represents 3-phenylisoquinoline), which is phototoxic towards both normoxic and hypoxic cancer cells.  Complex 1 photocatalytically oxidizes 1,4-dihydronicotinamide adenine dinucleotide (NADH)-an important coenzyme in living cells-generating NAD• radicals with a high turnover frequency in biol. media.  Moreover, complex 1 and NADH synergistically photoreduce cytochrome c under hypoxia.  D. functional theory calcns. reveal π stacking in adducts of complex 1 and NADH, facilitating photoinduced single-electron transfer.  In cancer cells, complex 1 localizes in mitochondria and disrupts electron transport via NADH photocatalysis.  On light irradn., complex 1 induces NADH depletion, intracellular redox imbalance and immunogenic apoptotic cancer cell death.  This photocatalytic redox imbalance strategy offers a new approach for efficient cancer phototherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoZNCvl9_iQLVg90H21EOLACvtfcHk0ljc6umJh2kXVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGgurfK&md5=b7774e96b85d9d648faa30c50bbea784</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fs41557-019-0328-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-019-0328-4%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DMalcomson%26aufirst%3DT.%26aulast%3DPaterson%26aufirst%3DM.%2BJ.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DStaniforth%26aufirst%3DM.%26aulast%3DStavros%26aufirst%3DV.%2BG.%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DTargeted%2520photoredox%2520catalysis%2520in%2520cancer%2520cells%26jtitle%3DNat.%2520Chem.%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D1041%26epage%3D1048%26doi%3D10.1038%2Fs41557-019-0328-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">The thioredoxin antioxidant system</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.freeradbiomed.2013.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=23899494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyitLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=75-87&author=J.+Luauthor=A.+Holmgren&title=The+thioredoxin+antioxidant+system&doi=10.1016%2Fj.freeradbiomed.2013.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The thioredoxin antioxidant system</span></div><div class="casAuthors">Lu, Jun; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-87</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The thioredoxin (Trx) system, which is composed of NADPH, thioredoxin reductase (TrxR), and thioredoxin, is a key antioxidant system in defense against oxidative stress through its disulfide reductase activity regulating protein dithiol/disulfide balance.  The Trx system provides the electrons to thiol-dependent peroxidases (peroxiredoxins) to remove reactive oxygen and nitrogen species with a fast reaction rate.  Trx antioxidant functions are also shown by involvement in DNA and protein repair by reducing ribonucleotide reductase, methionine sulfoxide reductases, and regulating the activity of many redox-sensitive transcription factors.  Moreover, Trx systems play crit. roles in the immune response, virus infection, and cell death via interaction with thioredoxin-interacting protein.  In mammalian cells, the cytosolic and mitochondrial Trx systems, in which TrxRs are high mol. wt. selenoenzymes, together with the glutathione-glutaredoxin (Grx) system (NADPH, glutathione reductase, GSH, and Grx) control the cellular redox environment.  Recently, mammalian thioredoxin and glutathione systems have been found to be able to provide the electrons crossly and to serve as a backup system for each other.  In contrast, bacterial TrxRs are low mol. wt. enzymes with a structure and reaction mechanism distinct from mammalian TrxR.  Many bacterial species possess specific thiol-dependent antioxidant systems, and the significance of the Trx system in the defense against oxidative stress is different.  Particularly, the absence of a GSH-Grx system in some pathogenic bacteria such as Helicobacter pylori, Mycobacterium tuberculosis, and Staphylococcus aureus makes the bacterial Trx system essential for survival under oxidative stress.  This provides an opportunity to kill these bacteria by targeting the TrxR-Trx system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnxEvRdPYfRbVg90H21EOLACvtfcHk0ljc6umJh2kXVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyitLzE&md5=b1b8a63b4cf4b0e8fe9476ef9b386240</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThe%2520thioredoxin%2520antioxidant%2520system%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D66%26spage%3D75%26epage%3D87%26doi%3D10.1016%2Fj.freeradbiomed.2013.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebden, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pask, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-sensitive metal beta-ketoiminato complexes showing induced single-strand DNA breaks and cancer cell death by apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4940</span>– <span class="NLM_lpage">4953</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4940-4953&issue=12&author=R.+M.+Lordauthor=A.+J.+Hebdenauthor=C.+M.+Paskauthor=I.+R.+Hendersonauthor=S.+J.+Allisonauthor=S.+L.+Shepherdauthor=R.+M.+Phillipsauthor=P.+C.+McGowan&title=Hypoxia-sensitive+metal+beta-ketoiminato+complexes+showing+induced+single-strand+DNA+breaks+and+cancer+cell+death+by+apoptosis&doi=10.1021%2Facs.jmedchem.5b00455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis</span></div><div class="casAuthors">Lord, Rianne M.; Hebden, Andrew J.; Pask, Christopher M.; Henderson, Imogen R.; Allison, Simon J.; Shepherd, Samantha L.; Phillips, Roger M.; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4940-4953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of ruthenium and iridium complexes have been synthesized and characterized with 20 novel crystal structures discussed.  The library of β-ketoiminato complexes has been shown to be active against MCF-7 (human breast carcinoma), HT-29 (human colon carcinoma), A2780 (human ovarian carcinoma), and A2780cis (cisplatin-resistant human ovarian carcinoma) cell lines, with selected complexes' being more than three times as active as cisplatin against the A2780cis cell line.  Selected complexes were also tested against the noncancerous ARPE-19 (retinal pigment epithelial cells) cell line, in order to evaluate the complexes selectivity for cancer cells.  Complexes have also been shown to be highly active under hypoxic conditions, with the activities of some complexes increasing with a decrease in O2 concn.  The enzyme thioredoxin reductase is overexpressed in cancer cells, and complexes reported herein have the advantage of inhibiting this enzyme, with IC50 values measured in the nanomolar range.  The anticancer activity of these complexes was further investigated to det. whether activity is due to effects on cellular growth or cell survival.  The complexes were found to induce significant levels of cancer cell death by apoptosis with levels induced correlating closely with activity in chemosensitivity studies.  As a possible cause of cell death, the ability of the complexes to induce damage to cellular DNA was also assessed.  The complexes failed to induce double-strand DNA breaks or DNA crosslinking but induced significant levels of single-strand DNA breaks, indicating a mechanism of action different from that of cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIteWGwVzu7LVg90H21EOLACvtfcHk0lj2M_XFNl0KRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsrg%253D&md5=23bc656d38c4b4c233a341538da2341f</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00455%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DHebden%26aufirst%3DA.%2BJ.%26aulast%3DPask%26aufirst%3DC.%2BM.%26aulast%3DHenderson%26aufirst%3DI.%2BR.%26aulast%3DAllison%26aufirst%3DS.%2BJ.%26aulast%3DShepherd%26aufirst%3DS.%2BL.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DHypoxia-sensitive%2520metal%2520beta-ketoiminato%2520complexes%2520showing%2520induced%2520single-strand%2520DNA%2520breaks%2520and%2520cancer%2520cell%2520death%2520by%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D12%26spage%3D4940%26epage%3D4953%26doi%3D10.1021%2Facs.jmedchem.5b00455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Almodares, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crossley, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basri, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pask, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebden, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1021/ic401529u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic401529u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=727-736&issue=2&author=Z.+Almodaresauthor=S.+J.+Lucasauthor=B.+D.+Crossleyauthor=A.+M.+Basriauthor=C.+M.+Paskauthor=A.+J.+Hebdenauthor=R.+M.+Phillipsauthor=P.+C.+McGowan&title=Rhodium%2C+iridium%2C+and+ruthenium+half-sandwich+picolinamide+complexes+as+anticancer+agents&doi=10.1021%2Fic401529u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodium, Iridium, and Ruthenium Half-Sandwich Picolinamide Complexes as Anticancer Agents</span></div><div class="casAuthors">Almodares, Zahra; Lucas, Stephanie J.; Crossley, Benjamin D.; Basri, Aida M.; Pask, Christopher M.; Hebden, Andrew J.; Phillips, Roger M.; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">727-736</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel rhodium, iridium, and ruthenium half-sandwich complexes contg. (N,N)-bound picolinamide ligands have been prepd. for use as anticancer agents.  The complexes show promising cytotoxicities, with the presence, position, and no. of halides having a significant effect on the corresponding IC50 values.  One ruthenium complex was found to be more cytotoxic than cisplatin on HT-29 and MCF-7 cells after 5 days and 1 h, resp., and it remains active with MCF-7 cells even under hypoxic conditions, making it a promising candidate for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg2mYpPJd7f7Vg90H21EOLACvtfcHk0lj2M_XFNl0KRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlahuw%253D%253D&md5=61171d68cf74c0628572c945c8e4b337</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fic401529u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic401529u%26sid%3Dliteratum%253Aachs%26aulast%3DAlmodares%26aufirst%3DZ.%26aulast%3DLucas%26aufirst%3DS.%2BJ.%26aulast%3DCrossley%26aufirst%3DB.%2BD.%26aulast%3DBasri%26aufirst%3DA.%2BM.%26aulast%3DPask%26aufirst%3DC.%2BM.%26aulast%3DHebden%26aufirst%3DA.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DRhodium%252C%2520iridium%252C%2520and%2520ruthenium%2520half-sandwich%2520picolinamide%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26issue%3D2%26spage%3D727%26epage%3D736%26doi%3D10.1021%2Fic401529u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species, antioxidants, and the mammalian thioredoxin system</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(01)00724-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2FS0891-5849%2801%2900724-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=11728801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Knu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=1287-1312&issue=11&author=J.+Nordbergauthor=E.+S.+Arner&title=Reactive+oxygen+species%2C+antioxidants%2C+and+the+mammalian+thioredoxin+system&doi=10.1016%2FS0891-5849%2801%2900724-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species, antioxidants, and the mammalian thioredoxin system</span></div><div class="casAuthors">Nordberg, Jonas; Arner, Elias S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1287-1312</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review. Reactive oxygen species (ROS) are known mediators of intracellular signaling cascades.  Excessive prodn. of ROS may, however, lead to oxidative stress, loss of cell function, and ultimately apoptosis or necrosis.  A balance between oxidant and antioxidant intracellular systems is hence vital for cell function, regulation, and adaptation to diverse growth conditions.  Thioredoxin reductase (TrxR) in conjunction with thioredoxin (Trx) is a ubiquitous oxidoreductase system with antioxidant and redox regulatory roles.  In mammals, extracellular forms of Trx also have cytokine-like effects.  Mammalian TrxR has a highly reactive active site selenocysteine residue resulting in a profound reductive capacity, reducing several substrates in addn. to Trx.  Due to the reactivity of TrxR, the enzyme is inhibited by many clin. used electrophilic compds. including nitrosoureas, aurothioglucose, platinum compds., and retinoic acid derivs.  The properties of TrxR in combination with the functions of Trx position this system at the core of cellular thiol redox control and antioxidant defense.  In this review, the authors focus on the reactions of the Trx system with ROS mols. and different cellular antioxidant enzymes.  The authors summarize the TrxR-catalyzed regeneration of several antioxidant compds., including ascorbic acid (vitamin C), selenium-contg. substances, lipoic acid, and ubiquinone (Q10).  The general cellular effects of TrxR inhibition are also discussed.  Dinitrohalobenzenes constitute a unique class of immunostimulatory TrxR inhibitors and the authors consider the immunomodulatory effects of dinitrohalobenzene compds. in view of their reactions with the Trx system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJu9k4Eie_urVg90H21EOLACvtfcHk0lg24wGY5QORbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Knu7w%253D&md5=dad917a71af0cc525d71a04ee5b92e9e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2801%2900724-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252801%252900724-9%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DJ.%26aulast%3DArner%26aufirst%3DE.%2BS.%26atitle%3DReactive%2520oxygen%2520species%252C%2520antioxidants%252C%2520and%2520the%2520mammalian%2520thioredoxin%2520system%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2001%26volume%3D31%26issue%3D11%26spage%3D1287%26epage%3D1312%26doi%3D10.1016%2FS0891-5849%2801%2900724-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Fanjul, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Torres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiola, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ejmech.2018.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29471123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2018&pages=372-383&author=V.+Rodriguez-Fanjulauthor=E.+Lopez-Torresauthor=M.+A.+Mendiolaauthor=A.+M.+Pizarro&title=Gold%28III%29+bis%28thiosemicarbazonate%29+compounds+in+breast+cancer+cells%3A+Cytotoxicity+and+thioredoxin+reductase+targeting&doi=10.1016%2Fj.ejmech.2018.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting</span></div><div class="casAuthors">Rodriguez-Fanjul, Vanessa; Lopez-Torres, Elena; Mendiola, M. Antonia; Pizarro, Ana Maria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">372-383</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Gold(III) compds. have received increasing attention in cancer research.  Three gold complexes of general formula [AuIIIL]Cl, where L is benzil bis(thiosemicarbazonate), compd. 1, benzil bis(4-methyl-3-thiosemicarbazonate), compd. 2, or benzil bis(4-cyclohexyl-3-thiosemicarbazonate), compd. 3, have been synthesized and fully characterized, including the x-ray crystal structure of compd. 3, confirming square-planar geometry around the gold(III) center.  Compd. 1 showed moderate cytotoxicity and accumulation in MCF7 breast cancer cells but did not inhibit thioredoxin reductase (TrxR) activity and did not induce reactive oxygen species (ROS) prodn.  Compd. 2, the least cytotoxic, is capable of modestly inhibiting TrxR activity and produced low levels of ROS in the MCF7 cell line.  The most cytotoxic compd., 3, had the highest cellular accumulation and its distribution pattern showed a clear preference for the cytosol and mitochondria of MCF7 cells.  It readily hampered intracellular TrxR activity leading to a dramatic alteration of the cellular redox state and to the induction of cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVVvtPX_hrXrVg90H21EOLACvtfcHk0lg24wGY5QORbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt12jt78%253D&md5=b0fb5c61224cbda5f0c78f33808eba8a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Fanjul%26aufirst%3DV.%26aulast%3DLopez-Torres%26aufirst%3DE.%26aulast%3DMendiola%26aufirst%3DM.%2BA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DGold%2528III%2529%2520bis%2528thiosemicarbazonate%2529%2520compounds%2520in%2520breast%2520cancer%2520cells%253A%2520Cytotoxicity%2520and%2520thioredoxin%2520reductase%2520targeting%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D148%26spage%3D372%26epage%3D383%26doi%3D10.1016%2Fj.ejmech.2018.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>441</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1042/BJ20111451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1042%2FBJ20111451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=22187934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Wksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=523-540&issue=2&author=J.+Leeauthor=S.+Giordanoauthor=J.+Zhang&title=Autophagy%2C+mitochondria+and+oxidative+stress%3A+cross-talk+and+redox+signalling&doi=10.1042%2FBJ20111451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling</span></div><div class="casAuthors">Lee, Jisun; Giordano, Samantha; Zhang, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">523-540</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen and nitrogen species change cellular responses through diverse mechanisms that are now being defined.  At low levels, they are signalling mols., and at high levels, they damage organelles, particularly the mitochondria.  Oxidative damage and the assocd. mitochondrial dysfunction may result in energy depletion, accumulation of cytotoxic mediators and cell death.  Understanding the interface between stress adaptation and cell death then is important for understanding redox biol. and disease pathogenesis.  Recent studies have found that one major sensor of redox signalling at this switch in cellular responses is autophagy.  Autophagic activities are mediated by a complex mol. machinery including more than 30 Atg (AuTophaGy-related) proteins and 50 lysosomal hydrolases.  Autophagosomes form membrane structures, sequester damaged, oxidized or dysfunctional intracellular components and organelles, and direct them to the lysosomes for degrdn.  This autophagic process is the sole known mechanism for mitochondrial turnover.  It has been speculated that dysfunction of autophagy may result in abnormal mitochondrial function and oxidative or nitrative stress.  Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is controlled, and the impact of autophagic dysfunction on cellular oxidative stress.  The present review highlights recent studies on redox signalling in the regulation of autophagy, in the context of the basic mechanisms of mitophagy.  Furthermore, we discuss the impact of autophagy on mitochondrial function and accumulation of reactive species.  This is particularly relevant to degenerative diseases in which oxidative stress occurs over time, and dysfunction in both the mitochondrial and autophagic pathways play a role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt-vtoOFiawLVg90H21EOLACvtfcHk0lg24wGY5QORbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wksw%253D%253D&md5=f2d18d9c8cef7cd3b932799d22951bb4</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1042%2FBJ20111451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111451%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAutophagy%252C%2520mitochondria%2520and%2520oxidative%2520stress%253A%2520cross-talk%2520and%2520redox%2520signalling%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26issue%3D2%26spage%3D523%26epage%3D540%26doi%3D10.1042%2FBJ20111451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">How mitochondria produce reactive oxygen species</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>417</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1042/BJ20081386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1042%2FBJ20081386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19061483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2lt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2009&pages=1-13&issue=1&author=M.+P.+Murphy&title=How+mitochondria+produce+reactive+oxygen+species&doi=10.1042%2FBJ20081386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">How mitochondria produce reactive oxygen species</span></div><div class="casAuthors">Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The prodn. of reactive O species (ROS) by mammalian mitochondria is important because it underlies oxidative damage in many pathologies and contributes to retrograde redox signalling from the organelle to the cytosol and nucleus.  Superoxide (O2•-) is the proximal mitochondrial ROS, and here the author outlines the principles that govern O2•- prodn. within the matrix of mammalian mitochondria.  The flux of O2•- is related to the concn. of potential electron donors, the local concn. of O2, and the 2nd-order rate consts. for the reactions between them.  Two modes of operation by isolated mitochondria result in significant O2•- prodn., predominantly from complex I: (1) when the mitochondria are not making ATP and consequently have a high protonmotive force (Δp) and a reduced coenzyme Q (CoQ) pool; and (2) when there is a high NADH/NAD ratio in the mitochondrial matrix.  For mitochondria that are actively synthesizing ATP, and consequently have a lower Δp and NADH/NAD ratio, the extent of O2•- prodn. is far lower.  The generation of O2•- within the mitochondrial matrix depends critically on Δp, the NADH/NAD and CoQH2/CoQ ratios, and the local O2 concn., which are all highly variable and difficult to measure in vivo.  Consequently, it is not possible to est. O2•- generation by mitochondria in vivo from O2•--prodn. rates by isolated mitochondria, and such extrapolations in the literature are misleading.  Even so, the description outlined here facilitates the understanding of factors that favor mitochondrial ROS prodn.  There is a clear need to develop better methods to measure mitochondrial O2•- and H2O2 formation in vivo, as uncertainty about these values hampers studies on the role of mitochondrial ROS in pathol. oxidative damage and redox signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp75BMAKvYJ4rVg90H21EOLACvtfcHk0lijReKmj0fIQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2lt77F&md5=ed7944f6fe333d32e29dd55446cd9611</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1042%2FBJ20081386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20081386%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DHow%2520mitochondria%2520produce%2520reactive%2520oxygen%2520species%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D417%26issue%3D1%26spage%3D1%26epage%3D13%26doi%3D10.1042%2FBJ20081386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youle, R. J.</span></span> <span> </span><span class="NLM_article-title">The role of mitochondria in apoptosis</span>. <i>Annu. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1146/annurev-genet-102108-134850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1146%2Fannurev-genet-102108-134850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19659442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2qtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=95-118&author=C.+Wangauthor=R.+J.+Youle&title=The+role+of+mitochondria+in+apoptosis&doi=10.1146%2Fannurev-genet-102108-134850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitochondria in apoptosis</span></div><div class="casAuthors">Wang, Chunxin; Youle, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-118</span>CODEN:
                <span class="NLM_cas:coden">ARVGB7</span>;
        ISSN:<span class="NLM_cas:issn">0066-4197</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Mitochondria play key roles in activating apoptosis in mammalian cells.  Bcl-2 protein family members regulate the release of proteins from the space between the mitochondrial inner and outer membrane that, once in the cytosol, activate caspase proteases that dismantle cells and signal efficient phagocytosis of cell corpses.  Here, the authors review the extensive literature on proteins released from the intermembrane space and consider genetic evidence for and against their roles in apoptosis activation.  The authors also compare and contrast apoptosis pathways in Caenorhabditis elegans, Drosophila melanogaster, and mammals that indicate major mysteries remaining to be solved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu8f1OWWH817Vg90H21EOLACvtfcHk0lijReKmj0fIQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2qtrjL&md5=1d30fe7bf06950278cf57a64d5a17d4a</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genet-102108-134850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genet-102108-134850%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYoule%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520role%2520of%2520mitochondria%2520in%2520apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2009%26volume%3D43%26spage%3D95%26epage%3D118%26doi%3D10.1146%2Fannurev-genet-102108-134850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria: dynamic organelles in disease, aging, and development</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1241</span>– <span class="NLM_lpage">1252</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.cell.2006.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=16814712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=1241-1252&issue=7&author=D.+C.+Chan&title=Mitochondria%3A+dynamic+organelles+in+disease%2C+aging%2C+and+development&doi=10.1016%2Fj.cell.2006.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria: dynamic organelles in disease, aging, and development</span></div><div class="casAuthors">Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1241-1252</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria are the primary energy-generating system in most eukaryotic cells.  Addnl., they participate in intermediary metab., Ca2+ signaling, and apoptosis.  Given these well-established functions, it might be expected that mitochondrial dysfunction would give rise to a simple and predictable set of defects in all tissues.  However, mitochondrial dysfunction has pleiotropic effects in multicellular organisms.  Clearly, much about the basic biol. of mitochondria remains to be understood.  Here, the authors discuss recent work that suggests that the dynamics (fusion and fission) of these organelles is important in development and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHxWfcOENvbVg90H21EOLACvtfcHk0lijReKmj0fIQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D&md5=2de7a7341c3294779ad85b276a7d38e5</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DMitochondria%253A%2520dynamic%2520organelles%2520in%2520disease%252C%2520aging%252C%2520and%2520development%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D7%26spage%3D1241%26epage%3D1252%26doi%3D10.1016%2Fj.cell.2006.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit43c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria and apoptosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">5381</span>),  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1126/science.281.5381.1309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1126%2Fscience.281.5381.1309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=9721092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1309-1312&issue=5381&author=D.+R.+Greenauthor=J.+C.+Reed&title=Mitochondria+and+apoptosis&doi=10.1126%2Fscience.281.5381.1309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43cR"><div class="casContent"><span class="casTitleNuber">43c</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria and apoptosis</span></div><div class="casAuthors">Green, Douglas R.; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5381</span>),
    <span class="NLM_cas:pages">1309-1312</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 57 refs.  A variety of key events in apoptosis focus on mitochondria, including the release of caspase activators (such as cytochrome c), changes in electron transport, loss of mitochondrial transmembrane potential, altered cellular oxidn.-redn., and participation of pro- and antiapoptotic Bcl-2 family proteins.  The different signals that converge on mitochondria to trigger or inhibit these events and their downstream effects delineate several major pathways in physiol. cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl-fY3nIsc1rVg90H21EOLACvtfcHk0lijReKmj0fIQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVegsLo%253D&md5=9c60b89ccad05a8304df63f09f1b7792</span></div><a href="/servlet/linkout?suffix=cit43c&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5381.1309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5381.1309%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DMitochondria%2520and%2520apoptosis%26jtitle%3DScience%26date%3D1998%26volume%3D281%26issue%3D5381%26spage%3D1309%26epage%3D1312%26doi%3D10.1126%2Fscience.281.5381.1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated iridium(III) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6942</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1039/C8DT00783G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8DT00783G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29721561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFCmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=6942-6953&issue=20&author=L.+Heauthor=K.+N.+Wangauthor=Y.+Zhengauthor=J.+J.+Caoauthor=M.+F.+Zhangauthor=C.+P.+Tanauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Cyclometalated+iridium%28III%29+complexes+induce+mitochondria-derived+paraptotic+cell+death+and+inhibit+tumor+growth+in+vivo&doi=10.1039%2FC8DT00783G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated iridium(III) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo</span></div><div class="casAuthors">He, Liang; Wang, Kang-Nan; Zheng, Yue; Cao, Jian-Jun; Zhang, Ming-Fang; Tan, Cai-Ping; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6942-6953</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of iridium complexes as potent anticancer agents has received increasing attention in recent years.  In this study, four cyclometalated Ir(III) complexes with good photophys. properties and potent anticancer activity have been synthesized and characterized.  They are taken up by human lung adenocarcinoma A549 cells very quickly and specifically target mitochondria.  Mechanism studies reveal that one of them, namely IrM2, induces paraptosis accompanied by excessive mitochondria-derived cytoplasmic vacuoles.  Meanwhile, IrM2 affects the ubiquitin-proteasome system (UPS) and mitogen-activated protein kinase (MAPK) signaling pathways.  Furthermore, IrM2 rapidly induces a series of mitochondria-related dysfunctional events, including the loss of mitochondrial membrane potential, cellular ATP depletion, mitochondrial respiration inhibition and reactive oxygen species (ROS) elevation.  The rapid loss of mitochondrial functions, elevation of ROS and impairment of the UPS induced by IrM2 lead to the collapse of mitochondria and the subsequent cytoplasmic vacuolation before the cells are ready to start the mechanisms of apoptosis and/or autophagy.  Among the ROS, superoxide anion radicals play a crit. role in IrM2-mediated cell death.  In vivo studies reveal that IrM2 can significantly inhibit tumor growth in a mouse model.  This work gives useful insights into the design and anticancer mechanisms of new metal-based anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBXBnL1N1a2LVg90H21EOLACvtfcHk0ljzFcFnpk988g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFCmtbY%253D&md5=9b094ef5dc37671e593a26874795a5d3</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.1039%2FC8DT00783G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT00783G%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DK.%2BN.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DM.%2BF.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DCyclometalated%2520iridium%2528III%2529%2520complexes%2520induce%2520mitochondria-derived%2520paraptotic%2520cell%2520death%2520and%2520inhibit%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26issue%3D20%26spage%3D6942%26epage%3D6953%26doi%3D10.1039%2FC8DT00783G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1039/C6SC02901A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC6SC02901A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29780446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=631-640&issue=1&author=J.+J.+Caoauthor=C.+P.+Tanauthor=M.+H.+Chenauthor=N.+Wuauthor=D.+Y.+Yaoauthor=X.+G.+Liuauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Targeting+cancer+cell+metabolism+with+mitochondria-immobilized+phosphorescent+cyclometalated+iridium%28III%29+complexes&doi=10.1039%2FC6SC02901A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44bR"><div class="casContent"><span class="casTitleNuber">44b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexes</span></div><div class="casAuthors">Cao, Jian-Jun; Tan, Cai-Ping; Chen, Mu-He; Wu, Na; Yao, De-Yang; Liu, Xing-Guo; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cancer cell metab. is reprogrammed to sustain the high metabolic demands of cell proliferation.  Recently, emerging studies have shown that mitochondrial metab. is a potential target for cancer therapy.  Herein, four mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes have been designed and synthesized.  Complexes 2 and 4, contg. reactive chloromethyl groups for mitochondrial fixation, show much higher cytotoxicity than complexes 1 and 3 without mitochondria-immobilization properties against the cancer cells screened.  Further studies show that complexes 2 and 4 induce caspase-dependent apoptosis through mitochondrial damage, cellular ATP depletion, mitochondrial respiration inhibition and reactive oxygen species (ROS) elevation.  The phosphorescence of complexes 2 and 4 can be utilized to monitor the perinuclear clustering of mitochondria in real time, which provides a reliable and convenient method for in situ monitoring of the therapeutic effect and gives hints for the investigation of anticancer mechanisms.  Genome-wide transcriptional anal. shows that complex 2 exerts its anticancer activity through metab. repression and multiple cell death signalling pathways.  Our work provides a strategy for the construction of highly effective anticancer agents targeting mitochondrial metab. through rational modification of phosphorescent iridium complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmldi39219rLVg90H21EOLACvtfcHk0ljzFcFnpk988g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOqsLvK&md5=a4b85756d0d0d37b8cce2bd50a44f506</span></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=10.1039%2FC6SC02901A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02901A%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%2BJ.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DChen%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DX.%2BG.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DTargeting%2520cancer%2520cell%2520metabolism%2520with%2520mitochondria-immobilized%2520phosphorescent%2520cyclometalated%2520iridium%2528III%2529%2520complexes%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D631%26epage%3D640%26doi%3D10.1039%2FC6SC02901A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit44c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Oncosis-inducing cyclometalated iridium(III) complexes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5183</span>– <span class="NLM_lpage">5190</span>, <span class="refDoi"> DOI: 10.1039/C8SC01142G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8SC01142G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29997872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosl2lsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=5183-5190&issue=23&author=R.+Guanauthor=Y.+Chenauthor=L.+Zengauthor=T.+W.+Reesauthor=C.+Jinauthor=J.+Huangauthor=Z.+S.+Chenauthor=L.+Jiauthor=H.+Chao&title=Oncosis-inducing+cyclometalated+iridium%28III%29+complexes&doi=10.1039%2FC8SC01142G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44cR"><div class="casContent"><span class="casTitleNuber">44c</span><div class="casTitle"><span class="NLM_cas:atitle">Oncosis-inducing cyclometalated iridium(III) complexes</span></div><div class="casAuthors">Guan, Ruilin; Chen, Yu; Zeng, Leli; Rees, Thomas W.; Jin, Chengzhi; Huang, Juanjuan; Chen, Zhe-Sheng; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5183-5190</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Oncosis is a non-apoptotic form of programmed cell death (PCD), which differs from apoptosis in both morphol. changes and inner pathways, and might hold the key to defeating a major obstacle in cancer therapy - drug-resistance, which is often a result of the intrinsic apoptosis resistance of tumors.  However, despite the fact that the term "oncosis" was coined and used much earlier than apoptosis, little effort has been made to discover new drugs which can initiate this form of cell death, in comparison to drugs inducing apoptosis or any other type of PCD.  So herein, we present the synthesis of a series of mitochondria-targeting cyclometalated Ir(III) complexes, which activated the oncosis-specific protein porimin and calpain in cisplatin-resistant cell line A549R, and detd. their cytotoxicity against a wide range of drug-resistant cancer types.  To the best of our knowledge, these complexes are the very first metallo-components to induce oncosis in drug-resistant cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU0FFH72dklLVg90H21EOLACvtfcHk0ljzFcFnpk988g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosl2lsrs%253D&md5=66eb866af7d165a6887ac64bd2b894c9</span></div><a href="/servlet/linkout?suffix=cit44c&amp;dbid=16384&amp;doi=10.1039%2FC8SC01142G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC01142G%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DRees%26aufirst%3DT.%2BW.%26aulast%3DJin%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DOncosis-inducing%2520cyclometalated%2520iridium%2528III%2529%2520complexes%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D23%26spage%3D5183%26epage%3D5190%26doi%3D10.1039%2FC8SC01142G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millett, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Contrasting anticancer activity of half-sandwich iridium(III) complexes bearing functionally ddiverse 2-phenylpyridine ligands</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.5b00097</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.5b00097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1Wltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=2683-2694&issue=11&author=A.+J.+Millettauthor=A.+Habtemariamauthor=I.+Romero-Canelonauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Contrasting+anticancer+activity+of+half-sandwich+iridium%28III%29+complexes+bearing+functionally+ddiverse+2-phenylpyridine+ligands&doi=10.1021%2Facs.organomet.5b00097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands</span></div><div class="casAuthors">Millett, Adam J.; Habtemariam, Abraha; Romero-Canelon, Isolda; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2683-2694</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis, characterization, and antiproliferative activity of 15 iridium(III) half-sandwich complexes of the type [(η5-Cp*)Ir(2-(R'-phenyl)-R-pyridine)Cl] bearing either an electron-donating (-OH, -CH2OH, -CH3) or electron-withdrawing (-F, -CHO, -NO2) group at various positions on the 2-phenylpyridine (2-PhPy) chelating ligand giving rise to six sets of structural isomers.  The X-ray crystal structures of [(η5-Cp*)Ir(2-(2'-fluorophenyl)pyridine)Cl] (1) and [(η5-Cp*)Ir(2-(4'-fluorophenyl)pyridine)Cl] (2) exhibit the expected "piano-stool" configuration.  DFT calcns. showed that substituents caused only localized effects on the electrostatic potential surface of the chelating 2-PhPy ligand of the complexes.  Hydrolysis of all complexes is rapid, but readily reversed by addn. of NaCl.  The complexes show preferential binding to 9-ethylguanine over 9-methyladenine and are active catalysts for the oxidn. of NADH to NAD+.  Antiproliferative activity expts. in A2780 ovarian, MCF-7 breast, A549 lung, and HCT116 colon cancer cell lines showed IC50 values ranging from 1 to 89 μM, with the most potent complex, [(η5-Cp*)Ir(2-(2'-methylphenyl)pyridine)Cl] (13) (A2780 IC50 = 1.18 μM), being 10× more active than the parent, [(η5-Cp*)Ir(2-phenylpyridine)Cl], and 2× more active than [(η5-CpxPh)Ir(2-phenylpyridine)Cl].  Intriguingly, contrasting biol. activities are obsd. between structural isomers despite exhibiting similar chem. reactivity.  For pairs of structural isomers both the nature and position of the functional group can affect the hydrophobicity of the complex.  An increase in hydrophobicity resulted in enhanced cellular-iridium accumulation in A2780 ovarian cells, which generally gave rise to an increase in potency.  The structural isomers [(η5-Cp*)Ir(2-(4'-fluorophenyl)pyridine)Cl] (2) and [(η5-Cp*)Ir(2-phenyl-5-fluoropyridine)Cl] (4) preferentially localized in the cytosol > membrane and particulate > nucleus > cytoskeleton.  This work highlights the strong dependence of biol. behavior on the nature and position of the substituent on the chelating ligand and shows how this class of organometallic anticancer complexes can be fine-tuned to increase their potency without using extended cyclopentadienyl systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGNSGHEsAXLVg90H21EOLACvtfcHk0lh7jB4BLxZAGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1Wltbs%253D&md5=3257bbc7c2587b1338d3e960df64f4be</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.5b00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.5b00097%26sid%3Dliteratum%253Aachs%26aulast%3DMillett%26aufirst%3DA.%2BJ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DContrasting%2520anticancer%2520activity%2520of%2520half-sandwich%2520iridium%2528III%2529%2520complexes%2520bearing%2520functionally%2520ddiverse%25202-phenylpyridine%2520ligands%26jtitle%3DOrganometallics%26date%3D2015%26volume%3D34%26issue%3D11%26spage%3D2683%26epage%3D2694%26doi%3D10.1021%2Facs.organomet.5b00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vichai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirtikara, K.</span></span> <span> </span><span class="NLM_article-title">Sulforhodamine B colorimetric assay for cytotoxicity screening</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnprot.2006.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=17406391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1112-1116&issue=3&author=V.+Vichaiauthor=K.+Kirtikara&title=Sulforhodamine+B+colorimetric+assay+for+cytotoxicity+screening&doi=10.1038%2Fnprot.2006.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforhodamine B colorimetric assay for cytotoxicity screening</span></div><div class="casAuthors">Vichai, Vanicha; Kirtikara, Kanyawim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1112-1116</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The sulforhodamine B (SRB) assay is used for cell d. detn., based on the measurement of cellular protein content.  The method described here was optimized for the toxicity screening of compds. to adherent cells in a 96-well format.  After an incubation period, cell monolayers are fixed with 10% (wt/vol) trichloroacetic acid and stained for 30 min, after which the excess dye is removed by washing repeatedly with 1% (vol/vol) acetic acid.  The protein-bound dye is dissolved in 10 mM Tris base soln. for OD detn. at 510 nm using a microplate reader.  The results are linear over a 20-fold range of cell nos. and the sensitivity is comparable to those of fluorometric methods.  The method not only allows a large no. of samples to be tested within a few days, but also requires only simple equipment and inexpensive reagents.  The SRB assay is therefore an efficient and highly cost-effective method for screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGZ8pao808l7Vg90H21EOLACvtfcHk0lh7jB4BLxZAGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O&md5=7173035a1f9eb3f02dd7f1a947bca659</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.179%26sid%3Dliteratum%253Aachs%26aulast%3DVichai%26aufirst%3DV.%26aulast%3DKirtikara%26aufirst%3DK.%26atitle%3DSulforhodamine%2520B%2520colorimetric%2520assay%2520for%2520cytotoxicity%2520screening%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26issue%3D3%26spage%3D1112%26epage%3D1116%26doi%3D10.1038%2Fnprot.2006.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCollum, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, R. F.</span></span> <span> </span><span class="NLM_article-title">Determination of thioredoxin reductase activity in rat liver supernatant</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>253</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1006/abio.1997.2373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1006%2Fabio.1997.2373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=9356150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaK2sXnsVegt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1997&pages=123-125&issue=1&author=K.+E.+Hillauthor=G.+W.+McCollumauthor=R.+F.+Burk&title=Determination+of+thioredoxin+reductase+activity+in+rat+liver+supernatant&doi=10.1006%2Fabio.1997.2373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of thioredoxin reductase activity in rat liver supernatant</span></div><div class="casAuthors">Hill, Kristina E.; McCollum, Gary W.; Burk, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-125</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A simple assay based on the direct redn. of 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) by thioredoxin reductase has been used to qual. measure the enzyme activity during purifn.  However, it was not suitable for quant. detn. of thioredoxin reductase because it did not correct for DTNB redn. by other enzymes or endogenous thiols in tissue.  Here, the DTNB-based assay is modified to allow for correction of the non-specific DTNB redn.  Thioredoxin reductase, like most other selenoenzymes, is sensitive to inhibition by gold.  Thus, measurement of the enzyme activity in the absence and presence of gold thioglucose allows correction for non-thioredoxin reductase-dependent DTNB redn.  Thioredoxin reductase levels were detd. in liver supernatant of control and selenium-deficient rats.  Selenium deficiency caused a decrease in liver thioredoxin reductase activity to 10% of that in control liver, a result that is comparable to that obtained by the insulin-based assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqYiYZFe9mbVg90H21EOLACvtfcHk0lh7jB4BLxZAGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsVegt74%253D&md5=748b9ea85d71a331ac70296f9967f7d1</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1006%2Fabio.1997.2373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1997.2373%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DK.%2BE.%26aulast%3DMcCollum%26aufirst%3DG.%2BW.%26aulast%3DBurk%26aufirst%3DR.%2BF.%26atitle%3DDetermination%2520of%2520thioredoxin%2520reductase%2520activity%2520in%2520rat%2520liver%2520supernatant%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D253%26issue%3D1%26spage%3D123%26epage%3D125%26doi%3D10.1006%2Fabio.1997.2373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span>; <span class="NLM_string-name">Bjornstedt, M.</span></span>, <span> </span><span class="NLM_article-title">Thioredoxin and Thioredoxin Reductase</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_year">1995</span>; Vol.  <span class="NLM_volume">252</span>, pp  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=199-208&author=A.+Holmgren&author=M.+Bjornstedt&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520and%2520Thioredoxin%2520Reductase%26btitle%3DMethods%2520in%2520Enzymology%26pub%3DAcademic%2520Press%26date%3D1995%26volume%3D252%26spage%3D199%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingaiah, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K. P.</span></span> <span> </span><span class="NLM_article-title">Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e87371</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0087371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1371%2Fjournal.pone.0087371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24489904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVWlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&issue=1&author=P.+K.+Mahalingaiahauthor=K.+P.+Singh&title=Chronic+oxidative+stress+increases+growth+and+tumorigenic+potential+of+MCF-7+breast+cancer+cells&doi=10.1371%2Fjournal.pone.0087371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells</span></div><div class="casAuthors">Mahalingaiah, Prathap Kumar S.; Singh, Kamaleshwar P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e87371/1-e87371/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that exposures to elevated levels of either endogenous estrogen or environmental estrogenic chems. are assocd. with breast cancer development and progression.  These natural or synthetic estrogens are known to produce reactive oxygen species (ROS) and increased ROS has been implicated in both cellular apoptosis and carcinogenesis.  Though there are several studies on direct involvement of ROS in cellular apoptosis using short-term exposure model, there is no exptl. evidence to directly implicate chronic exposure to ROS in increased growth and tumorigenicity of breast cancer cells.  Therefore, the objective of this study was to evaluate the effects of chronic oxidative stress on growth, survival and tumorigenic potential of MCF-7 breast cancer cells.  MCF-7 cells were exposed to exogenous hydrogen peroxide (H2O2) as a source of ROS at doses of 25 μM and 250 μM for acute (24 h) and chronic period (3 mo) and their effects on cell growth/survival and tumorigenic potential were evaluated.  The results of cell count, MTT and cell cycle anal. showed that while acute exposure inhibits the growth of MCF-7 cells in a dose-dependent manner, the chronic exposure to H2O2-induced ROS leads to increased cell growth and survival of MCF-7 cells.  This was further confirmed by gene expression anal. of cell cycle and cell survival related genes.  Significant increase in no. of soft agar colonies, up-regulation of pro-metastatic genes VEGF, WNT1 and CD44, whereas down-regulation of anti-metastatic gene E-Cadherin in H2O2 treated MCF-7 cells obsd. in this study further suggests that persistent exposure to oxidative stress increases tumorigenic and metastatic potential of MCF-7 cells.  Since many chemotherapeutic drugs are known to induce their cytotoxicity by increasing ROS levels, the results of this study are also highly significant in understanding the mechanism for adaptation to ROS-induced toxicity leading to acquired chemotherapeutic resistance in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIR1-W7BT1r7Vg90H21EOLACvtfcHk0lh_2pxXV88Mig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVWlurk%253D&md5=20555f0961c5290619ec209306705187</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0087371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0087371%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingaiah%26aufirst%3DP.%2BK.%26aulast%3DSingh%26aufirst%3DK.%2BP.%26atitle%3DChronic%2520oxidative%2520stress%2520increases%2520growth%2520and%2520tumorigenic%2520potential%2520of%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26issue%3D1%26doi%3D10.1371%2Fjournal.pone.0087371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LeBel, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ischiropoulos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondy, S. C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1021/tx00026a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx00026a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaK38XhsVGmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1992&pages=227-231&issue=2&author=C.+P.+LeBelauthor=H.+Ischiropoulosauthor=S.+C.+Bondy&title=Evaluation+of+the+probe+2%E2%80%B2%2C7%E2%80%B2-dichlorofluorescin+as+an+indicator+of+reactive+oxygen+species+formation+and+oxidative+stress&doi=10.1021%2Ftx00026a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48bR"><div class="casContent"><span class="casTitleNuber">48b</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress</span></div><div class="casAuthors">LeBel, Carl P.; Ischiropoulos, Harry; Bondy, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-31</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    </div><div class="casAbstract">The use of dichlorofluorescin (DCFH) as a measure of reactive oxygen species was studied in aq. media.  Hydrogen peroxide oxidized DCFH to fluorescent dichlorofluorescein (DCF), and the oxidn. was amplified by the addn. of ferrous iron.  Hydrogen peroxide-induced DCF formation in the presence of ferrous iron was completely inhibited by deferoxamine and partially inhibited by EDTA, but was augmented by diethylenetriaminepentaacetic acid.  Iron peroxide-induced oxidn. of DCFH was partially inhibited by catalase but not by horseradish peroxidase.  Nonchelated iron peroxide oxidn. of DCFH was partially inhibited by several hydroxyl radical scavengers, but independent of the scavenger concn., and this suggests that free hydroxyl radical is not involved in the oxidn. of DCFH in this system.  Superoxide anion did not directly oxidize DCFH.  Data suggest that H2O2-Fe2+-derived oxidant is mainly responsible for the nonenzymic oxidn. of DCFH.  In addn., peroxidase alone and oxidants formed during the redn. of H2O2 by peroxidase oxidize DCFH.  Since DCFH oxidn. may be derived from several reactive intermediates, interpretation of specific reactive oxygen species involved in biol. systems should be approached with caution.  However, DCFH remains an attractive probe as an overall index of oxidative stress in toxicol. phenomena.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UcTWO9uvprVg90H21EOLACvtfcHk0lh_2pxXV88Mig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVGmtr8%253D&md5=6a1b478d7cde37d20e8ff349f6f8f186</span></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1021%2Ftx00026a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx00026a012%26sid%3Dliteratum%253Aachs%26aulast%3DLeBel%26aufirst%3DC.%2BP.%26aulast%3DIschiropoulos%26aufirst%3DH.%26aulast%3DBondy%26aufirst%3DS.%2BC.%26atitle%3DEvaluation%2520of%2520the%2520probe%25202%25E2%2580%25B2%252C7%25E2%2580%25B2-dichlorofluorescin%2520as%2520an%2520indicator%2520of%2520reactive%2520oxygen%2520species%2520formation%2520and%2520oxidative%2520stress%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1992%26volume%3D5%26issue%3D2%26spage%3D227%26epage%3D231%26doi%3D10.1021%2Ftx00026a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b','cit6c','cit6d'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c','cit22d','cit22e'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b','cit35c','cit35d','cit35e'],'ref36':['cit36a','cit36b','cit36c'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43a','cit43b','cit43c'],'ref44':['cit44a','cit44b','cit44c'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47a','cit47b'],'ref48':['cit48a','cit48b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ana C. Carrasco, Vanessa Rodríguez-Fanjul, <span class="NLM_string-name hlFld-ContribAuthor">Ana M. Pizarro</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of the Ir–N(pyridine) Bond in Half-Sandwich Tethered Iridium(III) Complexes. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (22)
                                     , 16454-16466. <a href="https://doi.org/10.1021/acs.inorgchem.0c02287" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.0c02287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.0c02287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.0c02287%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DActivation%252Bof%252Bthe%252BIr%2525E2%252580%252593N%252528pyridine%252529%252BBond%252Bin%252BHalf-Sandwich%252BTethered%252BIridium%252528III%252529%252BComplexes%26aulast%3DCarrasco%26aufirst%3DAna%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31072020%26date%3D26102020%26volume%3D59%26issue%3D22%26spage%3D16454%26epage%3D16466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Hao</span>, <span class="hlFld-ContribAuthor ">Huiwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Tian</span>, <span class="hlFld-ContribAuthor ">Linlin  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yunjun  Liu</span>, <span class="hlFld-ContribAuthor ">Degang  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>221 </em>, 111465. <a href="https://doi.org/10.1016/j.jinorgbio.2021.111465" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2021.111465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2021.111465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2021.111465%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DEvaluation%252Bof%252Banticancer%252Beffects%252Bin%252Bvitro%252Bof%252Bnew%252Biridium%252528III%252529%252Bcomplexes%252Btargeting%252Bthe%252Bmitochondria%26aulast%3DHao%26aufirst%3DJing%26date%3D2021%26volume%3D221%26spage%3D111465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Infante-Tadeo</span>, <span class="hlFld-ContribAuthor ">Vanessa  Rodríguez-Fanjul</span>, <span class="hlFld-ContribAuthor ">Abraha  Habtemariam</span>, <span class="hlFld-ContribAuthor ">Ana M.  Pizarro</span>. </span><span class="cited-content_cbyCitation_article-title">Osmium(
              ii
              ) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (27)
                                     , 9287-9297. <a href="https://doi.org/10.1039/D1SC01939B" title="DOI URL">https://doi.org/10.1039/D1SC01939B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC01939B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC01939B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DOsmium%252528%252Bii%252B%252529%252Btethered%252Bhalf-sandwich%252Bcomplexes%25253A%252BpH-dependent%252Baqueous%252Bspeciation%252Band%252Btransfer%252Bhydrogenation%252Bin%252Bcells%26aulast%3DInfante-Tadeo%26aufirst%3DSonia%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D27%26spage%3D9287%26epage%3D9297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nararak  Leesakul</span>, <span class="hlFld-ContribAuthor ">Keerati  Kullawanichaiyanan</span>, <span class="hlFld-ContribAuthor ">Sanja  Mutić</span>, <span class="hlFld-ContribAuthor ">Valéria  Guzsvány</span>, <span class="hlFld-ContribAuthor ">Tidarat  Nhukeaw</span>, <span class="hlFld-ContribAuthor ">Adisorn  Ratanaphan</span>, <span class="hlFld-ContribAuthor ">Saowanit  Saithong</span>, <span class="hlFld-ContribAuthor ">Takumi  Konno</span>, <span class="hlFld-ContribAuthor ">Uraiwan  Sirimahachai</span>, <span class="hlFld-ContribAuthor ">Vinich  Promarak</span>. </span><span class="cited-content_cbyCitation_article-title">A photoactive iridium(III) complex with 3-methyl-2-phenyl pyridine and 1,1-bis(diphenylphosphino)methane: Synthesis, structural characterization and cytotoxicity in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Coordination Chemistry</span><span> <strong>2021,</strong> <em>157 </em>, 1-15. <a href="https://doi.org/10.1080/00958972.2021.1949585" title="DOI URL">https://doi.org/10.1080/00958972.2021.1949585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00958972.2021.1949585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00958972.2021.1949585%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Coordination%2520Chemistry%26atitle%3DA%252Bphotoactive%252Biridium%252528III%252529%252Bcomplex%252Bwith%252B3-methyl-2-phenyl%252Bpyridine%252Band%252B1%25252C1-bis%252528diphenylphosphino%252529methane%25253A%252BSynthesis%25252C%252Bstructural%252Bcharacterization%252Band%252Bcytotoxicity%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DLeesakul%26aufirst%3DNararak%26date%3D2021%26date%3D2021%26volume%3D157%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  De Palo</span>, <span class="hlFld-ContribAuthor ">Dijana  Draca</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Murrali</span>, <span class="hlFld-ContribAuthor ">Stefano  Zacchini</span>, <span class="hlFld-ContribAuthor ">Guido  Pampaloni</span>, <span class="hlFld-ContribAuthor ">Sanja  Mijatovic</span>, <span class="hlFld-ContribAuthor ">Danijela  Maksimovic-Ivanic</span>, <span class="hlFld-ContribAuthor ">Fabio  Marchetti</span>. </span><span class="cited-content_cbyCitation_article-title">A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η5-C5Me4R} Complexes with Variable R Groups. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (14)
                                     , 7422. <a href="https://doi.org/10.3390/ijms22147422" title="DOI URL">https://doi.org/10.3390/ijms22147422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22147422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22147422%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DA%252BComparative%252BAnalysis%252Bof%252Bthe%252BIn%252BVitro%252BAnticancer%252BActivity%252Bof%252BIridium%252528III%252529%252B%25257B%2525CE%2525B75-C5Me4R%25257D%252BComplexes%252Bwith%252BVariable%252BR%252BGroups%26aulast%3DDe%2BPalo%26aufirst%3DAlice%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D14%26spage%3D7422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cigdem  Sahin</span>, <span class="hlFld-ContribAuthor ">Dogukan  Mutlu</span>, <span class="hlFld-ContribAuthor ">Farid  Nasirli</span>, <span class="hlFld-ContribAuthor ">Ghodrat  Mahmoudi</span>, <span class="hlFld-ContribAuthor ">Fedor I.  Zubkov</span>, <span class="hlFld-ContribAuthor ">Sevki  Arslan</span>, <span class="hlFld-ContribAuthor ">Nazime Mercan  Dogan</span>. </span><span class="cited-content_cbyCitation_article-title">New iridium bis‐terpyridine complexes: synthesis, characterization, antibiofilm and anticancer potentials. </span><span class="cited-content_cbyCitation_journal-name">BioMetals</span><span> <strong>2021,</strong> <em>34 </em>
                                    (3)
                                     , 701-713. <a href="https://doi.org/10.1007/s10534-021-00307-y" title="DOI URL">https://doi.org/10.1007/s10534-021-00307-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10534-021-00307-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10534-021-00307-y%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMetals%26atitle%3DNew%252Biridium%252Bbis%2525E2%252580%252590terpyridine%252Bcomplexes%25253A%252Bsynthesis%25252C%252Bcharacterization%25252C%252Bantibiofilm%252Band%252Banticancer%252Bpotentials%26aulast%3DSahin%26aufirst%3DCigdem%26date%3D2021%26date%3D2021%26volume%3D34%26issue%3D3%26spage%3D701%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabelle Marie  Daubit</span>, <span class="hlFld-ContribAuthor ">Svenja  Wortmann</span>, <span class="hlFld-ContribAuthor ">Daniel  Siegmund</span>, <span class="hlFld-ContribAuthor ">Stephan  Hahn</span>, <span class="hlFld-ContribAuthor ">Patrick  Nuernberger</span>, <span class="hlFld-ContribAuthor ">Nils  Metzler‐Nolte</span>. </span><span class="cited-content_cbyCitation_article-title">Unveiling Luminescent Ir
              I
              and Rh
              I
              N‐Heterocyclic Carbene Complexes: Structure, Photophysical Specifics, and Cellular Localization in the Endoplasmic Reticulum. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (22)
                                     , 6783-6794. <a href="https://doi.org/10.1002/chem.202100375" title="DOI URL">https://doi.org/10.1002/chem.202100375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100375%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DUnveiling%252BLuminescent%252BIr%252BI%252Band%252BRh%252BI%252BN%2525E2%252580%252590Heterocyclic%252BCarbene%252BComplexes%25253A%252BStructure%25252C%252BPhotophysical%252BSpecifics%25252C%252Band%252BCellular%252BLocalization%252Bin%252Bthe%252BEndoplasmic%252BReticulum%26aulast%3DDaubit%26aufirst%3DIsabelle%2BMarie%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D22%26spage%3D6783%26epage%3D6794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin F.  Hohlfeld</span>, <span class="hlFld-ContribAuthor ">Burkhard  Gitter</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Kingsbury</span>, <span class="hlFld-ContribAuthor ">Keith J.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Dorika  Steen</span>, <span class="hlFld-ContribAuthor ">Gerhard D.  Wieland</span>, <span class="hlFld-ContribAuthor ">Nora  Kulak</span>, <span class="hlFld-ContribAuthor ">Mathias O.  Senge</span>, <span class="hlFld-ContribAuthor ">Arno  Wiehe</span>. </span><span class="cited-content_cbyCitation_article-title">Dipyrrinato‐Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (21)
                                     , 6440-6459. <a href="https://doi.org/10.1002/chem.202004776" title="DOI URL">https://doi.org/10.1002/chem.202004776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202004776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202004776%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDipyrrinato%2525E2%252580%252590Iridium%252528III%252529%252BComplexes%252Bfor%252BApplication%252Bin%252BPhotodynamic%252BTherapy%252Band%252BAntimicrobial%252BPhotodynamic%252BInactivation%26aulast%3DHohlfeld%26aufirst%3DBenjamin%2BF.%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D21%26spage%3D6440%26epage%3D6459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cigdem  Sahin</span>, <span class="hlFld-ContribAuthor ">Murat  Sahin</span>. </span><span class="cited-content_cbyCitation_article-title">New iridium complexes(III) bearing 2-phenylimidazo[4,5-f][1,10]-phenanthroline ligand: Synthesis, characterization, electrochemical and photoluminescence studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1226 </em>, 129415. <a href="https://doi.org/10.1016/j.molstruc.2020.129415" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129415%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DNew%252Biridium%252Bcomplexes%252528III%252529%252Bbearing%252B2-phenylimidazo%25255B4%25252C5-f%25255D%25255B1%25252C10%25255D-phenanthroline%252Bligand%25253A%252BSynthesis%25252C%252Bcharacterization%25252C%252Belectrochemical%252Band%252Bphotoluminescence%252Bstudies%26aulast%3DSahin%26aufirst%3DCigdem%26date%3D2021%26volume%3D1226%26spage%3D129415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth J.  Anthony</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Bolitho</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Bridgewater</span>, <span class="hlFld-ContribAuthor ">Oliver W. L.  Carter</span>, <span class="hlFld-ContribAuthor ">Jane M.  Donnelly</span>, <span class="hlFld-ContribAuthor ">Cinzia  Imberti</span>, <span class="hlFld-ContribAuthor ">Edward C.  Lant</span>, <span class="hlFld-ContribAuthor ">Frederik  Lermyte</span>, <span class="hlFld-ContribAuthor ">Russell J.  Needham</span>, <span class="hlFld-ContribAuthor ">Marta  Palau</span>, <span class="hlFld-ContribAuthor ">Peter J.  Sadler</span>, <span class="hlFld-ContribAuthor ">Huayun  Shi</span>, <span class="hlFld-ContribAuthor ">Fang-Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Zijin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Metallodrugs are unique: opportunities and challenges of discovery and development. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (48)
                                     , 12888-12917. <a href="https://doi.org/10.1039/D0SC04082G" title="DOI URL">https://doi.org/10.1039/D0SC04082G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC04082G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC04082G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DMetallodrugs%252Bare%252Bunique%25253A%252Bopportunities%252Band%252Bchallenges%252Bof%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DAnthony%26aufirst%3DElizabeth%2BJ.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D48%26spage%3D12888%26epage%3D12917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin  Ramos</span>, <span class="hlFld-ContribAuthor ">Jérémy M.  Zimbron</span>, <span class="hlFld-ContribAuthor ">Serge  Thorimbert</span>, <span class="hlFld-ContribAuthor ">Lise-Marie  Chamoreau</span>, <span class="hlFld-ContribAuthor ">Annie  Munier</span>, <span class="hlFld-ContribAuthor ">Candice  Botuha</span>, <span class="hlFld-ContribAuthor ">Anthi  Karaiskou</span>, <span class="hlFld-ContribAuthor ">Michèle  Salmain</span>, <span class="hlFld-ContribAuthor ">Joëlle  Sobczak-Thépot</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the antiproliferative mechanism of (C^N)-chelated half-sandwich iridium complexes. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (48)
                                     , 17635-17641. <a href="https://doi.org/10.1039/D0DT03414B" title="DOI URL">https://doi.org/10.1039/D0DT03414B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT03414B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT03414B%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DInsights%252Binto%252Bthe%252Bantiproliferative%252Bmechanism%252Bof%252B%252528C%25255EN%252529-chelated%252Bhalf-sandwich%252Biridium%252Bcomplexes%26aulast%3DRamos%26aufirst%3DRobin%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D48%26spage%3D17635%26epage%3D17641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Zu-Zhuang  Wei</span>, <span class="hlFld-ContribAuthor ">Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Xian-Xian  Liu</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structures, and anticancer potentials of four platinum (II) complexes with benzopyran derivatives targeting mitochondria. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Communications</span><span> <strong>2020,</strong> <em>122 </em>, 108267. <a href="https://doi.org/10.1016/j.inoche.2020.108267" title="DOI URL">https://doi.org/10.1016/j.inoche.2020.108267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.inoche.2020.108267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.inoche.2020.108267%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Communications%26atitle%3DSynthesis%25252C%252Bstructures%25252C%252Band%252Banticancer%252Bpotentials%252Bof%252Bfour%252Bplatinum%252B%252528II%252529%252Bcomplexes%252Bwith%252Bbenzopyran%252Bderivatives%252Btargeting%252Bmitochondria%26aulast%3DLiu%26aufirst%3DJun-Hong%26date%3D2020%26volume%3D122%26spage%3D108267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tai-Ming  Shao</span>, <span class="hlFld-ContribAuthor ">Zu-Zhuang  Wei</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Luo</span>, <span class="hlFld-ContribAuthor ">Qi-Pin  Qin</span>, <span class="hlFld-ContribAuthor ">Ming-Xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Jia-Jing  Zeng</span>, <span class="hlFld-ContribAuthor ">Chun-Jie  Liang</span>, <span class="hlFld-ContribAuthor ">Hong  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">High cytotoxic and apoptotic effects of platinum(
              ii
              ) complexes bearing the 4-acridinol ligand. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (45)
                                     , 19885-19890. <a href="https://doi.org/10.1039/D0NJ04753H" title="DOI URL">https://doi.org/10.1039/D0NJ04753H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ04753H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ04753H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DHigh%252Bcytotoxic%252Band%252Bapoptotic%252Beffects%252Bof%252Bplatinum%252528%252Bii%252B%252529%252Bcomplexes%252Bbearing%252Bthe%252B4-acridinol%252Bligand%26aulast%3DShao%26aufirst%3DTai-Ming%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D45%26spage%3D19885%26epage%3D19890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Iridium(III) Cyclopentadienyl Complexes Synthesized in This Work<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Complexes <b>1</b>–<b>6</b>, <b>1b</b>, <b>1d</b>, and <b>2b</b> are monocations and were isolated as hexafluorofosphate salts. Complexes <b>1a</b>, <b>1c</b>, <b>2a</b>, and <b>2c</b>, are neutral. Z is the monodentate labile ligand in nontethered complexes of formula [Ir(η<sup>5</sup>-C<sub>5</sub>Me<sub>4</sub>R)(C,N)(Z)]<sup>0/+</sup>.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of complexes: [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Phpy)]PF<sub>6</sub> (<b>1</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(Bzq)]PF<sub>6</sub> (<b>2</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(MePhpy)]PF<sub>6</sub> (<b>4</b>), [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(ClPhq)]PF<sub>6</sub> (<b>5</b>), and [Ir(η<sup>5</sup>:κ<sup>1</sup>-C<sub>5</sub>Me<sub>4</sub>CH<sub>2</sub>py)(dFPhpy)]PF<sub>6</sub> (<b>6</b>). Thermal ellipsoids show 50% probability. Hydrogen atoms and counterions (PF<sub>6</sub>) have been omitted for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the parameters that relate to the tether ring constraint by X-ray structure analysis in closed-tether complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b> (left), versus their nontether Ir(III) half-sandwich analogues (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cytotoxicity/antiproliferative activity of Ir(III) compounds in MCF7 breast cancer cells. Cells were treated with different concentrations of each iridium complex for 24 h and allowed to recover for 72 h. CDDP was used as positive control (IC<sub>50</sub> = 9.7 ± 1.9 μM). Experiments were performed in triplicate, and data are displayed as an average of at least two independent experiments. All values were compared to the untreated controls and to one another for statistical significance calculations: <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. ROS induction by Ir(III) complexes in MCF7 cells. Cells were incubated for 90 min with Ir(III) compounds <b>1</b>, <b>1a</b>, <b>1b</b>, <b>1c</b>, <b>1d</b> (A), <b>2</b>, <b>2a</b>, <b>2b</b>, <b>2c</b> (B), and <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, and <b>6</b> (C). Concentrations are expressed in micromolar units (μM). ROS levels were measured by fluorescence spectroscopy after DCFH-DA treatment. The results are expressed as the fold increase of cell fluorescence compared to control. Data are representative of three independent experiments. All values were compared to the untreated controls and to one another for statistical significance calculations; <i>p</i> < 0.001 for ***.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/medium/jm9b02000_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of Ir(III) complexes on loss of mitochondrial membrane potential (ΔΨ<sub><i>m</i></sub>) in MCF7 cells. Ratio of fluorescence in F4/F2 of a flow cytometry dot plot for MCF7 cells treated with iridium complexes for 24 h compared to negative (untreated) and positive (100 μM carbonyl cyanide 3-chlorophenylhydrazone (CCCP)) control cells. Data are representative of three independent experiments and values are expressed in mean ± SD. All values were compared to the untreated controls and to one another for statistical significance calculations; <i>p</i> < 0.001 for ***.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02000/20200416/images/large/jm9b02000_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02000&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i55">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzler-Nolte, N.</span></span> <span> </span><span class="NLM_article-title">Organometallic anticancer compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1021/jm100020w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100020w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVeksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3-25&issue=1&author=G.+Gasserauthor=I.+Ottauthor=N.+Metzler-Nolte&title=Organometallic+anticancer+compounds&doi=10.1021%2Fjm100020w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic anticancer compounds</span></div><div class="casAuthors">Gasser, Gilles; Ott, Ingo; Metzler-Nolte, Nils</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The quest for alternative drugs to the well-known cisplatin and its derivs., which are still used in more than 50% of the treatment regimes for patients suffering from cancer, is highly needed.  In this context, organometallic compds., which are defined as metal complexes contg. at least one direct, covalent metal-carbon bond, have recently been found to be promising anticancer drug candidates.  Organometallics have a great structural variety (ranging from linear to octahedral and even beyond), have far more diverse stereochem. than org. compds. (for an octahedral complex with six different ligands, 30 stereoisomers exist!), and by rational ligand design, provide control over key kinetic properties (such as hydrolysis rate of ligands).  Furthermore, they are kinetically stable, usually uncharged, and relatively lipophilic and their metal atom is in a low oxidn. state.  Because of these fundamental differences compared to "classical coordination metal complexes", organometallics offer ample opportunities in the design of novel classes of medicinal compds., potentially with new metal-specific modes of action.  Interestingly, all the typical classes of organometallics such as metallocenes, half-sandwich, carbene-, CO-, or -ligands, which have been widely used for catalysis or biosensing purposes, have now also found application in medicinal chem..  In this Perspective, we report on the recent advances in the discovery of organometallics with proven antiproliferative activity.  We are emphasizing those compds. where efforts have been made to identify their mol. target and mode of action by biochem. or cell biol. studies.  This Perspective covers more classes of compds. and in more detail than a recent tutorial review by Hartinger and Dyson.  Furthermore, whereas recent reviews and book contributions attest to the rapid development of bioorganometallic chem. in general, this Perspective focuses on their potential application as anticancer chemotherapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51OmjvSXWo7Vg90H21EOLACvtfcHk0lguIg4tMTIqdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVeksb3N&md5=2a95cf3540aed5e66aa655bb38ef4ff8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm100020w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100020w%26sid%3Dliteratum%253Aachs%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DOtt%26aufirst%3DI.%26aulast%3DMetzler-Nolte%26aufirst%3DN.%26atitle%3DOrganometallic%2520anticancer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D3%26epage%3D25%26doi%3D10.1021%2Fjm100020w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Caporale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massi, M.</span></span> <span> </span><span class="NLM_article-title">Cyclometallated iridium(III) complexes for life science</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2018.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ccr.2018.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslGjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2018&pages=71-91&author=C.+Caporaleauthor=M.+Massi&title=Cyclometallated+iridium%28III%29+complexes+for+life+science&doi=10.1016%2Fj.ccr.2018.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated iridium(III) complexes for life science</span></div><div class="casAuthors">Caporale, Chiara; Massi, Massimiliano</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">71-91</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photoluminescent cyclometalated iridium(III) complexes are now a well established class of organometallic compds. with advantageous potential applications in biol. and life science.  While these complexes, along with other luminescent transition metals and lanthanoid complexes, were initially proposed as alternative markers to org. fluorophores in the staining of cells, it is now evident that their specific biol. behavior makes this class of compds. useful in broader areas of life science such as imaging, sensing and therapy.  The crit. factors for the effective design of cyclometalated iridium(III) complexes with specific biol. properties are still rather difficult to rationalize, and often mainly rely of aspects such as the intrinsic charge of the complex, its lipophilicity and its aq. soly.  This review overviews the area of cyclometalated iridium(III) complexes in biol., with an emphasis on comparing the various conditions that these compds. have been assessed for their biol. potential, such as the specific tested cells lines, concn. of internalization, incubation time, and mechanism of cellular entrance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK_6EFQtoARLVg90H21EOLACvtfcHk0lg5yAr97Xkzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslGjsrk%253D&md5=bcdc5fc7074ced9f63ec4752a50418af</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2018.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2018.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DCaporale%26aufirst%3DC.%26aulast%3DMassi%26aufirst%3DM.%26atitle%3DCyclometallated%2520iridium%2528III%2529%2520complexes%2520for%2520life%2520science%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2018%26volume%3D363%26spage%3D71%26epage%3D91%26doi%3D10.1016%2Fj.ccr.2018.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qamar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hands-Portman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organometallic iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1335</span>– <span class="NLM_lpage">1343</span>, <span class="refDoi"> DOI: 10.1021/cb400070a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400070a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1335-1343&issue=6&author=J.+M.+Hearnauthor=I.+Romero-Canelonauthor=B.+Qamarauthor=Z.+Liuauthor=I.+Hands-Portmanauthor=P.+J.+Sadler&title=Organometallic+iridium%28III%29+anticancer+complexes+with+new+mechanisms+of+action%3A+NCI-60+screening%2C+mitochondrial+targeting%2C+and+apoptosis&doi=10.1021%2Fcb400070a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis</span></div><div class="casAuthors">Hearn, Jessica M.; Romero-Canelon, Isolda; Qamar, Bushra; Liu, Zhe; Hands-Portman, Ian; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1335-1343</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Platinum complexes related to cisplatin, cis-[PtCl2(NH3)2], are successful anticancer drugs; however, other transition metal complexes offer potential for combating cisplatin resistance, decreasing side effects, and widening the spectrum of activity.  Organometallic half-sandwich iridium (IrIII) complexes [Ir(Cpx)(XY)Cl]+/0 (Cpx = biphenyltetramethylcyclopentadienyl and XY = phenanthroline , bipyridine , or phenylpyridine ) all hydrolyze rapidly, forming monofunctional G adducts on DNA with addnl. intercalation of the Ph substituents on the Cpx ring.  In comparison, highly potent [Ir(η5-Cpxph)(NMe2-azpy)Cl]PF6 (complex 4, Cpx = phenyltetramethylcyclopentadienyl and XY = N,N-dimethylphenylazopyridine) does not hydrolyze.  All show higher potency toward A2780 human ovarian cancer cells compared to cisplatin, with [Ir(η5-Cp xbiph)(phen)Cl]PF6 (complex 1), [Ir(η5-Cpxbiph)(ppy)Cl] (complex 3), and complex 4 also demonstrating higher potency in the National Cancer Institute (NCI) NCI-60 cell-line screen.  Use of the NCI COMPARE algorithm (which predicts mechanisms of action (MoAs) for emerging anticancer compds. by correlating NCI-60 patterns of sensitivity) shows that the MoA of these IrIII complexes has no correlation to cisplatin (or oxaliplatin), with complex 3 and complex 4 emerging as particularly novel compds.  Those findings by COMPARE were exptl. probed by TEM of A2780 cells exposed to complex 1, showing mitochondrial swelling and activation of apoptosis after 24 h.  Significant changes in mitochondrial membrane polarization were detected by flow cytometry, and the potency of the complexes was enhanced ∼5× by co-administration with a low concn. (5 μM) of the γ-glutamyl cysteine synthetase inhibitor L-buthionine sulfoximine (L-BSO).  These studies reveal potential polypharmacol. of organometallic IrIII complexes, with MoA and cell selectivity governed by structural changes in the chelating ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdNXSST9mEbbVg90H21EOLACvtfcHk0lg5yAr97Xkzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVCnt70%253D&md5=a5b824f70514e503cb25b07dfcefab74</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1021%2Fcb400070a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400070a%26sid%3Dliteratum%253Aachs%26aulast%3DHearn%26aufirst%3DJ.%2BM.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DQamar%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHands-Portman%26aufirst%3DI.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganometallic%2520iridium%2528III%2529%2520anticancer%2520complexes%2520with%2520new%2520mechanisms%2520of%2520action%253A%2520NCI-60%2520screening%252C%2520mitochondrial%2520targeting%252C%2520and%2520apoptosis%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D1335%26epage%3D1343%26doi%3D10.1021%2Fcb400070a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rovira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hally, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galindo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandioso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svitelova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresoli-Obach, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchan, V.</span></span> <span> </span><span class="NLM_article-title">Towards novel photodynamic anticancer agents generating superoxide anion radicals: a cyclometalated Ir(III) complex conjugated to a far-red emitting coumarin</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6311</span>– <span class="NLM_lpage">6315</span>, <span class="refDoi"> DOI: 10.1002/anie.201901268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fanie.201901268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvVCjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=6311-6315&issue=19&author=V.+Novohradskyauthor=A.+Roviraauthor=C.+Hallyauthor=A.+Galindoauthor=G.+Viguerasauthor=A.+Gandiosoauthor=M.+Svitelovaauthor=R.+Bresoli-Obachauthor=H.+Kostrhunovaauthor=L.+Markovaauthor=J.+Kasparkovaauthor=S.+Nonellauthor=J.+Ruizauthor=V.+Brabecauthor=V.+Marchan&title=Towards+novel+photodynamic+anticancer+agents+generating+superoxide+anion+radicals%3A+a+cyclometalated+Ir%28III%29+complex+conjugated+to+a+far-red+emitting+coumarin&doi=10.1002%2Fanie.201901268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated IrIII Complex Conjugated to a Far-Red Emitting Coumarin</span></div><div class="casAuthors">Novohradsky, Vojtech; Rovira, Anna; Hally, Cormac; Galindo, Alex; Vigueras, Gloria; Gandioso, Albert; Svitelova, Marie; Bresoli-Obach, Roger; Kostrhunova, Hana; Markova, Lenka; Kasparkova, Jana; Nonell, Santi; Ruiz, Jose; Brabec, Viktor; Marchan, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6311-6315</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Although cyclometalated IrIII complexes have emerged as promising photosensitizers for photodynamic therapy, some key drawbacks still hamper clin. translation, such as operability in the phototherapeutic window and reactive oxygen species (ROS) prodn. efficiency and selectivity.  In this work, a cyclometalated IrIII complex conjugated to a far-red-emitting coumarin, IrIII-COUPY, is reported with highly favorable properties for cancer phototherapy.  IrIII-COUPY was efficiently taken up by HeLa cells and showed no dark cytotoxicity and impressive photocytotoxicity indexes after irradn. with green and blue light, even under hypoxia.  Importantly, a clear correlation between cell death and intracellular generation of superoxide anion radicals after visible light irradn. was demonstrated.  This strategy opens the door to novel fluorescent photodynamic therapy agents with promising applications in theragnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9slQpnjEet7Vg90H21EOLACvtfcHk0lg5yAr97Xkzdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvVCjs7c%253D&md5=83a14a65fc4640b504a3ee147449e887</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201901268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201901268%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DRovira%26aufirst%3DA.%26aulast%3DHally%26aufirst%3DC.%26aulast%3DGalindo%26aufirst%3DA.%26aulast%3DVigueras%26aufirst%3DG.%26aulast%3DGandioso%26aufirst%3DA.%26aulast%3DSvitelova%26aufirst%3DM.%26aulast%3DBresoli-Obach%26aufirst%3DR.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DMarkova%26aufirst%3DL.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DNonell%26aufirst%3DS.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DMarchan%26aufirst%3DV.%26atitle%3DTowards%2520novel%2520photodynamic%2520anticancer%2520agents%2520generating%2520superoxide%2520anion%2520radicals%253A%2520a%2520cyclometalated%2520Ir%2528III%2529%2520complex%2520conjugated%2520to%2520a%2520far-red%2520emitting%2520coumarin%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26issue%3D19%26spage%3D6311%26epage%3D6315%26doi%3D10.1002%2Fanie.201901268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2018.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ccr.2018.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&pages=34-76&author=A.+Zamoraauthor=G.+Viguerasauthor=V.+Rodr%C3%ADguezauthor=M.+D.+Santanaauthor=J.+Ruiz&title=Cyclometalated+iridium%28III%29+luminescent+complexes+in+therapy+and+phototherapy&doi=10.1016%2Fj.ccr.2018.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy</span></div><div class="casAuthors">Zamora, Ana; Vigueras, Gloria; Rodriguez, Venancio; Santana, M. Dolores; Ruiz, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-76</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Octahedral Ir(III) complexes bearing cyclometalated ligands exhibit a great stability in biol. media and are excellent therapeutical and phototherapeutical candidates for some major human ailments.  Interesting examples of the use of luminescent iridium compds. in the area of cancer diagnosis and treatment have been recently reported, including modulators in protein-protein interactions, membrane-disruptors or mitochondria-targeted agents.  Likewise, the scope of their conjugation to targeting vehicles as well as to smart nanoplatforms has been studied as a mean for an adequate delivery to cancer cells.  Furthermore, several Ir(III) compds. have recently been found to be promising photodynamic therapy (PDT) agents both for cancer and Alzheimer's disease.  Addnl., their use as photoactive species in photoactivated chemotherapy (PACT) has also been explored in spite of their high photostability.  Finally, new developments of Ir(III)-based drugs in infectious and inflammatory diseases, and neurol. disorders, will be also discussed, including a direct inhibitor of Staphylococcus aureus, contg. one amino group in the N̂N ligand, a TACE inhibitor (an enzyme involved in the formation of the biol. active form of TNF-α) and a photosensitizer inducing oxidn. of amyloidogenic peptides and controlling their aggregation pathways under mild conditions.  The mechanism of action of Ir(III) agents together with the relationship between their structures and biomedicinal activities will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLTlzv1pXTKbVg90H21EOLACvtfcHk0ljOZT1fZ88YcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWntbo%253D&md5=92e1198e87793fb1249ed293679f9247</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2018.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2018.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DZamora%26aufirst%3DA.%26aulast%3DVigueras%26aufirst%3DG.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DV.%26aulast%3DSantana%26aufirst%3DM.%2BD.%26aulast%3DRuiz%26aufirst%3DJ.%26atitle%3DCyclometalated%2520iridium%2528III%2529%2520luminescent%2520complexes%2520in%2520therapy%2520and%2520phototherapy%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2018%26volume%3D360%26spage%3D34%26epage%3D76%26doi%3D10.1016%2Fj.ccr.2018.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Organometallic iridium arene compounds: the effects of C-donor ligands on anticancer activity</span>. <i>Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1246/cl.190179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1246%2Fcl.190179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVygsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2019&pages=916-924&issue=8&author=R.+M.+Lordauthor=P.+C.+McGowan&title=Organometallic+iridium+arene+compounds%3A+the+effects+of+C-donor+ligands+on+anticancer+activity&doi=10.1246%2Fcl.190179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2e</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Iridium Arene Compounds: The Effects of C-Donor Ligands on Anticancer Activity</span></div><div class="casAuthors">Lord, Rianne M.; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">916-924</span>CODEN:
                <span class="NLM_cas:coden">CMLTAG</span>;
        ISSN:<span class="NLM_cas:issn">0366-7022</span>.
    
            (<span class="NLM_cas:orgname">Chemical Society of Japan</span>)
        </div><div class="casAbstract">A review.  In the past decade, libraries of iridium organometallic arene compds. have expanded rapidly, with the majority of their applications aimed towards effective catalysts and potential anti-cancer drug candidates.  Researchers have begun to adapt the traditional "piano-stool" structures to include different bidentate ligands, ancillary ligands and extend the aromaticity and functionality of the arene substituent, all in the hope to optimize their activities and allow the detn. of structure activity relationships.  Many of the complexes incorporate N- and O-donor ligands, but more recently, these structures have been expanded to include C-donor ligands such as cyclometalated bidentate ligands and N-heterocyclic carbenes.  This mini-review highlights the recent and ongoing research in C-donor iridium arene complexes, and discusses their importance as potential anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo03nxcgwhbKLVg90H21EOLACvtfcHk0ljOZT1fZ88YcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVygsLrL&md5=3fcbc5f2f7b98fc99416fa10b086027c</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=10.1246%2Fcl.190179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1246%252Fcl.190179%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DOrganometallic%2520iridium%2520arene%2520compounds%253A%2520the%2520effects%2520of%2520C-donor%2520ligands%2520on%2520anticancer%2520activity%26jtitle%3DChem.%2520Lett.%26date%3D2019%26volume%3D48%26issue%3D8%26spage%3D916%26epage%3D924%26doi%3D10.1246%2Fcl.190179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puckett, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, J. K.</span></span> <span> </span><span class="NLM_article-title">Exploring the cellular accumulation of metal complexes</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1170</span>, <span class="refDoi"> DOI: 10.1039/B922209J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FB922209J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=20104335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFehsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2010&pages=1159-1170&issue=5&author=C.+A.+Puckettauthor=R.+J.+Ernstauthor=J.+K.+Barton&title=Exploring+the+cellular+accumulation+of+metal+complexes&doi=10.1039%2FB922209J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the cellular accumulation of metal complexes</span></div><div class="casAuthors">Puckett, Cindy A.; Ernst, Russell J.; Barton, Jacqueline K.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1159-1170</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Transition metal complexes offer great potential as diagnostic and therapeutic agents, and a growing no. of biol. applications have been explored.  To be effective, these complexes must reach their intended target inside the cell.  Here the authors review the cellular accumulation of metal complexes, including their uptake, localization, and efflux.  Metal complexes are taken up inside cells through various mechanisms, including passive diffusion and entry through org. and metal transporters.  Emphasis is placed on the methods used to examine cellular accumulation, to identify the mechanism(s) of uptake, and to monitor possible efflux.  Conjugation strategies that have been employed to improve the cellular uptake characteristics of metal complexes are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvQprb0Iwsx7Vg90H21EOLACvtfcHk0ljOZT1fZ88YcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFehsrc%253D&md5=3bf675e26d83b0b088347acb0453d357</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2FB922209J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB922209J%26sid%3Dliteratum%253Aachs%26aulast%3DPuckett%26aufirst%3DC.%2BA.%26aulast%3DErnst%26aufirst%3DR.%2BJ.%26aulast%3DBarton%26aufirst%3DJ.%2BK.%26atitle%3DExploring%2520the%2520cellular%2520accumulation%2520of%2520metal%2520complexes%26jtitle%3DDalton%2520Trans.%26date%3D2010%26volume%3D39%26issue%3D5%26spage%3D1159%26epage%3D1170%26doi%3D10.1039%2FB922209J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pracharova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutillas, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiak, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Exploring the effect of polypyridyl ligands on the anticancer activity of phosphorescent iridium(III) complexes: from proteosynthesis inhibitors to photodynamic therapy agents</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4619</span>, <span class="refDoi"> DOI: 10.1002/chem.201705362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fchem.201705362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29369444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlaqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=4607-4619&issue=18&author=J.+Pracharovaauthor=G.+Viguerasauthor=V.+Novohradskyauthor=N.+Cutillasauthor=C.+Janiakauthor=H.+Kostrhunovaauthor=J.+Kasparkovaauthor=J.+Ruizauthor=V.+Brabec&title=Exploring+the+effect+of+polypyridyl+ligands+on+the+anticancer+activity+of+phosphorescent+iridium%28III%29+complexes%3A+from+proteosynthesis+inhibitors+to+photodynamic+therapy+agents&doi=10.1002%2Fchem.201705362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the Effect of Polypyridyl Ligands on the Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents</span></div><div class="casAuthors">Pracharova, Jitka; Vigueras, Gloria; Novohradsky, Vojtech; Cutillas, Natalia; Janiak, Christoph; Kostrhunova, Hana; Kasparkova, Jana; Ruiz, Jose; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4607-4619</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of five kinetically inert bis-cyclometalated IrIII complexes of general formula [Ir(ĈN)2(N̂N)][PF6] [ĈN = 2-(para-trifluoromethylphenyl)benzimidazol-κN,-κC; N̂N = 1,10-phenanthroline (phen, 1), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq, 2), dipyrido[3,2-a:2',3'-c]phenazine (dppz, 3), benzo[i]dipyrido[3,2-a:2',3'-c]phenazine (dppn, 4), and dipyrido[3,2-a:2',3'-c]phenazine-10,11-imidazolone (dppz-izdo, 5)] were designed and synthesized to explore the effect of the degree of π conjugation of the polypyridyl ligand on their toxicity in cancer cells.  We show that less-lipophilic complexes 1 and 2 exhibit the highest toxicity [sub-micromolar inhibitory concn. (IC50) values] in A2780, HeLa, and MCF-7 cancer cells, and they are markedly more efficient than clin. used platinum drugs.  It is noteworthy that the investigated Ir agents display the capability to overcome acquired and inherent resistance to conventional cisplatin (in A2780cisR and MCF-7 cells, resp.).  We demonstrate that the Ir complexes, unlike clin. used platinum antitumor drugs, do not kill cells through DNA-damage response.  Rather, they kill cells by inhibiting protein translation by targeting preferentially the endoplasmic reticulum.  Our findings also reveal that the toxic effect of the Ir complexes can be significantly potentiated by irradn. with visible light (by more than two orders of magnitude).  The photopotentiation of the investigated Ir complexes can be attributed to a marked increase (≈10-30-fold) in intracellular reactive oxygen species.  Collectively, these data highlight the functional diversity of antitumor metal-based drugs and the usefulness of a mechanism-based rationale for selecting candidate agents that are effective against chemoresistant tumors for further preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tyZA_6aPyrVg90H21EOLACvtfcHk0lgA53P9jOTEYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlaqsr0%253D&md5=20a1115cc9f05a8151cdc5b2360d72ba</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fchem.201705362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201705362%26sid%3Dliteratum%253Aachs%26aulast%3DPracharova%26aufirst%3DJ.%26aulast%3DVigueras%26aufirst%3DG.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DCutillas%26aufirst%3DN.%26aulast%3DJaniak%26aufirst%3DC.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DExploring%2520the%2520effect%2520of%2520polypyridyl%2520ligands%2520on%2520the%2520anticancer%2520activity%2520of%2520phosphorescent%2520iridium%2528III%2529%2520complexes%253A%2520from%2520proteosynthesis%2520inhibitors%2520to%2520photodynamic%2520therapy%2520agents%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2018%26volume%3D24%26issue%3D18%26spage%3D4607%26epage%3D4619%26doi%3D10.1002%2Fchem.201705362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">44</span>),  <span class="NLM_fpage">15772</span>– <span class="NLM_lpage">15782</span>, <span class="refDoi"> DOI: 10.1039/C8DT02963F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8DT02963F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=30357192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOjtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=15772-15782&issue=44&author=J.+Liauthor=Z.+Tianauthor=Z.+Xuauthor=S.+Zhangauthor=Y.+Fengauthor=L.+Zhangauthor=Z.+Liu&title=Highly+potent+half-sandwich+iridium+and+ruthenium+complexes+as+lysosome-targeted+imaging+and+anticancer+agents&doi=10.1039%2FC8DT02963F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents</span></div><div class="casAuthors">Li, JuanJuan; Tian, Zhenzhen; Xu, Zhishan; Zhang, Shumiao; Feng, Yaqian; Zhang, Lingdong; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">15772-15782</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this study, six half-sandwich luminescent iridium (Ir) and ruthenium (Ru) anticancer complexes bearing P̂ P-chelating ligands 1,2-bis(diphenylphosphino)benzene (dppbz) and 1,8-bis(diphenylphosphino)naphthalene (dppn) were synthesized and characterized via1H-NMR spectroscopy, 31P-NMR spectroscopy, mass spectrometry, elemental anal. and X-ray crystallog.  All the complexes displayed more potent anticancer activity than cisplatin towards A549 lung cancer cells and HeLa cervical cancer cells, esp. the most potent iridium complex Ir3, which was 73 times more potent than cisplatin against A549 cells.  Different from cisplatin, no nucleobase adducts of Ir3 were detected.  With the help of the self-luminescence of complex Ir3 and confocal microscopy, it was obsd. that Ir3 efficiently penetrated into the A549 cells via energy-dependent active transport, and specifically accumulated in lysosomes, affected the permeabilization of the lysosomal membranes and induced caspase-dependent cell death through lysosomal damage.  Both apoptosis and autophagy of the A549 cells were obsd.  The reactive oxygen species (ROS) elevation, redn. of the mitochondrial membrane potential and cell cycle arrest at the G0/G1 phase also contributed to the obsd. cytotoxicity of Ir3.  We demonstrate that these half-sandwich Ir and Ru anticancer complexes have different anticancer mechanism of action from that of cisplatin, which can be developed as potential multifunctional theranostic platforms that combine bioimaging and anticancer capabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-AeBQkxg7cLVg90H21EOLACvtfcHk0lgA53P9jOTEYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOjtb3N&md5=1b6b52b9a411ab835e3afa68a3333063</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1039%2FC8DT02963F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT02963F%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DHighly%2520potent%2520half-sandwich%2520iridium%2520and%2520ruthenium%2520complexes%2520as%2520lysosome-targeted%2520imaging%2520and%2520anticancer%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26issue%3D44%26spage%3D15772%26epage%3D15782%26doi%3D10.1039%2FC8DT02963F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Lysosome-targeted phosphine-imine half-sandwich iridium(III) anticancer complexes: synthesis, characterization, and biological activity</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1761</span>– <span class="NLM_lpage">1769</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.9b00080</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.9b00080" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmvVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=1761-1769&issue=8&author=Y.+Yangauthor=L.+Guoauthor=Z.+Tianauthor=X.+Geauthor=Y.+Gongauthor=H.+Zhengauthor=S.+Shiauthor=Z.+Liu&title=Lysosome-targeted+phosphine-imine+half-sandwich+iridium%28III%29+anticancer+complexes%3A+synthesis%2C+characterization%2C+and+biological+activity&doi=10.1021%2Facs.organomet.9b00080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosome-Targeted Phosphine-Imine Half-Sandwich Iridium(III) Anticancer Complexes: Synthesis, Characterization, and Biological Activity</span></div><div class="casAuthors">Yang, Yuliang; Guo, Lihua; Tian, Zhenzhen; Ge, Xingxing; Gong, Yuteng; Zheng, Hongmei; Shi, Shaopeng; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1761-1769</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis, characterization, and catalytic ability of converting coenzyme NADH to NAD+ and the anticancer activity of half-sandwich iridium(III) complexes with general formula of [(η5-Cpx)Ir(P̂N)Cl]PF6 (Cpx: Cp* or biphenyl Cpxbiph derivs.; P̂N: various phosphine-imine ligands) were investigated.  The crystal structure of the complex Ir4 showed a piano-stool geometry around the iridium(III) center.  This type of iridium(III) complexes had sufficient stability in aq. soln.  Most of the complexes showed good anticancer activities toward A549 cancer cells, which were higher than the clin. drug cisplatin.  In this series, complex Ir8 displayed the highest anticancer activity against A549 cells (IC50 = 4.7 μM), showing an approx. 4.5-fold more potent activity than cisplatin (IC50 = 21.30 μM).  The structure-activity relationship study showed that the cytotoxicity of these complexes may be primarily attributed to the coordination between iridium(III) and the coordinating atoms, and the nature of the imine N-substituents may not be a major factor affecting cytotoxicity.  Furthermore, this family of complexes causes cell death by cell stress, inducing apoptosis and necrosis, overprodn. of reactive oxygen species, and disruption of the mitochondrial membrane potential.  Most interestingly, the use of confocal microscopy provides insights into the microscopic mechanism that the typical complex Ir3 can penetrate into A549 cancer cells through a non-energy-dependent pathway and specifically distribute in lysosomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqqI_P9Qb_EbVg90H21EOLACvtfcHk0lgA53P9jOTEYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmvVGisL0%253D&md5=0013db9fe57e22a890980f9181d52f84</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.9b00080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.9b00080%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DLysosome-targeted%2520phosphine-imine%2520half-sandwich%2520iridium%2528III%2529%2520anticancer%2520complexes%253A%2520synthesis%252C%2520characterization%252C%2520and%2520biological%2520activity%26jtitle%3DOrganometallics%26date%3D2019%26volume%3D38%26issue%3D8%26spage%3D1761%26epage%3D1769%26doi%3D10.1021%2Facs.organomet.9b00080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Theranostic lysosomal targeting anticancer and antimetastatic agents: half-sandwich iridium(III) rhodamine complexes</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">15240</span>– <span class="NLM_lpage">15248</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b01863</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b01863" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A280%3ADC%252BB3MnhvVOquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=15240-15248&issue=12&author=W.+Maauthor=X.+Geauthor=Z.+Xuauthor=S.+Zhangauthor=X.+Heauthor=J.+Liauthor=X.+Xiaauthor=X.+Chenauthor=Z.+Liu&title=Theranostic+lysosomal+targeting+anticancer+and+antimetastatic+agents%3A+half-sandwich+iridium%28III%29+rhodamine+complexes&doi=10.1021%2Facsomega.9b01863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes</span></div><div class="casAuthors">Ma Wenli; Ge Xingxing; Xu Zhishan; Zhang Shumiao; He Xiangdong; Li JuanJuan; Xia Xiaorong; Chen Xiaobing; Liu Zhe; Xu Zhishan</div><div class="citationInfo"><span class="NLM_cas:title">ACS omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">15240-15248</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Two rhodamine-modified half-sandwich Ir(III) complexes with the general formula [(Cp(x))Ir(CN) Cl] were synthesized and characterized, where Cp(x) is 1-biphenyl-2,3,4,5-tetramethylcyclopentadienyl (Cp(xbiph)).  Both complexes showed potent anticancer activity against A549, HeLa, and HepG2 cancer cells and normal cells, and altered ligands had an effect on proliferation resistance.  The complex enters cells through energy dependence, and because of the different ligands, not only could it affect the anticancer ability of the complex but also could affect the degree of complex lysosome targeting, lysosomal damage, and further prove the antiproliferative mechanism of the complex.  Excitingly, antimetastatic experiments demonstrated that complex 1 has the ability to block the migration of cancer cells.  Furthermore, although the complex did not show a stronger ability to interfere with the coenzyme NAD(+)/NADH pair by transfer hydrogenation, the intracellular reactive oxygen species (ROS) content has shown a marked increase.  NF-κB activity is increased by ROS regulation, and the role of ROS-NF-κB signaling pathway further induces apoptosis.  Moreover, cell flow experiments also demonstrated that complex 1 blocked the cell cycle in S phase, but the complex did not cause significant changes in the mitochondrial membrane potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTJXPyXuaAyJw7prLlxLOzfW6udTcc2eZReAfSjLtGDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnhvVOquw%253D%253D&md5=594f6cc1e2054e8b2da30fca1d2a984a</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b01863%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DTheranostic%2520lysosomal%2520targeting%2520anticancer%2520and%2520antimetastatic%2520agents%253A%2520half-sandwich%2520iridium%2528III%2529%2520rhodamine%2520complexes%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26issue%3D12%26spage%3D15240%26epage%3D15248%26doi%3D10.1021%2Facsomega.9b01863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeting cyclometalated iridium(III) complexes for tumor hypoxic imaging and therapy</span>. <i>Inorg. Chem. Front.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1003</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1039/C9QI00081J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC9QI00081J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFSnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=1003-1010&issue=4&author=J.+Liauthor=H.+Chenauthor=L.+Zengauthor=T.+W.+Reesauthor=K.+Xiongauthor=Y.+Chenauthor=L.+Jiauthor=H.+Chao&title=Mitochondria-targeting+cyclometalated+iridium%28III%29+complexes+for+tumor+hypoxic+imaging+and+therapy&doi=10.1039%2FC9QI00081J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-targeting cyclometalated iridium(III) complexes for tumor hypoxic imaging and therapy</span></div><div class="casAuthors">Li, Jia; Chen, Hongmin; Zeng, Leli; Rees, Thomas W.; Xiong, Kai; Chen, Yu; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry Frontiers</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1003-1010</span>CODEN:
                <span class="NLM_cas:coden">ICFNAW</span>;
        ISSN:<span class="NLM_cas:issn">2052-1553</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Hypoxia is frequently found in the center of solid tumors.  It contributes to drug resistance and is a major obstacle in the development of effective cancer therapy.  Designing activatable theranostic agents for hypoxic cancer cells remains a big challenge.  We herein report five novel cyclometalated iridium(III) complexes with an attached anthraquinone moiety (Ir1-5) for hypoxic cancer cell therapy.  The complexes efficiently respond to hypoxia with a turn-on yellow phosphorescence and were successfully used to detect hypoxia within 3D multicellular tumor spheroids.  Moreover, the complexes are cytotoxic towards HeLa (human cervical carcinoma), HepG2 (Human hepatocellular carcinoma), A549 (human lung carcinoma), and A549R (cisplatin-resistant human lung carcinoma) cell lines, with Ir2 more than 50 times as active as cisplatin against the A549R cell line.  Investigation of the localization of Ir1-5 indicates that mitochondria are the main cellular targets.  Mitochondrial dysfunction and caspase-3 activation were found to be involved in the apoptotic cell death pathway induced by the complexes.  These results demonstrate that the complexes have great potential for tumor diagnosis and therapy in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLkTViELGGXLVg90H21EOLACvtfcHk0lhFFWqHa-yS7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFSnsrg%253D&md5=29ddb97ff6b3959588cfca2104ce269d</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1039%2FC9QI00081J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9QI00081J%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DRees%26aufirst%3DT.%2BW.%26aulast%3DXiong%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DMitochondria-targeting%2520cyclometalated%2520iridium%2528III%2529%2520complexes%2520for%2520tumor%2520hypoxic%2520imaging%2520and%2520therapy%26jtitle%3DInorg.%2520Chem.%2520Front.%26date%3D2019%26volume%3D6%26issue%3D4%26spage%3D1003%26epage%3D1010%26doi%3D10.1039%2FC9QI00081J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Anticancer cyclometalated iridium(III) complexes with planar ligands: mitochondrial DNA damage and metabolism disturbance</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3311</span>– <span class="NLM_lpage">3322</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3311-3322&issue=7&author=J.+J.+Caoauthor=Y.+Zhengauthor=X.+W.+Wuauthor=C.+P.+Tanauthor=M.+H.+Chenauthor=N.+Wuauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Anticancer+cyclometalated+iridium%28III%29+complexes+with+planar+ligands%3A+mitochondrial+DNA+damage+and+metabolism+disturbance&doi=10.1021%2Facs.jmedchem.8b01704"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance</span></div><div class="casAuthors">Cao, Jian-Jun; Zheng, Yue; Wu, Xiao-Wen; Tan, Cai-Ping; Chen, Mu-He; Wu, Na; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3311-3322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Emerging studies have shown that mitochondrial DNA (mtDNA) is a potential target for cancer therapy.  Herein, six cyclometalated Ir(III) complexes Ir1-Ir6 contg. a series of extended planar diimine ligands have been designed and assessed for their efficacy as anticancer agents.  Ir1-Ir6 show much higher cytotoxicity than cisplatin and they can effectively localize to mitochondria.  Among them, complexes Ir3 and Ir4 with dipyrido[3,2-a:2',3'-c]phenazine (dppz) ligands can bind to DNA tightly in vitro, intercalate to mtDNA in situ, and induce mtDNA damage.  Ir3- and Ir4-impaired mitochondria exhibit decline of mitochondrial membrane potential, disability of ATP generation, disruption of mitochondrial energetic and metabolic status, which subsequently cause protective mitophagy, G0/G1 phase cell cycle arrest, and apoptosis.  In vivo antitumor evaluations also show that Ir4 can inhibit tumor xenograft growth effectively.  Overall, our work proves that targeting the mitochondrial genome may present an effective strategy to develop metal-based anticancer agents to overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR7bmxWFP0m7Vg90H21EOLACvtfcHk0lhFFWqHa-yS7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFCrsbo%253D&md5=a2468f56f12e5b0d7b47fbfcc2b91d3e</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01704%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DX.%2BW.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DChen%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DAnticancer%2520cyclometalated%2520iridium%2528III%2529%2520complexes%2520with%2520planar%2520ligands%253A%2520mitochondrial%2520DNA%2520damage%2520and%2520metabolism%2520disturbance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D7%26spage%3D3311%26epage%3D3322%26doi%3D10.1021%2Facs.jmedchem.8b01704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span> <span> </span><span class="NLM_article-title">Imaging of a clickable anticancer iridium catalyst</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2017.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.jinorgbio.2017.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29306719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1Kqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2018&pages=179-185&author=X.+Wangauthor=M.+Zhuauthor=F.+Gaoauthor=W.+Weiauthor=Y.+Qianauthor=H.+K.+Liuauthor=J.+Zhao&title=Imaging+of+a+clickable+anticancer+iridium+catalyst&doi=10.1016%2Fj.jinorgbio.2017.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of a clickable anticancer iridium catalyst</span></div><div class="casAuthors">Wang, Xiuxiu; Zhu, Mingli; Gao, Fei; Wei, Wei; Qian, Yong; Liu, Hong-Ke; Zhao, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-185</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Iridium-based anticancer reagents are receiving increasing attention for their high cytotoxicity.  Herein, by activating C-H bonds in the well-known antioxidant α-phenyl-N-tert-butylnitrone (PBN), the authors synthesized and characterized a series of new iridium complexes.  Complex 1-AMP exhibited the best antiproliferation activity towards human ovarian cancer A2780 cells.  The azide group in complex 1-AMP underwent the Cu(I)-catalyzed azide - alkyne cycloaddn. (CuAAC) reaction and the resulting fluorescent imaging in cells suggested it mainly accumulated in mitochondria.  In comparison, to eliminate cytotoxicity of Cu(I) catalyst, the authors conducted a reaction between complex 1-AMP and a commercialized dye via strain-promoted alkyne-azide cycloaddn. (SPAAC) reaction in live cells, confirming its targeting mainly in the mitochondria.  Iridium-based anticancer complexes contg. a nitrone ligand and azide group may offer a useful tool to probe the mechanism of metallodrugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPshoq2YgcPLVg90H21EOLACvtfcHk0lhFFWqHa-yS7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1Kqtg%253D%253D&md5=80a57c2c0e15690a5531db2f17a5635a</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%2BK.%26aulast%3DZhao%26aufirst%3DJ.%26atitle%3DImaging%2520of%2520a%2520clickable%2520anticancer%2520iridium%2520catalyst%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D180%26spage%3D179%26epage%3D185%26doi%3D10.1016%2Fj.jinorgbio.2017.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zielonka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikora, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez-Vivar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, B.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">10043</span>– <span class="NLM_lpage">10120</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00042</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00042" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGrs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=10043-10120&issue=15&author=J.+Zielonkaauthor=J.+Josephauthor=A.+Sikoraauthor=M.+Hardyauthor=O.+Ouariauthor=J.+Vasquez-Vivarauthor=G.+Chengauthor=M.+Lopezauthor=B.+Kalyanaraman&title=Mitochondria-targeted+triphenylphosphonium-based+compounds%3A+syntheses%2C+mechanisms+of+action%2C+and+therapeutic+and+diagnostic+applications&doi=10.1021%2Facs.chemrev.7b00042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications</span></div><div class="casAuthors">Zielonka, Jacek; Joseph, Joy; Sikora, Adam; Hardy, Micael; Ouari, Olivier; Vasquez-Vivar, Jeannette; Cheng, Gang; Lopez, Marcos; Kalyanaraman, Balaraman</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10043-10120</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mitochondria are recognized as one of the most important targets for new drug design in cancer, cardiovascular, and neurol. diseases.  Currently, the most effective way to deliver drugs specifically to mitochondria is by covalent linking a lipophilic cation such as an alkyltriphenylphosphonium moiety to a pharmacophore of interest.  Other delocalized lipophilic cations, such as rhodamine, natural and synthetic mitochondria-targeting peptides, and nanoparticle vehicles, have also been used for mitochondrial delivery of small mols.  Depending on the approach used, and the potentials of cell and mitochondrial membranes, more than 1000-fold higher mitochondrial concn. can be achieved.  Mitochondrial targeting has been developed to study mitochondrial physiol. and dysfunction and the interaction between mitochondria and other subcellular organelles and for treatment of a variety of diseases such as neurodegeneration and cancer.  In this review, the authors discuss efforts to target small-mol. compds. to mitochondria for probing mitochondria function, as diagnostic tools and potential therapeutics.  The authors describe the physicochem. basis for mitochondrial accumulation of lipophilic cations, synthetic chem. strategies to target compds. to mitochondria, mitochondrial probes and sensors, and examples of mitochondrial targeting of bioactive compds.  Finally, the authors review published attempts to apply mitochondria-targeted agents for the treatment of cancer and neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWcZcFkSXk57Vg90H21EOLACvtfcHk0ljxLNfMPygoeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGrs7fJ&md5=53093198d06913e216b0614a8c7ff579</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00042%26sid%3Dliteratum%253Aachs%26aulast%3DZielonka%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DSikora%26aufirst%3DA.%26aulast%3DHardy%26aufirst%3DM.%26aulast%3DOuari%26aufirst%3DO.%26aulast%3DVasquez-Vivar%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DKalyanaraman%26aufirst%3DB.%26atitle%3DMitochondria-targeted%2520triphenylphosphonium-based%2520compounds%253A%2520syntheses%252C%2520mechanisms%2520of%2520action%252C%2520and%2520therapeutic%2520and%2520diagnostic%2520applications%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26issue%3D15%26spage%3D10043%26epage%3D10120%26doi%3D10.1021%2Facs.chemrev.7b00042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heerdt, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augenlicht, L. H.</span></span> <span> </span><span class="NLM_article-title">Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1591</span>– <span class="NLM_lpage">1596</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1158%2F0008-5472.CAN-05-2717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=16452217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVentw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=1591-1596&issue=3&author=B.+G.+Heerdtauthor=M.+A.+Houstonauthor=L.+H.+Augenlicht&title=Growth+properties+of+colonic+tumor+cells+are+a+function+of+the+intrinsic+mitochondrial+membrane+potential&doi=10.1158%2F0008-5472.CAN-05-2717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Growth Properties of Colonic Tumor Cells Are a Function of the Intrinsic Mitochondrial Membrane Potential</span></div><div class="casAuthors">Heerdt, Barbara G.; Houston, Michele A.; Augenlicht, Leonard H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1591-1596</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Development of malignant transformation in the colonic mucosa includes disruption in the equil. between proliferation and apoptosis, decreased expression and deletions of the mitochondrial genome, alterations in mitochondrial enzymic activity, and elevations in the mitochondrial membrane potential (Δψm).  Focusing on the role of the Δψm in tumor development and progression, we generated novel isogenic colonic carcinoma cell lines that exhibit highly significant, stable differences in their intrinsic Δψm.  Using these cell lines, we have recently shown that the intrinsic Δψm has a significant influence on steady state mitochondrial activity and the extent to which cells enter butyrate-mediated growth arrest and apoptotic cascades.  Here, we report that the Δψm is also profoundly linked to important tumorigenic properties of the cells.  Compared with cells with lower Δψm, cells with elevated intrinsic Δψm have an enhanced capacity to (a) respond to hypoxia by avoiding apoptosis and initiating angiogenesis, (b) escape anoikis and grow under anchorage-independent conditions, and (c) invade the basement membrane.  Combined with our previous work, these data implicate the intrinsic Δψm of colonic carcinoma cells in detg. the probability of tumor expansion and progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRcqIWT8kVh7Vg90H21EOLACvtfcHk0ljxLNfMPygoeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVentw%253D%253D&md5=2063013c39d7fea69216a7aeb7c2485b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2717%26sid%3Dliteratum%253Aachs%26aulast%3DHeerdt%26aufirst%3DB.%2BG.%26aulast%3DHouston%26aufirst%3DM.%2BA.%26aulast%3DAugenlicht%26aufirst%3DL.%2BH.%26atitle%3DGrowth%2520properties%2520of%2520colonic%2520tumor%2520cells%2520are%2520a%2520function%2520of%2520the%2520intrinsic%2520mitochondrial%2520membrane%2520potential%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D3%26spage%3D1591%26epage%3D1596%26doi%3D10.1158%2F0008-5472.CAN-05-2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepp, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Metabolic targets for cancer therapy</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">829</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1038/nrd4145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnrd4145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24113830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2nsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=829-846&issue=11&author=L.+Galluzziauthor=O.+Keppauthor=M.+G.+Vander+Heidenauthor=G.+Kroemer&title=Metabolic+targets+for+cancer+therapy&doi=10.1038%2Fnrd4145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic targets for cancer therapy</span></div><div class="casAuthors">Galluzzi, Lorenzo; Kepp, Oliver; Vander Heiden, Matthew G.; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">829-846</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Malignant cells exhibit metabolic changes, when compared to their normal counterparts, owing to both genetic and epigenetic alterations.  Although such a metabolic rewiring has recently been indicated as yet another general hallmark of cancer, accumulating evidence suggests that the metabolic alterations of each neoplasm represent a mol. signature that intimately accompanies and allows for different facets of malignant transformation.  During the past decade, targeting cancer metab. has emerged as a promising strategy for the development of selective antineoplastic agents.  Here, we discuss the intimate relationship between metab. and malignancy, focusing on strategies through which this central aspect of tumor biol. might be turned into cancer's Achilles heel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWJB7NELP1nLVg90H21EOLACvtfcHk0ljxLNfMPygoeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2nsr3M&md5=1c7d31d1d4494cfabe08604fbd44ffe0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd4145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4145%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMetabolic%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2013%26volume%3D12%26issue%3D11%26spage%3D829%26epage%3D846%26doi%3D10.1038%2Fnrd4145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porporato, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filigheddu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedro, J. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial metabolism and cancer</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1038/cr.2017.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fcr.2017.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29219147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCrt7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=265-280&issue=3&author=P.+E.+Porporatoauthor=N.+Filighedduauthor=J.+M.+B.+Pedroauthor=G.+Kroemerauthor=L.+Galluzzi&title=Mitochondrial+metabolism+and+cancer&doi=10.1038%2Fcr.2017.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial metabolism and cancer</span></div><div class="casAuthors">Porporato, Paolo Ettore; Filigheddu, Nicoletta; Pedro, Jose Manuel Bravo-San; Kroemer, Guido; Galluzzi, Lorenzo</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-280</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Glycolysis has long been considered as the major metabolic process for energy prodn. and anabolic growth in cancer cells.  Although such a view has been instrumental for the development of powerful imaging tools that are still used in the clinics, it is now clear that mitochondria play a key role in oncogenesis.  Besides exerting central bioenergetic functions, mitochondria provide indeed building blocks for tumor anabolism, control redox and calcium homeostasis, participate in transcriptional regulation, and govern cell death.  Thus, mitochondria constitute promising targets for the development of novel anticancer agents.  However, tumors arise, progress, and respond to therapy in the context of an intimate crosstalk with the host immune system, and many immunol. functions rely on intact mitochondrial metab.  Here, we review the cancer cell-intrinsic and cell-extrinsic mechanisms through which mitochondria influence all steps of oncogenesis, with a focus on the therapeutic potential of targeting mitochondrial metab. for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsiHEGIV3l-rVg90H21EOLACvtfcHk0lgsz7ICzWdhFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCrt7jP&md5=5ec7ae200ec5b2268ad6b33eb2a2ad91</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fcr.2017.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2017.155%26sid%3Dliteratum%253Aachs%26aulast%3DPorporato%26aufirst%3DP.%2BE.%26aulast%3DFiligheddu%26aufirst%3DN.%26aulast%3DPedro%26aufirst%3DJ.%2BM.%2BB.%26aulast%3DKroemer%26aufirst%3DG.%26aulast%3DGalluzzi%26aufirst%3DL.%26atitle%3DMitochondrial%2520metabolism%2520and%2520cancer%26jtitle%3DCell%2520Res.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D265%26epage%3D280%26doi%3D10.1038%2Fcr.2017.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Metabolic control of cell death</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span> (<span class="NLM_issue">6203</span>),  <span class="NLM_fpage">1250256</span>, <span class="refDoi"> DOI: 10.1126/science.1250256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1126%2Fscience.1250256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=25237106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A280%3ADC%252BC2M7isl2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=1250256&issue=6203&author=D.+R.+Greenauthor=L.+Galluzziauthor=G.+Kroemer&title=Metabolic+control+of+cell+death&doi=10.1126%2Fscience.1250256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Cell biology. Metabolic control of cell death</span></div><div class="casAuthors">Green Douglas R; Galluzzi Lorenzo; Kroemer Guido</div><div class="citationInfo"><span class="NLM_cas:title">Science (New York, N.Y.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6203</span>),
    <span class="NLM_cas:pages">1250256</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Beyond their contribution to basic metabolism, the major cellular organelles, in particular mitochondria, can determine whether cells respond to stress in an adaptive or suicidal manner.  Thus, mitochondria can continuously adapt their shape to changing bioenergetic demands as they are subjected to quality control by autophagy, or they can undergo a lethal permeabilization process that initiates apoptosis.  Along similar lines, multiple proteins involved in metabolic circuitries, including oxidative phosphorylation and transport of metabolites across membranes, may participate in the regulated or catastrophic dismantling of organelles.  Many factors that were initially characterized as cell death regulators are now known to physically or functionally interact with metabolic enzymes.  Thus, several metabolic cues regulate the propensity of cells to activate self-destructive programs, in part by acting on nutrient sensors.  This suggests the existence of "metabolic checkpoints" that dictate cell fate in response to metabolic fluctuations.  Here, we discuss recent insights into the intersection between metabolism and cell death regulation that have major implications for the comprehension and manipulation of unwarranted cell loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyuIOgwhutwFVwdslNBF-tfW6udTcc2eZO2jk5e1332rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7isl2lsA%253D%253D&md5=7b486b5c05c3780ac01f4d97025bf65e</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1250256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1250256%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DMetabolic%2520control%2520of%2520cell%2520death%26jtitle%3DScience%26date%3D2014%26volume%3D345%26issue%3D6203%26spage%3D1250256%26doi%3D10.1126%2Fscience.1250256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of reactive oxygen species in signaling or stress responses</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nchembio.607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnchembio.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=21769097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=504-511&issue=8&author=B.+C.+Dickinsonauthor=C.+J.+Chang&title=Chemistry+and+biology+of+reactive+oxygen+species+in+signaling+or+stress+responses&doi=10.1038%2Fnchembio.607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of reactive oxygen species in signaling or stress responses</span></div><div class="casAuthors">Dickinson, Bryan C.; Chang, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">504-511</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Reactive O species (ROS) are a family of mols. that are continuously generated, transformed and consumed in all living organisms as a consequence of aerobic life.  The traditional view of these reactive O metabolites is one of oxidative stress and damage that leads to decline of tissue and organ systems in aging and disease.  However, emerging data show that ROS produced in certain situations can also contribute to physiol. and increased fitness.  Here, the authors provide a focused discussion on what factors lead ROS mols. to become signal and/or stress agents, highlighting how increasing knowledge of the underlying chem. of ROS can lead to advances in understanding their disparate contributions to biol.  An important facet of this emerging area at the chem.-biol. interface is the development of new tools to study these small mols. and their reactivity in complex biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8yowqTyr7O7Vg90H21EOLACvtfcHk0lgsz7ICzWdhFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyhsL4%253D&md5=320823c1c7f9013a7c8f3d6c2f3f6952</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.607%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%26aufirst%3DB.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BJ.%26atitle%3DChemistry%2520and%2520biology%2520of%2520reactive%2520oxygen%2520species%2520in%2520signaling%2520or%2520stress%2520responses%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26issue%3D8%26spage%3D504%26epage%3D511%26doi%3D10.1038%2Fnchembio.607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schieber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">ROS function in redox signaling and oxidative stress</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">R453</span>– <span class="NLM_lpage">R462</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2014.03.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.cub.2014.03.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24845678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=R453-R462&issue=10&author=M.+Schieberauthor=N.+S.+Chandel&title=ROS+function+in+redox+signaling+and+oxidative+stress&doi=10.1016%2Fj.cub.2014.03.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">ROS Function in Redox Signaling and Oxidative Stress</span></div><div class="casAuthors">Schieber, Michael; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">R453-R462</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxidative stress refers to elevated intracellular levels of reactive oxygen species (ROS) that cause damage to lipids, proteins and DNA.  Oxidative stress has been linked to a myriad of pathologies.  However, elevated ROS also act as signaling mols. in the maintenance of physiol. functions - a process termed redox biol.  In this review we discuss the two faces of ROS - redox biol. and oxidative stress - and their contribution to both physiol. and pathol. conditions.  Redox biol. involves a small increase in ROS levels that activates signaling pathways to initiate biol. processes, while oxidative stress denotes high levels of ROS that result in damage to DNA, protein or lipids.  Thus, the response to ROS displays hormesis, given that the opposite effect is obsd. at low levels compared with that seen at high levels.  Here, we argue that redox biol., rather than oxidative stress, underlies physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQKHDL4BvUHLVg90H21EOLACvtfcHk0lgsz7ICzWdhFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWktL4%253D&md5=04979c81b50c4aefc5d19152d832febc</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2014.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2014.03.034%26sid%3Dliteratum%253Aachs%26aulast%3DSchieber%26aufirst%3DM.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DROS%2520function%2520in%2520redox%2520signaling%2520and%2520oxidative%2520stress%26jtitle%3DCurr.%2520Biol.%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3DR453%26epage%3DR462%26doi%3D10.1016%2Fj.cub.2014.03.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogvadze, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span> <span> </span><span class="NLM_article-title">Mitochondria, oxidative stress and cell death</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1007/s10495-007-0756-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1007%2Fs10495-007-0756-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=17453160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFamtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=913-922&issue=5&author=M.+Ottauthor=V.+Gogvadzeauthor=S.+Orreniusauthor=B.+Zhivotovsky&title=Mitochondria%2C+oxidative+stress+and+cell+death&doi=10.1007%2Fs10495-007-0756-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria, oxidative stress and cell death</span></div><div class="casAuthors">Ott, Martin; Gogvadze, Vladimir; Orrenius, Sten; Zhivotovsky, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In addn. to the well-established role of the mitochondria in energy metab., the regulation of cell death has recently emerged as a 2nd major function of these organelles.  This, in turn, seems to be intimately linked to their role as the major intracellular source of reactive O species (ROS), which are mainly generated at complex I and III of the respiratory chain.  Excessive ROS prodn. can lead to oxidn. of macromols. and has been implicated in mtDNA mutations, aging, and cell death.  Mitochondria-generated ROS play an important role in the release of cytochrome c and other pro-apoptotic proteins, which can trigger caspase activation and apoptosis.  Cytochrome c release occurs by a 2-step process that is initiated by the dissocn. of the hemoprotein from its binding to cardiolipin, which anchors it to the inner mitochondrial membrane.  The oxidn. of cardiolipin reduces cytochrome c binding and results in an increased level of "free" cytochrome c in the intermembrane space.  Conversely, mitochondrial antioxidant enzymes protect from apoptosis.  Hence, there is accumulating evidence supporting a direct link between mitochondria, oxidative stress, and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqDJmXD2adfbVg90H21EOLACvtfcHk0lio4it9JLHvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFamtrw%253D&md5=8179de86db9a99c69c4b32c6164be463</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1007%2Fs10495-007-0756-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-007-0756-2%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DM.%26aulast%3DGogvadze%26aufirst%3DV.%26aulast%3DOrrenius%26aufirst%3DS.%26aulast%3DZhivotovsky%26aufirst%3DB.%26atitle%3DMitochondria%252C%2520oxidative%2520stress%2520and%2520cell%2520death%26jtitle%3DApoptosis%26date%3D2007%26volume%3D12%26issue%3D5%26spage%3D913%26epage%3D922%26doi%3D10.1007%2Fs10495-007-0756-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jezek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strich, R.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression</span>. <i>Antioxidants</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13</span>, <span class="refDoi"> DOI: 10.3390/antiox7010013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.3390%2Fantiox7010013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWhsbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=13&author=J.+Jezekauthor=K.+F.+Cooperauthor=R.+Strich&title=Reactive+oxygen+species+and+mitochondrial+dynamics%3A+the+yin+and+yang+of+mitochondrial+dysfunction+and+cancer+progression&doi=10.3390%2Fantiox7010013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species and mitochondrial dynamics: The yin and yang of mitochondrial dysfunction and cancer progression</span></div><div class="casAuthors">Jezek, Jan; Cooper, Katrina F.; Strich, Randy</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13/1-13/24</span>CODEN:
                <span class="NLM_cas:coden">ANTIGE</span>;
        ISSN:<span class="NLM_cas:issn">2076-3921</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Mitochondria are organelles with a highly dynamic ultrastructure maintained by a delicate equil. between its fission and fusion rates.  Understanding the factors influencing this balance is important as perturbations to mitochondrial dynamics can result in pathol. states.  As a terminal site of nutrient oxidn. for the cell, mitochondrial powerhouses harness energy in the form of ATP in a process driven by the electron transport chain.  Contemporaneously, electrons translocated within the electron transport chain undergo spontaneous side reactions with oxygen, giving rise to superoxide and a variety of other downstream reactive oxygen species (ROS).  Mitochondrially-derived ROS can mediate redox signaling or, in excess, cause cell injury and even cell death.  Recent evidence suggests that mitochondrial ultrastructure is tightly coupled to ROS generation depending on the physiol. status of the cell.  Yet, the mechanism by which changes in mitochondrial shape modulate mitochondrial function and redox homeostasis is less clear.  Aberrant mitochondrial morphol. may lead to enhanced ROS formation, which, in turn, may deteriorate mitochondrial health and further exacerbate oxidative stress in a self-perpetuating vicious cycle.  Here, we review the latest findings on the intricate relationship between mitochondrial dynamics and ROS prodn., focusing mainly on its role in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9aXAJ8k2K7LVg90H21EOLACvtfcHk0lio4it9JLHvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWhsbnL&md5=b1446a6dc2334495ea28d50cfd632cc9</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.3390%2Fantiox7010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fantiox7010013%26sid%3Dliteratum%253Aachs%26aulast%3DJezek%26aufirst%3DJ.%26aulast%3DCooper%26aufirst%3DK.%2BF.%26aulast%3DStrich%26aufirst%3DR.%26atitle%3DReactive%2520oxygen%2520species%2520and%2520mitochondrial%2520dynamics%253A%2520the%2520yin%2520and%2520yang%2520of%2520mitochondrial%2520dysfunction%2520and%2520cancer%2520progression%26jtitle%3DAntioxidants%26date%3D2018%26volume%3D7%26spage%3D13%26doi%3D10.3390%2Fantiox7010013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trachootham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1038/nrd2803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnrd2803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19478820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=579-591&issue=7&author=D.+Trachoothamauthor=J.+Alexandreauthor=P.+Huang&title=Targeting+cancer+cells+by+ROS-mediated+mechanisms%3A+a+radical+therapeutic+approach%3F&doi=10.1038%2Fnrd2803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?</span></div><div class="casAuthors">Trachootham, Dunyaporn; Alexandre, Jerome; Huang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">579-591</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Increased generation of reactive oxygen species (ROS) and an altered redox status have long been obsd. in cancer cells, and recent studies suggest that this biochem. property of cancer cells can be exploited for therapeutic benefits.  Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacol. ROS insults.  However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance.  Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications.  We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgIa2fgBPBrVg90H21EOLACvtfcHk0lio4it9JLHvcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFWqsLk%253D&md5=d50931b8de8bcab62d376becc768a71c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd2803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2803%26sid%3Dliteratum%253Aachs%26aulast%3DTrachootham%26aufirst%3DD.%26aulast%3DAlexandre%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DP.%26atitle%3DTargeting%2520cancer%2520cells%2520by%2520ROS-mediated%2520mechanisms%253A%2520a%2520radical%2520therapeutic%2520approach%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D579%26epage%3D591%26doi%3D10.1038%2Fnrd2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qamar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">The potent oxidant anticancer activity of organoiridium catalysts</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">3941</span>– <span class="NLM_lpage">3946</span>, <span class="refDoi"> DOI: 10.1002/anie.201311161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fanie.201311161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkt1SqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=3941-3946&issue=15&author=Z.+Liuauthor=I.+Romero-Canelonauthor=B.+Qamarauthor=J.+M.+Hearnauthor=A.+Habtemariamauthor=N.+P.+Barryauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=The+potent+oxidant+anticancer+activity+of+organoiridium+catalysts&doi=10.1002%2Fanie.201311161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">The Potent Oxidant Anticancer Activity of Organoiridium Catalysts</span></div><div class="casAuthors">Liu, Zhe; Romero-Canelon, Isolda; Qamar, Bushra; Hearn, Jessica M.; Habtemariam, Abraha; Barry, Nicolas P. E.; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3941-3946</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Platinum complexes are the most widely used anticancer drugs; however, new generations of agents are needed.  The organoiridium(III) complex [(η5-Cpxbiph)Ir(phpy)(Cl)] (1-Cl), which contains π-bonded biphenyltetramethylcyclopentadienyl (Cpxbiph) and ĈN-chelated phenylpyridine (phpy) ligands, undergoes rapid hydrolysis of the chlorido ligand.  In contrast, the pyridine complex [(η5-Cpxbiph)Ir(phpy)(py)]+ (1-py) aquates slowly, and is more potent (in nanomolar amts.) than both 1-Cl and cisplatin towards a wide range of cancer cells.  The pyridine ligand protects 1-py from rapid reaction with intracellular glutathione.  The high potency of 1-py correlates with its ability to increase substantially the level of reactive oxygen species (ROS) in cancer cells.  The unprecedented ability of these iridium complexes to generate H2O2 by catalytic hydride transfer from the coenzyme NADH to oxygen is demonstrated.  Such organoiridium complexes are promising as a new generation of anticancer drugs for effective oxidant therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJEEYeD3qBGrVg90H21EOLACvtfcHk0li-o_iatOr_gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkt1SqtL4%253D&md5=302598b00ad64fcbb966b4d711511531</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1002%2Fanie.201311161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201311161%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DQamar%26aufirst%3DB.%26aulast%3DHearn%26aufirst%3DJ.%2BM.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DN.%2BP.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520potent%2520oxidant%2520anticancer%2520activity%2520of%2520organoiridium%2520catalysts%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26issue%3D15%26spage%3D3941%26epage%3D3946%26doi%3D10.1002%2Fanie.201311161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munro, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio-Ruiz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1039/C7MT00242D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC7MT00242D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29131211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSit7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=93-107&issue=1&author=J.+M.+Hearnauthor=G.+M.+Hughesauthor=I.+Romero-Canelonauthor=A.+F.+Munroauthor=B.+Rubio-Ruizauthor=Z.+Liuauthor=N.+O.+Carragherauthor=P.+J.+Sadler&title=Pharmaco-genomic+investigations+of+organo-iridium+anticancer+complexes+reveal+novel+mechanism+of+action&doi=10.1039%2FC7MT00242D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action</span></div><div class="casAuthors">Hearn, Jessica M.; Hughes, George M.; Romero-Canelon, Isolda; Munro, Alison F.; Rubio-Ruiz, Belen; Liu, Zhe; Carragher, Neil O.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-107</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Resistance to platinum drugs (used in >50% of cancer chemotherapies) is a clin. problem.  Other precious metal complexes with distinct mechanisms of action might overcome this.  Half-sandwich organometallic complexes contg. arene or cyclopentadienyl (Cp) ligands show promise.  We screened two iridium(III) complexes [Ir(CpXbiph)(ppy)Cl] (ZL49, 1, ppy = phenylpyridine) and [Ir(CpXph)(azpyNMe2)Cl]PF6 (ZL109, 2, azpyNMe2 = N,N-dimethylphenylazopyridine) in 916 cancer cell lines from 28 tissue types.  On av., complex 2 was 78x more potent than 1, 36x more active than cisplatin (CDDP), and strongly active (nanomolar) in patient-derived ovarian cancer cell lines.  RNA sequencing of A2780 ovarian cells revealed upregulation of antioxidant responses (NRF2, AP-1) consistent with obsd. induction of reactive oxygen species (ROS).  Protein microarrays, high content imaging and cell cycle anal. showed S/G2 arrest, and late-stage DNA damage response without p53 requirement.  The triple-neg. breast cancer cell line OCUB-M was highly sensitive to 2 as were cell lines with KIT mutations.  Complex 2 exhibits a markedly different pattern of antiproliferative activity compared to the 253 drugs in the Sanger Cancer Genome database, but is most similar to osmium(II) arene complexes which share the same azopyridine ligand.  Redox modulation and DNA damage can provide a multi-targeting strategy, allowing compds. such as 2 to overcome cellular resistance to platinum anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBczIp0DsJF7Vg90H21EOLACvtfcHk0li-o_iatOr_gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSit7%252FJ&md5=d9c4d2fa7700f3f1c3b047ff07bcbf6d</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1039%2FC7MT00242D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MT00242D%26sid%3Dliteratum%253Aachs%26aulast%3DHearn%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DG.%2BM.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DMunro%26aufirst%3DA.%2BF.%26aulast%3DRubio-Ruiz%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DCarragher%26aufirst%3DN.%2BO.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPharmaco-genomic%2520investigations%2520of%2520organo-iridium%2520anticancer%2520complexes%2520reveal%2520novel%2520mechanism%2520of%2520action%26jtitle%3DMetallomics%26date%3D2018%26volume%3D10%26issue%3D1%26spage%3D93%26epage%3D107%26doi%3D10.1039%2FC7MT00242D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerzankova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepankova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1491</span>– <span class="NLM_lpage">1501</span>, <span class="refDoi"> DOI: 10.1039/C4MT00112E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC4MT00112E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24828756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1491-1501&issue=8&author=V.+Novohradskyauthor=L.+Zerzankovaauthor=J.+Stepankovaauthor=A.+Kisovaauthor=H.+Kostrhunovaauthor=Z.+Liuauthor=P.+J.+Sadlerauthor=J.+Kasparkovaauthor=V.+Brabec&title=A+dual-targeting%2C+apoptosis-inducing+organometallic+half-sandwich+iridium+anticancer+complex&doi=10.1039%2FC4MT00112E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex</span></div><div class="casAuthors">Novohradsky, Vojtech; Zerzankova, Lenka; Stepankova, Jana; Kisova, Anna; Kostrhunova, Hana; Liu, Zhe; Sadler, Peter J.; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1491-1501</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cellular mechanism of action of an iridium(III) half-sandwich complex [(η5-C5Me4C6H4C6H5)Ir(phen)Cl]PF6 (phen = phenanthroline) (1) is reported.  Complex 1 was used to treat several cell lines, including cisplatin-sensitive, cisplatin-resistant (with intrinsic and acquired resistance) carcinoma cells with wild type p53 status as well as the cells with no intact p53 gene, and nontumorigenic cells.  Complex 1 preferentially kills cancer cells over nontumorigenic cells and exhibits no cross-resistance with cisplatin.  It appears to retain significant activity in human tumor cell lines that are refractory or poorly responsive to cisplatin, and in contrast to cisplatin it displays a high activity in human tumor cell lines that are characterized by both wild type and mutant p53 gene.  The mechanism of cell killing was established through detailed cell-based assays.  Complex 1 exhibits dual effects in killing cancer cells causing nuclear DNA damage and mitochondrial dysfunction involving ROS prodn. simultaneously.  Flow cytometric studies and impedance-based monitoring of cellular responses to 1 demonstrated that 1 acts more quickly than cisplatin to induce cell death and that 1 is a more effective apoptosis inducer than cisplatin in particular in early stages of treatment, when the apoptotic effects predominate over necrosis.  Overall, our findings confirm that 1 and its iridium derivs. represent promising candidates for further pre-clin. studies and new addns. to the growing family of nonplatinum metal-based anticancer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rhP03baUXLVg90H21EOLACvtfcHk0li-o_iatOr_gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2rsrbK&md5=5180cef5e67873d2336bb4cf2b24f95a</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1039%2FC4MT00112E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00112E%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DZerzankova%26aufirst%3DL.%26aulast%3DStepankova%26aufirst%3DJ.%26aulast%3DKisova%26aufirst%3DA.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DA%2520dual-targeting%252C%2520apoptosis-inducing%2520organometallic%2520half-sandwich%2520iridium%2520anticancer%2520complex%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D1491%26epage%3D1501%26doi%3D10.1039%2FC4MT00112E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Half-sandwich iridium(III) and ruthenium(II) complexes containing P^P-chelating ligands: a new class of potent anticancer agents with unusual redox features</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1705</span>– <span class="NLM_lpage">1716</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.7b01959</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.7b01959" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1705-1716&issue=4&author=J.+Liauthor=M.+Tianauthor=Z.+Tianauthor=S.+Zhangauthor=C.+Yanauthor=C.+Shaoauthor=Z.+Liu&title=Half-sandwich+iridium%28III%29+and+ruthenium%28II%29+complexes+containing+P%5EP-chelating+ligands%3A+a+new+class+of+potent+anticancer+agents+with+unusual+redox+features&doi=10.1021%2Facs.inorgchem.7b01959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P-P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features</span></div><div class="casAuthors">Li, JuanJuan; Tian, Meng; Tian, Zhenzhen; Zhang, Shumiao; Yan, Chao; Shao, Changfang; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1705-1716</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Half-sandwich Ir(III) pentamethylcyclopentadienyl and Ru(II) arene complexes contg. P-P-chelating ligands [(Cpx/arene)M(P-P)Cl]PF6, where M = Ir, Cpx is pentamethylcyclopentadienyl (Cp*), or 1-biphenyl-2,3,4,5-tetramethyl cyclopentadienyl (CpxbiPh); M = Ru, arene is 3-phenylpropan-1-ol (bz-PA), 4-phenylbutan-1-ol (bz-BA), or p-cymene (p-cym), and P-P is 2,20-bis(diphenylphosphino)-1,10-binaphthyl (BINAP), were synthesized and fully characterized, three of them by x-ray crystallog., and their potential as anticancer agents explored.  All five complexes showed potent anticancer activity toward HeLa and A549 cancer cells.  The introduction of a biphenyl substituent on the Cp* ring for the Ir complexes has no effect on the antiproliferative potency.  Ru complex [(η6-p-cym)Ru(P-P)Cl]PF6 (5) displayed the highest potency, ∼15 and 7.5 times more active than the clin. used cisplatin against A549 and HeLa cells, resp.  No binding to 9-MeA and 9-EtG nucleobases was obsd.  Although these types of complexes interact with ctDNA, DNA appears not to be the major target.  Compared to Ir complex [(η5-Cp*)Ir(P-P)Cl]PF6 (1), Ru complex (5) showed stronger ability to interfere with coenzyme NAD+/NADH couple through transfer hydrogenation reactions and to induce ROS in cells, which is consistent with their anticancer activities.  The redox properties of the complexes 1, 5, and ligand BINAP were evaluated by cyclic voltammetry.  Complexes 1 and 5 arrest cell cycles at the S phase, Sub-G1 phase and G1 phase, resp., and cause cell apoptosis toward A549 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19k_C9XVkq7Vg90H21EOLACvtfcHk0lgdxeUeqnLeQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitV2qu7c%253D&md5=728e52ac5ae4c1bed9c9a01b2bb36e07</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.7b01959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.7b01959%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DShao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DHalf-sandwich%2520iridium%2528III%2529%2520and%2520ruthenium%2528II%2529%2520complexes%2520containing%2520P%255EP-chelating%2520ligands%253A%2520a%2520new%2520class%2520of%2520potent%2520anticancer%2520agents%2520with%2520unusual%2520redox%2520features%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26issue%3D4%26spage%3D1705%26epage%3D1716%26doi%3D10.1021%2Facs.inorgchem.7b01959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Novel and versatile imine-N-heterocyclic carbene half-sandwich iridium(III) complexes as lysosome-targeted anticancer agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">11087</span>– <span class="NLM_lpage">11098</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b01656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b01656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGisLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=11087-11098&issue=17&author=Y.+Yangauthor=L.+Guoauthor=Z.+Tianauthor=Y.+Gongauthor=H.+Zhengauthor=S.+Zhangauthor=Z.+Xuauthor=X.+Geauthor=Z.+Liu&title=Novel+and+versatile+imine-N-heterocyclic+carbene+half-sandwich+iridium%28III%29+complexes+as+lysosome-targeted+anticancer+agents&doi=10.1021%2Facs.inorgchem.8b01656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents</span></div><div class="casAuthors">Yang, Yuliang; Guo, Lihua; Tian, Zhenzhen; Gong, Yuteng; Zheng, Hongmei; Zhang, Shumiao; Xu, Zhishan; Ge, Xingxing; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">11087-11098</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We herein report the synthesis, characterization, luminescence properties, anticancer and antibacterial activities of a family of novel half-sandwich iridium(III) complexes of the general formula [(η5-Cpx)Ir(ĈN)Cl]PF6- [Cpx = pentamethylcyclopentadienyl (Cp*) or tetramethyl(biphenyl)-cyclopentadienyl (Cpxbiph)] bearing versatile imine-N-heterocyclic carbene ligands.  In this complex framework, substituents on four positions could be modulated, which distinguishes this class of complex and provides a large amt. of flexibilities and opportunities to tune the cytotoxicity of complexes.  The X-ray crystal structures of complexes 4 and 10 exhibit the expected "piano-stool" geometry.  With the exception of 1, 2 and 11, each complex shows potent cytotoxicity, with IC50 values ranging from 1.99 to 25.86 μM toward A549 human lung cancer cells.  First, the effect of four positions bearing different substituents in the complex framework on the anticancer activity, i.e. structure-activity relationship, was systematically studied.  Complex 8 (IC50 = 1.99 μM) displays the highest anticancer activities, whose cytotoxicity is more than 10-fold higher than that of the clin. platinum drug cisplatin against A549 cancer cells.  Second, their chem. reactivity including nucleobases binding, catalytic activity in converting coenzyme NADH to NAD+, reaction with glutathione (GSH), and bovine serum albumin (BSA) binding is investigated.  No reaction with nucleobase is obsd.  However, these iridium(III) complexes bind rapidly to GSH and can catalyze oxidn. of NADH to NAD+.  In addn., they show moderate binding affinity to BSA and the fluorescence quenching of BSA by the metal complexes is due to the static quenching.  Third, the mode of cell death was also explored through flow cytometry expts., including cell cycle, apoptosis induction, reactive oxygen species (ROS) and mitochondrial membrane potential.  It seems that cell cycle perturbation, apoptosis induction, increase of ROS level and loss of mitochondrial membrane potential together contribute to the anticancer potency of these complexes.  Last, the use of confocal microscopy provides insights into the microscopic mechanism that the typical and most active complex 8 enters A549 lung cancer cells mainly through energy-dependent pathway and is located in lysosome.  Furthermore, lysosome damage and nuclear morphol. were detected by confocal microscopy.  Nuclear condensation and apoptotic bodies may finally induce cells apoptosis.  Interestingly, complex 8 also shows antibacterial activity against Gram-pos. Staphyloccocus aureus (S. aureus).  This work may provide an alternative and effective strategy to smart design of potent organometallic half-sandwich iridium(III) anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryA_KrhDUdw7Vg90H21EOLACvtfcHk0lgdxeUeqnLeQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGisLnI&md5=345e3e156257d405eab2daa17a85bb2c</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b01656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b01656%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DNovel%2520and%2520versatile%2520imine-N-heterocyclic%2520carbene%2520half-sandwich%2520iridium%2528III%2529%2520complexes%2520as%2520lysosome-targeted%2520anticancer%2520agents%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26issue%3D17%26spage%3D11087%26epage%3D11098%26doi%3D10.1021%2Facs.inorgchem.8b01656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organoiridium complexes: anticancer agents and catalysts</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1174</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1021/ar400266c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar400266c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivFWisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=1174-1185&issue=4&author=Z.+Liuauthor=P.+J.+Sadler&title=Organoiridium+complexes%3A+anticancer+agents+and+catalysts&doi=10.1021%2Far400266c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Organoiridium Complexes: Anticancer Agents and Catalysts</span></div><div class="casAuthors">Liu, Zhe; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1174-1185</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this Account, we review recent developments in organoiridium complexes as both catalysts and anticancer agents.  Initial studies of anticancer activity with organoiridium complexes focused on square-planar IrI complexes because of their structural and electronic similarity to PtII anticancer complexes such as cisplatin.  Recently, researchers have studied half-sandwich IrIII anticancer complexes.  These complexes with the formula [(Cpx)Ir(L-L)Z]0/n+ (with Cp* or extended Cp* and L-L = chelated C-N or N-N ligands) have a much greater potency (nanomolar) toward a range of cancer cells (esp. leukemia, colon cancer, breast cancer, prostate cancer, and melanoma) than cisplatin.  Their mechanism of action may involve both an attack on DNA and a perturbation of the redox status of cells.  Some of these complexes can form IrIII-hydride complexes using coenzyme NAD(P)H as a source of hydride to catalyze the generation of H2 or the redn. of quinones to semiquinones.  Intriguingly, relatively unreactive organoiridium complexes contg. an imine as a monodentate ligand have prooxidant activity, which appears to involve catalytic hydride transfer to oxygen and the generation of hydrogen peroxide in cells.  In addn., researchers have designed inert IrIII complexes as potent kinase inhibitors.  Octahedral cyclometalated IrIII complexes not only serve as cell imaging agents, but can also inhibit tumor necrosis factor α, promote DNA oxidn., generate singlet oxygen when photoactivated, and exhibit good anticancer activity.  Although relatively unexplored, organoiridium chem. offers unique features that researchers can exploit to generate novel diagnostic agents and drugs with new mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1UaAsXCZPqbVg90H21EOLACvtfcHk0lgdxeUeqnLeQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivFWisLs%253D&md5=149684628c06aa2b8e317acc778d6504</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Far400266c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far400266c%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganoiridium%2520complexes%253A%2520anticancer%2520agents%2520and%2520catalysts%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2014%26volume%3D47%26issue%3D4%26spage%3D1174%26epage%3D1185%26doi%3D10.1021%2Far400266c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruijnincx, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organometallic half-sandwich iridium anticancer complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3011</span>– <span class="NLM_lpage">3026</span>, <span class="refDoi"> DOI: 10.1021/jm2000932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2000932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2gsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3011-3026&issue=8&author=Z.+Liuauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=S.+A.+Fletcherauthor=A.+Kisovaauthor=O.+Vranaauthor=L.+Salassaauthor=P.+C.+Bruijnincxauthor=G.+J.+Clarksonauthor=V.+Brabecauthor=P.+J.+Sadler&title=Organometallic+half-sandwich+iridium+anticancer+complexes&doi=10.1021%2Fjm2000932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic half-sandwich iridium anticancer complexes</span></div><div class="casAuthors">Liu, Zhe; Habtemariam, Abraha; Pizarro, Ana M.; Fletcher, Sally A.; Kisova, Anna; Vrana, Oldrich; Salassa, Luca; Bruijnincx, Pieter C. A.; Clarkson, Guy J.; Brabec, Viktor; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3011-3026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The low-spin 5d6 IrIII organometallic half-sandwich complexes [(η5-Cpx)Ir(XY)Cl]0/+, Cpx = Cp*, tetramethyl(phenyl)cyclopentadienyl (Cpxph), or tetramethyl(biphenyl)cyclopentadienyl (Cpxbiph), XY = 1,10-phenanthroline (4-6), 2,2'-bipyridine (7-9), ethylenediamine (10 and 11), or picolinate (12-14), hydrolyze rapidly.  Complexes with N,N-chelating ligands readily form adducts with 9-ethylguanine but not 9-ethyladenine; picolinate complexes bind to both purines.  Cytotoxic potency toward A2780 human ovarian cancer cells increases with Ph substitution on Cp*: Cpxbiph > Cpxph > Cp*; Cpxbiph complexes 6 and 9 have submicromolar activity.  Guanine residues are preferential binding sites for 4-6 on plasmid DNA.  Hydrophobicity (log P), cell and nucleus accumulation of Ir correlate with cytotoxicity, 6>5>4; they distribute similarly within cells.  The ability to displace DNA intercalator ethidium bromide from DNA correlates with cytotoxicity and viscosity of Ir-DNA adducts.  The hydrophobicity and intercalative ability of Cpxph and Cpxbiph make a major contribution to the anticancer potency of their IrIII complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUJTiS3baZTrVg90H21EOLACvtfcHk0lg9WsUl_O6NiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2gsr4%253D&md5=38ab54bd3bac6e28fca46bbdbe01a91d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm2000932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2000932%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DFletcher%26aufirst%3DS.%2BA.%26aulast%3DKisova%26aufirst%3DA.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DBruijnincx%26aufirst%3DP.%2BC.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganometallic%2520half-sandwich%2520iridium%2520anticancer%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D3011%26epage%3D3026%26doi%3D10.1021%2Fjm2000932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Organometallic iridium(III) cyclopentadienyl anticancer complexes containing C,N-chelating ligands</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">4702</span>– <span class="NLM_lpage">4710</span>, <span class="refDoi"> DOI: 10.1021/om2005468</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om2005468" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpslGisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=4702-4710&issue=17&author=Z.+Liuauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Organometallic+iridium%28III%29+cyclopentadienyl+anticancer+complexes+containing+C%2CN-chelating+ligands&doi=10.1021%2Fom2005468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands</span></div><div class="casAuthors">Liu, Zhe; Habtemariam, Abraha; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4702-4710</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organometallic Ir(III) cyclopentadienyl complexes [(η5-Cpx)Ir(C*N)Cl] {Cpx = Cp*, C*N = 2-(p-tolyl)pyridine (1), 2-phenylquinoline (2), 2-(2,4-difluorophenyl)pyridine (3), Cpx = tetramethyl(phenyl)cyclopentadienyl (Cpxph), C*N = 2-phenylpyridine (4), and Cpx = tetramethyl(biphenyl)cyclopentadienyl (Cpxbiph), C N = 2-phenylpyridine (5)} were synthesized and characterized.  The x-ray crystal structures of 2 and 5 were detd. and show typical piano-stool geometry.  All the complexes hydrolyzed rapidly in aq. soln. (<5 min) even at 278 K.  The pKa values of the aqua adducts 1A-5A are in the range 8.31-8.87 and follow the order 1A > 2A > 4A > 5A ≈ 3A.  Hydroxo-bridged dimers {[(η5-Cpx)Ir]2(μ-OD)3}+ (Cpx = Cp*, 6; Cpxph, 7; Cpxbiph, 8) are readily formed during pH titrns. at ca. pH 8.7.  Complexes 1 and 3-5 bind strongly to 9-ethylguanine (9-EtG), moderately strongly to 9-methyladenine (9-MeA), and hence preferentially to 9-EtG when in competition with 9-MeA.  The extent of guanine and adenine binding to complex 2 was significantly lower for both purines due to steric hindrance from the chelating ligand.  All complexes showed potent cytotoxicity, with IC50 values ranging from 6.5 to 0.7 μM toward A2780 human ovarian cancer cells.  Potency toward these cancer cells increased with addnl. Ph substitution on Cp*: Cpxbiph > Cpxph > Cp*.  Cpxbiph with complex 5 exhibited submicromolar activity (2× as active as cisplatin).  These data demonstrate how the aq. chem., nucleobase binding, and anticancer activity of C,N-bound Ir(III) cyclopentadienyl complexes can be controlled and fine-tuned by the modification of the chelating and cyclopentadienyl ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_bT6kaxdTcbVg90H21EOLACvtfcHk0lg9WsUl_O6NiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpslGisLk%253D&md5=cd92942df6d6d29d1978ea7b1b447ccc</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fom2005468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom2005468%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DOrganometallic%2520iridium%2528III%2529%2520cyclopentadienyl%2520anticancer%2520complexes%2520containing%2520C%252CN-chelating%2520ligands%26jtitle%3DOrganometallics%26date%3D2011%26volume%3D30%26issue%3D17%26spage%3D4702%26epage%3D4710%26doi%3D10.1021%2Fom2005468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5777</span>– <span class="NLM_lpage">5783</span>, <span class="refDoi"> DOI: 10.1021/ic200607j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic200607j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=5777-5783&issue=12&author=Z.+Liuauthor=L.+Salassaauthor=A.+Habtemariamauthor=A.+M.+Pizarroauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Contrasting+reactivity+and+cancer+cell+cytotoxicity+of+isoelectronic+organometallic+iridium%28III%29+complexes&doi=10.1021%2Fic200607j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes</span></div><div class="casAuthors">Liu, Zhe; Salassa, Luca; Habtemariam, Abraha; Pizarro, Ana M.; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5777-5783</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iridium(III) half-sandwich neutral cyclometalated 2-phenylpyridine (Hphpy) complex [Cp*Ir(phpy)Cl] (2, Cp* = η5-C5Me5) undergo substitution of the chloro ligand for nucleobases, exhibiting a promising cytotoxicity against human ovarian cancer cells.  Replacing the N,N-chelating ligand 2,2'-bipyridine (bpy) in the IrIII η5-pentamethylcyclopentadienyl complex [Cp*Ir(bpy)Cl]+ (1) with the C,N-chelating ligand Hphpy to give 2 switches on cytotoxicity toward A2780 human ovarian cancer cells (IC50 values of >100 μM for 1 and 10.8 μM for 2).  Ir-Cl hydrolysis is rapid for both complexes (hydrolysis equil. reached in <5 min at 278 K).  Complex 2 forms adducts with both 9-ethylguanine (9-EtG) and 9-methyladenine (9-MeA), but preferentially with 9-EtG when in competition (ca. 85% of total Ir after 24 h).  The x-ray crystal structure of [(η5-C5Me5)Ir(phpy)(9-EtG-N7)]NO3·1.5CH2Cl2 (3) confirms N7 binding to guanine.  Two-dimensional NMR spectra show that complex 2 binds to adenine mainly through N1, consistent with d. functional theory (DFT) calcns.  DFT calcns. indicate an interaction between the nitrogen of the NH2 group (9-MeA) and carbons from phpy in the adenine adduct of complex 2.  Calcns. show that the most stable geometry of the adduct [Cp*Ir(phpy)(9-EtG-κN7)]+ (3b) has the C6 of 9-EtG orientated toward the pyridine ring of phpy, and for [Cp*Ir(phpy)(9-MeA-κN1)]+ (4(N1)a), the NH2 group of 9-EtA is adjacent to the Ph ring side of phpy.  Complex 2 is more hydrophobic than complex 1, with log P values of 1.57 and -0.95, resp.  The strong nucleobase binding and high hydrophobicity of complex 2 probably contribute to its promising anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqMjGMrbypdbVg90H21EOLACvtfcHk0lg9WsUl_O6NiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslOgu7w%253D&md5=b60e6409afb934203732b78ce3169b6e</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fic200607j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic200607j%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DContrasting%2520reactivity%2520and%2520cancer%2520cell%2520cytotoxicity%2520of%2520isoelectronic%2520organometallic%2520iridium%2528III%2529%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D2011%26volume%3D50%26issue%3D12%26spage%3D5777%26epage%3D5783%26doi%3D10.1021%2Fic200607j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Potent half-sandwich iridium(III) anticancer complexes containing C^N-chelated and pyridine ligands</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5324</span>– <span class="NLM_lpage">5333</span>, <span class="refDoi"> DOI: 10.1021/om500644f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om500644f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2qtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=5324-5333&issue=19&author=Z.+Liuauthor=I.+Romero-Canelonauthor=A.+Habtemariamauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Potent+half-sandwich+iridium%28III%29+anticancer+complexes+containing+C%5EN-chelated+and+pyridine+ligands&doi=10.1021%2Fom500644f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C N-Chelated and Pyridine Ligands</span></div><div class="casAuthors">Liu, Zhe; Romero-Canelon, Isolda; Habtemariam, Abraha; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5324-5333</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis and characterization of eight half-sandwich cyclopentadienyl IrIII pyridine complexes of the type [(η5-Cpxph)Ir(phpy)Z]PF6, in which Cpxph = C5Me4C6H5 (tetramethyl(phenyl)cyclopentadienyl), phpy = 2-phenylpyridine as C N-chelating ligand, and Z = pyridine (py) or a pyridine deriv.  Three X-ray crystal structures have been detd.  The monodentate py ligands blocked hydrolysis; however, antiproliferative studies showed that all the Ir compds. are highly active toward A2780, A549, and MCF-7 human cancer cells.  In general the introduction of an electron-donating group (e.g., Me, NMe2) at specific positions on the pyridine ring resulted in increased antiproliferative activity, whereas electron-withdrawing groups (e.g., COMe, COOMe, CONEt2) decreased anticancer activity.  Complex 5 displayed the highest anticancer activity, exhibiting submicromolar potency toward a range of cancer cell lines in the National Cancer Institute NCI-60 screen, ca. 5 times more potent than the clin. platinum(II) drug cisplatin.  DNA binding appears not to be the major mechanism of action.  Although complexes [(η5-Cpxph)Ir(phpy)(py)]+ (1) and [(η5-Cpxph)Ir(phpy)(4-NMe2-py)]+ (5) did not cause cell apoptosis or cell cycle arrest after 24 h drug exposure in A2780 human ovarian cancer cells at IC50 concns., they increased the level of reactive oxygen species (ROS) dramatically and led to a loss of mitochondrial membrane potential (ΔΨm), which appears to contribute to the anticancer activity.  This class of organometallic Ir complexes has unusual features worthy of further exploration in the design of novel anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4VhzRgPrfYLVg90H21EOLACvtfcHk0lip6KUPvqwKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2qtrbN&md5=169fe702747f0c67d7c8c86f22ad8673</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fom500644f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom500644f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPotent%2520half-sandwich%2520iridium%2528III%2529%2520anticancer%2520complexes%2520containing%2520C%255EN-chelated%2520and%2520pyridine%2520ligands%26jtitle%3DOrganometallics%26date%3D2014%26volume%3D33%26issue%3D19%26spage%3D5324%26epage%3D5333%26doi%3D10.1021%2Fom500644f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2018.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.jinorgbio.2018.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=30445339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2019&pages=1-7&author=Y.+Yangauthor=L.+Guoauthor=X.+Geauthor=S.+Shiauthor=Y.+Gongauthor=Z.+Xuauthor=X.+Zhengauthor=Z.+Liu&title=Structure-activity+relationships+for+highly+potent+half-sandwich+organoiridium%28III%29+anticancer+complexes+with+C%5EN-chelated+ligands&doi=10.1016%2Fj.jinorgbio.2018.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with ĈN-chelated ligands</span></div><div class="casAuthors">Yang, Yuliang; Guo, Lihua; Ge, Xingxing; Shi, Shaopeng; Gong, Yuteng; Xu, Zhishan; Zheng, Xiaofeng; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The authors herein report the synthesis, characterization, catalytic ability in converting coenzyme NADH to NAD+ and anticancer activity of half-sandwich iridium(III) complexes.  The mol. structure of the most cytotoxic complex (I), exhibiting the familiar "piano-stool" geometry, has been authenticated by x-ray crystallog.  The anticancer activities of these complexes can be governed via substituent effects of three tunable domains and the ligand substituted variants offer an effective chelate ligand set that distinguishes anticancer activity and catalytic ability.  Notably, complex I displays the greatest cytotoxic activities (IC50 = 0.85 μM), whose anticancer activity is more approx. 25-fold higher than that of cisplatin.  The initial cell death mechanistic insight displays that this group of iridium(III) complexes exerts anticancer effects via cell cycle arrest, apoptosis induction and loss of the mitochondrial membrane potential.  In addn., the confocal microscopy imaging shows that the complex I can damage lysosome.  Overall, preliminary structure-activity relationships study and understanding of the cell death mechanism perhaps provide a rational strategy for enhancing anticancer activity of this family of complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW7f7tIODFG7Vg90H21EOLACvtfcHk0lip6KUPvqwKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqt77P&md5=9de0bb1e253551e98e62473476bad8b1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2018.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2018.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DStructure-activity%2520relationships%2520for%2520highly%2520potent%2520half-sandwich%2520organoiridium%2528III%2529%2520anticancer%2520complexes%2520with%2520C%255EN-chelated%2520ligands%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2019%26volume%3D191%26spage%3D1%26epage%3D7%26doi%3D10.1016%2Fj.jinorgbio.2018.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Phenoxide chelated Ir(III) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">13781</span>– <span class="NLM_lpage">13787</span>, <span class="refDoi"> DOI: 10.1039/C8DT03159B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8DT03159B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=30238113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Gktb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=13781-13787&issue=39&author=Y.+Zhangauthor=S.+Zhangauthor=Z.+Tianauthor=J.+Liauthor=Z.+Xuauthor=S.+Liauthor=Z.+Liu&title=Phenoxide+chelated+Ir%28III%29+N-heterocyclic+carbene+complexes%3A+synthesis%2C+characterization%2C+and+evaluation+of+their+in+vitro+anticancer+activity&doi=10.1039%2FC8DT03159B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phenoxide chelated Ir(III) N-heterocyclic carbene complexes: synthesis, characterization, and evaluation of their in vitro anticancer activity</span></div><div class="casAuthors">Zhang, Yujiao; Zhang, Shumiao; Tian, Zhenzhen; Li, Juanjuan; Xu, Zhishan; Li, Shanshan; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">13781-13787</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Twelve novel half-sandwich Ir(III)-NHC complexes [(η5-Cpx)Ir(C-O)Cl] (C-O = bidentate imidazolylidenylphenoxide ligand) were synthesized and characterized.  These complexes showed higher cytotoxic activity toward A549 cells and HeLa cells than cisplatin.  An increase in the no. of contained Ph groups was related to better anticancer activity.  The reaction of complexes with nucleobases 9-MeA, nucleobases 9-EtG, plasmid DNA and CT-DNA showed no significant effects.  These complexes captured H from NADH and converted it to NAD+, which produced the reactive O species (ROS).  ROS decreased the mitochondrial membrane potential and lysosomal damage, finally inducing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr04mX8qAJFKbVg90H21EOLACvtfcHk0lip6KUPvqwKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Gktb7M&md5=325a39b789721ecc3fcb36628ffd4c21</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2FC8DT03159B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT03159B%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DPhenoxide%2520chelated%2520Ir%2528III%2529%2520N-heterocyclic%2520carbene%2520complexes%253A%2520synthesis%252C%2520characterization%252C%2520and%2520evaluation%2520of%2520their%2520in%2520vitro%2520anticancer%2520activity%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26issue%3D39%26spage%3D13781%26epage%3D13787%26doi%3D10.1039%2FC8DT03159B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basri, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6812</span>– <span class="NLM_lpage">6815</span>, <span class="refDoi"> DOI: 10.1039/C6DT00186F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC6DT00186F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=26924272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis1Cru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=6812-6815&issue=16&author=S.+J.+Lucasauthor=R.+M.+Lordauthor=A.+M.+Basriauthor=S.+J.+Allisonauthor=R.+M.+Phillipsauthor=A.+J.+Blackerauthor=P.+C.+McGowan&title=Increasing+anti-cancer+activity+with+longer+tether+lengths+of+group+9+Cp*+complexes&doi=10.1039%2FC6DT00186F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes</span></div><div class="casAuthors">Lucas, Stephanie. J.; Lord, Rianne M.; Basri, Aida M.; Allison, Simon J.; Phillips, Roger M.; Blacker, A. John; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6812-6815</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Here in, authors report the cytotoxicity of both rhodium and iridium functionalized Cp* analogs of the [Cp*MCl2]2 dimers.  The functionalized dimers contain a hydroxy tethered arm of differing carbon length.  These show promising IC50 values when tested against HT-29, A2780 and cisplatin-resistant A2780cis human cancer cell lines, with the cytotoxicity improving proportionally with an increase in carbon tether length of the Cp* ring.  The most promising results are seen for the 14-carbon Cp* tethered rhodium (2d) and iridium (3b) complexes, which show up to a 24-fold increase in IC50 compared to the unfunctionalized [Cp*MCl2]2 dimer.  All complexes were potent inhibitors of purified thioredoxin reductase suggesting that disruption of cellular anti-oxidant function is one potential mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGQ-QoVtxExLVg90H21EOLACvtfcHk0liUD9vkG_lqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis1Cru7o%253D&md5=34c1aecd2a9c0a25ea6b461caa5ccd09</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2FC6DT00186F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT00186F%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%2BJ.%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DBasri%26aufirst%3DA.%2BM.%26aulast%3DAllison%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DBlacker%26aufirst%3DA.%2BJ.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DIncreasing%2520anti-cancer%2520activity%2520with%2520longer%2520tether%2520lengths%2520of%2520group%25209%2520Cp%252A%2520complexes%26jtitle%3DDalton%2520Trans.%26date%3D2016%26volume%3D45%26issue%3D16%26spage%3D6812%26epage%3D6815%26doi%3D10.1039%2FC6DT00186F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, S. P.</span>; <span class="NLM_string-name">McGowan, P. C.</span>; <span class="NLM_string-name">Lanaro, R.</span>; <span class="NLM_string-name">Blacker, A. J.</span></span> <span> </span><span class="NLM_article-title">Metal complexes</span>. WO <span class="NLM_patent">2017103623</span>, June 22, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+P.+Marsden&author=P.+C.+McGowan&author=R.+Lanaro&author=A.+J.+Blacker&title=Metal+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarsden%26aufirst%3DS.%2BP.%26atitle%3DMetal%2520complexes%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Peña, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Control of reversible activation dynamics of [Ru{η<sup>6</sup>:κ<sup>1</sup>-C<sub>6</sub>H<sub>5</sub>(C<sub>6</sub>H<sub>4</sub>)NH<sub>2</sub>}(XY)]<sup>n+</sup> and the effect of chelating-ligand variation</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">64</span>),  <span class="NLM_fpage">16231</span>– <span class="NLM_lpage">16241</span>, <span class="refDoi"> DOI: 10.1002/chem.201701681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fchem.201701681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=28734001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=16231-16241&issue=64&author=F.+Martinez-Pe%C3%B1aauthor=A.+M.+Pizarro&title=Control+of+reversible+activation+dynamics+of+%5BRu%7B%CE%B76%3A%CE%BA1-C6H5%28C6H4%29NH2%7D%28XY%29%5Dn%2B+and+the+effect+of+chelating-ligand+variation&doi=10.1002%2Fchem.201701681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Control of Reversible Activation Dynamics of [Ru{η6:κ1-C6H5(C6H4)NH2}(XY)]n+ and the Effect of Chelating-Ligand Variation</span></div><div class="casAuthors">Martinez-Pena, Francisco; Pizarro, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">64</span>),
    <span class="NLM_cas:pages">16231-16241</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The potential use of organoruthenium complexes as anticancer drugs is well known.  Herein, a family of activatable tethered ruthenium(II) arene complexes of general formula [Ru{η6:κ1-C6H5(C6H4)NH2}(XY)]n+ (closed tether ring) bearing different chelating XY ligands (XY=aliph. diamine, phenylenediamine, oxalato, bis(phosphino)ethane) is reported.  The activation of these complexes (closed- to open-tether conversion) occurs in methanol and DMSO at different rates and to different reaction extents at equil.  Most importantly, RuII-complex activation (cleavage of the Ru-Ntether bond) occurs in aq. soln. at high proton concn. (upon Ntether protonation).  The activation dynamics can be modulated by rational variation of the XY chelating ligand.  The electron-donating capability and steric hindrance of XY have a direct impact on the reactivity of the Ru-N bond, and XY=N,N'-dimethyl-, N,N'-diethyl-, and N,N,N',N'-tetramethylethylenediamine afford complexes that are more prone to activation.  Such activation in acidic media is fully reversible, and proton concn. also governs the deactivation rate, i.e., tether-ring closure slows down with decreasing pH.  Interaction of a closed-tether complex and its open-tether counterpart with 5'-guanosine monophosphate revealed selectivity of the active (open) complex towards interaction with nucleobases.  This work presents ruthenium tether complexes as exceptional pH-dependent switches with potential applications in cancer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIXCi-JoklMrVg90H21EOLACvtfcHk0liUD9vkG_lqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOjsr3O&md5=ed28817ec8c3577eef9bdab196939268</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201701681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201701681%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Pe%25C3%25B1a%26aufirst%3DF.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DControl%2520of%2520reversible%2520activation%2520dynamics%2520of%2520%255BRu%257B%25CE%25B76%253A%25CE%25BA1-C6H5%2528C6H4%2529NH2%257D%2528XY%2529%255Dn%252B%2520and%2520the%2520effect%2520of%2520chelating-ligand%2520variation%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26issue%3D64%26spage%3D16231%26epage%3D16241%26doi%3D10.1002%2Fchem.201701681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Peña, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante-Tadeo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Reversible pH-responsive behavior of ruthenium(II) arene complexes with tethered carboxylate</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">5657</span>– <span class="NLM_lpage">5668</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.8b00625</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.8b00625" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFeksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=5657-5668&issue=9&author=F.+Martinez-Pe%C3%B1aauthor=S.+Infante-Tadeoauthor=A.+Habtemariamauthor=A.+M.+Pizarro&title=Reversible+pH-responsive+behavior+of+ruthenium%28II%29+arene+complexes+with+tethered+carboxylate&doi=10.1021%2Facs.inorgchem.8b00625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate</span></div><div class="casAuthors">Martinez-Pena, Francisco; Infante-Tadeo, Sonia; Habtemariam, Abraha; Pizarro, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5657-5668</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Five complexes [Ru(η6-C6H5CH2COOH)(XY)Cl]Cl/Na (XY = ethylenediamine (1), o-phenylenediamine (2), phenanthroline (3), and oxalato (4)) and [Ru(η6:κ1-C6H5CH2COO)(tmen)]Cl (tmen = N,N,N',N'-tetramethylethylenediamine, 5C) were synthesized and fully characterized.  Five new x-ray crystal structures ([Ru(η6-C6H5CH2COOH)(μ-Cl)Cl]2, 1, 3, 4, and 5C·PF6) were detd., which are the 1st examples of Ru(II) structures with phenylacetic acid as arene ligand.  Also, 5C·PF6 is the 1st example of a five-membered tether ring with a Ru(η6:κ1-arene:O) bond.  The tether ring in these complexes opens in acidic pH (<5) and closes reversibly in aq. soln.  The chlorido open-form undergoes aquation, and the aqua adduct can be obsd. (prior to ring closure) by NMR.  The speciation has an attractive complexity in the pH range 0-12, showing interconversion of the three species (chlorido, aqua, and closed tether), dependent on the proton concn. and the nature of the XY chelating ligand.  The closed tether version of 3, complex 3C, with σ-donor/π-acceptor phenanthroline as chelating ligand, opens up more readily (pH 4), while the tether ring in complex 5C hardly opens even at pH ≥1.  The authors detd. the pKa of the pendant carboxylic group and that of the aqua adduct (∼3 and ∼7, resp.), which can be finely tuned by the appropriate choice of XY.  Complexes 1 and 2, which predominate in their inactive (closed-tether) form in intracellular conditions, show some cytotoxic activity (IC50 130 and 117 μM, resp.) in A2780 ovarian cancer cells.  Complex 1 catalyzes the redn. through transfer hydrogenation of pyruvate to lactate and NAD+ to NADH in the presence of formate as H-source.  Co-incubation with Na formate decreases the IC50 value of 1 in A2780 cancer cells significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJkFUxNYPurVg90H21EOLACvtfcHk0liUD9vkG_lqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFeksro%253D&md5=e6e2301b58ef181364392616c7c18c6e</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.8b00625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.8b00625%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Pe%25C3%25B1a%26aufirst%3DF.%26aulast%3DInfante-Tadeo%26aufirst%3DS.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DReversible%2520pH-responsive%2520behavior%2520of%2520ruthenium%2528II%2529%2520arene%2520complexes%2520with%2520tethered%2520carboxylate%26jtitle%3DInorg.%2520Chem.%26date%3D2018%26volume%3D57%26issue%3D9%26spage%3D5657%26epage%3D5668%26doi%3D10.1021%2Facs.inorgchem.8b00625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savoie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. S.</span></span> <span> </span><span class="NLM_article-title">pH-dependent modulation of reactivity in ruthenium(II) organometallics</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.7b00868</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.7b00868" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=294-297&issue=3&author=T.+J.+Priorauthor=H.+Savoieauthor=R.+W.+Boyleauthor=B.+S.+Murray&title=pH-dependent+modulation+of+reactivity+in+ruthenium%28II%29+organometallics&doi=10.1021%2Facs.organomet.7b00868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Dependent Modulation of Reactivity in Ruthenium(II) Organometallics</span></div><div class="casAuthors">Prior, Timothy J.; Savoie, Huguette; Boyle, Ross W.; Murray, Benjamin S.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-297</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The pH-dependent intramol. chelation of a tethered sulfonamide ligand in Ru(II) arene complexes is demonstrated, a process shown to modulate metal-centered reactivity toward the model ligand GMP within the physiol. relevant pH region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsgiFJTFtIH7Vg90H21EOLACvtfcHk0liUD9vkG_lqag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKms7s%253D&md5=a79c66b44243539399f9d0f2dd76dfaf</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.7b00868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.7b00868%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DT.%2BJ.%26aulast%3DSavoie%26aufirst%3DH.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26aulast%3DMurray%26aufirst%3DB.%2BS.%26atitle%3DpH-dependent%2520modulation%2520of%2520reactivity%2520in%2520ruthenium%2528II%2529%2520organometallics%26jtitle%3DOrganometallics%26date%3D2018%26volume%3D37%26issue%3D3%26spage%3D294%26epage%3D297%26doi%3D10.1021%2Facs.organomet.7b00868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stodt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gencaslan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, W. S.</span></span> <span> </span><span class="NLM_article-title">Preparation, reactivity and peptide labelling properties of (η<sup>6</sup>-arene)ruthenium(II) complexes with pendant carboxylate groups</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2003</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1873</span>– <span class="NLM_lpage">1882</span>, <span class="refDoi"> DOI: 10.1002/ejic.200200599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fejic.200200599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=1873-1882&issue=10&author=R.+Stodtauthor=S.+Gencaslanauthor=I.+M.+M%C3%BCllerauthor=W.+S.+Sheldrick&title=Preparation%2C+reactivity+and+peptide+labelling+properties+of+%28%CE%B76-arene%29ruthenium%28II%29+complexes+with+pendant+carboxylate+groups&doi=10.1002%2Fejic.200200599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1002%2Fejic.200200599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200200599%26sid%3Dliteratum%253Aachs%26aulast%3DStodt%26aufirst%3DR.%26aulast%3DGencaslan%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DI.%2BM.%26aulast%3DSheldrick%26aufirst%3DW.%2BS.%26atitle%3DPreparation%252C%2520reactivity%2520and%2520peptide%2520labelling%2520properties%2520of%2520%2528%25CE%25B76-arene%2529ruthenium%2528II%2529%2520complexes%2520with%2520pendant%2520carboxylate%2520groups%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2003%26volume%3D2003%26issue%3D10%26spage%3D1873%26epage%3D1882%26doi%3D10.1002%2Fejic.200200599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Amarasekera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauchfuss, T. B.</span></span> <span> </span><span class="NLM_article-title">Interconversion of persulfido, sulfur hydride, and hydride ligands coordinated to CpRu(PPh<sub>3</sub>)<sub>2</sub><sup>+</sup></span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3883</span>, <span class="refDoi"> DOI: 10.1021/ic00319a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic00319a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaL1MXlsFCjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1989&pages=3875-3883&issue=20&author=J.+Amarasekeraauthor=T.+B.+Rauchfuss&title=Interconversion+of+persulfido%2C+sulfur+hydride%2C+and+hydride+ligands+coordinated+to+CpRu%28PPh3%292%2B&doi=10.1021%2Fic00319a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">Interconversion of persulfido, sulfur hydride, and hydride ligands coordinated to CpRu(PPh3)2+</span></div><div class="casAuthors">Amarasekera, Jayantha; Rauchfuss, Thomas B.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3875-83</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">The electron-rich metallothiol CpRu(PPh3)2SH (I, Cp = η5-cyclopentadienyl) has been prepd. from the reactions of CpRu(PPh3)2Cl with NaSH and CpRu(PPh3)2H with elemental sulfur.  Carbonylation of I gives CpRu(PPh3)(CO)SH whereas the carbonylation of CpRu(PPh3)2Cl is thermodynamically unfavorable.  Protonation of I gives [CpRu(PPh3)2(SH2)]+.  Alkylation of I gives thiol complexes [CpRu(PPh3)2(RSH)]+ (R = Me); such complexes were also prepd. directly from CpRu(PPh3)2OTf (OTf = CF3SO3) and RSH.  The structure of the thiol complex [CpRu(PPh3)2(PrSH)]BF4·CH2Cl2 was detd. by x-ray methods.  [CpRu(PPh3)2(SH2)]+ reacts reversibly with H2 to give the dihydride [CpRu(PPh3)2H2]+.  Analogous results were found for [((2-SC4H3)CH2C5H4)Ru(PPh3)2]+; the S-bound thiophene ligand can be displaced by H2S, H2, H-, and SH-.  [CpRu(PPh3)2(H2S)]+ oxidizes in air to give [CpRu(PPh3)2]2(μ-S2]2+ (II).  Salts of II are formed in two-electron oxidns. of I with Ph3CBF4, Cp2Fe+, and I2 as well as electrochem.  A presumed intermediate in this oxidn. is [CpRu(PPh3)2]2(μ-S2)+.  This mixed-valence compd. disproportionates upon addn. of HOTf to give II and [CpRu(PPh3)2(SH2)]+.  The reaction of I with sulfur gave ruthenium polysulfides [CpRu(PPh3)]2Sx (x = 4, 6).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO_L-chZ0t7bVg90H21EOLACvtfcHk0lgjbX-PIRwpgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXlsFCjtb8%253D&md5=8149d2ea836929605afc6a84c0bb339b</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1021%2Fic00319a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic00319a024%26sid%3Dliteratum%253Aachs%26aulast%3DAmarasekera%26aufirst%3DJ.%26aulast%3DRauchfuss%26aufirst%3DT.%2BB.%26atitle%3DInterconversion%2520of%2520persulfido%252C%2520sulfur%2520hydride%252C%2520and%2520hydride%2520ligands%2520coordinated%2520to%2520CpRu%2528PPh3%25292%252B%26jtitle%3DInorg.%2520Chem.%26date%3D1989%26volume%3D28%26issue%3D20%26spage%3D3875%26epage%3D3883%26doi%3D10.1021%2Fic00319a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span> <span> </span><span class="NLM_article-title">pH-dependent transfer hydrogenation, reductive amination, and dehalogenation of water-soluble carbonyl compounds and alkyl halides promoted by Cp*Ir complexes</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4903</span>– <span class="NLM_lpage">4910</span>, <span class="refDoi"> DOI: 10.1021/om010523v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om010523v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVyns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=4903-4910&issue=23&author=S.+Ogoauthor=N.+Makiharaauthor=Y.+Kanekoauthor=Y.+Watanabe&title=pH-dependent+transfer+hydrogenation%2C+reductive+amination%2C+and+dehalogenation+of+water-soluble+carbonyl+compounds+and+alkyl+halides+promoted+by+Cp*Ir+complexes&doi=10.1021%2Fom010523v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">pH-Dependent Transfer Hydrogenation, Reductive Amination, and Dehalogenation of Water-Soluble Carbonyl Compounds and Alkyl Halides Promoted by Cp*Ir Complexes</span></div><div class="casAuthors">Ogo, Seiji; Makihara, Nobuyuki; Kaneko, Yuichi; Watanabe, Yoshihito</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4903-4910</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper reports pH-dependent transfer hydrogenation, reductive amination, and dehalogenation of water-sol. substrates with the organometallic aqua complexes [Cp*IrIII(H2O)3]2+ (1, Cp* = η5-pentamethylcyclopentadienyl), [(Cp-py)IrIII(H2O)2]2+ (2, Cp-py = η5-(tetramethylcyclopentadienyl)methylpyridine), and [Cp*IrIII(bpy)(H2O)]2+ (3, bpy = 2,2'-bipyridine) as catalyst precursors and the formate ions HCOONa and HCOONH4 as H donors.  Because of the difference in the electron-donating ability of the Cp*, Cp-py, and bpy ligands, the Lewis acidity of the Ir ions of 1-3 are ordered in strength as follows: 1 > 2 > 3.  Complexes 1-3 are reversibly deprotonated to form the catalytically inactive hydroxo complexes [(Cp*IrIII)2(μ-OH)3]+ (5), [{(Cp-py)IrIII}2(μ-OH)2]2+ (6), and [Cp*IrIII(bpy)(OH)]+ (7) around pH 2.8, 4.5, and 6.6, resp.  The deprotonation behavior of 1-3 indicates that the more Lewis acidic Ir ions would lower the pKa values of the coordinated H2O ligands.  As a function of pH, the catalyst precursors 1 and 3 react with the formate ions to form the hydride complexes [(Cp*IrIII)2(μ-H)(μ-OH)(μ-HCOO)]+ (8) and [Cp*IrIII(bpy)(H)]+ (9), resp., which act as active catalysts in these catalytic redns.  A similar hydride complex would be formed from the reaction of 2 with the formate ions, though the authors have no definite structural information on the hydride complex.  The structures of 3(OTf)2·H2O (OTf = CF3SO3-), [(Cp-py)IrIIICl2] (4), 6(OTf)2, 7(OTf)·2H2O, and 8(PF6) were unequivocally detd. by x-ray anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnUp0HLLIHYrVg90H21EOLACvtfcHk0lgjbX-PIRwpgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVyns70%253D&md5=84edfbaabe5cc5fa85baf4f439386654</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fom010523v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom010523v%26sid%3Dliteratum%253Aachs%26aulast%3DOgo%26aufirst%3DS.%26aulast%3DMakihara%26aufirst%3DN.%26aulast%3DKaneko%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DY.%26atitle%3DpH-dependent%2520transfer%2520hydrogenation%252C%2520reductive%2520amination%252C%2520and%2520dehalogenation%2520of%2520water-soluble%2520carbonyl%2520compounds%2520and%2520alkyl%2520halides%2520promoted%2520by%2520Cp%252AIr%2520complexes%26jtitle%3DOrganometallics%26date%3D2001%26volume%3D20%26issue%3D23%26spage%3D4903%26epage%3D4910%26doi%3D10.1021%2Fom010523v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iggo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Half-sandwich iridium complexes—Synthesis and applications in catalysis</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>252</i></span> (<span class="NLM_issue">5–7</span>),  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">809</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2008.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ccr.2008.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislajs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2008&pages=782-809&issue=5%E2%80%937&author=J.+Liuauthor=X.+Wuauthor=J.+A.+Iggoauthor=J.+Xiao&title=Half-sandwich+iridium+complexes%E2%80%94Synthesis+and+applications+in+catalysis&doi=10.1016%2Fj.ccr.2008.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Half-sandwich iridium complexes-Synthesis and applications in catalysis</span></div><div class="casAuthors">Liu, Jianke; Wu, Xiaofeng; Iggo, Jon A.; Xiao, Jianliang</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">782-809</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A brief summary of the organometallic chem. of half-sandwich iridium complexes accomplished in the last a few years is given, with emphasis on chiral-at-metal complexes, the synthetic protocols employed and the stereochem. involved in relevant transformations.  The applications of these complexes in catalysis are highlighted by selected examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jMPMUw-MF7Vg90H21EOLACvtfcHk0lgjbX-PIRwpgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislajs7o%253D&md5=03d22d55eba553258c7254081a651aa6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DIggo%26aufirst%3DJ.%2BA.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DHalf-sandwich%2520iridium%2520complexes%25E2%2580%2594Synthesis%2520and%2520applications%2520in%2520catalysis%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2008%26volume%3D252%26issue%3D5%25E2%2580%25937%26spage%3D782%26epage%3D809%26doi%3D10.1016%2Fj.ccr.2008.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikariya, T.</span></span> <span> </span><span class="NLM_article-title">Bifunctional triflylamide-tethered Cp′Rh and Cp′Ir complexes: A new entry for asymmetric hydrogenation catalysts</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2399</span>, <span class="refDoi"> DOI: 10.1021/om1001809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om1001809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=2397-2399&issue=11&author=M.+Itoauthor=Y.+Endoauthor=N.+Tejimaauthor=T.+Ikariya&title=Bifunctional+triflylamide-tethered+Cp%E2%80%B2Rh+and+Cp%E2%80%B2Ir+complexes%3A+A+new+entry+for+asymmetric+hydrogenation+catalysts&doi=10.1021%2Fom1001809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional Triflylamide-Tethered Cp'Rh and Cp'Ir Complexes: A New Entry for Asymmetric Hydrogenation Catalysts</span></div><div class="casAuthors">Ito, Masato; Endo, Yoshinori; Tejima, Noriko; Ikariya, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2397-2399</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triflylamide-tethered complexes, [η5:η1-Me4C5(CH2)nNTf]MCl(MeCN) and [η5:η1-Me4C5(CH2)nNTf]M((R,R)-Msdpen) (M = Rh, Ir, n = 2-4, Tf = CF3SO2, Msdpen = MsNCH(C6H5)CH(C6H5)NH2, Ms = CH3SO2), were prepd. via ring closure of pendant NHTf groups of dimeric [η5-Me4C5(CH2)nNHTf]2M2Cl4 complexes and replacement of chloro and acetonitrile ligands with (R,R)-Msdpen-H.  The mol. structures of 9 complexes were detd. by x-ray crystallog. and their three-legged piano-stool structure characterized.  The tethered complexes [η5:η1-Me4C5(CH2)nNTf]M((R,R)-Msdpen) promote asym. hydrogenation of acetophenone, which indicates that the introduction of a suitable triflylamide tether unit changes their catalytic function from transfer hydrogenation to hydrogenation.  The catalytic activity of the C4 tethered complexes (94% to 96% yield and 93% ee) proved to be superior to those of C2 and C3 tethered ones, whose inferiority should be originated from the presence of a H bond between the protic amine and the sulfonyl O.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJBqwOv-PT7Vg90H21EOLACvtfcHk0li6y3oDZUzF1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFehsb8%253D&md5=a23db403fc2d141b6378b2fb4a87af1a</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fom1001809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom1001809%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DTejima%26aufirst%3DN.%26aulast%3DIkariya%26aufirst%3DT.%26atitle%3DBifunctional%2520triflylamide-tethered%2520Cp%25E2%2580%25B2Rh%2520and%2520Cp%25E2%2580%25B2Ir%2520complexes%253A%2520A%2520new%2520entry%2520for%2520asymmetric%2520hydrogenation%2520catalysts%26jtitle%3DOrganometallics%26date%3D2010%26volume%3D29%26issue%3D11%26spage%3D2397%26epage%3D2399%26doi%3D10.1021%2Fom1001809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritzkow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enders, M.</span></span> <span> </span><span class="NLM_article-title">Rhodium(III) and iridium(III) complexes with quinolyl-functionalized Cp Ligands: synthesis and catalytic hydrogenation activity</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>2008</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">4230</span>– <span class="NLM_lpage">4235</span>, <span class="refDoi"> DOI: 10.1002/ejic.200800217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fejic.200800217" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=4230-4235&issue=27&author=G.+Kohlauthor=H.+Pritzkowauthor=M.+Enders&title=Rhodium%28III%29+and+iridium%28III%29+complexes+with+quinolyl-functionalized+Cp+Ligands%3A+synthesis+and+catalytic+hydrogenation+activity&doi=10.1002%2Fejic.200800217"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1002%2Fejic.200800217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.200800217%26sid%3Dliteratum%253Aachs%26aulast%3DKohl%26aufirst%3DG.%26aulast%3DPritzkow%26aufirst%3DH.%26aulast%3DEnders%26aufirst%3DM.%26atitle%3DRhodium%2528III%2529%2520and%2520iridium%2528III%2529%2520complexes%2520with%2520quinolyl-functionalized%2520Cp%2520Ligands%253A%2520synthesis%2520and%2520catalytic%2520hydrogenation%2520activity%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2008%26volume%3D2008%26issue%3D27%26spage%3D4230%26epage%3D4235%26doi%3D10.1002%2Fejic.200800217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Esteruelas, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Alvarez, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oñate, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Sánchez, P.</span></span> <span> </span><span class="NLM_article-title">Iridium(I), iridium(III), and iridium(V) complexes containing the (2-methoxyethyl)cyclopentadienyl ligand</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5131</span>– <span class="NLM_lpage">5138</span>, <span class="refDoi"> DOI: 10.1021/om060511f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om060511f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVyrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5131-5138&issue=21&author=M.+A.+Esteruelasauthor=F.+J.+Fern%C3%A1ndez-Alvarezauthor=A.+M.+L%C3%B3pezauthor=E.+O%C3%B1ateauthor=P.+Ruiz-S%C3%A1nchez&title=Iridium%28I%29%2C+iridium%28III%29%2C+and+iridium%28V%29+complexes+containing+the+%282-methoxyethyl%29cyclopentadienyl+ligand&doi=10.1021%2Fom060511f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Iridium(I), Iridium(III), and Iridium(V) Complexes Containing the (2-Methoxyethyl)cyclopentadienyl Ligand</span></div><div class="casAuthors">Esteruelas, Miguel A.; Fernandez-Alvarez, Francisco J.; Lopez, Ana M.; Onate, Enrique; Ruiz-Sanchez, Pilar</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5131-5138</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Treatment of [Ir(μ-Cl)(COE)2]2 (1) with LiCpO gives Ir(η5-CpO)(COE)2 (2; CpO = C5H4(CH2)2OMe; COE = cis-cyclooctene), which reacts with X2 to afford the Ir(III) derivs. [Ir(η5-CpO)X(μ-X)]2 [X = I (3), Cl (4)].  Complexes 3 and 4 react with PiPr3 to yield the corresponding species Ir(η5-CpO)(PiPr3)X2 [X = iodo (5), Cl (6)], which by addn. of LiHBEt3 give Ir(η5-CpO)(PiPr3)H2 (7).  The reactions of 5 and 6 with 2.0 equiv of AgBF4 in MeCN lead to [Ir(η5-CpO)(PiPr3)(NCMe)2][BF4]2 (8).  Treatment of 3 with 2.0 equiv of HSiEt3 per Ir affords the monohydride dimer [Ir(η5-CpO)I]2(μ-H)(μ-I) (9).  Complex 4 reacts with 4.0 equiv of HSiEt3 per Ir to give the Ir(V) silyl trihydride deriv. IrH3(η5-CpO)(SiEt3) (10), which in the presence of excess of HSiEt3 is transformed into IrH2(η5-CpO)(SiEt3)2 (11).  Treatment at -40° of 4 with 2.0 equiv of HSiEt3 per Ir leads to a mixt. of the hydride dichloro triethylsilyl complex IrH(η5-CpO)Cl2(SiEt3) (12), the dihydride chloro triethylsilyl compd. IrH2(η5-CpO)Cl(SiEt3) (14), and the monohydride dimer [Ir(η5-CpO)Cl]2(μ-H)(μ-Cl) (16).  Complex 16 was also prepd. by reaction of 4 with 1.0 equiv of HSiEt3 per Ir.  Complex 10 is easily deuterated in C6D6 at 80°.  The x-ray structures of 4, 8, and 9 are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlg5IKpmCrXLVg90H21EOLACvtfcHk0li6y3oDZUzF1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVyrs70%253D&md5=8b4142d1b404967d76279ce223f89be8</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Fom060511f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom060511f%26sid%3Dliteratum%253Aachs%26aulast%3DEsteruelas%26aufirst%3DM.%2BA.%26aulast%3DFern%25C3%25A1ndez-Alvarez%26aufirst%3DF.%2BJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DA.%2BM.%26aulast%3DO%25C3%25B1ate%26aufirst%3DE.%26aulast%3DRuiz-S%25C3%25A1nchez%26aufirst%3DP.%26atitle%3DIridium%2528I%2529%252C%2520iridium%2528III%2529%252C%2520and%2520iridium%2528V%2529%2520complexes%2520containing%2520the%2520%25282-methoxyethyl%2529cyclopentadienyl%2520ligand%26jtitle%3DOrganometallics%26date%3D2006%26volume%3D25%26issue%3D21%26spage%3D5131%26epage%3D5138%26doi%3D10.1021%2Fom060511f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conesa, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Fanjul, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrascosa, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloetens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Unambiguous intracellular localization and quantification of a potent iridium anticancer compound by correlative 3D cryo X-ray imaging</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">59</span>),  <span class="NLM_fpage">1270</span>– <span class="NLM_lpage">1278</span>, <span class="refDoi"> DOI: 10.1002/anie.201911510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fanie.201911510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyitb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=1270-1278&issue=59&author=J.+J.+Conesaauthor=A.+C.+Carrascoauthor=V.+Rodriguez-Fanjulauthor=Y.+Yangauthor=J.+L.+Carrascosaauthor=P.+Cloetensauthor=E.+Pereiroauthor=A.+M.+Pizarro&title=Unambiguous+intracellular+localization+and+quantification+of+a+potent+iridium+anticancer+compound+by+correlative+3D+cryo+X-ray+imaging&doi=10.1002%2Fanie.201911510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Unambiguous Intracellular Localization and Quantification of a Potent Iridium Anticancer Compound by Correlative 3D Cryo X-Ray Imaging</span></div><div class="casAuthors">Conesa, Jose Javier; Carrasco, Ana C.; Rodriguez-Fanjul, Vanessa; Yang, Yang; Carrascosa, Jose L.; Cloetens, Peter; Pereiro, Eva; Pizarro, Ana M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1270-1278</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The iridium half-sandwich complex [Ir(η5:κ1-C5Me4CH2py)(2-phenylpyridine)]PF6 is highly cytotoxic: 15-250× more potent than clin. used cisplatin in several cancer cell lines.  We have developed a correlative 3D cryo x-ray imaging approach to specifically localize and quantify iridium within the whole hydrated cell at nanometer resoln.  By means of cryo soft x-ray tomog. (cryo-SXT), which provides the cellular ultrastructure at 50 nm resoln., and cryo hard x-ray fluorescence tomog. (cryo-XRF), which provides the elemental sensitivity with a 70 nm step size, we have located the iridium anticancer agent exclusively in the mitochondria.  Our methodol. provides unique information on the intracellular fate of the metallodrug, without chem. fixation, labeling, or mech. manipulation of the cells.  This cryo-3D correlative imaging method can be applied to a no. of biochem. processes for specific elemental localization within the native cellular landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppmD9mj5i-CLVg90H21EOLACvtfcHk0lhpv2AJpVYApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyitb3J&md5=84ce048de8e589b0edf5148dbecde34c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fanie.201911510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201911510%26sid%3Dliteratum%253Aachs%26aulast%3DConesa%26aufirst%3DJ.%2BJ.%26aulast%3DCarrasco%26aufirst%3DA.%2BC.%26aulast%3DRodriguez-Fanjul%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCarrascosa%26aufirst%3DJ.%2BL.%26aulast%3DCloetens%26aufirst%3DP.%26aulast%3DPereiro%26aufirst%3DE.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DUnambiguous%2520intracellular%2520localization%2520and%2520quantification%2520of%2520a%2520potent%2520iridium%2520anticancer%2520compound%2520by%2520correlative%25203D%2520cryo%2520X-ray%2520imaging%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2020%26volume%3D59%26issue%3D59%26spage%3D1270%26epage%3D1278%26doi%3D10.1002%2Fanie.201911510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Betanzos-Lara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salassa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Photocontrolled nucleobase binding to an organometallic Ru(II) arene complex</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>, (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">6622</span>– <span class="NLM_lpage">6624</span>, <span class="refDoi"> DOI: 10.1039/b914153g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2Fb914153g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19865670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlalur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=6622-6624&issue=43&author=S.+Betanzos-Laraauthor=L.+Salassaauthor=A.+Habtemariamauthor=P.+J.+Sadler&title=Photocontrolled+nucleobase+binding+to+an+organometallic+Ru%28II%29+arene+complex&doi=10.1039%2Fb914153g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Photocontrolled nucleobase binding to an organometallic RuII arene complex</span></div><div class="casAuthors">Betanzos-Lara, Soledad; Salassa, Luca; Habtemariam, Abraha; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">6622-6624</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">[(P-cym)Ru(bpm)(py)][PF6]2 (p-cym = para-cymene, bpm = 2,2'-bipyrimidine and py = pyridine) is the 1st Ru(II) arene complex that can selectively photodissociate a monodentate ligand (py) when excited with visible light and form a reactive aqua deriv. ([(p-cym)Ru(bpm)(H2O)]2+) able to bind to a DNA base.  A complete set of DFT and TDDFT calcns. on [(p-cym)Ru(bpm)(py)]2+ was performed to characterize the singlet and triplet excited states of the complex and to obtain insights into the mechanism of ligand photodissocn.  To study the ability of [(p-cym)Ru(bpm)(py)]2+ to bind to DNA bases the authors performed an irradn. expt. of [(p-cym)Ru(bpm)(py)]2+ in the presence of 9-EtG (9-ethylguanine).  Irradn. of [(p-cym)Ru(bpm)(py)]2+ with white light at 310 K in D2O in the presence of 1 mol equiv. of 9-EtG results in the initial formation of the aqua complex followed by coordination of the nucleobase to the Ru center to form [(p-cym)Ru(bpm)(9-EtG)]2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlDJEskjoYv7Vg90H21EOLACvtfcHk0lhpv2AJpVYApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlalur%252FJ&md5=8b001e72fde1fc40c06814f7955aba09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fb914153g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb914153g%26sid%3Dliteratum%253Aachs%26aulast%3DBetanzos-Lara%26aufirst%3DS.%26aulast%3DSalassa%26aufirst%3DL.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DPhotocontrolled%2520nucleobase%2520binding%2520to%2520an%2520organometallic%2520Ru%2528II%2529%2520arene%2520complex%26jtitle%3DChem.%2520Commun.%26date%3D2009%26issue%3D43%26spage%3D6622%26epage%3D6624%26doi%3D10.1039%2Fb914153g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennessel, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span> <span> </span><span class="NLM_article-title">An efficient low-temperature route to polycyclic isoquinoline salt synthesis via C-H activation with [Cp*MCl<sub>2</sub>]<sub>2</sub> (M = Rh, Ir)</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">12414</span>– <span class="NLM_lpage">12419</span>, <span class="refDoi"> DOI: 10.1021/ja802415h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja802415h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtValu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=12414-12419&issue=37&author=L.+Liauthor=W.+W.+Brennesselauthor=W.+D.+Jones&title=An+efficient+low-temperature+route+to+polycyclic+isoquinoline+salt+synthesis+via+C-H+activation+with+%5BCp*MCl2%5D2+%28M+%3D+Rh%2C+Ir%29&doi=10.1021%2Fja802415h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient Low-Temperature Route to Polycyclic Isoquinoline Salt Synthesis via C-H Activation with [Cp*MCl2]2 (M = Rh, Ir)</span></div><div class="casAuthors">Li, Ling; Brennessel, William W.; Jones, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12414-12419</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bi-, tri-, and tetracyclic isoquinoline salts were readily synthesized in excellent yields at room temp. from readily available starting materials after three reaction steps.  Arom. C-H activation was first promoted by sodium acetate with [Cp*MCl2]2 (M = Rh, Ir) at room temp. to form cyclometalated compds.  Dimethylacetylenedicarboxylate was then found to insert into the metal-carbon bonds of the cyclometalated compds.  Finally, the insertion compds. underwent oxidative coupling to form the desired isoquinoline salts and regenerate [Cp*MCl2]2.  All of the intermediate compds. following C-H activation, alkyne insertion, and oxidative coupling were fully characterized, including the detn. of X-ray structures in several cases, and the results shed light on the overall mechanism.  Moreover, it was possible to synthesize the isoquinoline salts from readily available starting materials using one-pot procedures; thus, this work provides a novel, efficient method for metal-mediated synthesis of heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHn36vG-iy7rVg90H21EOLACvtfcHk0lhpv2AJpVYApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtValu7%252FO&md5=21e6e55944575f2dee7a6e5727ac3a0d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja802415h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja802415h%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DBrennessel%26aufirst%3DW.%2BW.%26aulast%3DJones%26aufirst%3DW.%2BD.%26atitle%3DAn%2520efficient%2520low-temperature%2520route%2520to%2520polycyclic%2520isoquinoline%2520salt%2520synthesis%2520via%2520C-H%2520activation%2520with%2520%255BCp%252AMCl2%255D2%2520%2528M%2520%253D%2520Rh%252C%2520Ir%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26issue%3D37%26spage%3D12414%26epage%3D12419%26doi%3D10.1021%2Fja802415h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennessel, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, W. D.</span></span> <span> </span><span class="NLM_article-title">C-H activation of phenyl imines and 2-phenylpyridines with [Cp*MCl<sub>2</sub>]<sub>2</sub>(M = Ir, Rh): regioselectivity, kinetics, and mechanism</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3492</span>– <span class="NLM_lpage">3500</span>, <span class="refDoi"> DOI: 10.1021/om9000742</span> </span><div class="citationLinks">[<a href="/doi/10.1021/om9000742" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3492-3500&issue=12&author=L.+Liauthor=W.+W.+Brennesselauthor=W.+D.+Jones&title=C-H+activation+of+phenyl+imines+and+2-phenylpyridines+with+%5BCp*MCl2%5D2%28M+%3D+Ir%2C+Rh%29%3A+regioselectivity%2C+kinetics%2C+and+mechanism&doi=10.1021%2Fom9000742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">C-H Activation of phenyl imines and 2-phenylpyridines with [Cp*MCl2]2 (M = Ir, Rh): regioselectivity, kinetics, and mechanism</span></div><div class="casAuthors">Li, Ling; Brennessel, William W.; Jones, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3492-3500</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium acetate promoted C-H activation in a series of para-substituted Ph imines has been examd. using [Cp*MCl2]2 (M = Ir, Rh).  The regioselectivity was investigated using a series of meta-substituted Ph imines (-OMe, -CH3, -F, -COOMe, -CF3, and -CN) and 2-phenylpyridines (-OMe, -Me, -CF3).  It was found that substrates with electron-donating substituents react significantly faster than substrates with electron-withdrawing substituents, which is consistent with an electrophilic C-H activation mechanism.  It was also found that the regioselectivity of the C-H activation was extremely sensitive to steric effects, with a meta Me group leading to only one regioisomer.  Solvent and temp. studies showed that the reaction rate can be increased both by increasing temp. and by using polar solvents such as methanol.  The regioselectivity was solvent dependent for the reaction with [Cp*IrCl2]2 but independent of solvent for the reaction with [Cp*RhCl2]2.  The regioselectivity was temp. independent for both metals.  With added acid, the arom. C-H activation was shown to be reversible.  Kinetic studies were performed, leading to the conclusion that [Cp*M(OAc)]+ is the key catalytic species responsible for the electrophilic C-H activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqnLGHN52E_LVg90H21EOLACvtfcHk0lhpv2AJpVYApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlKltro%253D&md5=9c8c6085e8de58df274267d7b958b901</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fom9000742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom9000742%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DBrennessel%26aufirst%3DW.%2BW.%26aulast%3DJones%26aufirst%3DW.%2BD.%26atitle%3DC-H%2520activation%2520of%2520phenyl%2520imines%2520and%25202-phenylpyridines%2520with%2520%255BCp%252AMCl2%255D2%2528M%2520%253D%2520Ir%252C%2520Rh%2529%253A%2520regioselectivity%252C%2520kinetics%252C%2520and%2520mechanism%26jtitle%3DOrganometallics%26date%3D2009%26volume%3D28%26issue%3D12%26spage%3D3492%26epage%3D3500%26doi%3D10.1021%2Fom9000742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGeagh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Peña, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merola, J. S.</span></span> <span> </span><span class="NLM_article-title">Extending the range of pentasubstituted cyclopentadienyl compounds: The synthesis of a series of tetramethyl(alkyl or aryl)cyclopentadienes (Cp<sup>*R</sup>), their iridium complexes and their catalytic activity for asymmetric transfer hydrogenation</span>. <i>Polyhedron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.poly.2014.06.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.poly.2014.06.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1CktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=120-135&author=D.+M.+Morrisauthor=M.+McGeaghauthor=D.+De+Pe%C3%B1aauthor=J.+S.+Merola&title=Extending+the+range+of+pentasubstituted+cyclopentadienyl+compounds%3A+The+synthesis+of+a+series+of+tetramethyl%28alkyl+or+aryl%29cyclopentadienes+%28Cp*R%29%2C+their+iridium+complexes+and+their+catalytic+activity+for+asymmetric+transfer+hydrogenation&doi=10.1016%2Fj.poly.2014.06.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Extending the range of pentasubstituted cyclopentadienyl compounds: The synthesis of a series of tetramethyl(alkyl or aryl)cyclopentadienes (Cp*R), their iridium complexes and their catalytic activity for asymmetric transfer hydrogenation</span></div><div class="casAuthors">Morris, David M.; McGeagh, Michael; De Pena, David; Merola, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Polyhedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-135</span>CODEN:
                <span class="NLM_cas:coden">PLYHDE</span>;
        ISSN:<span class="NLM_cas:issn">0277-5387</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tetramethyl(alkyl or aryl)cyclopentadienes were synthesized and the organometallic half-sandwich iridium complexes of the form [(η5-Cp*R)Ir(aa)Cl], Cp*R = tetramethyl(phenyl)cyclopentadienyl (Cp*Ph), tetramethyl(benzyl)cyclopentadienyl (Cp*Bn), tetramethyl(2-propyl)cyclopentadienyl (Cp*iPr), or tetramethyl(cyclohexyl)cyclopentadienyl (Cp*Cy) were prepd. and characterized.  The complexes adopt a piano stool configuration, forming diastereomers, with ratios similar to reported [(η5-Cp*)Ir(aa)Cl] complexes.  The complexes display an intermol. hydrogen bonding network in the solid state.  These complexes were tested for the asym. transfer hydrogenation of several ketones, showing that the R of the Cp*R drastically impacts both selectivity and rate of reaction.  Addnl., severe solvent effects are displayed when the reaction media is changed from aq. to org. solvent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouJ1mzgmiiMLVg90H21EOLACvtfcHk0lj16cKOIiUATA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1CktbbO&md5=43108cf82cdcf9af3c1ea0e8ed0416bc</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1016%2Fj.poly.2014.06.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.poly.2014.06.053%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DD.%2BM.%26aulast%3DMcGeagh%26aufirst%3DM.%26aulast%3DDe%2BPe%25C3%25B1a%26aufirst%3DD.%26aulast%3DMerola%26aufirst%3DJ.%2BS.%26atitle%3DExtending%2520the%2520range%2520of%2520pentasubstituted%2520cyclopentadienyl%2520compounds%253A%2520The%2520synthesis%2520of%2520a%2520series%2520of%2520tetramethyl%2528alkyl%2520or%2520aryl%2529cyclopentadienes%2520%2528Cp%252AR%2529%252C%2520their%2520iridium%2520complexes%2520and%2520their%2520catalytic%2520activity%2520for%2520asymmetric%2520transfer%2520hydrogenation%26jtitle%3DPolyhedron%26date%3D2014%26volume%3D84%26spage%3D120%26epage%3D135%26doi%3D10.1016%2Fj.poly.2014.06.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">White, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitlis, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinekey, D. M.</span></span> <span> </span><span class="NLM_article-title">(η<sup>5</sup>-Pentamethylcyclopentadienyl)rhodium and -iridium compounds</span>. <i>Inorg. Synth.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1002/9780470132609.ch53</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2F9780470132609.ch53" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=228-234&author=C.+Whiteauthor=A.+Yatesauthor=P.+M.+Maitlisauthor=D.+M.+Heinekey&title=%28%CE%B75-Pentamethylcyclopentadienyl%29rhodium+and+-iridium+compounds&doi=10.1002%2F9780470132609.ch53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1002%2F9780470132609.ch53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470132609.ch53%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DC.%26aulast%3DYates%26aufirst%3DA.%26aulast%3DMaitlis%26aufirst%3DP.%2BM.%26aulast%3DHeinekey%26aufirst%3DD.%2BM.%26atitle%3D%2528%25CE%25B75-Pentamethylcyclopentadienyl%2529rhodium%2520and%2520-iridium%2520compounds%26jtitle%3DInorg.%2520Synth.%26date%3D2007%26spage%3D228%26epage%3D234%26doi%3D10.1002%2F9780470132609.ch53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alessio, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide complexes</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>104</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4203</span>– <span class="NLM_lpage">4242</span>, <span class="refDoi"> DOI: 10.1021/cr0307291</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0307291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt12kt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=4203-4242&issue=9&author=E.+Alessio&title=Synthesis+and+reactivity+of+Ru-%2C+Os-%2C+Rh-%2C+and+Ir-halide-sulfoxide+complexes&doi=10.1021%2Fcr0307291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-Halide-Sulfoxide Complexes</span></div><div class="casAuthors">Alessio, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4203-4242</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review is presented on the synthesis and reactivity of ruthenium, osmium, rhodium, and iridium halide sulfoxide complexes.  Example complexes include [(DMSO)2H][trans-RuCl4(DMSO-S)] and mer,cis-[RuCl3(DPSO-O)2(DPSO)] (DPSO = di-Ph sulfoxide).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxy_YTdTN5cbVg90H21EOLACvtfcHk0lj16cKOIiUATA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt12kt7o%253D&md5=68570193fbd2199cb87a3c60ed5e7cb3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr0307291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0307291%26sid%3Dliteratum%253Aachs%26aulast%3DAlessio%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520Ru-%252C%2520Os-%252C%2520Rh-%252C%2520and%2520Ir-halide-sulfoxide%2520complexes%26jtitle%3DChem.%2520Rev.%26date%3D2004%26volume%3D104%26issue%3D9%26spage%3D4203%26epage%3D4242%26doi%3D10.1021%2Fcr0307291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Geer, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeth, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aird, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbiani, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano-Casal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswald, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jodrell, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">18269</span>– <span class="NLM_lpage">18274</span>, <span class="refDoi"> DOI: 10.1073/pnas.0505798102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1073%2Fpnas.0505798102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=16352726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1aq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=18269-18274&issue=51&author=F.+Wangauthor=A.+Habtemariamauthor=E.+P.+van+der+Geerauthor=R.+Fernandezauthor=M.+Melchartauthor=R.+J.+Deethauthor=R.+Airdauthor=S.+Guichardauthor=F.+P.+Fabbianiauthor=P.+Lozano-Casalauthor=I.+D.+Oswaldauthor=D.+I.+Jodrellauthor=S.+Parsonsauthor=P.+J.+Sadler&title=Controlling+ligand+substitution+reactions+of+organometallic+complexes%3A+tuning+cancer+cell+cytotoxicity&doi=10.1073%2Fpnas.0505798102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Controlling ligand substitution reactions of organometallic complexes: Tuning cancer cell cytotoxicity</span></div><div class="casAuthors">Wang, Fuyi; Habtemariam, Abraha; van der Geer, Erwin P. L.; Fernandez, Rafael; Melchart, Michael; Deeth, Robert J.; Aird, Rhona; Guichard, Sylvie; Fabbiani, Francesca P. A.; Lozano-Casal, Patricia; Oswald, Iain D. H.; Jodrell, Duncan I.; Parsons, Simon; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">18269-18274</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Organometallic compds. offer broad scope for the design of therapeutic agents, but this avenue has yet to be widely explored.  A key concept in the design of anticancer complexes is optimization of chem. reactivity to allow facile attack on the target site (e.g., DNA) yet avoid attack on other sites assocd. with unwanted side effects.  How this result can be achieved for monofunctional "piano-stool" ruthenium(II) arene complexes of the type [(η6-arene)Ru(ethylenediamine)(X)]n+ was discussed.  A potentially important activation mechanism for reactions with biomols. is hydrolysis.  D. functional calcns. suggested that aquation (substitution of X by H2O) occurs by a concerted ligand interchange mechanism.  The kinetics and equil. for hydrolysis of 21 complexes, contg., as X, halides and pseudohalides, pyridine derivs., and a thiolate, together with benzene (bz) or a substituted bz as arene, using UV-visible spectroscopy, HPLC, and electrospray MS was studied.  The x-ray structures of six complexes are reported.  In general, complexes that hydrolyze either rapidly {e.g., X = halide [arene = hexamethylbenzene (hmb)]} or moderately slowly [e.g., X = azide, dichloropyridine (arene = hmb)] are active toward A2780 human ovarian cancer cells, whereas complexes that do not aquate (e.g., X = py) are inactive.  An intriguing exception is the X = thiophenolate complex, which undergoes little hydrolysis and appears to be activated by a different mechanism.  The ability to tune the chem. reactivity of this class of organometallic ruthenium arene compds. should be useful in optimizing their design as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2O8dQ7-JN3rVg90H21EOLACvtfcHk0lgY0E-CQDUkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1aq&md5=6fe88ad4395d83e757ba0a2c10b11599</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0505798102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0505798102%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BGeer%26aufirst%3DE.%2BP.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DMelchart%26aufirst%3DM.%26aulast%3DDeeth%26aufirst%3DR.%2BJ.%26aulast%3DAird%26aufirst%3DR.%26aulast%3DGuichard%26aufirst%3DS.%26aulast%3DFabbiani%26aufirst%3DF.%2BP.%26aulast%3DLozano-Casal%26aufirst%3DP.%26aulast%3DOswald%26aufirst%3DI.%2BD.%26aulast%3DJodrell%26aufirst%3DD.%2BI.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DControlling%2520ligand%2520substitution%2520reactions%2520of%2520organometallic%2520complexes%253A%2520tuning%2520cancer%2520cell%2520cytotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26issue%3D51%26spage%3D18269%26epage%3D18274%26doi%3D10.1073%2Fpnas.0505798102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridgewater, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldevila-Barreda, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imberti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Ligand-controlled reactivity and cytotoxicity of cyclometalated rhodium(III) complexes</span>. <i>Eur. J. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>2020</i></span>,  <span class="NLM_fpage">1052</span>, <span class="refDoi"> DOI: 10.1002/ejic.201901055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1002%2Fejic.201901055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFyrtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2020&publication_year=2020&pages=1052&author=W.-Y.+Zhangauthor=H.+E.+Bridgewaterauthor=S.+Banerjeeauthor=J.+J.+Soldevila-Barredaauthor=G.+J.+Clarksonauthor=H.+Shiauthor=C.+Imbertiauthor=P.+J.+Sadler&title=Ligand-controlled+reactivity+and+cytotoxicity+of+cyclometalated+rhodium%28III%29+complexes&doi=10.1002%2Fejic.201901055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Controlled Reactivity and Cytotoxicity of Cyclometalated Rhodium(III) Complexes</span></div><div class="casAuthors">Zhang, Wen-Ying; Bridgewater, Hannah E.; Banerjee, Samya; Soldevila-Barreda, Joan J.; Clarkson, Guy J.; Shi, Huayun; Imberti, Cinzia; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">2020</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1052-1060</span>CODEN:
                <span class="NLM_cas:coden">EJICFO</span>;
        ISSN:<span class="NLM_cas:issn">1434-1948</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report the synthesis, characterization and cytotoxicity of six cyclometalated rhodium(III) complexes [CpXRh(ĈN)Z]0/+, in which CpX = Cp*, Cpph, or Cpbiph, ĈN = benzo[h]quinoline, and Z = chloride or pyridine.  Three X-ray crystal structures showing the expected "piano-stool" configurations have been detd.  The chlorido complexes hydrolyzed faster in aq. soln., and reacted preferentially with 9-Et guanine or glutathione compared to their pyridine analogs.  The 1-biphenyl-2,3,4,5-tetramethylcyclopentadienyl complex [CpbiphRh(benzo-[h]quinoline)Cl] (3a) was the most efficient catalyst in coenzyme reduced NAD (NADH) oxidn. to NAD+ and induced an elevated level of reactive oxygen species (ROS) in A549 human lung cancer cells.  The pyridine complex [CpbiphRh(benzo[h]quinoline)py]+ (3b) was the most potent against A549 lung and A2780 ovarian cancer cell lines, being 5-fold more active than cisplatin towards A549 cells, and acted as a ROS scavenger.  This work highlights a ligand-controlled strategy to modulate the reactivity and cytotoxicity of cyclometalated rhodium anticancer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6VQ6ztgy5AbVg90H21EOLACvtfcHk0lgY0E-CQDUkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFyrtLfJ&md5=8feb307309d12215fea24f37f6ee67d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fejic.201901055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejic.201901055%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.-Y.%26aulast%3DBridgewater%26aufirst%3DH.%2BE.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DSoldevila-Barreda%26aufirst%3DJ.%2BJ.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DImberti%26aufirst%3DC.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DLigand-controlled%2520reactivity%2520and%2520cytotoxicity%2520of%2520cyclometalated%2520rhodium%2528III%2529%2520complexes%26jtitle%3DEur.%2520J.%2520Inorg.%2520Chem.%26date%3D2020%26volume%3D2020%26spage%3D1052%26doi%3D10.1002%2Fejic.201901055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojtiskova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span> <span> </span><span class="NLM_article-title">Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1039/C3MT00341H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC3MT00341H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24448555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsFGguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=682-690&issue=3&author=V.+Novohradskyauthor=Z.+Liuauthor=M.+Vojtiskovaauthor=P.+J.+Sadlerauthor=V.+Brabecauthor=J.+Kasparkova&title=Mechanism+of+cellular+accumulation+of+an+iridium%28III%29+pentamethylcyclopentadienyl+anticancer+complex+containing+a+C%2CN-chelating+ligand&doi=10.1039%2FC3MT00341H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of cellular accumulation of an iridium(iii) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand</span></div><div class="casAuthors">Novohradsky, Vojtech; Liu, Zhe; Vojtiskova, Marie; Sadler, Peter J.; Brabec, Viktor; Kasparkova, Jana</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">682-690</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The effect of replacement of the N,N-chelating ligand 1,10-phenanthroline (phen) in the IrIII pentamethylcyclopentadienyl (Cp*) complex [(η5-Cp*)(Ir)(phen)Cl]+ (2) with the C,N-chelating ligand 7,8-benzoquinoline (bq) to give [(η5-Cp*)(Ir)(bq)Cl] (1) on the cytotoxicity of these Cp*IrIII complexes toward cancer cell lines was investigated.  Complex 2 is inactive, similar to other Cp*IrIII complexes contg. the N,N-chelating ligands.  In contrast, a single atom change (C- for N) in the chelating N,N ligand resulted in potency in human ovarian carcinoma cisplatin-sensitive A2780 cells, and, strikingly, 1 is active in the cisplatin-resistant human breast cancer MCF-7 and A2780/cisR cells.  Replacement of the N,N-chelating ligand with the C,N-chelating ligand gives rise to increased hydrophobicity, leading to higher cellular accumulation, higher DNA-bound iridium in cells and higher cytotoxicity.  The pathways involved in cellular accumulation of 1 have been further explored and compared with conventional cisplatin.  The results show that both energy-independent passive diffusion and energy-dependent transport play a role in accumulation of 1.  Further results were consistent with involvement of p-glycoprotein, multidrug resistance-assocd. protein 1 and glutathione metab. in the efflux of 1.  In contrast, the internalization of 1 mediated by the endocytotic uptake pathway(s) seems less likely.  Understanding the factors which contribute to the mechanism of cellular accumulation of this IrIII complex can now lead to the design of structurally similar metal complexes for antitumor chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmCkjVEglT3LVg90H21EOLACvtfcHk0lgY0E-CQDUkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsFGguro%253D&md5=af8e7c06d3f791a4854f5fae66d164f4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC3MT00341H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MT00341H%26sid%3Dliteratum%253Aachs%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DVojtiskova%26aufirst%3DM.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26aulast%3DBrabec%26aufirst%3DV.%26aulast%3DKasparkova%26aufirst%3DJ.%26atitle%3DMechanism%2520of%2520cellular%2520accumulation%2520of%2520an%2520iridium%2528III%2529%2520pentamethylcyclopentadienyl%2520anticancer%2520complex%2520containing%2520a%2520C%252CN-chelating%2520ligand%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26issue%3D3%26spage%3D682%26epage%3D690%26doi%3D10.1039%2FC3MT00341H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of iridium and ruthenium complexes with (N, N), (N, O) and (O, O) coordinating bidentate ligands as potential anti-cancer agents</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">13800</span>– <span class="NLM_lpage">13802</span>, <span class="refDoi"> DOI: 10.1039/c2dt32104a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2Fc2dt32104a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=23015068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFygurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=13800-13802&issue=45&author=S.+J.+Lucasauthor=R.+M.+Lordauthor=R.+L.+Wilsonauthor=R.+M.+Phillipsauthor=V.+Sridharanauthor=P.+C.+McGowan&title=Synthesis+of+iridium+and+ruthenium+complexes+with+%28N%2C+N%29%2C+%28N%2C+O%29+and+%28O%2C+O%29+coordinating+bidentate+ligands+as+potential+anti-cancer+agents&doi=10.1039%2Fc2dt32104a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents</span></div><div class="casAuthors">Lucas, Stephanie J.; Lord, Rianne M.; Wilson, Rachel L.; Phillips, Roger M.; Sridharan, Visuvanathar; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">13800-13802</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Several Ru-arene and Ir-Cp* complexes have been prepd. incorporating (N,N), (N,O) and (O,O) coordinating bidentate ligands and have been active against both HT-29 and MCF-7 cell lines.  By incorporating a biol. active ligand into a metal complex the anti-cancer activity is increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorFglt1DDjDLVg90H21EOLACvtfcHk0lhVar3LCRFZwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFygurvK&md5=6541d905c0bcac9fde8d042448e79af2</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1039%2Fc2dt32104a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2dt32104a%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%2BJ.%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DWilson%26aufirst%3DR.%2BL.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DSridharan%26aufirst%3DV.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DSynthesis%2520of%2520iridium%2520and%2520ruthenium%2520complexes%2520with%2520%2528N%252C%2520N%2529%252C%2520%2528N%252C%2520O%2529%2520and%2520%2528O%252C%2520O%2529%2520coordinating%2520bidentate%2520ligands%2520as%2520potential%2520anti-cancer%2520agents%26jtitle%3DDalton%2520Trans.%26date%3D2012%26volume%3D41%26issue%3D45%26spage%3D13800%26epage%3D13802%26doi%3D10.1039%2Fc2dt32104a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paitandi, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundal, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, D. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, structure, DNA/protein binding, and anticancer activity of some half-sandwich cyclometalated Rh(III) and Ir(III) complexes</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">4491</span>– <span class="NLM_lpage">4506</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.5b00475</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.5b00475" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWns7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=4491-4506&issue=18&author=S.+Mukhopadhyayauthor=R.+K.+Guptaauthor=R.+P.+Paitandiauthor=N.+K.+Ranaauthor=G.+Sharmaauthor=B.+Kochauthor=L.+K.+Ranaauthor=M.+S.+Hundalauthor=D.+S.+Pandey&title=Synthesis%2C+structure%2C+DNA%2Fprotein+binding%2C+and+anticancer+activity+of+some+half-sandwich+cyclometalated+Rh%28III%29+and+Ir%28III%29+complexes&doi=10.1021%2Facs.organomet.5b00475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure, DNA/Protein Binding, and Anticancer Activity of Some Half-Sandwich Cyclometalated Rh(III) and Ir(III) Complexes</span></div><div class="casAuthors">Mukhopadhyay, Sujay; Gupta, Rakesh Kumar; Paitandi, Rajendra Prasad; Rana, Nishant Kumar; Sharma, Gunjan; Koch, Biplob; Rana, Love Karan; Hundal, Maninder Singh; Pandey, Daya Shankar</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4491-4506</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Schiff base ligands benzylidene(4-tert-butylphenyl)amine 4-Me ester (L1), (4-nitrobenzylidene)(4-tert-butylphenyl)amine (L2), and (4-cyanobenzylidene)(4-tert-butylphenyl)amine (L3) and the new series of cyclometalated mononuclear piano-stool complexes [(η5-C5Me5)RhCl(L1)] (1), [(η5-C5Me5)RhCl(L2)] (2), [(η5-C5Me5)RhCl(L3)] (3), [(η5-C5Me5)IrCl(L1)] (4), [(η5-C5Me5)IrCl(L2)] (5), and [(η5-C5Me5)IrCl(L3)] (6) have been synthesized.  The ligands L1-L3 and complexes 1-6 have been thoroughly characterized by satisfactory elemental analyses, spectral studies (ESI-MS, IR, 1H and 13C NMR, UV-vis), and structures of 1-3 authenticated by x-ray single-crystal analyses.  Efficient binding of 1-6 with calf thymus DNA (CT DNA) have been established by UV-vis and emission spectroscopic studies.  Protein binding (bovine serum albumin, BSA) has been investigated by UV-vis, fluorescence, synchronous, and 3D fluorescence spectroscopy.  Binding of the complexes with DNA through minor groove and hydrophobic interaction with proteins via sub domain IIA cavity has been substantiated by mol. docking studies.  The complexes exhibited significant cytotoxicity against the human lung cancer cell line (A549), and 1 and 2 showed better activity than cisplatin.  The cytotoxicity, morphol. changes, and apoptosis have been assessed by MTT assay, Hoechst 33342/PI staining, cell cycle anal. by fluorescence-activated cell sorting (FACS), and reactive oxygen species (ROS) generation by DCFH-DA dye.  The complexes 1-6 induce apoptosis in the order 2 > 1 > 4 > 3 > 5 > 6.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDo45FSN-GgbVg90H21EOLACvtfcHk0lhVar3LCRFZwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWns7zK&md5=44b44c05a869dd8fcf80b5e8c2397446</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.5b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.5b00475%26sid%3Dliteratum%253Aachs%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DPaitandi%26aufirst%3DR.%2BP.%26aulast%3DRana%26aufirst%3DN.%2BK.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DRana%26aufirst%3DL.%2BK.%26aulast%3DHundal%26aufirst%3DM.%2BS.%26aulast%3DPandey%26aufirst%3DD.%2BS.%26atitle%3DSynthesis%252C%2520structure%252C%2520DNA%252Fprotein%2520binding%252C%2520and%2520anticancer%2520activity%2520of%2520some%2520half-sandwich%2520cyclometalated%2520Rh%2528III%2529%2520and%2520Ir%2528III%2529%2520complexes%26jtitle%3DOrganometallics%26date%3D2015%26volume%3D34%26issue%3D18%26spage%3D4491%26epage%3D4506%26doi%3D10.1021%2Facs.organomet.5b00475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit35c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Štarha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trávníček, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crlíková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vančo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kašpárková, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvořák, Z.</span></span> <span> </span><span class="NLM_article-title">Half-sandwich Ir(III) complex of <i>N</i>1-pyridyl-7-azaindole exceeds cytotoxicity of cisplatin at various human cancer cells and 3D multicellular tumor spheroids</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2749</span>– <span class="NLM_lpage">2759</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.8b00415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.8b00415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVyksrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2749-2759&issue=16&author=P.+%C5%A0tarhaauthor=Z.+Tr%C3%A1vn%C3%AD%C4%8Dekauthor=H.+Crl%C3%ADkov%C3%A1author=J.+Van%C4%8Doauthor=J.+Ka%C5%A1p%C3%A1rkov%C3%A1author=Z.+Dvo%C5%99%C3%A1k&title=Half-sandwich+Ir%28III%29+complex+of+N1-pyridyl-7-azaindole+exceeds+cytotoxicity+of+cisplatin+at+various+human+cancer+cells+and+3D+multicellular+tumor+spheroids&doi=10.1021%2Facs.organomet.8b00415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35cR"><div class="casContent"><span class="casTitleNuber">35c</span><div class="casTitle"><span class="NLM_cas:atitle">Half-Sandwich Ir(III) Complex of N1-Pyridyl-7-azaindole Exceeds Cytotoxicity of Cisplatin at Various Human Cancer Cells and 3D Multicellular Tumor Spheroids</span></div><div class="casAuthors">Starha, Pavel; Travnicek, Zdenek; Crlikova, Hana; Vanco, Jan; Kasparkova, Jana; Dvorak, Zdenek</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2749-2759</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The half-sandwich Ir(III) complexes [Ir(η5-Cpx)(phaza-)Cl] (1, 2), [Ir(η5-Cpx)(thaza-)Cl] (3, 4), and [Ir(η5-Cpx)(pyaza)Cl]PF6 (5, 6) contg. deprotonated 1-phenyl-7-azaindole (phaza-) and 1-(thiophen-2-yl)-7-azaindole (thaza-) and electroneutral 1-(pyridin-2-yl)-7-azaindole (pyaza), were prepd.; Cpx = pentamethylcyclopentadienyl (Cp*; for 1, 3, and 5) or 1,2,3,4-tetramethyl-5-phenylcyclopentadienyl (Cpph; for 2, 4, and 6).  The complexes were thoroughly characterized, including a single-crystal x-ray anal. of complexes 1, 5, and 6.  All of the complexes were screened for their in vitro cytotoxicity at the A2780 human ovarian carcinoma cell line and its A2780R cisplatin-resistant variant (2-dimensional culture cells).  The best-performing complex 6 was further studied against the human DU-145 prostatic carcinoma, A549 lung carcinoma, HCT116 colon carcinoma, HeLa cervix adenocarcinoma, and MCF7 breast adenocarcinoma cell lines (2-dimensional culture cells).  Complex 6 showed a cytotoxic profile different from that of cisplatin at the used cells, with the highest activity detected at the A2780, MCF7, and HCT116 cells (IC50 = 3.1, 6.9, and 10.4 μM, resp.).  Complex 6 exhibited relevant selectivity toward cancer cells (IC50 = 3.1-13.0 μM) over the MRC-5 human noncancerous lung fibroblast cells (IC50 > 50.0 μM).  Complex 6 was markedly more accumulated by the A2780 cells in comparison to cisplatin after 24 h exposure.  Flow cytometry studies showed that the cell cycle of the A2780 cells treated by complex 6 is modified differently (G0/G1 arrest) in comparison to cisplatin (G2/M arrest).  Addnl. to the monolayer (2D) cancer cell cultures, the cytotoxicity of complex 6 was for the 1st time among half-sandwich Ir(III) complexes also assessed at spheroid (3D) MCF7 cells, where its potency (IC50 = 22.9 μM for complex 6) remained significantly better than that for the ref. drug cisplatin (IC50 = 35.4 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsmZ9Qa7xIqrVg90H21EOLACvtfcHk0lhVar3LCRFZwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVyksrnJ&md5=033a05f9e4207e828bee77d440dc6fc8</span></div><a href="/servlet/linkout?suffix=cit35c&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.8b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.8b00415%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0tarha%26aufirst%3DP.%26aulast%3DTr%25C3%25A1vn%25C3%25AD%25C4%258Dek%26aufirst%3DZ.%26aulast%3DCrl%25C3%25ADkov%25C3%25A1%26aufirst%3DH.%26aulast%3DVan%25C4%258Do%26aufirst%3DJ.%26aulast%3DKa%25C5%25A1p%25C3%25A1rkov%25C3%25A1%26aufirst%3DJ.%26aulast%3DDvo%25C5%2599%25C3%25A1k%26aufirst%3DZ.%26atitle%3DHalf-sandwich%2520Ir%2528III%2529%2520complex%2520of%2520N1-pyridyl-7-azaindole%2520exceeds%2520cytotoxicity%2520of%2520cisplatin%2520at%2520various%2520human%2520cancer%2520cells%2520and%25203D%2520multicellular%2520tumor%2520spheroids%26jtitle%3DOrganometallics%26date%3D2018%26volume%3D37%26issue%3D16%26spage%3D2749%26epage%3D2759%26doi%3D10.1021%2Facs.organomet.8b00415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit35d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Potent half-sandwich iridium(III) and ruthenium(II) anticancer complexes containing a P^O-chelated ligand</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2880</span>– <span class="NLM_lpage">2889</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.8b00402</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.8b00402" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCgtrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=2880-2889&issue=17&author=Q.+Duauthor=L.+Guoauthor=M.+Tianauthor=X.+Geauthor=Y.+Yangauthor=X.+Jianauthor=Z.+Xuauthor=Z.+Tianauthor=Z.+Liu&title=Potent+half-sandwich+iridium%28III%29+and+ruthenium%28II%29+anticancer+complexes+containing+a+P%5EO-chelated+ligand&doi=10.1021%2Facs.organomet.8b00402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35dR"><div class="casContent"><span class="casTitleNuber">35d</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Half-Sandwich Iridium(III) and Ruthenium(II) Anticancer Complexes Containing a P̂ O-Chelated Ligand</span></div><div class="casAuthors">Du, Qing; Guo, Lihua; Tian, Meng; Ge, Xingxing; Yang, Yuliang; Jian, Xiyan; Xu, Zhishan; Tian, Zhenzhen; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2880-2889</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Authors herein report the synthesis, characterization, and anticancer activity of a series of iridium(III) and ruthenium(II) half-sandwich complexes of the type [(Cpx/arene)M(P̂ O)Cl]PF6 (M = Ir, Cpx = pentamethylcyclopentadienyl (Cp*) or its Ph (Cpxph = C5Me4C6H5) or biphenyl (Cpxbiph = C5Me4C6H4C6H5) derivs.; M = Ru, arene = p-cymene (p-cym); P̂ O = phosphine phosphonic amide ligand (PPOA)).  The x-ray crystal structures of all complexes, in which the ligand can form six-membered rings with the metal center, have been detd.  All of the complexes show remarkable anticancer activities toward HeLa and A549 cancer cells, activities which are higher than that of the clin. anticancer drug cisplatin.  The incorporation of Ph substituents on the Cp* ring for iridium(III) complexes results in little variation in their anticancer activities.  These results can be attributed to the combinatorial action of the metal and PPOA ligand.  Hydrolysis and DNA cleavage are not the major mechanisms of action.  These complexes show potent catalytic activity in the transfer hydrogenation of NADH to NAD+.  Addnl., complexes [(η5-C5Me5)Ir(P̂ O)Cl]PF6 (1) and [(η6-p-cym)Ru(P̂ O)Cl]PF6 (4) arrest cell cycles at S and G2/M phase and S phase, resp.  Complexes 1 and 4 both can induce apoptosis of HeLa cancer cells.  Reactive oxygen species (ROS) and mitochondrial membrane potential tests were also performed to explore the mechanism of action.  When the concn. of the complexes is increased, the amt. of reactive oxygen species (ROS) increases dramatically and the mitochondrial membrane potential decreases significantly in HeLa cancer cells.  Overall, cell stress including cell cycle perturbation, apoptosis induction, increase in ROS level, and loss of mitochondrial membrane potential contributes to the anticancer potency of these complexes.  Interestingly, the use of confocal microscopy provides insights into the microscopic mechanism in which the typical and most active complex 1 can damage lysosomes.  This type of complex represents a potent platform for development of metal anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomw5aJyUsqBbVg90H21EOLACvtfcHk0lh-bZ45RUy3Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCgtrbP&md5=3eafda74018c1fcc5b220c69d187ddae</span></div><a href="/servlet/linkout?suffix=cit35d&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.8b00402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.8b00402%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DJian%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DPotent%2520half-sandwich%2520iridium%2528III%2529%2520and%2520ruthenium%2528II%2529%2520anticancer%2520complexes%2520containing%2520a%2520P%255EO-chelated%2520ligand%26jtitle%3DOrganometallics%26date%3D2018%26volume%3D37%26issue%3D17%26spage%3D2880%26epage%3D2889%26doi%3D10.1021%2Facs.organomet.8b00402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit35e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Fluorescent half-sandwich phosphine-sulfonate iridium(III) and ruthenium(II) complexes as potential lysosome-targeted anticancer agents</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2018.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.dyepig.2018.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Chtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=821-830&author=Q.+Duauthor=Y.+Yangauthor=L.+Guoauthor=M.+Tianauthor=X.+Geauthor=Z.+Tianauthor=L.+Zhaoauthor=Z.+Xuauthor=J.+Liauthor=Z.+Liu&title=Fluorescent+half-sandwich+phosphine-sulfonate+iridium%28III%29+and+ruthenium%28II%29+complexes+as+potential+lysosome-targeted+anticancer+agents&doi=10.1016%2Fj.dyepig.2018.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35eR"><div class="casContent"><span class="casTitleNuber">35e</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent half-sandwich phosphine-sulfonate iridium(III) and ruthenium(II) complexes as potential lysosome-targeted anticancer agents</span></div><div class="casAuthors">Du, Qing; Yang, Yuliang; Guo, Lihua; Tian, Meng; Ge, Xingxing; Tian, Zhenzhen; Zhao, Liping; Xu, Zhishan; Li, Juanjuan; Liu, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">821-830</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis, characterization and biol. activity of neutral fluorescent Ir(III) and Ru(II) half-sandwich organometallic complexes contg. phosphine-sulfonate ligands are reported.  X-ray crystal structure of complexes 1-3, 10 and 11 exhibits the expected half-sandwich "three-legged piano-stool" pseudo-octahedral geometry.  Spectroscopic properties study displays that these complexes show rich fluorescence properties.  With the exception of 9, 10 and 11 toward A549 human lung cancer cells and 10 towards HeLa human cervical cancer cells, each complex shows promising cytotoxicity toward HeLa and A549 cells line with IC50 values in the range of 3.6-53.1 μM, and 6.5-34.5 μM, resp.  Hydrolysis, DNA cleavage and depolarization of the mitochondrial membrane potential (MMP) appear not to be the main mechanism of action.  However, these complexes are able to covert NADH to NAD+ via the transfer hydrogenation.  Mechanism studies by flow cytometry display that the complexes exert their anticancer efficacy by inducing apoptosis, perturbing the cell cycle and increasing the intracellular ROS level.  Furthermore, fluorescence property of these complexes provides a tool to investigate the microscopic mechanism by confocal microscopy.  Notably, the typical Ir(III) complex 3 can specially localize to lysosome and damage it.  In addn., complex 3 enters into HeLa cells mainly through energy-dependent pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriesZrNPsiK7Vg90H21EOLACvtfcHk0lh-bZ45RUy3Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Chtr7L&md5=b5f3ca656352010a21340968c79b2f12</span></div><a href="/servlet/linkout?suffix=cit35e&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2018.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2018.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DFluorescent%2520half-sandwich%2520phosphine-sulfonate%2520iridium%2528III%2529%2520and%2520ruthenium%2528II%2529%2520complexes%2520as%2520potential%2520lysosome-targeted%2520anticancer%2520agents%26jtitle%3DDyes%2520Pigm.%26date%3D2019%26volume%3D162%26spage%3D821%26epage%3D830%26doi%3D10.1016%2Fj.dyepig.2018.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj-Yehia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi-Schaffer, F.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in apoptosis induction</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1023/A:1009616228304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1023%2FA%3A1009616228304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=11256882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=415-418&issue=5&author=H.+U.+Simonauthor=A.+Haj-Yehiaauthor=F.+Levi-Schaffer&title=Role+of+reactive+oxygen+species+%28ROS%29+in+apoptosis+induction&doi=10.1023%2FA%3A1009616228304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of reactive oxygen species (ROS) in apoptosis induction</span></div><div class="casAuthors">Simon, H.-U.; Haj-Yehia, A.; Levi-Schaffer, F.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-418</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 49 refs.  Reactive O species (ROS) and mitochondria play an important role in apoptosis induction under both physiol. and pathol. conditions.  Interestingly, mitochondria are both source and target of ROS.  Cytochrome c release from mitochondria, that triggers caspase activation, appears to be largely mediated by direct or indirect ROS action.  On the other hand, ROS have also anti-apoptotic effects.  This review focuses on the role of ROS in the regulation of apoptosis, esp. in inflammatory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPu13B3_9rGLVg90H21EOLACvtfcHk0lgxHCSv0ZVSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D&md5=752558ae104d1b8446ab51c6a63c8331</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1023%2FA%3A1009616228304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1009616228304%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DH.%2BU.%26aulast%3DHaj-Yehia%26aufirst%3DA.%26aulast%3DLevi-Schaffer%26aufirst%3DF.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520apoptosis%2520induction%26jtitle%3DApoptosis%26date%3D2000%26volume%3D5%26issue%3D5%26spage%3D415%26epage%3D418%26doi%3D10.1023%2FA%3A1009616228304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Circu, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aw, T. Y.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species, cellular redox systems, and apoptosis</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2009.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.freeradbiomed.2009.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=20045723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=749-762&issue=6&author=M.+L.+Circuauthor=T.+Y.+Aw&title=Reactive+oxygen+species%2C+cellular+redox+systems%2C+and+apoptosis&doi=10.1016%2Fj.freeradbiomed.2009.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species, cellular redox systems, and apoptosis</span></div><div class="casAuthors">Circu, Magdalena L.; Aw, Tak Yee</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">749-762</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) are products of normal metab. and xenobiotic exposure, and depending on their concn., ROS can be beneficial or harmful to cells and tissues.  At physiol. low levels, ROS function as "redox messengers" in intracellular signaling and regulation, whereas excess ROS induce oxidative modification of cellular macromols., inhibit protein function, and promote cell death.  Addnl., various redox systems, such as the glutathione, thioredoxin, and pyridine nucleotide redox couples, participate in cell signaling and modulation of cell function, including apoptotic cell death.  Cell apoptosis is initiated by extracellular and intracellular signals via two main pathways, the death receptor- and the mitochondria-mediated pathways.  Various pathologies can result from oxidative stress-induced apoptotic signaling that is consequent to ROS increases and/or antioxidant decreases, disruption of intracellular redox homeostasis, and irreversible oxidative modifications of lipid, protein, or DNA.  In this review, we focus on several key aspects of ROS and redox mechanisms in apoptotic signaling and highlight the gaps in knowledge and potential avenues for further investigation.  A full understanding of the redox control of apoptotic initiation and execution could underpin the development of therapeutic interventions targeted at oxidative stress-assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDErrUmQqbTbVg90H21EOLACvtfcHk0lgxHCSv0ZVSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKms78%253D&md5=8d9396ff7d0d303d853cd1edacb51a34</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2009.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2009.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DCircu%26aufirst%3DM.%2BL.%26aulast%3DAw%26aufirst%3DT.%2BY.%26atitle%3DReactive%2520oxygen%2520species%252C%2520cellular%2520redox%2520systems%252C%2520and%2520apoptosis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26issue%3D6%26spage%3D749%26epage%3D762%26doi%3D10.1016%2Fj.freeradbiomed.2009.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marullo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degtyareva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altavilla, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalingam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doetsch, P. W.</span></span> <span> </span><span class="NLM_article-title">Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e81162</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0081162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1371%2Fjournal.pone.0081162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24260552" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=11&author=R.+Marulloauthor=E.+Wernerauthor=N.+Degtyarevaauthor=B.+Mooreauthor=G.+Altavillaauthor=S.+S.+Ramalingamauthor=P.+W.+Doetsch&title=Cisplatin+induces+a+mitochondrial-ROS+response+that+contributes+to+cytotoxicity+depending+on+mitochondrial+redox+status+and+bioenergetic+functions&doi=10.1371%2Fjournal.pone.0081162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0081162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0081162%26sid%3Dliteratum%253Aachs%26aulast%3DMarullo%26aufirst%3DR.%26aulast%3DWerner%26aufirst%3DE.%26aulast%3DDegtyareva%26aufirst%3DN.%26aulast%3DMoore%26aufirst%3DB.%26aulast%3DAltavilla%26aufirst%3DG.%26aulast%3DRamalingam%26aufirst%3DS.%2BS.%26aulast%3DDoetsch%26aufirst%3DP.%2BW.%26atitle%3DCisplatin%2520induces%2520a%2520mitochondrial-ROS%2520response%2520that%2520contributes%2520to%2520cytotoxicity%2520depending%2520on%2520mitochondrial%2520redox%2520status%2520and%2520bioenergetic%2520functions%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0081162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacque, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcomson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paterson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staniforth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stavros, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Targeted photoredox catalysis in cancer cells</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1038/s41557-019-0328-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fs41557-019-0328-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=31548671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVGgurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1041-1048&issue=11&author=H.+Huangauthor=S.+Banerjeeauthor=K.+Qiuauthor=P.+Zhangauthor=O.+Blacqueauthor=T.+Malcomsonauthor=M.+J.+Patersonauthor=G.+J.+Clarksonauthor=M.+Staniforthauthor=V.+G.+Stavrosauthor=G.+Gasserauthor=H.+Chaoauthor=P.+J.+Sadler&title=Targeted+photoredox+catalysis+in+cancer+cells&doi=10.1038%2Fs41557-019-0328-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted photoredox catalysis in cancer cells</span></div><div class="casAuthors">Huang, Huaiyi; Banerjee, Samya; Qiu, Kangqiang; Zhang, Pingyu; Blacque, Olivier; Malcomson, Thomas; Paterson, Martin J.; Clarkson, Guy J.; Staniforth, Michael; Stavros, Vasilios G.; Gasser, Gilles; Chao, Hui; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1041-1048</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Hypoxic tumors are a major problem for cancer photodynamic therapy.  Here, we show that photoredox catalysis can provide an oxygen-independent mechanism of action to combat this problem.  We have designed a highly oxidative Ir(III) photocatalyst, [Ir(ttpy)(pq)Cl]PF6 ([1]PF6, where 'ttpy' represents 4'-(p-tolyl)-2,2':6',2''-terpyridine and 'pq' represents 3-phenylisoquinoline), which is phototoxic towards both normoxic and hypoxic cancer cells.  Complex 1 photocatalytically oxidizes 1,4-dihydronicotinamide adenine dinucleotide (NADH)-an important coenzyme in living cells-generating NAD• radicals with a high turnover frequency in biol. media.  Moreover, complex 1 and NADH synergistically photoreduce cytochrome c under hypoxia.  D. functional theory calcns. reveal π stacking in adducts of complex 1 and NADH, facilitating photoinduced single-electron transfer.  In cancer cells, complex 1 localizes in mitochondria and disrupts electron transport via NADH photocatalysis.  On light irradn., complex 1 induces NADH depletion, intracellular redox imbalance and immunogenic apoptotic cancer cell death.  This photocatalytic redox imbalance strategy offers a new approach for efficient cancer phototherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoZNCvl9_iQLVg90H21EOLACvtfcHk0lgxHCSv0ZVSpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGgurfK&md5=b7774e96b85d9d648faa30c50bbea784</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fs41557-019-0328-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-019-0328-4%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DBlacque%26aufirst%3DO.%26aulast%3DMalcomson%26aufirst%3DT.%26aulast%3DPaterson%26aufirst%3DM.%2BJ.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DStaniforth%26aufirst%3DM.%26aulast%3DStavros%26aufirst%3DV.%2BG.%26aulast%3DGasser%26aufirst%3DG.%26aulast%3DChao%26aufirst%3DH.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DTargeted%2520photoredox%2520catalysis%2520in%2520cancer%2520cells%26jtitle%3DNat.%2520Chem.%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D1041%26epage%3D1048%26doi%3D10.1038%2Fs41557-019-0328-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">The thioredoxin antioxidant system</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2013.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.freeradbiomed.2013.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=23899494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyitLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=75-87&author=J.+Luauthor=A.+Holmgren&title=The+thioredoxin+antioxidant+system&doi=10.1016%2Fj.freeradbiomed.2013.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The thioredoxin antioxidant system</span></div><div class="casAuthors">Lu, Jun; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-87</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The thioredoxin (Trx) system, which is composed of NADPH, thioredoxin reductase (TrxR), and thioredoxin, is a key antioxidant system in defense against oxidative stress through its disulfide reductase activity regulating protein dithiol/disulfide balance.  The Trx system provides the electrons to thiol-dependent peroxidases (peroxiredoxins) to remove reactive oxygen and nitrogen species with a fast reaction rate.  Trx antioxidant functions are also shown by involvement in DNA and protein repair by reducing ribonucleotide reductase, methionine sulfoxide reductases, and regulating the activity of many redox-sensitive transcription factors.  Moreover, Trx systems play crit. roles in the immune response, virus infection, and cell death via interaction with thioredoxin-interacting protein.  In mammalian cells, the cytosolic and mitochondrial Trx systems, in which TrxRs are high mol. wt. selenoenzymes, together with the glutathione-glutaredoxin (Grx) system (NADPH, glutathione reductase, GSH, and Grx) control the cellular redox environment.  Recently, mammalian thioredoxin and glutathione systems have been found to be able to provide the electrons crossly and to serve as a backup system for each other.  In contrast, bacterial TrxRs are low mol. wt. enzymes with a structure and reaction mechanism distinct from mammalian TrxR.  Many bacterial species possess specific thiol-dependent antioxidant systems, and the significance of the Trx system in the defense against oxidative stress is different.  Particularly, the absence of a GSH-Grx system in some pathogenic bacteria such as Helicobacter pylori, Mycobacterium tuberculosis, and Staphylococcus aureus makes the bacterial Trx system essential for survival under oxidative stress.  This provides an opportunity to kill these bacteria by targeting the TrxR-Trx system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnxEvRdPYfRbVg90H21EOLACvtfcHk0lgRHly85BvXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyitLzE&md5=b1b8a63b4cf4b0e8fe9476ef9b386240</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThe%2520thioredoxin%2520antioxidant%2520system%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2014%26volume%3D66%26spage%3D75%26epage%3D87%26doi%3D10.1016%2Fj.freeradbiomed.2013.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebden, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pask, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-sensitive metal beta-ketoiminato complexes showing induced single-strand DNA breaks and cancer cell death by apoptosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4940</span>– <span class="NLM_lpage">4953</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4940-4953&issue=12&author=R.+M.+Lordauthor=A.+J.+Hebdenauthor=C.+M.+Paskauthor=I.+R.+Hendersonauthor=S.+J.+Allisonauthor=S.+L.+Shepherdauthor=R.+M.+Phillipsauthor=P.+C.+McGowan&title=Hypoxia-sensitive+metal+beta-ketoiminato+complexes+showing+induced+single-strand+DNA+breaks+and+cancer+cell+death+by+apoptosis&doi=10.1021%2Facs.jmedchem.5b00455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis</span></div><div class="casAuthors">Lord, Rianne M.; Hebden, Andrew J.; Pask, Christopher M.; Henderson, Imogen R.; Allison, Simon J.; Shepherd, Samantha L.; Phillips, Roger M.; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4940-4953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of ruthenium and iridium complexes have been synthesized and characterized with 20 novel crystal structures discussed.  The library of β-ketoiminato complexes has been shown to be active against MCF-7 (human breast carcinoma), HT-29 (human colon carcinoma), A2780 (human ovarian carcinoma), and A2780cis (cisplatin-resistant human ovarian carcinoma) cell lines, with selected complexes' being more than three times as active as cisplatin against the A2780cis cell line.  Selected complexes were also tested against the noncancerous ARPE-19 (retinal pigment epithelial cells) cell line, in order to evaluate the complexes selectivity for cancer cells.  Complexes have also been shown to be highly active under hypoxic conditions, with the activities of some complexes increasing with a decrease in O2 concn.  The enzyme thioredoxin reductase is overexpressed in cancer cells, and complexes reported herein have the advantage of inhibiting this enzyme, with IC50 values measured in the nanomolar range.  The anticancer activity of these complexes was further investigated to det. whether activity is due to effects on cellular growth or cell survival.  The complexes were found to induce significant levels of cancer cell death by apoptosis with levels induced correlating closely with activity in chemosensitivity studies.  As a possible cause of cell death, the ability of the complexes to induce damage to cellular DNA was also assessed.  The complexes failed to induce double-strand DNA breaks or DNA crosslinking but induced significant levels of single-strand DNA breaks, indicating a mechanism of action different from that of cisplatin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIteWGwVzu7LVg90H21EOLACvtfcHk0lgRHly85BvXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsrg%253D&md5=23bc656d38c4b4c233a341538da2341f</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00455%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DR.%2BM.%26aulast%3DHebden%26aufirst%3DA.%2BJ.%26aulast%3DPask%26aufirst%3DC.%2BM.%26aulast%3DHenderson%26aufirst%3DI.%2BR.%26aulast%3DAllison%26aufirst%3DS.%2BJ.%26aulast%3DShepherd%26aufirst%3DS.%2BL.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DHypoxia-sensitive%2520metal%2520beta-ketoiminato%2520complexes%2520showing%2520induced%2520single-strand%2520DNA%2520breaks%2520and%2520cancer%2520cell%2520death%2520by%2520apoptosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D12%26spage%3D4940%26epage%3D4953%26doi%3D10.1021%2Facs.jmedchem.5b00455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Almodares, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crossley, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basri, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pask, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebden, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, P. C.</span></span> <span> </span><span class="NLM_article-title">Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1021/ic401529u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic401529u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlahuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=727-736&issue=2&author=Z.+Almodaresauthor=S.+J.+Lucasauthor=B.+D.+Crossleyauthor=A.+M.+Basriauthor=C.+M.+Paskauthor=A.+J.+Hebdenauthor=R.+M.+Phillipsauthor=P.+C.+McGowan&title=Rhodium%2C+iridium%2C+and+ruthenium+half-sandwich+picolinamide+complexes+as+anticancer+agents&doi=10.1021%2Fic401529u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodium, Iridium, and Ruthenium Half-Sandwich Picolinamide Complexes as Anticancer Agents</span></div><div class="casAuthors">Almodares, Zahra; Lucas, Stephanie J.; Crossley, Benjamin D.; Basri, Aida M.; Pask, Christopher M.; Hebden, Andrew J.; Phillips, Roger M.; McGowan, Patrick C.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">727-736</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel rhodium, iridium, and ruthenium half-sandwich complexes contg. (N,N)-bound picolinamide ligands have been prepd. for use as anticancer agents.  The complexes show promising cytotoxicities, with the presence, position, and no. of halides having a significant effect on the corresponding IC50 values.  One ruthenium complex was found to be more cytotoxic than cisplatin on HT-29 and MCF-7 cells after 5 days and 1 h, resp., and it remains active with MCF-7 cells even under hypoxic conditions, making it a promising candidate for in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg2mYpPJd7f7Vg90H21EOLACvtfcHk0lgRHly85BvXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlahuw%253D%253D&md5=61171d68cf74c0628572c945c8e4b337</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1021%2Fic401529u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic401529u%26sid%3Dliteratum%253Aachs%26aulast%3DAlmodares%26aufirst%3DZ.%26aulast%3DLucas%26aufirst%3DS.%2BJ.%26aulast%3DCrossley%26aufirst%3DB.%2BD.%26aulast%3DBasri%26aufirst%3DA.%2BM.%26aulast%3DPask%26aufirst%3DC.%2BM.%26aulast%3DHebden%26aufirst%3DA.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DMcGowan%26aufirst%3DP.%2BC.%26atitle%3DRhodium%252C%2520iridium%252C%2520and%2520ruthenium%2520half-sandwich%2520picolinamide%2520complexes%2520as%2520anticancer%2520agents%26jtitle%3DInorg.%2520Chem.%26date%3D2014%26volume%3D53%26issue%3D2%26spage%3D727%26epage%3D736%26doi%3D10.1021%2Fic401529u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. S.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species, antioxidants, and the mammalian thioredoxin system</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(01)00724-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2FS0891-5849%2801%2900724-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=11728801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Knu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=1287-1312&issue=11&author=J.+Nordbergauthor=E.+S.+Arner&title=Reactive+oxygen+species%2C+antioxidants%2C+and+the+mammalian+thioredoxin+system&doi=10.1016%2FS0891-5849%2801%2900724-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species, antioxidants, and the mammalian thioredoxin system</span></div><div class="casAuthors">Nordberg, Jonas; Arner, Elias S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1287-1312</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review. Reactive oxygen species (ROS) are known mediators of intracellular signaling cascades.  Excessive prodn. of ROS may, however, lead to oxidative stress, loss of cell function, and ultimately apoptosis or necrosis.  A balance between oxidant and antioxidant intracellular systems is hence vital for cell function, regulation, and adaptation to diverse growth conditions.  Thioredoxin reductase (TrxR) in conjunction with thioredoxin (Trx) is a ubiquitous oxidoreductase system with antioxidant and redox regulatory roles.  In mammals, extracellular forms of Trx also have cytokine-like effects.  Mammalian TrxR has a highly reactive active site selenocysteine residue resulting in a profound reductive capacity, reducing several substrates in addn. to Trx.  Due to the reactivity of TrxR, the enzyme is inhibited by many clin. used electrophilic compds. including nitrosoureas, aurothioglucose, platinum compds., and retinoic acid derivs.  The properties of TrxR in combination with the functions of Trx position this system at the core of cellular thiol redox control and antioxidant defense.  In this review, the authors focus on the reactions of the Trx system with ROS mols. and different cellular antioxidant enzymes.  The authors summarize the TrxR-catalyzed regeneration of several antioxidant compds., including ascorbic acid (vitamin C), selenium-contg. substances, lipoic acid, and ubiquinone (Q10).  The general cellular effects of TrxR inhibition are also discussed.  Dinitrohalobenzenes constitute a unique class of immunostimulatory TrxR inhibitors and the authors consider the immunomodulatory effects of dinitrohalobenzene compds. in view of their reactions with the Trx system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJu9k4Eie_urVg90H21EOLACvtfcHk0lhNzsBVX2z2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Knu7w%253D&md5=dad917a71af0cc525d71a04ee5b92e9e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2801%2900724-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252801%252900724-9%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DJ.%26aulast%3DArner%26aufirst%3DE.%2BS.%26atitle%3DReactive%2520oxygen%2520species%252C%2520antioxidants%252C%2520and%2520the%2520mammalian%2520thioredoxin%2520system%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2001%26volume%3D31%26issue%3D11%26spage%3D1287%26epage%3D1312%26doi%3D10.1016%2FS0891-5849%2801%2900724-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Fanjul, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Torres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiola, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizarro, A. M.</span></span> <span> </span><span class="NLM_article-title">Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">372</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.ejmech.2018.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29471123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjt12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2018&pages=372-383&author=V.+Rodriguez-Fanjulauthor=E.+Lopez-Torresauthor=M.+A.+Mendiolaauthor=A.+M.+Pizarro&title=Gold%28III%29+bis%28thiosemicarbazonate%29+compounds+in+breast+cancer+cells%3A+Cytotoxicity+and+thioredoxin+reductase+targeting&doi=10.1016%2Fj.ejmech.2018.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Gold(III) bis(thiosemicarbazonate) compounds in breast cancer cells: Cytotoxicity and thioredoxin reductase targeting</span></div><div class="casAuthors">Rodriguez-Fanjul, Vanessa; Lopez-Torres, Elena; Mendiola, M. Antonia; Pizarro, Ana Maria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">372-383</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Gold(III) compds. have received increasing attention in cancer research.  Three gold complexes of general formula [AuIIIL]Cl, where L is benzil bis(thiosemicarbazonate), compd. 1, benzil bis(4-methyl-3-thiosemicarbazonate), compd. 2, or benzil bis(4-cyclohexyl-3-thiosemicarbazonate), compd. 3, have been synthesized and fully characterized, including the x-ray crystal structure of compd. 3, confirming square-planar geometry around the gold(III) center.  Compd. 1 showed moderate cytotoxicity and accumulation in MCF7 breast cancer cells but did not inhibit thioredoxin reductase (TrxR) activity and did not induce reactive oxygen species (ROS) prodn.  Compd. 2, the least cytotoxic, is capable of modestly inhibiting TrxR activity and produced low levels of ROS in the MCF7 cell line.  The most cytotoxic compd., 3, had the highest cellular accumulation and its distribution pattern showed a clear preference for the cytosol and mitochondria of MCF7 cells.  It readily hampered intracellular TrxR activity leading to a dramatic alteration of the cellular redox state and to the induction of cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVVvtPX_hrXrVg90H21EOLACvtfcHk0lhNzsBVX2z2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjt12jt78%253D&md5=b0fb5c61224cbda5f0c78f33808eba8a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Fanjul%26aufirst%3DV.%26aulast%3DLopez-Torres%26aufirst%3DE.%26aulast%3DMendiola%26aufirst%3DM.%2BA.%26aulast%3DPizarro%26aufirst%3DA.%2BM.%26atitle%3DGold%2528III%2529%2520bis%2528thiosemicarbazonate%2529%2520compounds%2520in%2520breast%2520cancer%2520cells%253A%2520Cytotoxicity%2520and%2520thioredoxin%2520reductase%2520targeting%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D148%26spage%3D372%26epage%3D383%26doi%3D10.1016%2Fj.ejmech.2018.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>441</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1042/BJ20111451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1042%2FBJ20111451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=22187934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Wksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2012&pages=523-540&issue=2&author=J.+Leeauthor=S.+Giordanoauthor=J.+Zhang&title=Autophagy%2C+mitochondria+and+oxidative+stress%3A+cross-talk+and+redox+signalling&doi=10.1042%2FBJ20111451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling</span></div><div class="casAuthors">Lee, Jisun; Giordano, Samantha; Zhang, Jianhua</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">523-540</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen and nitrogen species change cellular responses through diverse mechanisms that are now being defined.  At low levels, they are signalling mols., and at high levels, they damage organelles, particularly the mitochondria.  Oxidative damage and the assocd. mitochondrial dysfunction may result in energy depletion, accumulation of cytotoxic mediators and cell death.  Understanding the interface between stress adaptation and cell death then is important for understanding redox biol. and disease pathogenesis.  Recent studies have found that one major sensor of redox signalling at this switch in cellular responses is autophagy.  Autophagic activities are mediated by a complex mol. machinery including more than 30 Atg (AuTophaGy-related) proteins and 50 lysosomal hydrolases.  Autophagosomes form membrane structures, sequester damaged, oxidized or dysfunctional intracellular components and organelles, and direct them to the lysosomes for degrdn.  This autophagic process is the sole known mechanism for mitochondrial turnover.  It has been speculated that dysfunction of autophagy may result in abnormal mitochondrial function and oxidative or nitrative stress.  Emerging investigations have provided new understanding of how autophagy of mitochondria (also known as mitophagy) is controlled, and the impact of autophagic dysfunction on cellular oxidative stress.  The present review highlights recent studies on redox signalling in the regulation of autophagy, in the context of the basic mechanisms of mitophagy.  Furthermore, we discuss the impact of autophagy on mitochondrial function and accumulation of reactive species.  This is particularly relevant to degenerative diseases in which oxidative stress occurs over time, and dysfunction in both the mitochondrial and autophagic pathways play a role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt-vtoOFiawLVg90H21EOLACvtfcHk0lhNzsBVX2z2gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wksw%253D%253D&md5=f2d18d9c8cef7cd3b932799d22951bb4</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1042%2FBJ20111451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20111451%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DGiordano%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAutophagy%252C%2520mitochondria%2520and%2520oxidative%2520stress%253A%2520cross-talk%2520and%2520redox%2520signalling%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D441%26issue%3D2%26spage%3D523%26epage%3D540%26doi%3D10.1042%2FBJ20111451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, M. P.</span></span> <span> </span><span class="NLM_article-title">How mitochondria produce reactive oxygen species</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>417</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1042/BJ20081386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1042%2FBJ20081386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19061483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2lt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2009&pages=1-13&issue=1&author=M.+P.+Murphy&title=How+mitochondria+produce+reactive+oxygen+species&doi=10.1042%2FBJ20081386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42bR"><div class="casContent"><span class="casTitleNuber">42b</span><div class="casTitle"><span class="NLM_cas:atitle">How mitochondria produce reactive oxygen species</span></div><div class="casAuthors">Murphy, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The prodn. of reactive O species (ROS) by mammalian mitochondria is important because it underlies oxidative damage in many pathologies and contributes to retrograde redox signalling from the organelle to the cytosol and nucleus.  Superoxide (O2•-) is the proximal mitochondrial ROS, and here the author outlines the principles that govern O2•- prodn. within the matrix of mammalian mitochondria.  The flux of O2•- is related to the concn. of potential electron donors, the local concn. of O2, and the 2nd-order rate consts. for the reactions between them.  Two modes of operation by isolated mitochondria result in significant O2•- prodn., predominantly from complex I: (1) when the mitochondria are not making ATP and consequently have a high protonmotive force (Δp) and a reduced coenzyme Q (CoQ) pool; and (2) when there is a high NADH/NAD ratio in the mitochondrial matrix.  For mitochondria that are actively synthesizing ATP, and consequently have a lower Δp and NADH/NAD ratio, the extent of O2•- prodn. is far lower.  The generation of O2•- within the mitochondrial matrix depends critically on Δp, the NADH/NAD and CoQH2/CoQ ratios, and the local O2 concn., which are all highly variable and difficult to measure in vivo.  Consequently, it is not possible to est. O2•- generation by mitochondria in vivo from O2•--prodn. rates by isolated mitochondria, and such extrapolations in the literature are misleading.  Even so, the description outlined here facilitates the understanding of factors that favor mitochondrial ROS prodn.  There is a clear need to develop better methods to measure mitochondrial O2•- and H2O2 formation in vivo, as uncertainty about these values hampers studies on the role of mitochondrial ROS in pathol. oxidative damage and redox signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp75BMAKvYJ4rVg90H21EOLACvtfcHk0li6Mb2hPuo9JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2lt77F&md5=ed7944f6fe333d32e29dd55446cd9611</span></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1042%2FBJ20081386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20081386%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26atitle%3DHow%2520mitochondria%2520produce%2520reactive%2520oxygen%2520species%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D417%26issue%3D1%26spage%3D1%26epage%3D13%26doi%3D10.1042%2FBJ20081386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youle, R. J.</span></span> <span> </span><span class="NLM_article-title">The role of mitochondria in apoptosis</span>. <i>Annu. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1146/annurev-genet-102108-134850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1146%2Fannurev-genet-102108-134850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=19659442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2qtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2009&pages=95-118&author=C.+Wangauthor=R.+J.+Youle&title=The+role+of+mitochondria+in+apoptosis&doi=10.1146%2Fannurev-genet-102108-134850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitochondria in apoptosis</span></div><div class="casAuthors">Wang, Chunxin; Youle, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-118</span>CODEN:
                <span class="NLM_cas:coden">ARVGB7</span>;
        ISSN:<span class="NLM_cas:issn">0066-4197</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Mitochondria play key roles in activating apoptosis in mammalian cells.  Bcl-2 protein family members regulate the release of proteins from the space between the mitochondrial inner and outer membrane that, once in the cytosol, activate caspase proteases that dismantle cells and signal efficient phagocytosis of cell corpses.  Here, the authors review the extensive literature on proteins released from the intermembrane space and consider genetic evidence for and against their roles in apoptosis activation.  The authors also compare and contrast apoptosis pathways in Caenorhabditis elegans, Drosophila melanogaster, and mammals that indicate major mysteries remaining to be solved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu8f1OWWH817Vg90H21EOLACvtfcHk0li6Mb2hPuo9JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2qtrjL&md5=1d30fe7bf06950278cf57a64d5a17d4a</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1146%2Fannurev-genet-102108-134850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-genet-102108-134850%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DYoule%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520role%2520of%2520mitochondria%2520in%2520apoptosis%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2009%26volume%3D43%26spage%3D95%26epage%3D118%26doi%3D10.1146%2Fannurev-genet-102108-134850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria: dynamic organelles in disease, aging, and development</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>125</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1241</span>– <span class="NLM_lpage">1252</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1016%2Fj.cell.2006.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=16814712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=1241-1252&issue=7&author=D.+C.+Chan&title=Mitochondria%3A+dynamic+organelles+in+disease%2C+aging%2C+and+development&doi=10.1016%2Fj.cell.2006.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria: dynamic organelles in disease, aging, and development</span></div><div class="casAuthors">Chan, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1241-1252</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria are the primary energy-generating system in most eukaryotic cells.  Addnl., they participate in intermediary metab., Ca2+ signaling, and apoptosis.  Given these well-established functions, it might be expected that mitochondrial dysfunction would give rise to a simple and predictable set of defects in all tissues.  However, mitochondrial dysfunction has pleiotropic effects in multicellular organisms.  Clearly, much about the basic biol. of mitochondria remains to be understood.  Here, the authors discuss recent work that suggests that the dynamics (fusion and fission) of these organelles is important in development and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHxWfcOENvbVg90H21EOLACvtfcHk0li6Mb2hPuo9JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVGrsrk%253D&md5=2de7a7341c3294779ad85b276a7d38e5</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%26atitle%3DMitochondria%253A%2520dynamic%2520organelles%2520in%2520disease%252C%2520aging%252C%2520and%2520development%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D7%26spage%3D1241%26epage%3D1252%26doi%3D10.1016%2Fj.cell.2006.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit43c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria and apoptosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">5381</span>),  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1126/science.281.5381.1309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1126%2Fscience.281.5381.1309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=9721092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVegsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1309-1312&issue=5381&author=D.+R.+Greenauthor=J.+C.+Reed&title=Mitochondria+and+apoptosis&doi=10.1126%2Fscience.281.5381.1309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43cR"><div class="casContent"><span class="casTitleNuber">43c</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria and apoptosis</span></div><div class="casAuthors">Green, Douglas R.; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">5381</span>),
    <span class="NLM_cas:pages">1309-1312</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 57 refs.  A variety of key events in apoptosis focus on mitochondria, including the release of caspase activators (such as cytochrome c), changes in electron transport, loss of mitochondrial transmembrane potential, altered cellular oxidn.-redn., and participation of pro- and antiapoptotic Bcl-2 family proteins.  The different signals that converge on mitochondria to trigger or inhibit these events and their downstream effects delineate several major pathways in physiol. cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl-fY3nIsc1rVg90H21EOLACvtfcHk0li6Mb2hPuo9JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVegsLo%253D&md5=9c60b89ccad05a8304df63f09f1b7792</span></div><a href="/servlet/linkout?suffix=cit43c&amp;dbid=16384&amp;doi=10.1126%2Fscience.281.5381.1309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.281.5381.1309%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DMitochondria%2520and%2520apoptosis%26jtitle%3DScience%26date%3D1998%26volume%3D281%26issue%3D5381%26spage%3D1309%26epage%3D1312%26doi%3D10.1126%2Fscience.281.5381.1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated iridium(III) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6942</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1039/C8DT00783G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8DT00783G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29721561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsFCmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=6942-6953&issue=20&author=L.+Heauthor=K.+N.+Wangauthor=Y.+Zhengauthor=J.+J.+Caoauthor=M.+F.+Zhangauthor=C.+P.+Tanauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Cyclometalated+iridium%28III%29+complexes+induce+mitochondria-derived+paraptotic+cell+death+and+inhibit+tumor+growth+in+vivo&doi=10.1039%2FC8DT00783G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44aR"><div class="casContent"><span class="casTitleNuber">44a</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated iridium(III) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo</span></div><div class="casAuthors">He, Liang; Wang, Kang-Nan; Zheng, Yue; Cao, Jian-Jun; Zhang, Ming-Fang; Tan, Cai-Ping; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6942-6953</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of iridium complexes as potent anticancer agents has received increasing attention in recent years.  In this study, four cyclometalated Ir(III) complexes with good photophys. properties and potent anticancer activity have been synthesized and characterized.  They are taken up by human lung adenocarcinoma A549 cells very quickly and specifically target mitochondria.  Mechanism studies reveal that one of them, namely IrM2, induces paraptosis accompanied by excessive mitochondria-derived cytoplasmic vacuoles.  Meanwhile, IrM2 affects the ubiquitin-proteasome system (UPS) and mitogen-activated protein kinase (MAPK) signaling pathways.  Furthermore, IrM2 rapidly induces a series of mitochondria-related dysfunctional events, including the loss of mitochondrial membrane potential, cellular ATP depletion, mitochondrial respiration inhibition and reactive oxygen species (ROS) elevation.  The rapid loss of mitochondrial functions, elevation of ROS and impairment of the UPS induced by IrM2 lead to the collapse of mitochondria and the subsequent cytoplasmic vacuolation before the cells are ready to start the mechanisms of apoptosis and/or autophagy.  Among the ROS, superoxide anion radicals play a crit. role in IrM2-mediated cell death.  In vivo studies reveal that IrM2 can significantly inhibit tumor growth in a mouse model.  This work gives useful insights into the design and anticancer mechanisms of new metal-based anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBXBnL1N1a2LVg90H21EOLACvtfcHk0liWEZFRVCkehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsFCmtbY%253D&md5=9b094ef5dc37671e593a26874795a5d3</span></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=10.1039%2FC8DT00783G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8DT00783G%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DK.%2BN.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DM.%2BF.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DCyclometalated%2520iridium%2528III%2529%2520complexes%2520induce%2520mitochondria-derived%2520paraptotic%2520cell%2520death%2520and%2520inhibit%2520tumor%2520growth%2520in%2520vivo%26jtitle%3DDalton%2520Trans.%26date%3D2018%26volume%3D47%26issue%3D20%26spage%3D6942%26epage%3D6953%26doi%3D10.1039%2FC8DT00783G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1039/C6SC02901A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC6SC02901A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29780446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOqsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=631-640&issue=1&author=J.+J.+Caoauthor=C.+P.+Tanauthor=M.+H.+Chenauthor=N.+Wuauthor=D.+Y.+Yaoauthor=X.+G.+Liuauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Targeting+cancer+cell+metabolism+with+mitochondria-immobilized+phosphorescent+cyclometalated+iridium%28III%29+complexes&doi=10.1039%2FC6SC02901A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44bR"><div class="casContent"><span class="casTitleNuber">44b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexes</span></div><div class="casAuthors">Cao, Jian-Jun; Tan, Cai-Ping; Chen, Mu-He; Wu, Na; Yao, De-Yang; Liu, Xing-Guo; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cancer cell metab. is reprogrammed to sustain the high metabolic demands of cell proliferation.  Recently, emerging studies have shown that mitochondrial metab. is a potential target for cancer therapy.  Herein, four mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes have been designed and synthesized.  Complexes 2 and 4, contg. reactive chloromethyl groups for mitochondrial fixation, show much higher cytotoxicity than complexes 1 and 3 without mitochondria-immobilization properties against the cancer cells screened.  Further studies show that complexes 2 and 4 induce caspase-dependent apoptosis through mitochondrial damage, cellular ATP depletion, mitochondrial respiration inhibition and reactive oxygen species (ROS) elevation.  The phosphorescence of complexes 2 and 4 can be utilized to monitor the perinuclear clustering of mitochondria in real time, which provides a reliable and convenient method for in situ monitoring of the therapeutic effect and gives hints for the investigation of anticancer mechanisms.  Genome-wide transcriptional anal. shows that complex 2 exerts its anticancer activity through metab. repression and multiple cell death signalling pathways.  Our work provides a strategy for the construction of highly effective anticancer agents targeting mitochondrial metab. through rational modification of phosphorescent iridium complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmldi39219rLVg90H21EOLACvtfcHk0liWEZFRVCkehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOqsLvK&md5=a4b85756d0d0d37b8cce2bd50a44f506</span></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=10.1039%2FC6SC02901A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02901A%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%2BJ.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DChen%26aufirst%3DM.%2BH.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DX.%2BG.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DTargeting%2520cancer%2520cell%2520metabolism%2520with%2520mitochondria-immobilized%2520phosphorescent%2520cyclometalated%2520iridium%2528III%2529%2520complexes%26jtitle%3DChem.%2520Sci.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D631%26epage%3D640%26doi%3D10.1039%2FC6SC02901A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit44c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, H.</span></span> <span> </span><span class="NLM_article-title">Oncosis-inducing cyclometalated iridium(III) complexes</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">5183</span>– <span class="NLM_lpage">5190</span>, <span class="refDoi"> DOI: 10.1039/C8SC01142G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1039%2FC8SC01142G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=29997872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosl2lsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=5183-5190&issue=23&author=R.+Guanauthor=Y.+Chenauthor=L.+Zengauthor=T.+W.+Reesauthor=C.+Jinauthor=J.+Huangauthor=Z.+S.+Chenauthor=L.+Jiauthor=H.+Chao&title=Oncosis-inducing+cyclometalated+iridium%28III%29+complexes&doi=10.1039%2FC8SC01142G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44cR"><div class="casContent"><span class="casTitleNuber">44c</span><div class="casTitle"><span class="NLM_cas:atitle">Oncosis-inducing cyclometalated iridium(III) complexes</span></div><div class="casAuthors">Guan, Ruilin; Chen, Yu; Zeng, Leli; Rees, Thomas W.; Jin, Chengzhi; Huang, Juanjuan; Chen, Zhe-Sheng; Ji, Liangnian; Chao, Hui</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5183-5190</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Oncosis is a non-apoptotic form of programmed cell death (PCD), which differs from apoptosis in both morphol. changes and inner pathways, and might hold the key to defeating a major obstacle in cancer therapy - drug-resistance, which is often a result of the intrinsic apoptosis resistance of tumors.  However, despite the fact that the term "oncosis" was coined and used much earlier than apoptosis, little effort has been made to discover new drugs which can initiate this form of cell death, in comparison to drugs inducing apoptosis or any other type of PCD.  So herein, we present the synthesis of a series of mitochondria-targeting cyclometalated Ir(III) complexes, which activated the oncosis-specific protein porimin and calpain in cisplatin-resistant cell line A549R, and detd. their cytotoxicity against a wide range of drug-resistant cancer types.  To the best of our knowledge, these complexes are the very first metallo-components to induce oncosis in drug-resistant cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU0FFH72dklLVg90H21EOLACvtfcHk0lif_nCyZ_jY_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosl2lsrs%253D&md5=66eb866af7d165a6887ac64bd2b894c9</span></div><a href="/servlet/linkout?suffix=cit44c&amp;dbid=16384&amp;doi=10.1039%2FC8SC01142G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8SC01142G%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DRees%26aufirst%3DT.%2BW.%26aulast%3DJin%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%2BS.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DH.%26atitle%3DOncosis-inducing%2520cyclometalated%2520iridium%2528III%2529%2520complexes%26jtitle%3DChem.%2520Sci.%26date%3D2018%26volume%3D9%26issue%3D23%26spage%3D5183%26epage%3D5190%26doi%3D10.1039%2FC8SC01142G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millett, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habtemariam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Canelon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadler, P. J.</span></span> <span> </span><span class="NLM_article-title">Contrasting anticancer activity of half-sandwich iridium(III) complexes bearing functionally ddiverse 2-phenylpyridine ligands</span>. <i>Organometallics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2694</span>, <span class="refDoi"> DOI: 10.1021/acs.organomet.5b00097</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.organomet.5b00097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1Wltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=2683-2694&issue=11&author=A.+J.+Millettauthor=A.+Habtemariamauthor=I.+Romero-Canelonauthor=G.+J.+Clarksonauthor=P.+J.+Sadler&title=Contrasting+anticancer+activity+of+half-sandwich+iridium%28III%29+complexes+bearing+functionally+ddiverse+2-phenylpyridine+ligands&doi=10.1021%2Facs.organomet.5b00097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands</span></div><div class="casAuthors">Millett, Adam J.; Habtemariam, Abraha; Romero-Canelon, Isolda; Clarkson, Guy J.; Sadler, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2683-2694</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the synthesis, characterization, and antiproliferative activity of 15 iridium(III) half-sandwich complexes of the type [(η5-Cp*)Ir(2-(R'-phenyl)-R-pyridine)Cl] bearing either an electron-donating (-OH, -CH2OH, -CH3) or electron-withdrawing (-F, -CHO, -NO2) group at various positions on the 2-phenylpyridine (2-PhPy) chelating ligand giving rise to six sets of structural isomers.  The X-ray crystal structures of [(η5-Cp*)Ir(2-(2'-fluorophenyl)pyridine)Cl] (1) and [(η5-Cp*)Ir(2-(4'-fluorophenyl)pyridine)Cl] (2) exhibit the expected "piano-stool" configuration.  DFT calcns. showed that substituents caused only localized effects on the electrostatic potential surface of the chelating 2-PhPy ligand of the complexes.  Hydrolysis of all complexes is rapid, but readily reversed by addn. of NaCl.  The complexes show preferential binding to 9-ethylguanine over 9-methyladenine and are active catalysts for the oxidn. of NADH to NAD+.  Antiproliferative activity expts. in A2780 ovarian, MCF-7 breast, A549 lung, and HCT116 colon cancer cell lines showed IC50 values ranging from 1 to 89 μM, with the most potent complex, [(η5-Cp*)Ir(2-(2'-methylphenyl)pyridine)Cl] (13) (A2780 IC50 = 1.18 μM), being 10× more active than the parent, [(η5-Cp*)Ir(2-phenylpyridine)Cl], and 2× more active than [(η5-CpxPh)Ir(2-phenylpyridine)Cl].  Intriguingly, contrasting biol. activities are obsd. between structural isomers despite exhibiting similar chem. reactivity.  For pairs of structural isomers both the nature and position of the functional group can affect the hydrophobicity of the complex.  An increase in hydrophobicity resulted in enhanced cellular-iridium accumulation in A2780 ovarian cells, which generally gave rise to an increase in potency.  The structural isomers [(η5-Cp*)Ir(2-(4'-fluorophenyl)pyridine)Cl] (2) and [(η5-Cp*)Ir(2-phenyl-5-fluoropyridine)Cl] (4) preferentially localized in the cytosol > membrane and particulate > nucleus > cytoskeleton.  This work highlights the strong dependence of biol. behavior on the nature and position of the substituent on the chelating ligand and shows how this class of organometallic anticancer complexes can be fine-tuned to increase their potency without using extended cyclopentadienyl systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGNSGHEsAXLVg90H21EOLACvtfcHk0lif_nCyZ_jY_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1Wltbs%253D&md5=3257bbc7c2587b1338d3e960df64f4be</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.organomet.5b00097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.organomet.5b00097%26sid%3Dliteratum%253Aachs%26aulast%3DMillett%26aufirst%3DA.%2BJ.%26aulast%3DHabtemariam%26aufirst%3DA.%26aulast%3DRomero-Canelon%26aufirst%3DI.%26aulast%3DClarkson%26aufirst%3DG.%2BJ.%26aulast%3DSadler%26aufirst%3DP.%2BJ.%26atitle%3DContrasting%2520anticancer%2520activity%2520of%2520half-sandwich%2520iridium%2528III%2529%2520complexes%2520bearing%2520functionally%2520ddiverse%25202-phenylpyridine%2520ligands%26jtitle%3DOrganometallics%26date%3D2015%26volume%3D34%26issue%3D11%26spage%3D2683%26epage%3D2694%26doi%3D10.1021%2Facs.organomet.5b00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vichai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirtikara, K.</span></span> <span> </span><span class="NLM_article-title">Sulforhodamine B colorimetric assay for cytotoxicity screening</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1116</span>, <span class="refDoi"> DOI: 10.1038/nprot.2006.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1038%2Fnprot.2006.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=17406391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1112-1116&issue=3&author=V.+Vichaiauthor=K.+Kirtikara&title=Sulforhodamine+B+colorimetric+assay+for+cytotoxicity+screening&doi=10.1038%2Fnprot.2006.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Sulforhodamine B colorimetric assay for cytotoxicity screening</span></div><div class="casAuthors">Vichai, Vanicha; Kirtikara, Kanyawim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1112-1116</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The sulforhodamine B (SRB) assay is used for cell d. detn., based on the measurement of cellular protein content.  The method described here was optimized for the toxicity screening of compds. to adherent cells in a 96-well format.  After an incubation period, cell monolayers are fixed with 10% (wt/vol) trichloroacetic acid and stained for 30 min, after which the excess dye is removed by washing repeatedly with 1% (vol/vol) acetic acid.  The protein-bound dye is dissolved in 10 mM Tris base soln. for OD detn. at 510 nm using a microplate reader.  The results are linear over a 20-fold range of cell nos. and the sensitivity is comparable to those of fluorometric methods.  The method not only allows a large no. of samples to be tested within a few days, but also requires only simple equipment and inexpensive reagents.  The SRB assay is therefore an efficient and highly cost-effective method for screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGZ8pao808l7Vg90H21EOLACvtfcHk0lif_nCyZ_jY_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOitL3O&md5=7173035a1f9eb3f02dd7f1a947bca659</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.179%26sid%3Dliteratum%253Aachs%26aulast%3DVichai%26aufirst%3DV.%26aulast%3DKirtikara%26aufirst%3DK.%26atitle%3DSulforhodamine%2520B%2520colorimetric%2520assay%2520for%2520cytotoxicity%2520screening%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26issue%3D3%26spage%3D1112%26epage%3D1116%26doi%3D10.1038%2Fnprot.2006.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCollum, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, R. F.</span></span> <span> </span><span class="NLM_article-title">Determination of thioredoxin reductase activity in rat liver supernatant</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>253</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1006/abio.1997.2373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1006%2Fabio.1997.2373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=9356150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaK2sXnsVegt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1997&pages=123-125&issue=1&author=K.+E.+Hillauthor=G.+W.+McCollumauthor=R.+F.+Burk&title=Determination+of+thioredoxin+reductase+activity+in+rat+liver+supernatant&doi=10.1006%2Fabio.1997.2373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of thioredoxin reductase activity in rat liver supernatant</span></div><div class="casAuthors">Hill, Kristina E.; McCollum, Gary W.; Burk, Raymond F.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">253</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">123-125</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A simple assay based on the direct redn. of 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) by thioredoxin reductase has been used to qual. measure the enzyme activity during purifn.  However, it was not suitable for quant. detn. of thioredoxin reductase because it did not correct for DTNB redn. by other enzymes or endogenous thiols in tissue.  Here, the DTNB-based assay is modified to allow for correction of the non-specific DTNB redn.  Thioredoxin reductase, like most other selenoenzymes, is sensitive to inhibition by gold.  Thus, measurement of the enzyme activity in the absence and presence of gold thioglucose allows correction for non-thioredoxin reductase-dependent DTNB redn.  Thioredoxin reductase levels were detd. in liver supernatant of control and selenium-deficient rats.  Selenium deficiency caused a decrease in liver thioredoxin reductase activity to 10% of that in control liver, a result that is comparable to that obtained by the insulin-based assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqYiYZFe9mbVg90H21EOLACvtfcHk0lif_nCyZ_jY_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsVegt74%253D&md5=748b9ea85d71a331ac70296f9967f7d1</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1006%2Fabio.1997.2373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1997.2373%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DK.%2BE.%26aulast%3DMcCollum%26aufirst%3DG.%2BW.%26aulast%3DBurk%26aufirst%3DR.%2BF.%26atitle%3DDetermination%2520of%2520thioredoxin%2520reductase%2520activity%2520in%2520rat%2520liver%2520supernatant%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D253%26issue%3D1%26spage%3D123%26epage%3D125%26doi%3D10.1006%2Fabio.1997.2373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span>; <span class="NLM_string-name">Bjornstedt, M.</span></span>, <span> </span><span class="NLM_article-title">Thioredoxin and Thioredoxin Reductase</span>. In  <i>Methods in Enzymology</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_year">1995</span>; Vol.  <span class="NLM_volume">252</span>, pp  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">208</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=199-208&author=A.+Holmgren&author=M.+Bjornstedt&title=Methods+in+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DThioredoxin%2520and%2520Thioredoxin%2520Reductase%26btitle%3DMethods%2520in%2520Enzymology%26pub%3DAcademic%2520Press%26date%3D1995%26volume%3D252%26spage%3D199%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mahalingaiah, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K. P.</span></span> <span> </span><span class="NLM_article-title">Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>), <span class="NLM_elocation-id">e87371</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0087371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=10.1371%2Fjournal.pone.0087371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=24489904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVWlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&issue=1&author=P.+K.+Mahalingaiahauthor=K.+P.+Singh&title=Chronic+oxidative+stress+increases+growth+and+tumorigenic+potential+of+MCF-7+breast+cancer+cells&doi=10.1371%2Fjournal.pone.0087371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells</span></div><div class="casAuthors">Mahalingaiah, Prathap Kumar S.; Singh, Kamaleshwar P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e87371/1-e87371/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Accumulating evidence suggests that exposures to elevated levels of either endogenous estrogen or environmental estrogenic chems. are assocd. with breast cancer development and progression.  These natural or synthetic estrogens are known to produce reactive oxygen species (ROS) and increased ROS has been implicated in both cellular apoptosis and carcinogenesis.  Though there are several studies on direct involvement of ROS in cellular apoptosis using short-term exposure model, there is no exptl. evidence to directly implicate chronic exposure to ROS in increased growth and tumorigenicity of breast cancer cells.  Therefore, the objective of this study was to evaluate the effects of chronic oxidative stress on growth, survival and tumorigenic potential of MCF-7 breast cancer cells.  MCF-7 cells were exposed to exogenous hydrogen peroxide (H2O2) as a source of ROS at doses of 25 μM and 250 μM for acute (24 h) and chronic period (3 mo) and their effects on cell growth/survival and tumorigenic potential were evaluated.  The results of cell count, MTT and cell cycle anal. showed that while acute exposure inhibits the growth of MCF-7 cells in a dose-dependent manner, the chronic exposure to H2O2-induced ROS leads to increased cell growth and survival of MCF-7 cells.  This was further confirmed by gene expression anal. of cell cycle and cell survival related genes.  Significant increase in no. of soft agar colonies, up-regulation of pro-metastatic genes VEGF, WNT1 and CD44, whereas down-regulation of anti-metastatic gene E-Cadherin in H2O2 treated MCF-7 cells obsd. in this study further suggests that persistent exposure to oxidative stress increases tumorigenic and metastatic potential of MCF-7 cells.  Since many chemotherapeutic drugs are known to induce their cytotoxicity by increasing ROS levels, the results of this study are also highly significant in understanding the mechanism for adaptation to ROS-induced toxicity leading to acquired chemotherapeutic resistance in breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIR1-W7BT1r7Vg90H21EOLACvtfcHk0ljKZCNgSuQngA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVWlurk%253D&md5=20555f0961c5290619ec209306705187</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0087371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0087371%26sid%3Dliteratum%253Aachs%26aulast%3DMahalingaiah%26aufirst%3DP.%2BK.%26aulast%3DSingh%26aufirst%3DK.%2BP.%26atitle%3DChronic%2520oxidative%2520stress%2520increases%2520growth%2520and%2520tumorigenic%2520potential%2520of%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26issue%3D1%26doi%3D10.1371%2Fjournal.pone.0087371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">LeBel, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ischiropoulos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondy, S. C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1021/tx00026a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx00026a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;key=1%3ACAS%3A528%3ADyaK38XhsVGmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1992&pages=227-231&issue=2&author=C.+P.+LeBelauthor=H.+Ischiropoulosauthor=S.+C.+Bondy&title=Evaluation+of+the+probe+2%E2%80%B2%2C7%E2%80%B2-dichlorofluorescin+as+an+indicator+of+reactive+oxygen+species+formation+and+oxidative+stress&doi=10.1021%2Ftx00026a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48bR"><div class="casContent"><span class="casTitleNuber">48b</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress</span></div><div class="casAuthors">LeBel, Carl P.; Ischiropoulos, Harry; Bondy, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-31</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    </div><div class="casAbstract">The use of dichlorofluorescin (DCFH) as a measure of reactive oxygen species was studied in aq. media.  Hydrogen peroxide oxidized DCFH to fluorescent dichlorofluorescein (DCF), and the oxidn. was amplified by the addn. of ferrous iron.  Hydrogen peroxide-induced DCF formation in the presence of ferrous iron was completely inhibited by deferoxamine and partially inhibited by EDTA, but was augmented by diethylenetriaminepentaacetic acid.  Iron peroxide-induced oxidn. of DCFH was partially inhibited by catalase but not by horseradish peroxidase.  Nonchelated iron peroxide oxidn. of DCFH was partially inhibited by several hydroxyl radical scavengers, but independent of the scavenger concn., and this suggests that free hydroxyl radical is not involved in the oxidn. of DCFH in this system.  Superoxide anion did not directly oxidize DCFH.  Data suggest that H2O2-Fe2+-derived oxidant is mainly responsible for the nonenzymic oxidn. of DCFH.  In addn., peroxidase alone and oxidants formed during the redn. of H2O2 by peroxidase oxidize DCFH.  Since DCFH oxidn. may be derived from several reactive intermediates, interpretation of specific reactive oxygen species involved in biol. systems should be approached with caution.  However, DCFH remains an attractive probe as an overall index of oxidative stress in toxicol. phenomena.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UcTWO9uvprVg90H21EOLACvtfcHk0ljKZCNgSuQngA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVGmtr8%253D&md5=6a1b478d7cde37d20e8ff349f6f8f186</span></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1021%2Ftx00026a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx00026a012%26sid%3Dliteratum%253Aachs%26aulast%3DLeBel%26aufirst%3DC.%2BP.%26aulast%3DIschiropoulos%26aufirst%3DH.%26aulast%3DBondy%26aufirst%3DS.%2BC.%26atitle%3DEvaluation%2520of%2520the%2520probe%25202%25E2%2580%25B2%252C7%25E2%2580%25B2-dichlorofluorescin%2520as%2520an%2520indicator%2520of%2520reactive%2520oxygen%2520species%2520formation%2520and%2520oxidative%2520stress%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1992%26volume%3D5%26issue%3D2%26spage%3D227%26epage%3D231%26doi%3D10.1021%2Ftx00026a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i51"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24435"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02000?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02000</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra of all complexes synthesized in this work; chemical reactivity of the iridium complexes in DMSO, water, and DMF; stability in aqueous solution and saline; aqueous solubility of complexes <b>1</b>–<b>6</b>; X-ray crystallographic data of complexes <b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, and <b>6</b>; IC<sub>50</sub> values in several cell lines, inhibition of TrxR, and effect of mitochondrial membrane potential of the iridium complexes in MCF7 cells (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>1</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_002.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>2</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_003.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>4</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_004.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>5</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_005.cif">CIF</a>)</p></li><li><p class="inline">Crystallographic data for complex <b>6</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_006.cif">CIF</a>)</p></li><li><p class="inline">Molecular formula strings and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_007.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_001.pdf">jm9b02000_si_001.pdf (3.17 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_002.cif">jm9b02000_si_002.cif (1.16 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_003.cif">jm9b02000_si_003.cif (938.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_004.cif">jm9b02000_si_004.cif (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_005.cif">jm9b02000_si_005.cif (2.9 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_006.cif">jm9b02000_si_006.cif (794.28 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02000/suppl_file/jm9b02000_si_007.csv">jm9b02000_si_007.csv (1.94 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02000&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-8%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02000%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02000" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a680c1f0e247f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
